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 Abstract 
 
Three epitope-mapping procedures were used to identify B-cell epitopes on 
Betanodaviruses: neutralisation escape mutant sequence analysis, phage display, and pepscan. 
Betanodaviruses have emerged as major pathogens of marine fish. These viruses are the 
aetiological agents of a disease referred to as viral nervous necrosis (VNN), which affects 
many species of fish that are economically valuable to the aquaculture industry. The 
identification of betanodavirus B-cell epitopes will facilitate the rational development of 
vaccines to counter VNN.  
A panel of mouse monoclonal antibodies (MAbs) was produced using hybridoma 
methodology for use in each of the epitope mapping procedures. These antibodies were 
characterised in Western blotting, ELISA, and virus neutralisation tests. Rabbit polyclonal 
sera, and serum samples from nodavirus-infected fish were also used for pepscan analyses. 
Attempts to produce betanodavirus neutralisation escape mutants, using plaque assay 
or limiting dilution based methods, were not successful. 
Two phage libraries expressing random peptides of seven (Ph.D.7™) or twelve 
(Ph.D.12™) amino acids in length as fusions to the coat protein were used to identify the 
ligands recognised by MAbs directed against betanodavirus. Neither of these phage libraries 
yielded conclusive results. Phage clones containing tandem inserts were obtained after MAb 
selection from library Ph.D.7™. Extensive screening and nucleotide sequence analysis of 
MAb-selected clones from library Ph.D.12™) failed to yield a consensus sequence.  
Pepscan analyses were performed using the recently developed suspension array 
technology (SAT). This was used to map the recognition sites of MAbs and serum samples 
onto a panel of overlapping synthetic peptides (12mers) that mimicked the betanodavirus coat 
protein. The results of pepscan analyses required careful interpretation due to the binding of 
antibodies and serum samples to multiple peptides. However, three regions of the nodavirus 
coat protein were identified as containing B-cell epitopes: amino acids 1-50, 141-162, and 
181-212. These results are discussed in relation to previous studies of immune responses to 
betanodaviruses, and to the future development of betanodavirus vaccines and diagnostic 
reagents. 
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SPDV Salmon Pancreatic Disease Virus 
SNP Single Nucleotide Polymorphism 
SNN-1 Striped Snakehead (Ophicephalus  striatus ) cell line 
SVE Sea bass Viral Encephalitis 
TPNNV  Tiger Puffer Nervous Necrosis Virus 
TRO Total Residual Oxidants 
UV Ultra-Violet  
VER Viral Encephalopathy and Retinopathy 
VHSV Viral Hemorrhagic Septicaemia Virus 
VNN Viral Nervous Necrosis 
YGNNV Yellow Grouper Nervous Necrosis Nodavirus  
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Chapter 1 - Introduction 
 
1.1 -  Betanodavirus  
1.1.1 - History of the disease  
 
 
Within the last 20 years a disease with distinct pathological features comprising 
vacuolation of the encephalon and retina has affected the marine fish-farming industry. The 
aetiologic agent of this disease has been identified as a virus belonging to the Nodaviridae 
family. Nodavirus infection is now recognised as a major problem for the marine aquaculture 
industry in many parts of the world. Nodavirus-associated disease can cause extensive 
mortalities (up to 100 % in larvae) in affected stocks. 
Nodavirus disease in marine fish is neuropathogenic and for this reason it was first 
named SVE (Sea bass Viral Encephalitis) by Bellance and Gallet de Saint-Aurin (1988). Since 
then it has been referred to as Viral Nervous Necrosis (VNN) (Yoshikoshi and Inoue, 1990), 
Viral Encephalopathy and Retinopathy (VER) (Munday et al. 1992), and Fish Viral 
Encephalitis (FVE) (Comps et al. 1994). The disease is officially denominated Viral 
Encephalopathy and Retinopathy by the OIE (Office International des Ėpizooties), based on 
the histopathological signs that accompany infection (Munday et al. 2002). Tanaka et al.  
(2004) suggested that the disease should be referred to as Viral Encephalitis and Retinitis 
based on histopathological studies. 
The first report of fish nodaviruses was made in Martinique where the production of 
sea-bass (Dicentrarchus labrax) alevins was completely halted by this virus in 1985 (Bellance 
and Gallet de Saint-Aurin, 1988, Breuil et al. 1991). Since then further disease outbreaks with 
similar symptoms have been reported with global distribution. More than 38 species 
belonging to 21 families of ten different orders have been affected (Table 1.1).  
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Table 1.1 - Fish species in which nodavirus infection has been reported 
 
 
 
 
 
 
Order Family Species Common name Country Reference 
Anguilliformes Anguillidae Anguilla anguilla L. European eel Taiwan Lai et al.  (2001b) 
Acipenseriformes   Acipenseridae Acipenser gueldenstaedtii Russian sturgeon Greece Athanassopoulou et al.  (2004) 
Cyprinodontiformes Poeciliidae Poecilia reticulata Guppy Singapore Hegde et al.  (2003) 
Gadiformes   Gadidae 
Gadus morhua 
 
Gadus macrocephalus 
Melanogrammus aeglefinus 
Atlantic cod 
 
Pacific cod 
Haddock 
United Kingdom 
Canada 
Japan 
 
 
Canada 
Starkey et al.  (2001) 
Johnson et al.  (2002) 
Arimoto et al.  (1993) 
Gagné et al.  (2004) 
Mugiliformes Mugilidae Mugil cephalus Black mullet Israel Ucko et al.  (2004) 
Perciformes   Carangidae   
Pseudocaranx dentex 
 
Seriola dumerili 
Trachinotus falcanus 
Striped jack 
 
Amberjack 
Yellow-wax pompano 
 
Japan 
 
 
Taiwan 
Mori et al.  (1992) 
Arimoto et al.  (1993) 
Nishizawa et al.  (1997) 
Lai et al.  (2001b) 
 Centropomidae Lates calcarifer Bloch Barramundi 
Australia 
Singapore 
Tahiti 
 
 
Israel 
Glazebrook et al.  (1990) 
Chew-Lim et al.  (1998) 
Renault et al.  (1991) 
Ucko et al.  (2004) 
 Lutjanidae Lutjarnus erythropterus  Taiwan Lai et al.  (2001b) 
 Moronidae Dicentrarchus labrax L. European sea bass 
Martinique 
France 
Italy 
 Israel 
Bellance and Gallet de Saint-Aurin (1988) 
Breuil et al.  (1991) 
Ucko et al.  (2004) 
 Rachycentridae Rachycentron canadum L. Cobia  Taiwan Lai et al.  (2001b) 
 Sciaenidae 
Umbrina cirrosa 
Atractoscion nobilis 
Sciaenops ocellatus 
Shi drum 
White sea bass 
Red drum 
 
Japan 
U.S.A 
Korea 
Israel 
Comps et al.  (1996) 
Nishizawa et al.  (1997) 
Curtis et al.  (2001) 
Oh et al.  (2002) 
Ucko et al.  (2004) 
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Order Family Species Common name Country Reference 
Perciformes  Serranidae 
Chromileptes altivelis 
Epinephelus 
    akaara 
 
    aeneus 
    awoara 
    fuscoguttatus 
    lanceolatus 
    malabaricus 
    moara 
    septemfasciatus 
    tauvina 
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Table 1.1 (continued)- Fish species in which nodavirus infection has been reported 
 
 
 
Humpback grouper 
 
Redspotted grouper 
 
White grouper 
Yellow grouper 
Black-spotted grouper 
Dragon grouper 
Brown-spotted grouper 
Kelp grouper 
Sevenband grouper 
Greasy grouper 
Indonesia 
 
Japan 
 
Israel 
Taiwan 
Taiwan 
Taiwan 
Thailand 
Japan 
Japan 
Singapore 
Zafran et al.  (2000) 
 
Mori et al.  (1991) 
Chi et al.  (1997) 
Ucko et al.  (2004) 
Lai et al.  (2001a) 
Chi et al.  (1997) 
Lin et al.  (2001) 
Danayadol and Direkbusarakom (1995) 
Nakai et al.  (1994) 
Fukuda et al.  (1996) 
Chua et al.  (1995) 
 Sparidae   Pagrus major Red seabream Japan Nishizawa et al.  (1997) 
 Oplegnathidae Oplegnathus fascinatus Japonese parrotfish Japan Yoshikoshi and Inoue (1990) 
Pleuronectiformes Paralichthyidae  Paralichthys olivaceus Japanese flounder Japan Nguyen et al.  (1994) 
 Pleuronectidae   
Hippoglossus hippoglossus 
 
Pleuronectes americanus 
Verasper moseri 
Atlantic halibut 
 
Winter flounder 
Barfin flounder 
Norway 
United Kingdom 
Canada 
Japan 
Grotmol et al.  (1997) 
Starkey et al.  (2000) 
Barker et al.  (2002) 
Nishizawa et al.  (1997) 
 Scophthalmidae  Scophthalmus maximus Turbot Denmark Bloch et al.  (1991) 
 Soleidae Solea vulgaris/Solea solea Dover sole United Kingdom Starkey et al.  (2001) 
Scorpaeniformes   Platycephalidae Platycephalus indicus Bartail flathead Japan Song et al.  (1997) 
Siluriformes Siluridae Parasilurus asotus Chinese catfish Taiwan Chi et al.  (2003) 
Tetraodontiformes Triodontidae Takifugu rubripes Tiger puffer Japan Nakai et al.  (1994) 
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Until very recently all fish nodavirus disease outbreaks were confined to marine 
species. The first indication that nodaviruses might infect freshwater fish was the occurrence 
of VER in barramundi, but this species is catadromous and part of the life cycle is in sea 
water. In 2000 the first occurrence of these viruses in a fresh water ornamental fish, guppy 
(Poecilia reticulata) was detected in Singapore (Hegde et al. 2003). In Greece two freshwater 
outbreaks of nodavirus disease have been described. One in sturgeon, (Acipenser 
gueldestaedi) and another in European sea bass (Dicentrarchus labrax) under production in 
freshwater (Athanassopoulou et al. 2003, Athanassopoulou et al. 2004). Mortalities over 70 % 
caused by VNN in European eel (Anguilla anguilla) were observed in fish-farms of Taiwan 
(Chi et al.  2003). 
The confirmation of nodavirus as the aetiological agent of VER in fulfilment of 
Koch’s postulates has been performed by experimental infection of several fish species 
including: Dicentrarchus labrax (Péducasse et al.  1999c, Skliris and Richards, 1999a), 
Epinephelus akaara (Mori et al. 1991), Epinephelus malabaricus (Boonyaratpalin et al.  
1996), Epinephelus septemfasciatus (Tanaka et al.  1998), Pseudocaranx dentex (Arimoto et 
al. 1993, Nguyen et al. 1996), Anarhicas minor (Amundsen and Sommer, 1999, Johansen et 
al.  2003, Sommer et al. 2004) Scophthalmus maximus (Húsgarð et al. 1999) and 
Hippoglossus hippoglossus (Grotmol et al. 1999).  
 
 
1.1.2 - Taxonomy  
 
Based on virion size and genome characteristics Mori et al. (1992) classified the virus 
isolated from striped jack as a member of the Nodaviridae family. The virus was designated 
Striped Jack Nervous Necrosis Virus (SJNNV). Comps et al. (1994), characterised a virus 
isolated from outbreaks of VNN in Dicentrarchus labrax and Lates calcarifer and obtained 
results similar to those reported by Mori et al. (1992). Comps et al. (1994) also concluded that 
the aetiological agent of VNN in these species was a nodavirus, and named the causative 
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agents Fish Encephalitis Viruses (FEV) to distinguish them from the previously described 
insect nodaviruses. 
Viruses with similar properties have been isolated from globally distributed outbreaks 
of VNN. In each instance, the virus particles isolated from diseased fish have exhibited 
physical and chemical properties characteristic of nodaviruses.  
The Nodaviridae were first identified from insects (Garzon and Charpentier, 1992), 
then from fish. More recently a nodavirus has been identified in a crustacean (Arcier et al.  
1999). 
Recently the viruses isolated from cases of VNN have been classified as belonging to 
the genus Betanodavirus within the Nodaviridae family to distinguish them from the insect 
nodavirus, which are classified as belonging to the genus Alphanodavirus (Ball et al. 2000). 
The lack of a permissive cell culture system for fish nodaviruses delayed the 
characterisation of the aetiological agent of VNN. The first studies described the agent of 
VNN as a "picorna-like virus" (Glazebrook et al. 1990, Breuil et al. 1991). 
 
 
1.1.3 - Characterisation of the virus 
 
Breuil et al. (1991) characterised virus particles isolated from European sea bass 
(Dicentrarchus labrax) larvae and juveniles as having a typical icosahedral shape and a 
diameter of 23 nm as determined by electron microscopy. After purification in CsCl gradients 
virus particles showed a diameter of 26 nm from side to side, 29 nm from point to point, and a 
buoyant density of 1.30 g per cm3 (Breuil et al. 1991). 
The nucleic acid and the structural proteins of striped jack nervous necrosis virus 
(SJNNV) were characterised by Mori et al. (1992). This study revealed that the virus 
associated with VNN consisted of non-enveloped particles about 25 nm in diameter, with two 
single-stranded positive-sense RNA molecules with molecular weights of 1.01 × 106 Da 
(RNA1) and 0.49 × 106 Da (RNA2), lacking a poly(A) sequence at the 3’ terminus. The same 
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authors identified two major polypeptides, one of approximately 100 kDa encoded by RNA1, 
and another of 42 kDa encoded by RNA2, which was deduced to represent the coat protein 
gene. Barramundi NNV, European sea bass NNV (DlNNV) and grouper NNV have the same 
major RNA2 polypeptide (42 kDa) (Comps et al. 1994, Hegde et al. 2002). 
The RNA1 genome segment encodes "protein A", which is the viral component of the 
RNA-dependent RNA polymerase (RdRp) (Nagai and Nishizawa, 1999). According to these 
authors, the nucleotide sequence of SJNNV RNA1 comprises 3081 bases and contains a 
single Open Reading Frame (ORF) encoding a protein of 983 aa (amino acids) of Mr 110 
kDa. However, the RNA1 segment from a nodavirus isolated from Atlantic cod, contains 
3100 nucleotides (nt), with one ORF between nt 79-3021 that encodes a 981 aa polypeptide 
(Sommerset and Nerland, 2004). In contrast, the greasy grouper NNV (GGNNV) RNA1 is 
3103 nt in length with one ORF (nt 79-3027) encoding a protein of 982 aa (Tan et al. 2001).  
Several studies of the RNA2 have indicated that this segment varies in length 
according to the virus strain analysed. The longest RNA2 was identified in GGNNV, 1433 nt, 
whereas SJNNV contained an RNA2 segment of 1410 nt, and that from SBNNV was only 
1406 nt long. Both GGNNV and SBNNV RNA2s encode coat proteins of the same size (338 
aa), while that from SJNNV is 2 amino acids longer. However all fish nodavirus coat proteins 
studied are of the same molecular weight (37 kDa) (Nishizawa et al. 1995a, Delsert et al. 
1997a, Tan et al. 2001). 
A nodavirus obtained from the freshwater fish species guppy (Poecilia reticulata) 
contained a shorter RNA2 (1367 base pairs) and the ORF coded for a protein of the same size 
as that found in sea water species – 338 amino acids (Hegde et al. 2003). 
The longer sequence length described for both GGNNV RNAs by Tan et al. (2001) 
have been attributed to the use of a different sequencing methodology involving  5’RACE. 
In alphanodavirus a subgenomic RNA3 is produced during RNA replication from the 
3’ terminus of RNA1. This transcript encodes one or two small proteins (B1 and B2) with 
unknown functions (Schneemann et al. 1998). A RNA3 transcript from a betanodavirus of 
approximately 400 base pairs was reported for the first time by Delsert et al. (1997b). Tan et 
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al. (2001) suggested that the RNA1 of GGNNV encoded two proteins designated B1 (111 aa) 
and B2 (75 aa). The B1 protein was translated in the same reading frame as the replicase 
protein A, whereas protein B2 was translated in the +1 reading frame and overlapped the C 
terminus of protein A. The amino acid sequence of Atlantic halibut RNA3 corresponded to nt 
2730-3100 of the RNA1 Atlantic halibut sequence (Sommerset and Nerland, 2004). The 
amino acid sequence indicated that only the B2 protein was expressed during virus 
replication. In flock house virus (FHV) the B2 protein has been identified as a potent RNA 
silencing inhibitor (Li et al. 2002). 
Protein α is the precursor of the capsid protein and is important for viral assembly 
(Guo et al. 2003). In alphanodaviruses, protein α is autocatalytically cleaved to form the 
mature coat protein subunits β and γ (Gallagher and Rueckert, 1988). With betanodaviruses 
this doublet formation does not occur as a result of autocatalysis, but instead results from the 
formation of an intramolecular disulfide bond between cystines 187 and 201 (Krondiris and 
Sideris, 2002). 
Analysis of the RNA2 genome segment from Atlantic halibut indicates that the 
deduced amino acid sequence contains two stretches of arginine residues that are found in all 
nodaviruses and are assumed to participate in the binding of the RNA genome to the internal 
capsid wall (Grotmol et al.  2000). An aspartic acid residue is present at position 75 that is 
also common to all nodaviruses This residue is believed to represent part of a catalytic site 
that is involved in capsid protein cleavage (Grotmol et al. 2000). 
The N-terminus of the coat protein is very rich in basic amino acids (nine arginines 
and six lysines), which might account for the observed irregularity in the mobility of this 
protein in SDS-PAGE (Sideris, 1997). The same pattern has been also observed in the coat 
protein of other insect nodaviruses and this region of the coat protein is thought to be involved 
in the coat protein-RNA interaction required for virus encapsidation (Schneemann et al. 
1998). 
Chi et al. (2001) demonstrated that the capsid proteins of GNNV is glycosylated  
based on their staining properties with periodic acid-silver. 
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1.1.4 - Clinical signs 
1.1.4.1  -  Signs 
 
The clinical signs of VNN include abnormal colouration, anorexia, and altered 
swimming in association with extensive mortalities that can approach 100 % (Table 1.2). In 
most cases the fish affected are larvae or juveniles, but there are a number of reports of VNN 
in adult fish. 
 
Table 1.2 - Clinical signs of nodavirus disease. 
 
Species Age Signs Reference 
Lates calcarifer 15-18 dph Lethargy, anorexia, pale-grey coloration, swimming in a darting or corkscrew fashion Glazebrook et al.  (1990) 
Epinephelus akaara  Whirling swimmimg pattern Munday and Nakai (1997) 
Pseudocaranx dentex  Abnormal swimming behaviour, swim bladder hyperinflation Munday and Nakai (1997) 
Hippoglossus hippoglossus  Lethargy, belly-up at rest, abnormal swimming, pale colour Grotmol et al. (1997) 
Scophthalmus maximus 50-100 mm 
Reduced feeding activity, dark colouration, 
lethargic, lying abdomen-up on the bottom, 
abnormal swimming such as rotating, 
spinning, horizontal looping 
Bloch et al. (1991) 
Oplegnathus fascinatus 6-25 mm TL Loss of swimming activity and equilibrium, Spiral swimming, dark colour Yoshikoshi and Inoue, (1990)
Paralichthys olivaceus 17-18 mm TL (35 dph) Whirling, abnormal swimming behaviour Nguyen et al. (1994) 
Epinephelus akaara 7-20 mm Listless swimming near the surface of the water, abrupt whirling, sinking to the bottom Mori et al. (1991) 
Epinephelus akaara 170-1850g Floating upside down around the surface of water Fukuda et al. (1996) 
Epinephelus tauvina Up to 40 mm Loss of equilibrium, corkscrew swimming Chua et al. (1995) 
Cromileptes altivelis 10-52 dph Twirling swimming, resting on the bottom, sluggish behaviour Zafran et al. (2000) 
 
TL – total length; dph - days post hatching 
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1.1.4.2  -  Tissue distribution and histopathology  
 
VNN is characterised by extensive necrosis of the central nervous system (CNS) with 
numerous virus particles present in the cytoplasm of affected nerve cells (Nishizawa et al.  
1995b). 
Glazebrook et al. (1990) observed extensive vacuolation and neuronal degeneration of 
the mid and hind brain and vacuolation of the retina in affected barramundi (Lates calarifer 
Bloch). Under electron microscopy, degeneration was evident in cells in the brain and retina. 
Virions were present within the cytoplasm of neurones, which showed margination of nuclear 
chromatin. In the retina, virions were either membrane bound by endoplasmic reticulum or 
free in the cytoplasm. Separation of the nuclear membrane was observed, and the inner cristae 
of mitochondria were disintegrated with only vestiges of the plasma membrane remaining. 
Under light microscopic examination, larvae of Oplegnathus fasciatus showed 
conspicuous vacuolation and pyknosis associated with marked shrinkage and basophilia in 
affected cells of the spinal cord and brain (Yoshikoshi and Inoue, 1990). Numerous virus 
particles were evident in the cytoplasm of neurones, and within inclusion bodies and nerve 
fibres of affected neurones. These included oligodendrocytes which formed the myelin sheath 
and probably astrocytes. The authors were able to differentiate two kinds of degenerative 
change – pyknosis and cell lysis. In pyknotic cells the virus particles were densely packed in 
the cytoplasm, which contained a few degenerating mitochondria. These cells appeared to be 
highly necrotic. Cell lysis occurred much more frequently and was closely associated with 
vacuolation (Yoshikoshi and Inoue, 1990). 
In larvae of Epinephelus akaara conspicuous vacuolation occurred in the nuclear 
layers of the retina and in various parts of the brain (Mori et al. 1991). When the same 
samples were observed by transmission electron microscopy, necrotic and lytic degeneration 
of neurons and other unidentified cells in the retina and brain, and numerous hexagonal virus 
particles in the heavily vacuolated cytoplasm and extracellular spaces were evident. 
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In the studies by Yoshikoshi and Inoue (1990) and Mori et al. (1991), lesions  were 
not found in tissue samples taken from the gills, heart, alimentary canal, liver, exocrine 
pancreas, kidney, spleen, skin and skeletal muscles. 
In nodavirus infected Lates calcarifer larvae Renault et al. (1991) described enlarged 
basophilic cells with a rounded shape, and inclusion bodies and cytoplasmic vacuolation in 
cells of the optic tectum, cerebellum, tegmentum, vagal lobes, medulla oblongata and spinal 
cord. The vacuoles were often very extensive and the resulting loss of neural substance gave a 
spongiform appearance to the tissue. A similar spongiform appearance was evident in the 
retina.               
Nguyen et al. (1997) studied the tissue distribution of virus replication in striped jack 
using Reverse Transcriptase – Polymerase Chain Reaction (RT-PCR) and Fluorescent 
Antibody Technique (FAT) and detected virus in the liver, kidney, stomach, intestine and 
gonadal fluid of 13 year old broodstock fish.  
 
 
1.1.5 - Route of infection 
 
Renault et al. (1991) reported that the cerebellum, the optic tectum and the retina were 
the primary sites of lesions in nodavirus-infected barramundi. The spinal cord and spinal 
ganglia were the primary sites of lesions in Japanese parrotfish (Oplegnathus fasciatus) 
(Yoshikoshi and Inoue, 1990). In striped jack, necrosis and vacuolation of nerve cells were 
first observed in the spinal cord, particularly in the area situated near to the swim bladder, 
with lesions occurring later in the brain and then in the retina (Nguyen et al. 1996). The 
authors suggested that one of the initial multiplication sites of the virus was the area of the 
spinal cord situated immediately above the swim bladder. From there the virus was postulated 
to spread in an anterior direction to the base of the spinal cord and forward to the brain 
terminating in the retina. 
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In a study performed in Atlantic halibut by Grotmol et al. (1999) the initial major 
focus of lesions in the central nervous system was the caudal part of the brain stem together 
with the stratified epithelium of the anterior intestine. The route of infection to the CNS may 
have been axonal transport to the brain stem through cranial nerves including the vagus nerve. 
Péducasse et al. (1999c) noted that after infecting Dicentrarchus labrax juveniles by 
subcutaneous injection, bath exposure, and caudal immersion, virus was first detected in the 
spinal cord, and then in the brain and in the retina. The infection appeared to progress from 
two major sites, the gills and skin and/or the lateral line to gain access to the central nervous 
system (Péducasse et al. 1999a). 
Possible nodavirus infection of the host through the nasal cavity has been suggested 
by Mladineo (2003) and Tanaka et al. (2004). These authors reported that the virus penetrates 
the nasal epithelium, disseminating through the olfactory nerve and olfactory bulb, to the 
aboral brain tissue, medulla oblongata, spinal cord and finally to the retina. 
Whereas there are histological differences according to the age of the host, there are 
no age related differences in tissue-distribution. Larvae exhibit heavy necrotization of the 
brain whereas juveniles and adults show higher concentrations of the virus in the brain but 
with lower necrotization of the tissue (Mladineo, 2003). 
 
 
1.1.6 - Transmission of disease 
 
Several outbreaks in fish larvae suggest that vertical transmission of VNN may occur. 
The detection of viral antigens in ovarian tissues, fertilised eggs and hatched larvae was 
achieved by Arimoto et al. (1992) and Breuil et al. (2002). The presence of Nodavirus in 
sperm and subsequent infection of eggs during fertilisation was demonstrated by Breuil et al. 
(2001). These authors infected sperm with Nodavirus and demonstrated infection of offspring.  
Nguyen et al. (1997) suggested that the broodstock can carry the virus in the gonads 
and several other organs (liver, kidney, stomach and intestine) and during the stress of 
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spawning virus replication occurred in these organs. Virus can then be shed from the gonads 
and digestive tract and infect eggs, sperm or larvae (Arimoto et al. 1992, Mushiake et al.  
1992). The carrier status of the broodstock was confirmed by the total absence of virus in 
nerve tissue (Nguyen et al. 1997).  
The infection of healthy fish by cohabitation with infected fish was demonstrated by 
Arimoto et al. (1993) in striped jack larvae. The survival of purified nodavirus particles and 
the ability to use water as a transmission vehicle has been demonstrated by Breuil et al. (2002) 
in a challenge of European sea bass larvae. 
Fish surviving natural infection can act as carriers. One year after infection, Atlantic 
halibut survivors were shown to carry betanodavirus (Johansen et al. 2004b). 
Horizontal transmission of VNN is problematic with respect to asymptomatic species 
and the use of polyculture systems. Skliris and Richards (1999b) demonstrated the presence 
and the viability of nodavirus in tilapia (Oreochromis mossambicus), and the absence of 
symptoms of the disease. For many years gilthead sea bream (Sparus aurata) was believed to 
be an asymptomatic carrier of VNN, but the carrier state was eventually demonstrated by 
Castric et al. in 2001.  
The transmission of VNN by contaminated equipment has been suggested with 
respect to the disease in sturgeon (Athanassopoulou et al. 2004).  
All marine fish larvae need to be fed with live food and this can act as a reservoir for 
many pathogens. Skliris and Richards (1998) assessed the susceptibility of the brineshrimp 
Artemia salina and the rotifer Brachionus plicatilis to nodavirus infection. Their results 
indicated that these invertebrates may act as a carrier for nodaviruses. No evidence was found 
for viral replication in the invertebrate hosts.  
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1.1.7 - Pathogenicity  
 
A number of factors have been found to influence the virulence of betanodavirus 
infections in marine fish. These include temperature, age and species of host. The genetic 
basis of virulence in betanodaviruses is currently poorly characterised, and this has impeded 
the development of effective vaccines. 
Betanodavirus virulence is associated with variation of water temperature. VNN-
associated mortalities tend to be more severe at elevated water temperatures (25-28°C). 
Mortality frequently decreases or ceases altogether at temperatures below 20-23°C (Mori et 
al.  1991, Le Breton et al. 1997). However, instances of VNN have occurred at low water 
temperatures (4-15°C) (Tanaka et al. 1998). 
The implication of elevated water temperatures as a factor influencing the severity of 
VNN was suggested by Fukuda et al. (1996) and Skliris and Richards (1997), who also noted 
high mortalities and relatively early disease signs in European sea bass held at elevated water 
temperatures (Skliris and Richards, 1999a). 
A relationship between water temperature and virulence in betanodaviruses was 
reported by Péducasse et al. (1999a) and Breuil et al. (2001). These authors found that a strain 
of DlNNV designated Sb2 was highly virulent at 25°C (Péducasse et al. 1999a) but less 
virulent at 14-15°C (Breuil et al. 2001).  
Based on in vitro studies utilising the GF-1 cell line, Chi et al. (1999b) proposed that 
in winter, nodaviruses enter a state of persistent infection within host cells, and do not cause 
necrosis or mortality in fish. These authors suggest that lower water temperatures delay the 
occurrence of mortalities in groupers. 
Betanodaviruses can replicate and cause disease with mortalities of 100 % in Atlantic 
halibut yolksac larvae at temperatures as low as 6°C (Grotmol et al. 1999). This high 
virulence may represent an adaptation to replication in cold-water fish, and may thus be a 
phenotypic feature of this virus strain compared to nodavirus pathogenic to warm-water 
species. 
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Significant differences in virulence between two nodavirus strains (striped jack and 
Atlantic halibut) in cross infections of their respective natural hosts were reported by Totland 
et al. (1999). However, the authors were unable to conclude whether the observed differences 
in mortality were an effect of water temperature or a result of the host specificity of the 
viruses studied. The inability of SJNNV to infect Atlantic halibut was also observed by 
Húsgarð et al. (2001).  
The susceptibility of European sea bass to nodavirus infection was shown to be age 
dependent (Breuil et al. 2001). A betanodavirus strain (Sb1) was pathogenic for larvae, but 
less to juveniles or adults. 
 
 
1.1.8 - Detection Methods 
 
The detection of fish nodaviruses can be achieved by several methods, including 
histology, FAT, in-situ hybridization, virus isolation in cell culture, enzyme linked 
immunosorbent assay (ELISA), immunohistochemistry, and molecular procedures such as 
RT-PCR. 
Histology using light and electron microscopy were the first techniques used for the 
identification of VNN (Yoshikoshi and Inoue, 1990). Recognition of the characteristic lesions 
of VNN in the brain and retina can easily be achieved by microscopy. 
Nguyen et al. (1996) used a fluorescent antibody technique (FAT) to detect 
betanodaviruses. It was possible to detect virus antigen in the nervous system with this 
technique. Since then this FAT has been used routinely to identify and confirm the presence 
of betanodavirus in outbreaks of VNN. 
 The detection of betanodaviruses with in situ hybridisation using probes labelled 
radioactively or DIG-labelled in DIEV infection was reported by Comps et al. (1996).  
The isolation of nodavirus in a cell line was reported for the first time by Frerichs et 
al. (1996), who used the SSN-1 cell line (derived from striped snakehead Ophicephalus 
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striatus) to isolate a nodavirus from a sample of D. labrax brain tissue. Nodavirus infected 
SSN-1 cells exhibited characteristic cytopathic effects. The GF-1 (derived from a grouper 
Epinephelus coioides) cell line has been used to successfully propagate GNNV (Chi et al.  
1999a, Chi and Lin, 1999). More recently, the cell line GB (Grouper Brain, derived from 
yellow grouper Epinephelus awoara) has also been used for propagation of betanodaviruses 
(Lai et al. 2001b). In other cell lines such as that from barramundi (Lates calcarifer) 
cytopathic effects are not obtained during primary culture, and blind passage is required (Chua 
et al.  1995). Cell lines of this type are less useful for betanodavirus detection. 
A major constraint of the above techniques is their requirement for lethal sampling of 
test fish. Consequently, they cannot be applied to the screening of broodstock fish. In these 
circumstances methods for detection of nodavirus antibody are advantageous, since they can 
be applied non destructively (Breuil and Romestad, 1999).  
The detection of SJNNV antibodies in broodstock of striped jack using indirect 
ELISA was achieved for the first time by Mushiake et al. (1992). Further attempts to detect 
nodavirus antibodies have been carried out in European sea bass, striped jack, barramundi and 
barfin flounder (Mushiake et al. 1992, Mushiake et al. 1993, Breuil and Romestad, 1999, 
Watanabe et al. 2000, Huang et al. 2001). Antibodies against betanodavirus can be detected 
one year after infection in halibut (Johansen et al. 2004b). 
Indirect ELISA was used for detection of nodavirus antigens in eggs, larvae and brood 
stock of striped jack (Arimoto et al. 1992), who used anti-nodavirus polyclonal antibodies 
produced in rabbits.  
Monoclonal antibodies represent useful diagnostic tools for betanodaviruses. 
Nishizawa et al. (1995b) succeeded in generating monoclonal antibodies (MAbs) against 
SJNNV that recognised the coat protein (42 kDa), and had neutralising activity as assessed in 
in vivo neutralisation assays. These MAbs did not react with other nodavirus strains 
suggesting different neutralising epitopes between SJNNV and other nodaviruses. Another 
panel of MAbs produced against Yellow Grouper Nervous Necrosis Nodavirus (YGNNV) 
exhibited in vitro neutralisation capacity and recognised the coat protein (42 kDa) (Lai et al.  
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2001a). MAbs against GNNV that were capable of neutralising several other strains of 
nodavirus isolated from grouper, tiger puffer, striped jack and barfin flounder were produced 
and characterised by Shieh and Chi (2005). 
Molecular diagnostic procedures have been applied to the detection of 
betanodaviruses. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) was used to 
detect nodaviruses by Nishizawa et al. (1994), who tested combinations of five different 
primers (2 forward and 3 reverse). The most efficient amplification was achieved with primers 
designed to target a region designated T4 (592-1017 nt) (F2 - 5’ 
CGTGTCAGTCATGTGTCGCT 3’ and R3 3’ AGAAGTGGGCACAACTGAGC 5’). This 
primer pair generates a 426 bp fragment and has a detection limit of 0.1 fg of virus. 
Nested RT-PCR has proven to be more sensitive than single step RT-PCR for 
monitoring the presence of the nodavirus genome in asymptomatic carriers (Thiéry et al.  
1999, Gomez et al. 2004).  
 Recently a real-time Nucleic Acid Sequence Based Amplification (NASBA) 
procedure has been described for detection of betanodaviruses. NASBA is an isothermal 
nucleic acid amplification method. This method was found to be more sensitive than 
conventional RT-PCR (Starkey et al. 2004). 
 
 
1.1.9 - Phylogeny 
1.1.9.1  -  Fish nodavirus 
 
The genus Betanodavirus has been divided into seven lineages: Dicentrarchus labrax 
encephalitis virus (DlEV); tiger puffer nervous necrosis virus (TPNNV), Lates calcarifer 
encephalitis virus (LcEV); Japanese flounder nervous necrosis virus (JFNNV); striped jack 
nervous necrosis virus (SJNNV)), barfin flounder nervous necrosis virus (BFNNV) and red-
spotted grouper nervous necrosis virus (RGNNV) (Ball et al. 2000). 
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The first phylogenetic analysis of fish nodaviruses was carried out with isolates from 
Japan, Italy and Australia (Nishizawa et al. 1997). The Japanese isolates diverged into four 
major clusters: TPNNV type (Tiger Puffer Nervous Necrosis Virus), SJNNV type (Striped 
Jack Nervous Necrosis Virus), BFNNV type (Barfin Flounder Nervous Necrosis Virus) and 
RGNNV type (Red-Spotted Grouper Nervous Necrosis Virus). The isolates from Italy and 
Australia were found to belong to the RGNNV type (see Figure 1.1). 
 
Figure 1.1 – Betanodavirus phylogenetic tree (Johansen et al. 2004a). 
 
 
Phylogenetic analysis of nodaviruses from European sea bass from two different 
regions of France (Atlantic and Mediterranean areas) showed isolates from both geographic 
areas belonged to the RGNNV group, but the Mediterranean viruses were more closely related 
to the RGNNV type than the Atlantic viruses, which were more similar to the JFNNV group 
(Thiéry et al. 1999). The nucleotide sequence of the coat protein gene of the French 
Mediterranean SBNNV isolate was identical to nodaviruses isolated from Greece and Italy, 
suggesting that nodaviruses from the Mediterranean coast region are closely related (Thiéry et 
al. 1999). 
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Atlantic halibut nodavirus has been classified as belonging to the BFNNV clade, 
which also contains nodaviruses isolated from Pacific cod (Gadus macrocephalus) and barfin 
flounder (Verasper moseri) - both cold-water species  (Grotmol et al. 2000). The T2 region of 
the Atlantic halibut nodavirus RNA2 has a nucleotide sequence practically identical (98.4 %) 
to the T2 region of the BFNNV and the T4 nucleotide sequence showed identities of 97.9 % 
with barfin flounder and 98.2 % with Pacific cod (Grotmol et al. 2000). 
Betanodaviruses isolated from Atlantic halibut in Scotland show 98 % homology with 
viruses from Atlantic halibut in Norway (Starkey et al. 2000). This study also indicated that 
U.K. halibut nodavirus isolates belong to the BFNNV clade. Recently, nodaviruses from 
Atlantic cod and Dover sole farmed in the UK have also been found to cluster with the 
BFNNV nodaviruses (Starkey et al. 2001). 
Skliris et al. (2001), studied the phylogenetic relationship between a collection of 
nodaviruses isolated from Europe, Asia and Japan. The results of this work show that 12 of 
the 13 isolates (all the isolates from European sea bass, brownspotted grouper, barramundi, 
rock porgy and shi drum) were found to belong to the RGNNV genotype while a single isolate 
from striped jack was found to belong to the SJNNV type. 
A betanodavirus isolated from the guppy, a freshwater species, exhibited 98.2 % 
nucleotide identity with Epinephelus tauvina based on sequence analysis of the T4 region of 
RNA2, indicating that this virus belongs to the RGNNV clade (Hegde et al. 2003). 
In 2004 two other genetic groups of betanodavirus were proposed, one for turbot and 
another for Atlantic North nodaviruses (from Atlantic cod, haddock and winter flounder).  The 
designation of a new clade for turbot was based on relatively low sequence identity (77-78 %) 
between the turbot nodavirus and representatives of the other four phylogenetic groups 
(Johansen et al. 2004a). At the amino acid level, differences between the Atlantic North 
America viruses and Atlantic halibut NNV from Norway are not so pronounced (93 % 
identity), though Gagné et al. (2004) proposed that Atlantic Cod Nervous Necrosis Virus 
(ACNNV) represents a distinct phylogenetic group. 
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Totland et al. (1999) claimed that genetic diversity among nodavirus strains reflects 
significant phenotypic differences, which may represent adaptation enabling infection of 
different host species and/or replication at different temperatures.  
The capacity for different strains of nodavirus to affect the same species, when 
considered with the diversity of species that can be infected, suggests that the host range of 
nodaviruses may reflect at least in part host availability as opposed to the consequences of 
coevolution between pathogen and host (Dalla Valle et al. 2001). The same authors suggested 
that the observed relatedness between nodaviruses from Australian and Mediterranean waters 
reflects a parallel or convergent evolution rather than an exchange of viruses between these 
geographical areas.  
 
1.1.9.2  -  Fish and other nodavirus 
 
The sequence identities between the RNA1 genome segments of SJNNV and the 
insect nodaviruses Black Beetle Virus (BBV) and Flock House Virus (FHV) were 
approximately 28.3 % at the nucleotide level and 27.6 % at amino acid level, although 
conserved motifs for the RNA-dependent RNA polymerase were located at almost identical 
positions within the deduced amino acid sequence of RNA 1  (Nagai and Nishizawa, 1999). 
The sequence similarities between the coat protein gene of SJNNV and other known 
insect nodavirus (nodamura virus (NOV), black beetle virus, flock house virus and boolarra 
virus (BOV)) are 28.6 % or less at the nucleotide level, 10.6 % or less at amino acid level. 
There is no conserved region of RNA2 between the fish and insect viruses (Nishizawa et al.  
1995a). This finding is supported by a sequencing study of the RNA2 segment of DlEV and 
other insect nodaviruses (Delsert et al. 1997a).  
The coat proteins of DIEV (338 amino acids) and SJNNV (340 amino acids) are 
shorter than those of the insect nodaviruses (399 to 407 amino acids) (Delsert et al. 1997a). 
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Based on nucleotide sequencing studies of SJNNV RNA1 and RNA2, Nagai and 
Nishizawa (1999) and Nishizawa et al. (1999) suggested that fish nodaviruses represent a new 
genus designated Piscinodavirus within the family Nodaviridae. 
In 2000 the Nodaviridae family was reclassified as having two genera: 
Alphanodavirus and Betanodavirus (Ball et al. 2000). The genus Alphanodavirus comprises 
insect nodaviruses and the genus Betanodavirus comprises fish nodaviruses. 
In 1997 a nodavirus was detected in the crustacean (Macrobrachium rosenbergii) 
(Arcier et al. 1999) in Guadeloupe, West Indies. To date Macrobrachium rosenbergii 
nodavirus (MrNV) has also been isolated in China and India (Hameed et al. 2004). Another 
unsually small virus named extra small virus (XSV) is invariably associated with MrNV 
infection in M. rosenbergii (Qian et al. 2003). MrNV has been characterised as a new type of 
nodavirus based on sequence analysis (Bonami et al.  2005) (Figure 1.2). 
 
 
 
Figure 1.2 – Phylogenetic tree of the Nodaviridae family 
(Thiéry et al. 2004). 
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1.1.10 - Control Measures 
1.1.10.1  -  Disinfection 
  
Attempts to control betanodaviruses in fish-farms are complicated by the relative 
stability of the nodavirus particle. These viruses are amongst the most stable of the fish viral 
pathogens (Frerichs et al. 1996).  
The implementation of effective disinfection procedures is one method that can be 
used to control VNN. To this end, studies have been performed to determine the susceptibility 
of betanodaviruses to physical and chemical inactivation. 
Striped jack NNV is completely inactivated at pH 12 so rubber shoes, plastic ware and 
nylon nets can be washed with an alkaline solution (pH 12) which can be neutralised with a 
hydrochloride solution (Arimoto et al. 1996). This betanodavirus strain is also inactivated by 
sodium hypochlorite, calcium hypochlorite, benzalkonium chloride and iodine. Heat treatment 
at 60°C for 30 min, ultra-violet light (UV) at an intensity of 410 μW per cm2 for 4 mins and 
ozone at 0.1 μg ml-1 also efficiently inactivate SJNNV. However, SJNNV viability was not 
reduced as efficiently by formalin, ethanol, methanol, ether or chloroform. 
The sensitivity of DlNNV to chlorine, iodine and peroxygen was noticeably different 
in the presence of organic matter (Frerichs et al. 2000). UV irradiation of 440 μW per cm2 for 
8 minutes reduced virus infectivity by 99.9%, and acid peroxygen also rapidly reduced the 
infectivity of DlNNV (Frerichs et al. 2000). 
 
1.1.10.2  -  Broodstock selection  
 
Vertical transmission represents one of the major obstacles to the control of VNN. 
Striped jack spawners have been identified as an important reservoir of infection, allowing the 
virus to propagate in the ovaries and to be subsequently released with the eggs into the 
environment (Arimoto et al.  1992). 
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As a first approach towards the control of vertical transmission, Mushiake et al.  
(1993) have suggested that broodstock should be screened for the presence of virus and that 
improvements should be made to the spawning induction method to minimise stress. The 
authors screened spawners using ELISA to detect nodavirus antibodies.  
However, VNN has occurred in offspring derived from spawners in which neither 
specific antibodies nor viral antigens were detected by ELISA (Mushiake et al. 1994). This 
illustrates the need for more sensitive screening methods for the detection of the virus. RT-
PCR has been shown to be more effective and sensitive than ELISA in the selection of the 
striped jack spawners (Mushiake et al. 1994). Dalla Valle et al. (2000) suggested that 
broodstock can be screened by analysing the blood, but nested RT-PCR needs to be used 
Watanabe et al. (1998) suggested that to prevent vertical transmission broodstock 
should be selected with ELISA titres less than 1:10 and subsequently reared in individual 
tanks. The eggs and sperm should be examined by RT-PCR in the spawning season, and only 
spawners that are negative by RT-PCR should be submitted to artificial fertilisation. Fertilised 
eggs should be disinfected with ozone and hatched larvae analysed by RT-PCR. 
The selection of brood stock by detection of serum antibodies and antigen detection in 
ovarian biopsies was also described by Breuil et al. (2000). 
Limiting the number of spawnings by broodstock fish to less than ten per season also 
reduces the incidence of vertical transmission, because nodavirus frequently occurs in larvae 
derived from eggs collected late in the spawning season (Mori et al. 1998). 
In striped jack and barfin flounders disinfection of eggs with ozone (0.5 μg l-1 of total 
residual oxidants (TROs) for 5 minutes) or with an oxidant (0.5 μg ml-1 TRO for a duration of 
30 sec generated by a corona discharge generator) has been shown to be effective (Mori et al. 
1998, Watanabe et al. 1998).  
The disinfection of the surface of Atlantic halibut eggs with 4 mg ozone per litre for 
30 seconds also reduces mortality from VNN (Grotmol and Totland, 2000). 
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1.1.10.3  -  Vaccines 
 
Aquaculture is a fast growing industry. However, approximately 10 % of the total 
production within this industry is lost due to infectious diseases (Benmansour and de 
Kinkelin, 1997).  
 Measures for the treatment and control of infectious diseases in aquaculture are 
inadequate, particularly in the case of viral diseases. Furthermore, the use of chemicals and 
antibiotics is associated with adverse environmental effects and potential risks to human 
health. For this reason, disease prevention is considered to be of increasing importance in the 
aquaculture industry.   
Vaccines can play a major role in disease prevention. They offer significant 
advantages over other methods of disease control as evidenced by the control of several 
important diseases like vibriosis, furunculosis and yersiniosis (Lillehaug, 1997).  Vaccines 
have facilitated a reduction in the use of antibiotics in Norway, of which 30 000 kg were used 
in 1987 and only 5 000 kg in 1995 (Markestad and Grave, 1997).  
Vaccination of fish can be performed by immersion, injection or by oral 
administration (Gudding et al. 1999). Immersion represents the only practical and economical 
technique for vaccinating fish fry, where efficacious protection is required at an early 
developmental stage. However, injection is preferred for mature fish since vaccination by this 
route offers better protection (Midtlyng, 1997).  
A viral vaccine should fulfil certain requirements (Leong and Fryer, 1993). These 
include: inexpensive production costs; the ability to confer protection in intensive aquaculture 
systems; the protection of fish at susceptible developmental stages; protection against all 
circulating types of a viral pathogen; induction of long lasting immunity; safety; and ease of 
administration. 
Since the early 1990s vaccination programs have been used in the aquaculture 
industry with promising results. Bacterial vaccines have proven to be easier to develop than 
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viral or parasitic vaccines. Some of the major bacterial diseases can now be controlled by 
vaccination programs.  
Different types of vaccines have been developed for the fish farm industry (live, 
attenuated, recombinant protein). More recently, special attention has focussed on the 
development of DNA vaccines as a result of the success obtained with experimental VHSV 
and IHNV DNA vaccines in rainbow trout (97 % survival for VHSV and 77 % survival for 
IHNV)  (Heppell et al. 1998, Corbeil et al. 2000, Lorenzen et al. 2000, LaPatra et al. 2001).  
There are several bacterial vaccines commercially available or in development 
including: vibriosis (Vibrio anguillarum, V.ordalii, V.salmonicida, V.vulnificus); bacterial 
kidney disease (BKD) (Renibacterium salmoninarum); furunculosis (Aeromonas 
salmonicida); enteric redmouth disease (ERM) (Yersinia ruckeri); edwardsiellosis 
(Edwardsiella ictaluri); piscirickettiosis (Piscirickettsia salmonis); pasteurella 
(Photobacterium damsela subspecie piscicida); several Flavobacterium strains (Bernardet, 
1997, Ellis, 1997, Kaattari and Piganelli, 1997, Romalde and Margariños, 1997, Smith et al. 
1997, Stevenson, 1997, Toranzo et al. 1997, Thune et al. 1997, Marsden et al. 1998, Kanellos 
et al. 1999). 
The development of efficacious viral vaccines has not lagged behind bacterial vaccine 
development. Some viral vaccines are currently available and others are in development 
including: infectious pancreatic necrosis (IPNV); spring viraemia of carp virus (SVC); grass 
carp haemorrhagic disease (GCHD); channel catfish virus disease (CCVD); several 
rhabdoviral diseases such as Hirame rhabdovirus (HIRRV), infectious hematopoietic necrosis 
(IHNV), viral hemorrhagic septicaemia virus (VHSV) (Heppell et al. 1995, Liao and Dobos, 
1995, Lorenzo et al. 1995, Christie, 1997, Dixon, 1997, Winton, 1997, LaPatra et al. 2001, 
Roche and Gaudin, 2001, Mas et al. 2002, Perez et al. 2002, Ronen et al. 2003, Takano et al. 
2004, Byon et al. 2005). 
There are four basic types of vaccines - live attenuated, whole inactivated (killed), 
purified proteins produced from cloned genes and purified subunits (Leong et al. 1997).  
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Live attenuated vaccines are produced by attenuating viruses in serial passage in cell 
culture or by isolating naturally occurring variants (Winton, 1998). These vaccines generally 
offer excellent protection and are cost-effective, but concerns exist regarding residual 
virulence, loss of attenuation, or consequential effects on other aquatic species, and thus 
licensing live attenuated vaccines can be problematic (Winton, 1998). The motivation for 
developing synthetic vaccines was driven by the need to overcome the drawbacks associated 
with live attenuated vaccines (Arnon and van Regenmortel, 1992). Synthetic vaccines offer 
major advantages over the other type of vaccines because they are: inexpensive; easy to 
produce; easily modified when needed; and stable not requiring preservation or  “cold-chain” 
supply. Multivalent vaccines can easily be produced by this means (Lorenzen, 1999, Heppell 
and Davis, 2000). 
Fully synthetic vaccines have been demonstrated to induce protective B-cell and T-
cell responses (Beck-Sickinger and Jung, 1993).  
Synthetic vaccines can be divided into two main groups; a) non-expression based and 
b) expression based. DNA vaccines are expression based vaccines, with the protein of interest 
being expressed in immunised fish after an injection in the form of a DNA plasmid containing 
an expression construct. DNA vaccines offer the advantage of conservation of the native 
structure of the protein and can elicit humoral immune response (Heppell et al. 1998, 
Lorenzen et al.  2002). However, DNA vaccines have not gained public acceptance as they are 
perceived to be a product of genetic manipulation. Consequently, their use in the aquaculture 
industry may confer adverse economic effects.  
Synthetic peptide based vaccines are an example of a non-expression based vaccine 
type. These are completely synthetic and thus relatively easy to licence. However there are 
also drawbacks with this type of vaccines. Firstly, they require the use of an adjuvant to 
increase their effectiveness, and secondly, knowledge of the antigenic structure of the target 
organism is required for their development (Winton, 1998). The use of synthetic peptides for 
immunisation of rainbow trout induced an antibody response against VHSV (Lorenzo et al. 
1995).  
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Both DNA and peptide vaccine offer the advantage of safety with respect to reversion 
to virulence, which is a critical factor in relation to environmental safety in aquaculture 
(Gudding et al. 1999). 
The potential advantages of synthetic vaccines has stimulated research aimed at an 
improved understanding of the molecular basis of the immunogenicity of proteins (Geysen et 
al. 1987b). 
Usually protein antigens contain several unique molecular structures, each of which 
can elicit an immune response (Lydyard et al. 2000). Antibodies produced against an antigen 
are not directed against the whole molecule but against a specific region of the molecule 
(immunogenic region) (Lydyard et al. 2000). 
The region of an antigen that is recognised by an antibody molecule is referred to as 
an epitope or an antigenic determinant (DeLisser, 1999, van Regenmortel, 2001). B-cell 
epitope mapping is the identification of the sites that are recognised by an antibody response 
to a defined antigen (Morris, 1996a).  
Viral epitopes have been classified into four categories (van Regenmortel, 1989b, van 
Regenmortel, 1990a, Arnon and van Regenmortel, 1992, van Regenmortel, 1992): 
cryptotopes, neotopes, metatopes and neutralisation epitopes. Cryptotopes are epitopes that 
can only be recognised when native virus particles are fragmented or denatured. Neotopes are 
epitopes that are only present when the quaternary structure of virus proteins is intact. 
Neotopes commonly occur in viral capsids. Epitopes present in both dissociated and 
polymerised forms of the viral coat proteins are designated as metatopes. Neutralising 
epitopes represent those epitopes that are recognised by neutralising antibodies.  
Neutralising epitopes are of great importance in the design of synthetic vaccines. 
Their identification can aid the rational design of vaccines by facilitating the induction of 
immune responses against relevant sites on pathogenic micro organisms (van Regenmortel, 
1989b). 
It is important to distinguish between antigenic and immunogenic epitopes. An 
antigenic epitope is the region of a protein molecule that an antibody can bind to, and an 
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immunogenic epitope is the region of a protein that can elicit an immune response (Geysen et 
al. 1984, Morris, 1996a). Immunogenicity is not solely a property of an antigen but is linked 
to features of the host immune system including B-cell and T-cell repertoires and the major 
histocompatibility complex (MHC)  (Benjamin et al. 1984). Residues involved in the high-
energy contacts between an antibody and its target epitope are called critical-binding residues 
(CBRs). Amino acid replacements at these sites usually reduce binding affinity greatly 
(Geysen et al. 1987b, Davies and Cohen, 1996). The CBRs located within a single contiguous 
polypeptide sequence are said to form a linear epitope, whereas CBRs comprised of residues 
from two or more distinct regions of a polypeptide that are brought together by protein folding 
form conformational epitopes (also referred to as discontinuous epitopes) (Barlow et al.  
1986). It is now widely believed that the majority of the protein epitopes are discontinuous 
(van Regenmortel, 2001). 
Structural studies (crystallography) reveal that 15-22 amino acids on the surface of a 
protein antigen make contact with a similar number of residues in an antibody binding site 
(Kuby, 1994). Contact involves ionic and hydrophobic interactions, and has between 75-120 
hydrogen bonds (Kuby, 1994). The surface area of this large complementary interface is 
between 650-900 Å2 (Kuby, 1994).  
Functional studies of antibody binding peptides have led to the general consensus that 
most of the binding energy of the epitope-antibody interaction results from the binding of 
between three and eight amino acid residues (Geysen et al. 1987a, van Regenmortel, 1989b). 
Clearly, there is a difference in the number of residues implicated in binding identified by 
structural and functional studies. This is believed to be due to the presence of residues on the 
antigen-antibody interface whose main contribution to the binding complex is the formation 
of complementary surfaces that act as a scaffold. These residues are identified by structural 
studies, wheras only critical binding residues influence functional studies (Scott, 2001).  
For the development of synthetic vaccines, efficient methods for epitope mapping are 
of considerable importance (Beck-Sickinger and Jung, 1993). Studies utilising monoclonal 
antibodies have been widely used to characterise viral epitopes (McCullough, 1986). The use 
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of monoclonal antibody based methods has allowed the delineation of antigenic structure at a 
level of precision not previously possible, because of their specificity for a single antigenic 
site (Benjamin et al. 1984). 
Several approaches have been used to characterise epitopes using MAbs: c 
competitive antibody binding; d immunological screening of recombinant expression 
libraries of random cDNA fragments; e antibody binding to chemically synthesised 
overlapping peptides, or to fragments generated by proteolytic cleavage; f MAb binding to 
recombinant proteins using panels of deletion mutants or chimeric constructs composed of 
different species of the same molecule, or bacterially expressed fusion proteins or proteins 
generated by site-directed mutagenesis; g escape mutants (van Regenmortel, 1990a, Tzartos, 
1996, DeLisser, 1999). Some of the methods used for localisation of viral epitopes are 
described in Table 1.3. 
 
Table 1.3 – Methods used in localisation of viral epitopes (van Regenmortel, 1990a). 
 
Epitope mapping method Type of epitope recognised 
X-ray crystallography of antigen-Mab complex Discontinuous and linear epitope 
Synthetic peptides as probes: 
     free peptides 
     peptides adsorbed to a solid-phase 
     peptides conjugated to a carrier 
     peptides attached to a support used for synthesis 
Linear epitope 
Use of fusion proteins and peptides: 
     chimaeras 
     prokaryotic expression vectors (e.g.phage display) 
Linear epitope 
Use of anti-peptide antibodies Cross-reacting linear epitopes 
Viral escape mutants with MAb Neutralising epitopes, discontinuous epitopes 
 Topographic mapping by competitive MAb binding assay Only relative position of epitope is defined 
 
 
1.1.10.3.1 -  Betanodavirus vaccines  
 
Fish surviving betanodavirus infection have been found to produce neutralising 
antibodies, which is believed to explain their resistance to natural re-infection (Tanaka et al. 
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2001). This observation suggests that vaccination represents a logical and effective means of 
controlling VNN. 
Intensive research efforts have been directed towards the development of a vaccine 
against betanodaviruses. The most successful approach to date has utilised recombinant 
nodavirus coat protein as a protective antigen. This type of vaccine successfully induced 
neutralising antibodies and reduced mortalities in experimentally challenged grouper 
(sevenband grouper, humpback grouper) (Tanaka et al. 2001, Yuasa et al. 2002), turbot and 
Atlantic halibut (Húsgarð et al. 2001, Sommerset et al. 2001). However, the survival rates 
indicate that the vaccine was not suitable for commercial use. For example Tanaka et al. 
(2001) obtained a relative percent survival (RPS) of 88 when fish were challenged with 103.4 
TCID50/fish, but the RPS decreased to 35 when fish were challenged with 104.4 TCID50/fish. 
After vaccinating with recombinant protein and challenged the fish Yuasa et al. (2002) 
obtained a survival rate of 67.5 RPS. A similar RPS value (66) was obtained by Húsgarð et al. 
(2001) using as well a recombinant protein vaccine. 
Initial work aimed at the development of DNA vaccines for use in fish suggest that 
this approach may be applicable to the control of VNN. Sommerset et al. (2005) developed an 
Atlantic halibut NNV (AHNNV) DNA vaccine. In protection trials, this vaccine was unable to 
induce an immune response and protect challenged fish. The analysis of immunised fish 
muscle demonstrated that transcription and translation of the construct had occured in vivo. 
However, a humoral immune response was not induced.  
Rhabdovirus DNA vaccines can induce non-specific immune responses that confer 
protection against other viruses. Consequently, a DNA vaccine directed against the 
rhabdovirus VHSV has been investigated as a potential nodavirus vaccine. In challenge 
studies, this VHSV vaccine protected turbot against betanodavirus infection (Sommerset et al. 
2003). The best results (100 RPS) were obtained when the fish were challenged 8 days post-
vaccination. When the challenge was performed 35 days post-vaccination the RPS was 63. 
The encouraging results obtained after 8 days post-vaccination are a consequence of cross-
protective anti-viral defence mechanisms that are not of long duration. The same non-specific 
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immune response was observed by Lorenzen et al. (2002) with rainbow trout vaccinated 
against VHSV or IHNV.  
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1.2 -  Aim and objectives 
 
In the past fifteen years, Betanodaviruses have emerged as major pathogens of marine 
fish, affecting many species of economic value to the aquaculture industry. Despite advances 
in our understanding of betanodaviruses, the development of effective vaccines to counter 
these viruses remains elusive. The betanodavirus vaccines that have been produced to date 
have not afforded a high degree of protection. The regions of the betanodavirus particle that 
serve as targets of protective immune responses are currently poorly characterised. This lack 
of knowledge represents a barrier to the rational development of betanodavirus vaccines. The 
identification of the targets of protective immune responses against fish nodaviruses could be 
used to inform future vaccine development programmes. It would be possible to direct 
immune responses towards protective epitopes through the use of vaccine constructs 
administered either alone, or in conjunction with adjuvants or other immunostimulants.  
The goal of this thesis is to identify betanodavirus B-cell epitopes. The successful 
identification of these structures would represent a significant step towards the rational 
development of vaccines to counter VNN. The thesis is comprised of the following four 
specific objectives: 
c To produce antibodies against betanodaviruses for use in epitope mapping studies. 
This work involves:  
a) the production and characterisation of mouse monoclonal antibodies directed 
against betanodavirus using conventional hybridoma methodology. Monoclonal antibodies 
will be screened for antibody class/isotype and the ability to neutralise betanodavirus.  
b) the production of rabbit polyclonal antibodies against betanodavirus.  
c) the collection of serum samples from fish (European sea bass) naturally-
infected with betanodavirus.  
The antibodies obtained in this stage of the project will be used to identify 
betanodavirus epitopes using one or more of the epitope mapping procedures summarised 
Chapter 1 – General introduction 
below in steps 2-4. In combination, these procedures permit the identification of both 
conformational and linear epitopes. 
d To produce and characterise betanodavirus neutralisation escape mutants. 
Monoclonal antibodies will be used to select betanodaviruses resistant to in-vitro 
neutralisation. Nucleotide sequence analysis of the coat-protein gene of isolated escape 
mutants will permit identification of the sequence changes conferring neutralisation 
resistance.  
e To identify the recognition sites of betanodavirus monoclonal antibodies using a 
random peptide library displayed on the surface of a filamentous bacteriophage. Phage clones 
binding to monoclonal antibodies will be isolated using conventional panning procedures. 
Nucleotide sequence analysis of isolated phage clones will permit identification of the amino 
acid sequence recognised by monoclonal antibodies.  
f To identify the recognition sites of antibodies using the "Pepscan" procedure. A 
series of short overlapping synthetic peptides mimicking the betanodavirus coat protein will 
be used to map the recognition sites of antibodies directed against betanodavirus. The recently 
developed suspension array technology will be used to quantitate the interaction between 
antibodies and synthetic peptides. This procedure will be used to identify regions of the coat 
protein recognised by mouse monoclonal antibodies, rabbit polyclonal antibodies, and serum 
samples from fish naturally infected with nodavirus.  
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Chapter 2 - General methods  
2.1 -  Virology 
2.1.1 - Cell culture 
 
Betanodaviruses were cultured in an SSN-1 cell line. This cell line was produced from 
whole fry tissue of Ophicephalus striatus (striped snakehead) at the Institute of Aquaculture, 
and is infected with an endogenous type C retrovirus (Frerichs et al. 1991). The optimal 
growth temperature for SSN-1 is 28°C. No supplementation with CO2 is required. 
The SSN-1 cell line was maintained in Leibovitz’s L-15 medium containing 
Glutamax-I (Gibco, Paisley, Scotland) supplemented with 10 % FBS (Foetal Bovine Serum, 
Gibco, Paisley, Scotland) (L-15/FBS). 
 SSN-1 cell monolayers were passaged every 4th to 7th day and were subcultured at a 
“split” ratio of between 1:3 and 1:4. This was chosen according to the degree of confluence of 
the monolayer and the anticipated cell growth period required for a given experiment 
To passage SSN-1 cells, the growth medium was removed and cells were washed 
twice with Dulbecco’s PBS without Ca and Mg (D-PBS, Gibco, Paisley, Scotland). Excess D-
PBS was removed prior to the addition of Trypsin-EDTA (1x concentrated, Gibco, Paisley, 
Scotland). Cell monolayers were then incubated until their appearance became white and 
opaque. Trypsin-EDTA solution was then removed and cells detached by gently tapping the 
flask. One third of the final volume of fresh L-15/FBS was added, and cells were resuspended 
and aliquoted evenly into new cell culture flasks (Nunc, Fisher Scientific, Leicestershire U.K.) 
containing fresh medium.  
The SSN-1 stock flasks were incubated at 28°C and split every 4-7 days. 
Volumes of D-PBS, Trypsin-EDTA and L-15/FBS medium used for each size of 
growth vessel are shown in Table 2.1. 
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Table 2.1  - Volumes of Dulbecco’s PBS, Trypsin-EDTA and L-15/FBS used 
for SSN-1 cell passage. 
 
Flask 
(cm2) 
Dulbecco’s PBS 
(ml per wash) 
Trypsin-EDTA 
(ml) 
New flask 
(final volume in ml) 
25 4 1 5-6 
75 10 2 18-20 
175 15 4 40-50 
 
 
2.1.2 - Virus culture 
 
During this study four betanodavirus isolates were used. These viruses were grouped 
depending on the temperature that the isolate can be propagated, 25°C and 20°C, respectively. 
All the betanodavirus strains details are listed in Table 2.2. 
 
Table 2.2 - Betanodavirus isolates used in this study. 
 
Propagation Strain reference Fish species Country 
25°C  Mt/01/Sba European sea bass (Dicentrarchus labrax L.) Malta 
 Jp/06/Sj Striped jack (Pseudocaranx dentex) Japan 
20°C GB/32/Cod Atlantic cod (Gadus morhua) United Kingdom 
 GB/30/Hal Halibut (Hippoglossus hippoglossus) United Kingdom 
 
 
2.1.2.1  -  Inoculation of SSN-1 cell monolayers with betanodavirus 
 
Betanodaviruses were propagated in either pre-formed SSN-1 monolayers or by 
simultaneous inoculation of SSN-1 cells. Both methods required highly confluent SSN-1 cell 
monolayers (typically seven days old).  
For infection of pre-formed monolayers, SSN-1 cells were split and incubated until 
the monolayer reached the required degree of confluence. Temperature and period of 
incubation varied according to the betanodavirus isolate propagated. The growth medium was 
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then removed, and virus and sufficient L-15/FBS to cover the cell monolayer were added and 
permitted to adsorb. The volume of medium and virus used varied according to the size of the 
tissue culture flask used (see Table 2.3). After adsorption, L-15/FBS medium was added and 
cells were incubated at appropriate temperatures until an extensive cytopathic effect (CPE) 
was observed. Adsorption and incubation temperature and period used were according to the 
isolate under propagation. Viral supernatant was harvested and clarified by centrifugation for 
15 mins at 1410 x g at 4°C (Eppendorf 5804R). 
Virus preparations were stored at 4°C for periods up to 30 days. For longer periods 
the virus was stored at -20°C or -70°C. 
For simultaneous inoculation SSN-1 cells were split and re-suspended in L-15/FBS as 
described in section 2.1.1. Virus was then added, and cells were incubated until an extensive 
CPE was evident. The amount of virus added was the same as used for infection of pre-
formed monolayers (Table 2.3). 
 
Table 2.3 – Volume of L15-FBS medium and virus used for 
infection of pre-formed monolayers. 
 
Size of flask 
(cm2) 
DMEM+ 
adsorption step (ml) 
Virus 
(ml) 
Final volume 
(ml) 
25 1 0.5 6 
75 2 1.5 20 
175 3 6.5 50 
 
 
2.1.2.2  -  Betanodavirus propagated at 25°C 
 
Two different strains of betanodavirus, European sea bass and striped jack were used 
during this study. A growth temperature of 25°C was found to be optimal for culture of these 
isolates of betanodavirus. SSN-1 cells were maintained at 28°C for 6-7 days prior to infection. 
For simultaneous inoculation, cells were split at a ratio of 1:3 and re-suspended in L-15/FBS. 
Hanks’ Balanced Salt Solution (HBSS, Gibco, Paisley, Scotland) was then added at a volume 
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necessary to decrease the FBS concentration to 5 % (v/v). Virus was added and mixed with 
the SSN-1 cells. Cells were incubated at 25°C until an extensive CPE was observed (typically 
4 – 7 days).  
For infection of pre-formed monolayers SSN-1 cells were split at a ratio of 1:3 and 
incubated at 28°C until monolayers attained 70 % of confluence (for growth of SJNNV) and 
80 % (for growth of DlNNV). Virus was added and allowed to adsorb for 60 mins at 25°C. 
Sufficient L-15/FBS and HBSS were then added in order to achieve a final concentration of 5 
% FBS. Cells were incubated at 25°C until an extensive CPE was observed (typically 4-7 
days).  
   
2.1.2.3  -  Betanodavirus propagated at 20°C 
 
During this study two isolates of betanodavirus that are propagated at lower 
temperatures were used – these were derived from Atlantic cod and Halibut. Optimal growth 
of these viruses was achieved at a growth temperature of 20°C and use of L-15/FBS. SSN-1 
stock cells were kept at either 28°C or 22°C, depending of the availability of the incubators, 
the amount of cells needed for the experiments and the type of virus inoculation to be 
performed (pre-formed monolayer or simultaneous inoculation).  
SSN-1 cells grown at 28°C were split at a ratio of 1:3 after 6-7 days growth and 
incubated overnight at 25°C. Cell monolayers exhibiting > 75 % confluence were then 
incubated at 22°C. Cells were used within 24 hours for infection experiments, or maintained 
at 22°C for up to 10 days for use as stock cells.  
SSN-1 cells maintained at 22°C required a different treatment. These cells were 
incubated for 7-10 days at 22°C. After this period the cells were split at a ratio of 1:2 and 
either used immediately or incubated for up to 10 days as stock cells. 
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Cells used for infection of Atlantic cod and halibut betanodavirus by simultaneous 
inoculation were maintained at 22°C. These cells were split at a ratio of 1:2, infected with 
betanodavirus and incubated until extensive CPE was observed.  
Infection of pre-formed SSN-1 monolayers was performed with the stock cells grown 
at 22°C or 28°C. Cells were infected when monolayers were > 85 % confluent. Virus was 
allowed to adsorb for 6 h at 20°C. L-15/FBS medium was then added and monolayers were 
incubated for 6-8 days until an extensive CPE was evident.  
 
 
2.1.3 - Virus quantification 
 
The concentration of the virus was determined by calculating the virus titre (number 
of infectious units per unit volume) by TCID50.  
The dilution of virus required to infect 50 % of inoculated cell cultures is defined as 
TCID50, and relies on the presence and detection of cytocidal virus particles (Burleson et al. 
1992). 
Infectivity titrations were performed in flat bottom 96 well plates (Nunc, Fisher 
Scientific Leicestershire U.K.) by adding 90 μl of diluent to each well. HBSS was used as 
diluent for warm-water betanodavirus isolates and L-15/FBS for cold-water isolates. Virus (10 
μl) or diluent (negative control) was added to the first well of each row. Virus samples were 
diluted ten-fold across the plate. Each individual dilution of virus was made with a new 
pipette tip to prevent carry-over. One 25 cm2 flask of highly confluent SSN-1 cells was 
harvested for each 96 well plate with betanodaviruses propagated at 25°C. For betanodavirus 
strains propagated at 20°C isolates from two 75 cm2 flasks of SSN-1 cells were used to 
prepare three 96 well plates.  Cells (100 μl) were added to each well of titration plates. These 
were sealed with Nescofilm (Bando Chemical Ind. Ltd, Japan, Fisher Scientific Leicestershire 
U.K.) and incubated at the appropriate temperature for 7 days, when monolayers were visually 
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assessed for cytopathic effects. Virus titres were calculated by the method of Spearman-
Karber (Hierholzer and Killington, 1996).  
 
Spearman-Karber formula:  Mean log TCID50 = ⎟⎠
⎞⎜⎝
⎛Σ×−×+
n
rddX
2
1  
 
Where, X = log of the highest reciprocal dilution. 
                      d = log of the dilution interval. 
                            r = number of test subjects not infected at any dilution. 
                           n = number of test subjects inoculated at any dilution. 
 
 
2.1.4 - Virus purification 
 
A Beckman L-80 ultracentrifuge was used for ultracentrifugation of betanodavirus 
preparations. Two sizes of centrifuge tubes (Ultra-Clear™ tubes, Beckman, High Wymcombe 
U.K.) were used, depending on the type of rotor used. For clarification an SW28 rotor was 
used together with 38.5 ml centrifuge tubes. The pelleting step and purification by caesium 
chloride (CsCl) gradient centrifugation were performed in an SW41Ti rotor together with 13.2 
ml centrifuge tubes. 
Centrifuge tubes were disinfected prior to use with 70 % ethanol (Fisher Scientific, 
Leicestershire U.K.). 
 
2.1.4.1  -  High speed clarification   
 
The first stage of the purification procedure was a high-speed clarification step 
performed using a SW28 rotor. Disinfected and dry centrifuge tubes were placed on a scale 
and tared. Virus preparation (36 g) was added to each centrifuge tube, which was balanced 
prior to centrifugation. Tubes were centrifuged at 12 000 x g at 4°C for 35 mins. Virus 
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supernatants were collected in a clean flask. The virus supernatant (≈ 2 ml) near the bottom of 
the tube was discarded.  
 
2.1.4.2  -  Pelleting 
 
Virus pelleting was performed using an SW41Ti rotor. High-speed clarified virus 
supernatant (12 g) was added to disinfected centrifuge tubes. The weight of tubes was 
adjusted to 12 g when necessary with HBSS. Tubes were cenrifuge at 100 000 x g, at 4°C for 
95 mins. Supernatant was discarded, more high-speed clarified virus supernatant was added 
and spun. The procedure was repeated 3 or 4 times. 
After the repeated pelleted centrifugations the tubes were inverted. After the majority 
of the supernatant had drained, 50 μl of TNE buffer (RNase free pH 7.4, Appendix 1) was 
added to the pellet and mixed well. Tubes were sealed with Nescofilm and incubated for 20 
mins at 4°C. Supernatants were collected into a cryovial. A further 50 μl of TNE buffer was 
then added to tubes, which were then and incubated for 20 mins at room temperature. 
Supernatants were collected and stored at -20°C. For logistical reasons, tubes were on 
occasion harvested using an alternative method. TNE buffer (100 μl) was added to centrifuge 
tubes, which were then seased with Nescofilm and stored overnight at 4°C. Virus was then 
harvested as described above. 
An average of 500 ml of virus supernatant was pelleted and resuspended in 1 ml of 
TNE buffer. 
 
2.1.4.3  -  Purification using caesium chloride  
 
The use of isopycnic gradient centrifugation with a high density and low viscosity 
medium like caesium chloride for the purification of non-enveloped viruses is of great 
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advantage for obtaining a purer product and relatively high volumes of sample can be 
processed in each gradient (Easton et al. 2000). 
 
2.1.4.3.1 -  Caesium chloride gradient 
 
A 50 % w/w stock of caesium chloride in TNE buffer (pH7.4, RNase free) was used 
to prepare CsCl gradients. This stock solution was autoclaved. All glassware was RNase-free 
treated with DEPC (Appendix 1). 
A capillary tube was rinsed with RNase-free water. Solutions of 40 %, 35 %, 30 %, 25 
% and 20 % w/v caesium chloride were prepared by diluting the stock solution in TNE buffer. 
The refractive index (RI) of each solution was measured using a refractometer (Bellingham & 
Stanley ABBE60).  
Syringes (5 ml, Terumo Merseyside U.K.) were filled with different amounts of 
caesium chloride solutions: 1.5 ml of 20 %, 2.5 ml of 25 %, 2.5 ml of 30 %, 2.5 ml of 35 % 
and 2 ml of 40 %. 
The capillary tube was placed adjacent to the bottom of the centrifuge tube and held in 
place with tape. A needle (25G) was attached to the other end of the tube (Figure 2.1 c). 
The caesium chloride solutions were added in sequence from the lowest to the highest 
concentration. Each solution was added very slowly to avoid the formation of bubbles. Care 
was taken not to disturb the CsCl solutions to ensure that the gradient formed efficiently. 
With this method it was very difficult to avoid the formation of bubbles and the 
injection of air bubbles into the gradient. In order to avoid such problems an isopycnic 
gradient maker was used to make the caesium chloride gradient. 
 The gradient maker contains two chambers connected by a tap (Figure 2.1 d). One of 
the chambers is joined to the centrifuge tube by an outlet tube. This chamber was filled with 
7.25 ml of 20 % caesium chloride. The other chamber was filled with 6.75 ml of 40 % 
caesium chloride. 
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CsCl  
20% 
CsCl  
40% 
magnetic stirrer 
c d 
Figure 2.1- c CsCl gradient by syringe method; d CsCl gradient maker using a column maker. 
 
 
The gradient maker was placed over a stirring plate and a magnetic flea was placed in 
the chamber with the outlet tube (Minor, 1999). 
The tap of the outlet tube was opened and 1 ml of solution allowed to drain before the 
tap linking both chambers was opened. This allows the CsCl solution to mix. The gradient 
becomes progressively denser as the CsCl solutions mix and drain. 
Betanodavirus in TNE buffer (1 ml) was added to gradients prepared by either of the 
methods described above.  
Gradients were centrifuged in an SW41Ti rotor 150 000 x g, for 17 hours at 4°C. 
 
2.1.4.3.2 -  Harvesting purified virus  
 
To harvest virus samples the centrifuge tube was held in the fraction collector 
(Fraction Recovery System 270-331580, Beckman). Because SSN-1 cells are endogenously 
infected with a type C retrovirus (Frerichs et al.  1991) two bands are visible in CsCl gradients 
of betanodaviruses grown in these cells. The upper band is composed of retrovirus particles 
and the lower band of betanodavirus particles. In runs where these bands were visible, the 
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centrifuge tube was pierced with a 25G needle immediately below the band corresponding to 
betanodavirus particles. A 5 ml syringe was used to collect between 750-1000 μl of sample.  
When the bands were not visible fractions of the gradient were collected using a 
fraction collector. Prior to use, this collector was thoroughly rinsed with RNase-free water. 
Centrifuge tubes containing CsCl gradients were placed into the fraction collector holder and 
the top of the centrifuge tube was then closed to create a vacuum. The bottom of the tube was 
pierced, and the vacuum valve was used to control the release of 40 drop fractions which were 
stored at 4°C after collection. The RI of each fraction was measured using a refractometer. 
Betanodavirus particles were obtained from fractions with a RI between 1.365 and 1.355. 
The presence of betanodavirus in harvested bands or fractions was confirmed by 
titration in SSN-1 cells as described in section 2.1.3. CsCl was removed from these samples 
by re-centrifugation through TNE buffer at 100 000 x g for 1 h and 35 mins at 4°C. The 
resulting pellet was re-suspended in TNE buffer and stored at -20°C. 
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2.2 -  Monoclonal antibodies 
2.2.1 - Culture of cell lines 
 
Myeloma cells (SP2/0, Sigma, Dorset U.K.) and hybridomas were cultured in 
DMEM+ [(Dulbecco’s Modified Eagle Medium (DMEM) (Sigma, Dorset U.K.) 
supplemented with 5 ml sodium pyruvate (100 mM) (Sigma, Dorset U.K.), 5 ml L-glutamine 
(200 mM) (Sigma, Dorset U.K.), 2.5 ml streptomycin/penicillin (10000 units penicillin in 20 
ml; 10 mg ml-1 streptomycin) (Sigma, Dorset U.K.), and 10 % FBS (Sigma, Dorset U.K.)] at 
37° C with 5 % CO2 supplementation. 
The SP2 cells grew at a faster rate than the hybridoma cells and consequently needed 
to be split every 3-4 days. Hybridoma cells were passaged at weekly intervals. 
 
 
2.2.2 - Storage in liquid nitrogen 
 
Cells were cultured in 24 well plates (Nunc, Fisher Scientific, Leicestershire U.K.). 
The cells from two wells were pooled and centrifuged at 150 x g for 7 mins (Wifug 500E). 
The supernatant was discarded and the pellet re-suspended by gently flicking. 
DMEM+ (1.5 ml) containing DMSO (10 % v/v, Sigma, Dorset U.K.) was added and 
mixed smoothly. The content of each tube was then aliquoted into two cryovials, which were 
immediately wrapped in bubble wrap and transferred to a -70°C freezer. The following day 
the cryovials were stored in liquid nitrogen.   
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2.2.2.1  -  Thawing cells  
 
To thaw cells 9 ml of DMEM with additives (5 ml sodium pyruvate (100 mM), 5 ml 
L-glutamine (200 mM), 2.5 ml streptomycin/penicillin (10000 units penicillin in 20 ml; 10 mg 
ml-1 streptomycin)), were placed into a 15 ml centrifuge tube (Sterilin, Scientific Laboratories 
Supplies, Lanarkshire, Scotland). To the bottom of the centrifuge tube 1 ml of FBS was added 
very carefully in order not to mix with the DMEM and 2 layers of solution could be observed. 
 Cryovials were placed into a 37°C waterbath (Techne UB-8) until their contents 
thawed. Cells were carefully added to the top of the medium and centrifuged 150 x g for 7 
mins. The medium was then discarded and the cell pellet resuspended by gently flicking the 
bottom of the tube. Myeloma cells were resuspended in 10 ml of medium and transferred to a 
25 cm3 flask (Nunc, Fisher Scientific Leicestershire U.K.). Hybridoma cells were resuspended 
in 1 ml of DMEM+ and transferred to a single well of a 24 well plate. 
 
 
2.2.3 - Concentration of monoclonal antibodies 
 
The concentration of MAbs was achieved by using 20 ml Vivaspin (VivaScience, 
Epsom U.K.) columns. These columns have a membrane with molecular weight cut off of 10 
000. The MAbs samples were spun at 3 000 x g at 4°C. 
 
 
2.2.4 - Purification of monoclonal antibodies 
 
Monoclonal antibodies were purified with pre-packed Protein-G columns  (Hi Trap 
Protein G HP, Amersham, Bucks U.K.). These columns were purchased pre-packed with 
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protein G Sepharose™. This protein is used for purification of IgG antibodies and all the 
MAbs purified are IgG. 
Hybridoma supernatant (50 ml) was filtered twice through a 0.45 μm filter (Sartorius, 
Surrey U.K.) and then diluted 1:1 in binding buffer (Appendix 1). Buffers used were freshly 
prepared and filtered though a 0.45 μm filter (Appendix 1). 
A liquid chromatography system (Econo System of Bio-Rad, composed of a pump, 
UV monitor, system controller and 2110 fraction collector) was used for purification of 
monoclonal antibodies. Prior to use by passing approximately 20 ml of distilled water through 
the tubing system the liquid chromatography system was cleaned. Binding buffer was run 
through the system prior to adding the purification columns.  
The Hi Trap column was placed in the Econo System and washed with binding buffer 
(∼10 ml). After washing, the MAb sample was added and run through the column. The sample 
was added carefully to prevent the formation of bubbles. The column was washed with 
binding buffer until all unbound material was removed as assessed by UV spectrophotometric 
analysis of the effluent. 
Bound antibodies were eluted with Glycine-HCl (0.1 M, pH 2.7, Appendix 1) and 
collected using a fraction collector (Econo System - 2110 fraction collector, Bio-Rad). The 
low pH of the elution buffer promotes the disruption of the covalent bonds between the 
antibodies and the protein G Sepharose. Collection tubes were prepared by the addition of 130 
μl of Tris-HCl (1 M, pH 9, Appendix 1). This buffer raises the pH of the antibody solution. 
Thirty drops of column eluante were collected per tube. The elution step was performed until 
no unbound material was present in the effluent as assessed by UV spectrophotometric 
analysis of the column eluante. 
Columns were cleaned with 20 % v/v ethanol, and stored in the same solution at 4°C. 
All the procedures performed with the column were at a speed of 1 ml per minute, the 
maximum recommended for the column by the manufactures. 
The liquid chromatography system was washed with distilled water (∼50 ml) after 
use. 
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Spectrophotometric analysis (Cecil CE 2021) at a wavelength of 280 nm was 
performed to identify the fractions containing monoclonal antibodies. 
 
 
2.3 -  Determination of protein concentration  
 
The protein concentration of purified betanodavirus samples was determined with 
either the Bio-Rad protein assay kit (Bio-Rad, Hertfordshire U.K.) or the BCA protein assay 
(Pierce, Northumberland U.K.). The protein concentration of purified monoclonal antibody 
samples was determined using the BCA protein assay. 
 
 
2.3.1 - Bio-Rad protein assay kit 
 
The Bio-Rad’s protein assay is based on the Bradford method. The absorbance of 
acidic Coomassie Blue Brilliant G-250 shifts from 465 to 595 nm when bound to protein.  
A 250 μg ml-1 stock solution of BSA (bovine serum albumine, Sigma, Dorset U.K.) in 
TNE buffer (pH 7.6) was used to prepare a set of standards with concentrations ranging from 
2.5 and 25 μg ml-1. Virus samples were diluted in the same buffer.  
The dye reagent was filtered through Whatman (Fisher Scientific, Leicestershire 
U.K.) number 1 filter paper prior to use. 
The standard or virus sample (800 μl) were mixed with 200 μl of dye reagent and 
vortexed gently. After 35 mins incubation at room temperature the absorbance of 
samples/standards was determined at a wavelength of 595 nm (Cecil CE 2041). A standard 
curve was constructed from the absorbance values of the BSA standards, and this was used to 
calculate the protein concentration of virus samples.  
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2.3.2 - BCA protein assay kit  
 
The BCA protein assay reagent kit (Pierce) is based on the application of 
bicinchoninic acid (BCA) for colorimetric detection and quantification of total proteins. 
The procedure could detect input concentrations of protein ranging from 20-2000 μg 
ml-1. Samples and detection reagent were mixed (1:8 ratio) in 96 well plates. The detection 
reagent was prepared by the addition of 50 parts reagent A to 1 part of reagent B. 
A series of protein standards was prepared by dilution of albumin standard (Pierce, 
Northumberland. U.K.) in Glycine-HCl (for analysis of Monoclonal antibodies) or TNE (for 
betanodavirus samples). 
Twenty five μl of sample or standard were mixed with 200 μl of detection reagent and 
mixed gently with a pipette tip. The samples were microwaved for 30 seconds at 850 V and 
allowed to stand for 10 mins at room temperature. The absorbance of samples was then read 
in an ELISA plate reader (Dynex Technologies MRXII) at a wavelength of 540 nm.  A 
standard curve was constructed from the absorbance values of the protein standards, and this 
was used to calculate the protein concentration of virus or monoclonal antibody samples. 
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2.4 -  ELISA 
 
ELISA plates (Immulon® 4 HBS flat bottom, Thermo Labsystems, Middlesex U.K.) 
were coated with 50 μl well-1 of 0.01 % poly-L-lysine (Sigma, Dorset U.K.) and left to adsorb 
for 60 mins at room temperature. The plates were washed 3 times with LSWB (Low Salt 
Washing Buffer, Appendix 1), 100 μl well-1 of antigen was added and incubated at 4°C 
overnight. 
Virus supernatant, cell line supernatant and bacteria (suspension in PBS) were used as 
antigens for coating the ELISA plates. 
The following morning, 50 μl well-1 of 0.05 % gluteraldehyde (Sigma, Dorset U.K.) 
(Appendix 1) was added and incubated for 20 mins at room temperature. Plates were washed 
3 times with LSWB and 250 μl well-1 of blocking buffer (Appendix 1) was added and left to 
block for 2 hours at room temperature. The washing procedure was repeated. 
Antibodies (mouse and rabbit sera, MAbs or polyclonal antibodies) were added (100 
μl well-1) and incubated for 90 mins at room temperature. Polyclonal antibody was used as a 
positive control and antibody buffer (Appendix 1) as a negative control. When needed, the 
antibodies were diluted in antibody buffer.  
After this incubation the wells were washed 5 times with HSWB (High Salt Washing 
Buffer) and soaked for 5 mins in the last wash. 
Either 100 μl well-1 of anti-mouse IgG conjugated with HRP (Diagnostics  Scotland, 
Edinburgh Scotland) or anti-rabbit IgG conjugated with HRP (Sigma, Dorset U.K.) was 
added. The antibody conjugated with HRP was diluted 1:1000 v/v in conjugated buffer 
(Appendix 1) and incubated for 60 mins at room temperature. The washing procedure with 
HSWB was repeated. 
Substrate (100 μl well-1, Appendix 1) was added to each well and incubated for 10 
mins at room temperature. After this period 50 μl well-1 of stop solution (Appendix 1) was 
added.  
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The ELISA assay was read at 450 nm in ELISA Reader (Dynex Technologies 
MRXII). 
The average of the negative control was calculated. A sample was considered positive 
when its value was 3 times higher than the negative control average. 
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2.5 -  Molecular biology 
2.5.1 - Nucleotide Sequencing 
2.5.1.1  -  Cycle-Sequencing PCR 
 
The DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Biosciences, Bucks 
U.K.) was used for nucleotide sequencing. 
The polymerase chain reaction (PCR) procedure was performed according to the 
manufacturer’s instruction. The premixed sequencing reagent was diluted 1:4 by addition of 
sequencing reagent buffer (Appendix 1). 
The PCR reaction solution was prepared by mixing 1 μl of primer (5 pmol), 2 μl 
sequencing reagent premix, 6 μl sequencing reagent buffer and 11 μl sample.  The DNA 
concentration was adjusted to between 0.1-0.2 pmol in nuclease-free water (Promega, 
Southamptan U.K.). The sequencing mix was briefly centrifuged (Heraus biofuge pico) prior 
to thermal cycling, which was performed in a Biometra Tgradient thermocycler.  
Cycling parameters were 25 cycles of:  
                     94°C, 10 seconds;  
                     50°C, 20 seconds;  
                     60°C, 1 minute.  
 
Samples were stored at at 4°C or -20° C according to the availability of an automated 
nucleotide sequencer 
 
2.5.1.2  -  Precipitation of sequencing-PCR reaction products 
 
Precipitation solution (52 μl, Appendix 1) was added to PCR reaction products which 
were vortexed briefly and incubated on ice for 5 mins. The tubes were then centrifuged at 13 
793 × g (Denville Scientific Inc. Micro 240A) for 20 mins at room temperature and the 
supernatant discarded. The pellet was washed with 190 μl of 70 % ethanol, then samples were 
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centrifuged at 13 793 × g for 5 mins at room temperature. The supernatant was discarded and 
samples were dried prior to addition of 2 μl of Formamide Loading dye (supplied with 
DYEnamic ET Terminator Cycle Sequencing Kit, Amersham, Bucks U. K.). 
Samples were stored at -20°C or analysed immediately. 
 
2.5.1.3  -   Sequencing  
 
Sequencing reactions were analysed on an ABI Prism™ 377 sequencer using 0.2 mm 
acrylamide gels of 36 cm length.  
Plates were washed with distilled water and allowed to air dry, then placed into the 
caster. A 0.2 mm thick spacers were placed between the 2 plates, aligned with the plates and 
clamped into the supporter. 
The acrylamide sequencing gel was prepared (Appendix 1), a 50 ml syringe was filled 
with the gel mix and immediately injected between the plates. This procedure was performed 
very carefully to prevent the formation of bubbles. The caster comb was then positioned on 
top of the gel, which was allowed to polymerise for 2 hours at room temperature. 
After this period the comb was removed and the upper surface of the gel was cleaned 
taking care to remove any gel debris. The area of the sequencing plates that are laser-scanned 
was cleaned with distilled water. 
Samples were loaded either manually or by the Ficoll method as explained below. 
Sequencing gels were electrophoresed at 3000 V, 50 mA, 150 W for 7 hours at 51°C. 
The power of the laser was 40 mW. ABI Prism® sequencing analysis software version 3.4.1 
(Applied Biosystems) was used to analyse electropherograms. Nucleotide sequences were 
compiled with BioEdit Sequence Alignment Editor software (Hall, 1999). The samples were 
analysed visually in order to establish if the sequence data could be further analysed or if the 
sample needed to be repeated. A sample was considered for further analysis when the graph 
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produced automatically by the program revealed clear peaks for each nucleotide. When some 
background occurred the reading was analysed and sequenced again if necessary.   
 
2.5.1.3.1 -  Manual loading method 
 
For manual loading a shark tooth comb (PE Biosystems, Cheshire U.K.) (48 or 62 
wells) was inserted into the gel to a maximum depth of 1mm. 
Sequencing gels were loaded into the sequencer and a plate check performed. The 
heating plate and the upper and lower buffer chambers were then clamped in position. The 
buffer chambers were filled with 1x TBE buffer (Appendix 1) and a pre-run was performed. 
When the gel reached a temperature of 48°C, the pre-run was stopped and the odd-numbered 
samples (0.8-1.3 μl) were loaded with Miniflex 0.2 mm tips (Sorenson™, Anachem, 
Bedfordshire U.K.). The gel was then run for 3-4 mins at 3 000 Volts and stopped before the 
even-numbered samples were loaded. When sample loading was complete, the gel was 
electrophoresed at 3 000 Volts for 7 hours. 
 
2.5.1.3.2 -  Ficoll loading method 
 
Plates were cleaned, loaded into the sequencer, and a plate check performed as 
described above. The lower buffer chamber and heating plate were positioned, and the 
chamber filled with 1x TBE buffer. A pre-run was performed until the gel reached a 
temperature of 51°C. To the top of the gel plate 400 μl of Ficoll loading buffer (Appendix 1) 
was added using 1 ml syringe with a 25G needle taking care to avoid the formation of 
bubbles. 
A loading tray was cooled down to 4°C and 0.8 μl of sample was added to the loading 
tray wells. Carefully a membrane comb (The Gel Company, Web Scientic Ltd, Cheshire 
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U.K.) was inserted into loading tray wells and allowed to absorb the samples for 10 seconds. 
The membrane was removed and immediately inserted into the sequencing gel. During this 
procedure the teeth of the comb slightly contacted the gel surface. 
The upper buffer chamber was positioned and filled with 1x TBE buffer. The gel was 
electrophoresed at 3000 Volts for 90 seconds, the membrane comb was removed and the gel 
rinsed thoroughly with 5 ml of TBE to remove the Ficoll solution. Electrophoresis was then 
continued for 7 hours.   
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Chapter 3 - Production of monoclonal and polyclonal antibodies 
against betanodavirus 
 
3.1 -  Introduction 
 
Immunity is defined as resistance to disease, especially infectious diseases. The 
collection of cells, tissues and organs involved in this resistance is the immune system, and 
the coordinated reaction of these cells and molecules to infectious microbes is the immune 
response (Abbas and Lichtman, 2001). The protective action of the immune system can range 
from simple biochemical and cellular defence mechanisms in invertebrates such as sponges 
and worms, to very complex networks of immune cells and molecules found in vertebrates 
like mammals and birds (Davey, 1989). 
The host defence mechanism consists of innate immunity and adaptive immunity. The 
first line of immune defence is the former being mainly responsible for the first stage of 
expulsion of microbes and it may provoke inflammation (Lydyard et al.  2000). The principal 
components of innate immunity are: c physical and chemical barriers, such as epithelial and 
antimicrobial substances produced at epithelial surfaces; d phagocytic cells (neutrophils and 
macrophages) and natural killer (NK) cells; e blood proteins, including components of the 
complement system and other mediators of inflammation; f proteins called cytokines such as 
IL-1 and TNFα that regulate and coordinate many of the activities of the cells involved in 
innate immunity (Abbas et al. 2000, Roitt and Rabson, 2000). The main characteristics of this 
type of immune response are the fact that is rapid, has some specificity and no memory 
(Lydyard et al. 2000). 
The second line of immune defence is adaptive immunity, comprising humoral and 
cell-mediated immunity. The former provides defence against extracellular microbes and is 
mediated by antibodies (Ab), which are produced by B-lymphocytes (Golub, 1981). The B-
cells have a high diversity, with the potential to generate ~ 108-1010 different antigen binding 
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antibodies (Kuby, 1994). The B-cell population matures under the influence of bone marrow 
and/or gut-associated tissue in mammals (Lydyard et al. 2000). Antibodies do not have access 
to intracellular microbes thus cell-mediated responses involving T-lymphocytes come into 
play (Abbas and Lichtman, 2001). The T-cells mature under the influence of the thymus (Bier 
et al. 1986). All humoral and cell mediated immune responses to foreign antigens have a 
number of fundamental properties (specificity, diversity, memory, specialization, self-
limitation and non-reactivity to self) that reflect the properties of the lymphocytes that mediate 
these responses (Table 3.1) (Abbas et al. 2000). 
 
Table 3.1 – Properties of the adaptive immune system (Abbas et al. 2000). 
 
Feature Function significance for immunity 
Specificity Guarantees that distinct microbes elicit specific responses 
Diversity Allow the immune system to respond to a large variety of microbes 
Memory Leads to enhanced responses to repeated exposures to the same microbe 
Specialization Generates responses that are optimal for defence against different types of microbes 
Self-limitation Allows immune system to respond to newly encountered microbes 
Non-reactivity to self Prevents injury to the host during response to microbes 
 
 
The adaptive immune response consists of sequential phases, each of them 
corresponding to a particular reaction of the lymphocytes and other components of the 
immune system (Figure 3.1).  
When a pathogen infects a host for the first time a primary response will develop 
within 4-5 days (Lydyard et al. 2000).  The response to this first exposure to an antigen is 
mediated by naïve lymphocytes and is called the recognition phase (Abbas and Lichtman, 
2001). For B-cells this response results in IgM being secreted initially and often followed by 
IgG (Kuby, 1994). Interaction of B-cells with antigen and the appropriate costimulatory 
signals leads to B-cell activation (activation phase) (Welsh et al. 2004). The B-cells are able 
to bind to both continuous and discontinuous sequences of amino acids, whereas the T-cell 
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recognises linear processed peptide epitopes bound to the major histocompatibility complexes 
(MHC) on molecules (Atabani, 2001). 
 
 
Figure 3.1 – Sequential phases of the adaptive immune response (Abbas and Lichtman, 2001). 
 
 
The activated B-cells proliferate and differentiate either into memory cells or plasma 
cells also known as effectors (effector phase) (Davey, 1989). The plasma cells may produce 
IgM or may undergo isotype switching and secrete IgG or IgA (Welsh et al. 2004).  When the 
antigen has been removed the antibody response will reach its peak; followed by a decrease in 
Ab concentration in the circulation (decline phase) as a result of the normal rate of catabolism 
of the antibody by the memory cells (memory phase) (Lydyard et al. 2000, Abbas and 
Lichtman, 2001). Subsequent encounters with the same antigen lead to immune responses that 
are usually faster, with higher affinity, reaching a greater magnitude and lasting longer (Kuby, 
1994). The characteristics of this secondary responses are the result of activation of memory 
lymphocytes, which are long-lived cells that were induced during the primary immune 
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response (Abbas and Lichtman, 2001) (Figure 3.2). Within humoral immunity this secondary 
response usually corresponds to the IgG class (Lydyard et al. 2000).   
 
 
Figure 3.2 – Primary and secondary humoral immune response (Abbas et al. 2000). 
 
 
Viruses may be extracellular before they enter host cells, or in the case of cytopathic 
viruses, when they are released from lysed infected cells (Abbas et al. 2000). Natural 
immunity to viral infections is associated with interferon type I (IFN) and NK cells. The 
interferons have a protective capacity before the virus infects a cell, by inducing resistance to 
viral multiplication (Roitt et al. 1985). Humoral immunity against viral infections is mediated 
by antibodies which block virus binding and entry into host cells (Abbas et al. 2000). Once a 
viral infection is established, cell mediated immune mechanisms are most important, with 
CD8+ cytotoxic T-cells and CD4+ TH1 cells being the main components involved (Kuby, 
1994). Both types of adaptive immunity interact with each other, with B-cells presenting 
peptide epitopes to CD4+ T-cells, and T-cells producing cytokines and other 
immunomodulators that provide help for antibody production and induction of memory B-
cells (Atabani, 2001). 
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Anti-viral antibodies are essential tools in the study of viruses and virus host 
interactions. B-cells can recognise a variety of viral proteins and glycoproteins, including 
components of the envelope and interior components of the nucleocapsid, which may be 
released from infected host-cells prior to complete viral assembly (Kuby, 1994).  
Viruses are often antigenically complex and one of the major problems associated 
with the use of antiviral antisera has been the difficulty of producing antisera of unequivocally 
defined specificity for individual viral components (Yewdell and Gerhard, 1981). The 
problems associated with polyspecificity of antisera are largely avoided by the use of 
monoclonal antibodies (MAbs). A monoclonal antibody is an antibody with a unique 
specificity derived from a single B-cell clone (Nelson et al. 2000). The production of 
monoclonal antibodies was achieved for the first time 30 years a go by Köhler and Milstein 
(1975). In 1986 these scientists were awarded the Nobel Prize for their contribution for the 
production of monoclonal antibodies. This award reflects the importance that this technique 
has had in the investigation, diagnosis and even treatment of diseases.  
Monoclonal antibodies against fish viruses have been developed against a variety of 
fish viruses including infectious haematopoietic necrosis virus (IHNV) (Schultz et al. 1985, 
Ristow and Arnzen, 1989), infectious pancreatic necrosis virus (IPNV) (Wolski et al. 1986), 
viral haemorrhagic septicaemia virus (VHSV) (Mourton et al. 1991), salmon pancreas disease 
virus (SPDV) (Todd et al. 2001), grouper iridovirus (Shi et al. 2003) and infectious salmon 
anaemia virus (ISAV) (Falk et al. 1998). The development of MAbs against nodavirus was 
already achieved by Nishizawa et al. (1995b) with the production of MAbs against striped 
jack betanodavirus strain (SJNNV). Lai et al. (2001a) also successfully obtained MAbs 
against yellow grouper betanodavirus strain (YGNNV). 
The exquisite specificity of MAbs is the main reason why they are so often considered 
superior to polyclonal antibodies (Peppard, 2000). Monoclonal antibodies have replaced 
polyclonal antibodies in most large-scale serology. In the basic science laboratory, however 
where smaller amounts of antibodies are required, conventional polyclonal antisera may still 
be preferable for many purposes (Yelton and Scharff, 1981). It usually takes four to six 
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months to generate a stable hybridoma cell line, if all goes well, whereas producing small 
amounts of antiserum requires less time, energy and expense. If an antigen does not yield a 
good antiserum it is often difficult to generate monoclonal antibodies to it (Yelton and 
Scharff, 1981). Any given MAb may be very sensitive to physical conditions such as pH and 
temperature, which may change its reactivity and functional activity (Mosmann et al. 1980).  
Monoclonal antibodies have only a subset of the properties of a conventional antiserum, and 
therefore it is unlikely that antibody produced by just one hybridoma cell line can fulfil all 
requirements for all assays (Yelton and Scharff, 1981). 
The recognition of multiple determinants limits antigenic analysis with polyspecific 
antisera and precludes characterization on individual antigenic sites of a protein (Yewdell and 
Gerhard, 1981). On the other hand, the use of monoclonal antibodies has allowed the 
delineation of antigenic structure at a level of precision not previously possible, because 
MAbs recognised only a single site and not an average of determinants (Benjamin et al.  
1984). 
Prior to the application of the MAbs to antigenic studies they need to be characterised, 
since the interpretation of antigenic analysis is dependent on the homogeneity and specificity 
of the hybridoma antibodies (Yewdell and Gerhard, 1981). 
Monoclonal antibodies have become key components in clinical laboratory diagnostic 
tests since they enable the development of standardises immunoassay systems. The wide 
application in detecting and identifying serum analytes, cell markers and pathogenic agents 
has largely arisen through the exquisite specificity of these unique reagents (Nelson et al.  
2000). 
 
 
3.1.1 - Production of hybridoma cells  
 
Monoclonal antibodies are obtained through the production of a specific hybridoma 
cell line to a pre-determined antigen. 
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Most MAbs have been produced using the BALB/C mouse because the fusion 
partners (myeloma cell lines) have been developed from plasmacytomas induced in this strain 
by the intraperitoneal injection (IP) of mineral oil (Dean and Shepherd, 2000).  
When soluble proteins or carbohydrates are used for immunising mice they are 
usually mixed with an adjuvant. Adjuvants are substances which non-specifically enhance the 
immune response to antigens (Roitt et al. 1985). An adjuvant may function as an antigen-
depot-forming substance, a delivery vehicle or inert carrier, an immunostimulator/ 
immunomodifier (able to stimulate cells of the immune system or modify immune cell 
activation), or a combination of these (Hanly et al. 1995). Certain adjuvants such as 
aluminium compounds, oil emulsions, liposomes, and synthetic polymers act through the 
effect of antigen localization ("depot" effect) (Jennings, 1995). This “depot” effect provides a 
protected reservoir of antigen for slow release to draining lymph nodes, helping promote 
formation of memory cells and prolonged Ab responses (Hanly et al. 1995), and inducing 
complex cell interactions between macrophages and lymphocytes (Jennings, 1995). Adjuvants 
can be been categorized according to: 1 their origins, whether they are derived from mineral, 
bacterial, plant, synthetic, or whether they are host a product, such as Interleukin 1; 2 their 
proposed mechanism of action. Freund’s complete adjuvant has been the most widely used 
adjuvant. This is a mineral oil containing mycobacteria that acts as a slow release agent 
preventing rapid dispersion of soluble immunogens and elicits a strong cellular infiltrate of 
neutrophils and macrophages at the site of injection (Dean and Shepherd, 2000).  
As a result of the memory of the adaptive immune system of mice and the fact that the 
strongest immune response follows secondary encounters with the antigen, the immunisation 
of the mice is usually performed twice. The booster immunity is given with Freund’s 
incomplete adjuvant (i.e. mineral only). These immunisations should be performed several 
weeks apart when the serum titres have dropped after immunisation. Re-immunisation when 
the levels of antibodies are still high will lower the effective strength of the boost (Harlow and 
Lane, 1988). 
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The antibody response is also influenced by the anatomical site at which immunogens 
are administered (Liddell and Cryer, 1991). Intraperitoneal injection (IP) is the most common 
immunisation method for mice used due to two factors (Harlow and Lane, 1988). Firstly the 
capacity of the peritoneal cavity allows the use of larger volumes of the immunogens. 
Secondly IP immunisation does not deliver antigens directly into the blood system and 
therefore adjuvants can be used  
Mature antibody-secreting cells fuse poorly with myeloma cells and it is the 
committed precursors that are required for hybridoma production. For this reason a third and 
final boost is given to the mouse 3-5 days before the fusion between the spleen cells and 
myeloma cells is performed (Dean and Shepherd, 2000). This boost is performed by 
intravenous injection (IV) without adjuvant and a rapid and strong response can be expected, 
as the antigen will be collected quickly in the spleen, liver and lungs (Harlow and Lane, 
1988). 
For MAb production the host spleen cells are mixed with a selected cell line and the 
mixed cells exposed to an agent that promotes the fusion between the cells (see Figure 3.3). 
The immortal cell partners for the antibody-producing cell are myeloma cells, cancerous cells 
derived from the immune system (Liddell and Cryer, 1991). The myeloma cell lines originally 
used secreted immunoglobulin molecules that were a mix of the spleen and the myeloma H 
and L chains (Yelton and Scharff, 1981). These problems were overcome by the use of 
myeloma cell lines, such as SP2/0, that do not produce L and H chains (Shulman et al. 1978). 
The maintenance and health of the myeloma fusion partner is of major importance for the 
success of the fusion, with the best results achieved with myeloma cells thawed from liquid 
nitrogen just a few days prior to the fusion procedure (Hunt et al. 2000). 
The mechanism of fusion is complex, involving cell agglutination, membrane fusion, 
cell swelling and optimal environmental conditions (Knutton and Pasternak, 1979). The 
original agent used by Köhler and Milstein (1975) for enhancing the frequency of fusion 
between cells was inactivated Sendai virus. Nowadays a large number of chemicals can be 
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used to induce the fusion between cells, but the most commonly used chemical “fusogen” is 
polyethylene glycol (PEG) (Klebe and Mancuso, 1981).  
 
 
Mouse immunised 
three times with 
antigen 
Mouse 
spleen 
cells
SP/0 
cells
PEG
Fusion
Mitosis
Hybrid cells
Fusion between mouse spleen 
cells and myeloma cells
Selection of fusion cell 
with HAT medium
Selection of 
antibody produced 
cells by ELISA
Selection of clones 
by limiting 
dilution
Hybridoma cells 
secreting the 
desired antibody
 
Figure 3.3 – Hybridoma cell line production. 
 
 
Polyethylene glycol (PEG) fuses the plasma membranes of adjacent myeloma and 
antibody secreting cells, forming a single cell with two or more nuclei. During mitosis and 
further rounds of division, the individual chromosomes are segregated into daughter cells 
(Harlow and Lane, 1988). In the presence of abnormal number of chromosomes, segregation 
does not always deliver identical sets of chromosomes to daughter cells, and chromosomes 
may be lost (Harlow and Lane, 1988, Nelson, 2001). If the chromosome that carries a 
functional gene (e.g. those responsible for rearranged immunoglobulin heavy or light chain 
genes) is lost then production of the antibody will stop, leading to unstable hybridoma cells 
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(Nelson, 2001). This unstable hybridoma cell line will be seen phenotypically by decreasing 
of antibody titres (Harlow and Lane, 1988).  
The fusion protocol results in a mixture of parental cells, hybrids of each parent to 
itself, and most importantly, hybrids between one parent and the other (Yelton and Scharff, 
1981). The selection of the hybrids between mouse spleen cells and myeloma cells is based on 
the fact that cells possess two pathways of nucleotide biosynthesis: c the de novo pathway, 
that is the normal pathway and d the salvage pathway which uses an enzyme called 
hypoxanthine guanine phosphoribosyl transferase (HGPRT) (Nelson, 2001). The 
hypoxanthine-aminopterin-thymidine (HAT) selection system is usually employed for the 
selection of the hybrids between the two parents. The myeloma parent has been engineered 
with a genetic defect for the enzyme hypoxanthine guanine phosphoribosyl transferase 
(HGPRT-) (Dean and Shepherd, 2000). The HGPRT- cells cannot use exogenous 
hypoxanthine to synthesize purines (salvage pathway) just being able to use the de novo 
pathway for this synthesis (Yelton and Scharff, 1981).  The de novo pathway is blocked by the 
aminopterin (Nelson, 2001). The myeloma cells die in the presence of hypoxanthine, 
aminopterin and thymidine because both pathways for the formation of the purine precursors 
of DNA are blocked (Liddell and Cryer, 1991). Spleen lymphocyte cells, although not killed 
by aminopterin, will not proliferate in culture, so after a few days the only rapidly dividing 
cells remaining are myeloma-spleen hybrids (Yelton and Scharff, 1981). Aminopterin inhibits 
many of the normal cell functions and should be removed from the feeding medium as soon as 
possible (Campbell, 1984). Usually the HAT is replaced with HT (hypoxanthine and 
thymidine) to allow the emerging cells to adapt to the main pathways of purine and 
pyrimidine biosynthesis (Campbell, 1984). 
The hybrids need to be screened with a rapid, simple and sensitive assay because just 
a small percentage of the hybrids generated produce the desired antibody (Yelton and Scharff, 
1981).  Screening is normally carried out 10-14 days post-fusion by removing samples of the 
cell culture supernatant. This screening is vital for the final result, because the selection of the 
hybridoma colony to pick, expand and clone is based on it (Dean and Shepherd, 2000). Once a 
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positive hybrid is identified it should be cloned to avoid overgrowth by other hybrids or by 
non-producing variants (Yelton and Scharff, 1981). Cloning is an essential part of MAb 
production, ensuring that a single clonally expanded B-cell produces the antibody (Melamed 
and Sutherland, 1997). Cloning by limiting dilution is the most common method used to 
obtain single clone wells (Harlow and Lane, 1988). The use of feeder cells is vital during this 
procedure in order to achieve reasonable cloning efficiencies (Melamed and Sutherland, 
1997). The isolated single cell clones are re-screened and re-cloned several times. After 
subclones are rescreened to identify those still producing the antibody of interest, just a few of 
them are grown to mass culture and frozen for future recovery and applications (Yelton and 
Scharff, 1981). Single-cell cloning ensures that the antibody producing cells are truly 
monoclonal (Harlow and Lane, 1988).  
 
 
3.1.2 - Objectives  
 
The aim of this study was to produce monoclonal antibodies against betanodavirus 
and to apply these in epitope mapping studies. 
The MAbs obtained were characterised and their application as diagnostic tools was 
explored. Western Blot, immunohistochemistry and neutralisation assays were also optimised 
using the anti-betanodavirus MAbs obtained. 
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3.2 -  Materials and Methods 
3.2.1 -  Antigen  
 
The European sea bass (Dicentrarcus labrax L.) betanodavirus strain used was used 
for the production of polyclonal and monoclonal antibodies. The virus was cultured and 
purified as described in Chapter 2.  
 
 
3.2.2 - Polyclonal antibodies 
3.2.2.1  -  Immunisation 
 
One female New Zealand rabbit was immunised in order to obtain polyclonal 
antibodies against European sea bass nodavirus. The purified nodavirus sample was obtained 
as described in Chapter 2. The virus (50 μg ml-1) was mixed 1:1 with Titremax® Gold 
(TitreMax, CyT Rx® corp. USA, Stratech Cambridgeshire U.K.).   Titremax® Gold, used as an 
adjuvant and does not contain mineral oil, proteins, polysaccharides or other microbial 
products. These characteristics minimise or eliminate the undesirable side effects caused by 
most common adjuvant used, such as Freund’s Complete Adjuvant (FCA). Titremax® is 
completely non-toxic to users and animals. It induces a moderate transitory inflammation, 
while FCA induces a severe inflammation. In addition it does not induce a hypersensitivity 
granulomatous response (http://www.titremax.com).  
The virus was mixed with the adjuvant using two latex free syringes (1 ml, Henke 
Sass Wolf GMBH, Germany) linked by a Leur lock and the solution was mixed until a white, 
thick solution was obtained.  
The rabbit was injected subcutaneously (SC) at 4 sites, with 0.1 ml of virus:adjuvant 
solution per site. This procedure was repeated 4 weeks later. The third and final immunisation 
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was given after another 4 weeks by intravenous injection (IV) with 600 μl of nodavirus (50 μg 
ml-1 of virus in TNE buffer). 
The rabbit was sacrificed 12 days later and blood collected by cardiac puncture (5 ml 
syringe, Terumo, Merseyside U.K.). 
 
3.2.2.2  -  Collection of rabbit blood  
 
In order to verify specific antibody production rabbit blood was collected. The blood 
was collected from the marginal ear vein. The fur on the ear was shaved off carefully with a 
scalpel blade, then the region was wiped with ethanol and the marginal ear vein was cut with a 
sterile scalpel. The drops of blood were collected into a 1.5 ml eppendorf tube. 
The blood was allowed to clot overnight at 4°C. On the following day it was 
centrifuged for 5 mins at 15 800 x g (Thermo IEC microlite), the serum collected and stored at 
-20°C. 
A pre-immunisation sample was collected on the same day as the first immunisation 
and another two samples were collected 10 days after the first and second immunisation. The 
rabbit serum was tested by ELISA (see Chapter 2). 
 
 
3.2.3 - Monoclonal antibody production 
3.2.3.1  -  Immunisation 
 
For the production of monoclonal antibodies against European sea bass betanodavirus 
3 mice were immunised with 30 μg ml-1 of virus. The nodavirus was diluted in TNE buffer 
and mixed with adjuvant Titremax® Gold as described in section 3.2.2.1.   
The mice were immunised IP with 0.2 ml of virus:adjuvant spread over 3 sites. The 
same procedure was performed for the first boost 4 weeks later. The final boost was given 
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without adjuvant IV (0.1 ml of virus in TNE buffer) after another 4 weeks. The mouse that 
presented the highest antibody titre by ELISA was chosen for the last boost.  
 
3.2.3.2  -  Collection of mouse blood 
 
Mouse blood was collected in order to test the titre against the virus. This operation 
was performed once before the first immunisation and 10-14 days after the first IP and the 
first boost. 
The mouse’s tail was wiped with alcohol and the tail vein cut with a sterile scalpel. 
The blood drops were collected into a 1.5 ml eppendorf tube and allowed to clot overnight at 
4°C. The following day the blood was centrifuged for 5 mins at 15 800 x g (Thermo IEC 
microlite), the upper serum layer collected and stored at -20°C. 
On the day that the mouse was sacrificed the blood was collected by cardiac puncture 
with a 2 ml sterile syringe (Terumo, Merseyside U.K.). 
Mice sera were screened by ELISA (as described in Chapter 2) using a 10-fold 
dilution series and the end-point titre of the sera antibodies was obtained.  
 
3.2.3.3  -  Fusion 
3.2.3.3.1 -  Myeloma cells 
 
Myeloma cells (SP2/0, Sigma, U.S.A.) were thawed for the fusion and cultured in 
DMEM+ (Chapter 2). 
On the fusion day, the cells were collected, DMEM with additives (sodium pyruvate, 
L-glutamine and streptamycin/penicillin) added up to 50 ml and then cells were centrifuged 
for 7 mins at 150 x g (Wifug 500E). The supernatant was discarded and the pellet was gently 
resuspended into 50 ml of DMEM with additives and placed in a CO2 incubator at 37°C. 
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3.2.3.3.2 -  Blood feeder medium   
 
Blood was collected from a non-immunised mouse in order to be used as feeder cells. 
The mouse was sacrificed using CO2 and blood collected by cardiac puncture using a 2 ml 
sterile syringe with sterile heparin (Sigma, Dorset U.K.) (10 i.u. in DMEM). 
A solution of DMEM+ and 10 % of HAT (hypoxanthine-aminopterine-thymidine, 
Sigma, Dorset U.K.) was prepared and kept at 37°C until mixed with the mouse blood. The 
mouse blood was mixed with DMEM+/HAT in a ratio of 1:300 of blood:medium and kept in 
the incubator until further utilization.  
 
3.2.3.3.3 -  Mouse spleen cells 
 
The immunised mouse was sacrificed using carbon dioxide. The abdomen was wiped 
with ethanol, aseptically opened and the spleen collected very carefully.  
The spleen was placed into 20 ml of DMEM, fat trimmed off and it was then washed 
by passing through three petri dishes containing DMEM. The organ was then “blown” by 
cutting off both ends and injecting 5 ml of DMEM through the spleen using a syringe and a 
needle. All the DMEM used was previously warmed up to 37°C. 
The cell suspension was placed into a centrifuge tube and DMEM with additives was 
added to make the volume up to 50 ml. The cells were then placed in the CO2 incubator at 
37°C. 
 
3.2.3.3.4 -  Fusion 
 
The spleen cells and the SP2 cells were centrifuged at 82.3 x g for 7 mins, supernatant 
discarded and the pellet gently resuspended in 10 ml of warmed DMEM with additives. 
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An aliquot of each type of cell was made and counted using a haemocytometer. 
All the spleen cells were mixed with myeloma cells to give a spleen:SP2 ratio of 4:1. 
The cell mix was centrifuged for 7 mins at 82.3 g. The pellet was aspirated as dry as possible 
and then resuspended by gently tapping. 
To the pellet was added 1 ml of warmed 50 % PEG (Sigma, Dorset U.K.) over 1 min, 
allowed to stand for 1½ mins swirling occasionally. Then 1 ml of warm DMEM was added 
over ½ min, 3 ml warm DMEM over ½ min, 16 ml warm DMEM over 1 min and the cells 
were left to stand for 5 mins. After this period the cells were centrifuged for 7 mins at 82.3 g, 
the pellet resuspended by gently tapping and 200 ml of blood feeder medium, was added. 
The cells were placed into sterile 96 well plates (Nunc, Fisher Scientific 
Leicestershire U.K) by adding 180 μl per well and incubated at 37°C with 5 % CO2. 
 
3.2.3.3.5 -  Screening the clones 
 
If the aim is generating as diverse an antibody panel as possible, a binary assay 
system should be used which is independent of antibody isotype and in which the binding of 
the antibody to the viral protein occurs in the absence of a competing interaction (Yewdell and 
Gerhard, 1981). Commonly used binary assays are the radioimmunoassay (RIA) and Enzyme-
Linked-Immunosorbent-Assay (ELISA) (Yewdell and Gerhard, 1981). In the present study 
the ELISA was the selection method chosen.  
The fused cells were allowed to stand for 10 days without being disturbed. After this 
period 100 μl of supernatant was collected and ELISA was performed to verify the production 
of antibodies (as described in Chapter 2). Positive antibody producing fusion cells were 
collected, placed into sterile 24 well plates (Nunc, Fisher Scientific Leicestershire U.K.) with 
1 ml of DMEM+ supplemented with 10 % HT (hypoxanthine-thymidine, Sigma, Dorset U.K.) 
and incubated for 7 days at 37°C with 5 % CO2. 
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After this period 100 μl of supernatant for each well was collected and ELISA was 
performed. The positive cells were selected, cloned by limiting dilution into 96 well plates 
and incubated for 7 days. The positive cells were also expanded to 2 wells of a 24 well plate 
and incubated for 7 days. After this period the cells were stored in liquid nitrogen (see Chapter 
2). These cells are called Parental cells.   
After a 7 day period of incubation the cloned cells were checked, wells with just one 
clone were selected and the supernatant screened by ELISA. The clones that were positive by 
ELISA were cloned again by limiting dilution in a 96 well plate and incubated for 7 days. 
This procedure was performed 3 times until the clone could be considered to be a hybridoma 
cell line producing antibodies. 
The positive clones of all the stages were expanded into 2 wells of a 24 well plate, 
incubated for 7 days and stored in liquid nitrogen.  
All the limiting dilution and expanding of the clones were performed with blood 
feeder medium. 
 
3.2.3.3.6 -  Expansion of hybridoma cell lines 
 
Following the selection procedure the hybridoma cells were expanded to a 24 well 
plate using 1 ml of blood feeder medium. After one week the cells were split into 1.5 ml of 
DMEM+. This procedure was repeated until the cells were used to growing without the mouse 
blood cells. After this period of adaptation the cells were expanded into 25 cm3 flask (Nunc, 
Fisher Scientific Leicestershire U.K.) in order to produce enough supernatant for further 
applications. 
The expansion was performed by adding 5 ml of DMEM+ to 25 cm3 flask. The 
content of 1 well of a 24 well plate was added per 25 cm3 flask and incubated for 7-10 days. 
The supernatant was collected, following centrifugation at 515 g for 10 mins and stored at -
20°C.  
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The cells were expanded into larger flasks, when larger volumes of antibody was 
required. 
 
 
3.2.4 - Characterisation of the antibodies 
 
The type of immunoglobulin and specificity of the monoclonal antibodies produced 
were determined. 
For both monoclonal and polyclonal antibodies, the neutralisation ability, molecular 
weight of antigen that they recognised and performance in immunohistochemistry was 
determined. 
 
3.2.4.1.1 -  Immunotyping 
 
The determination of the isotype serves not only to define the murine immunoglobulin 
class or subclass but also helps to identify the presence of a single isotype or a mixture isotype 
(Nelson et al.  2000). 
Immunotyping was performed using a Sigma ImmunoType™ kit (Sigma, Dorset 
U.K.). The procedure followed the manufacturer’s instructions. Forceps were used and all the 
incubations were performed at room temperature using a rocker shaker (Bibby Gyro-rocker). 
Briefly, the strip was placed into an assay tube, 3 ml of MAb supernatant was added 
and incubated for 30 mins. After this period the supernatant was decanted, the strip washed by 
adding 3-4 ml of PBS-T-BSA (PBS (Sigma, Dorset U.K.) with 0.05 % (v/v) Tween 20 
(Sigma, Dorset U.K.) and 2 % (w/v) BSA (Sigma, Dorset U.K.), and incubated for 5 mins. 
Meantime the biotinylated second antibody (anti-mouse conjugated with biotin) was prepared 
by adding 1 drop of biotinylated antibody to 2 ml of PBS-T-BSA (1:50 dilution). After the 
washing step, biotinylated antibody was added to the assay tube and incubated for 30 mins. 
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Once the incubation period had finished, the antibody was decanted and the strip was washed 
as previously described. The ExtrAvidin®-Peroxidase was added to the assay tube and 
incubated for 15 mins. The ExtrAvidin®-Peroxidase was prepared by adding 1 drop of 
extravidin to 2 ml of PBS-T-BSA. After the incubation period the ExtrAvidin®-Peroxidase 
was decanted and the strip was washed for 5 mins with PBS-T-BSA and 5 mins with PBS. 
The buffer was discarded and 2 ml of substrate solution was added. The substrate solution was 
prepared by mixing thoroughly 4 ml of water, 2 drops of substrate buffer (2.5 M Acetate 
buffer pH 5.0), 1 drop of substrate chromogen (3-amino-9-ethyl-carbazole in N,N-dimethyl 
formamide; AEC-DMF) and 1 drop of substrate (2 % v/v hydrogen peroxide). The reagents 
were added in this order. The strip was incubated until a clear, red insoluble signal was 
obtained for the positive control. Incubation was performed for a maximum of 10 mins. The 
strips were preserved by immersing them in distilled water for a few mins, drying in a paper 
towel and storing in a plastic sleeve protected from the light. 
 
3.2.4.2  -  Specificity 
 
The specificity of the MAbs was determined by screening them in ELISA (Chapter 2) 
against other strains of betanodavirus and different pathogens that may be present in fish or 
aquatic environment (Table 3.2). 
For the viruses tested the ELISA assays were performed with virus supernatant. The 
bacteria tested were resuspended in PBS.  
The antigenic specificity of the MAbs was analysed with other strains of 
betanodavirus belonging to different genotype clades. From BFNNV clade, Atlantic cod 
(Gadus morhua) and halibut (Hippoglossus hippoglossus) strains were used. Striped jack 
(Pseudocaranx dentex) strain was used for representing the SJNNV clade. 
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Table 3.2 – Strains of betanodavirus, cell lines and other fish viruses 
and bacteria used for test MAbs specificity. 
 
Antigen 
  
 Virus      Betanodavirus strains: 
            European sea bass (Dicentrarchus labrax) 
            Atlantic cod (Gadus morhua) 
            Halibut (Hippoglossus hippoglossus) 
            Striped jack (Pseudocaranx dentex) 
      Infectious Pancreatic Necrosis Virus - IPNV (serotype) 
      Salmon Pancreatic Disease Virus - SPPD 
      Infectious Salmon Anaemia Virus - ISAV 
      Sleeping Disease Virus -SDV 
       
  
Cell lines      CHSE - 214 
      SSN-1 
      SHK-1 
  
  
Bacteria      Vibrio vulnificus (biotype 2) 
      Vibrio harveyii (CECT 5978) 
      Vibrio anguillarum (type II) 
      Vibrio parahaemolyticus 
      Vibrio splendidus 
      Vibrio alginolyticus 
      Vibrio mimicus 
      Photobacterium damselae subspecies piscicida 
      Mycobacterium fortuitum (1294) 
      Mycobacterium chelonae 
      Piscirickettsia salmonis LF-89 (ATCC VR 1361) 
  
 
 
The viral supernatants (SPDV, ISAV and SDV) and cell line supernatants (SHK-1 and 
CHSE – 214) were kindly supplied by Dr. Kimberly Thompson (Aquatic Vaccine Unit, 
University of Stirling). The SPDV, ISAV and SDV isolated were originally obtained from Dr. 
David Smail (FRS Marine Lab, Aberdeen).  
The bacteria used for testing MAbs specificity belong to the Institute of Aquaculture 
(University of Stirling) bacteriology’s collection and were kindly supplied by several PhD 
students at the Institute of Aquaculture (Stirling) namely Fuad Matori (Vibrio species and 
Photobacterium damsela subspecies piscicida), Sandra Laffon (Mycobacterium species) and 
Úna McCarthy (Piscirickettsia salmonis and CHSE – 214).  
 
 
 
 
 73 
Chapter 3 – MAbs and polyclonal antibody production 
3.2.4.3  -  Neutralisation 
 
The neutralisation test is used to verify if an antibody has the ability to prevent the 
infection of cells by viruses (Cann, 1999). Neutralisation activity was performed using β 
neutralisation. This was performed in sterile flat bottom 96 well microtitre plates (Nunc, 
Fisher Scientific Leicestershire U.K.) by adding 40 μl of 5 fold serial dilutions of antibodies 
and 40 μl of 100 TCID50 ml-1 of betanodavirus. The plates were incubated for 90 mins. After 
this period 100 μl of SSN-1 cells was added to each well and incubated for 7 days at 25° C for 
European sea bass betanodavirus strain, and at 22°C for cod betanodavirus strain. After this 
period the cells were scored for cytopathic effect and antibodies titre was estimated by 50 % 
end-point Spearman-Karber method (LD50) (Chapter 2). 
The neutralisation index (NI) was calculated according to Rovozzo and Burke (1973). 
 
NI =  log10[(LD50 of virus with diluent) – (LD50 of virus with Mabs)] 
 
With:  NI < 1 considered not significant; 
           1 > NI < 1.6 considered questionable; 
           NI ≥ 1.7 considered significant. 
 
 
 
3.2.4.4  -  Western Blot 
 
Western blot was performed to determined the molecular weight of the antigen that 
the monoclonal antibodies recognised. 
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3.2.4.4.1 -  SDS-PAGE gel 
 
The SDS-PAGE was optimised to betanodavirus using the protocol established by 
Weins et al. (1990). 
The plates for running the SDS-PAGE were washed with tap water, rinsed with 
distilled water and dried with paper tissue. A spacer was placed between the plates and slid 
into the plate’s holder. The set was made even and the holder was screwed from the top to the 
bottom. A small amount of Vaseline® was spread on the bottom of the holder/plates in order 
to promote the adhesion of the plates to the caster (Dual gel caster, Might™ Small SE245, 
Hoefer Pharmacia Biotech Inc.).  
The plates where then placed in the caster and the separating gel (12 % acrylamide, 
Appendix 1) was added. A layer of butanol-2 (Fisher Scientific, Leicestershire U.K.) was 
added to the top of the gel in order to prevent gel oxidation. The gel polymerised for 60 mins 
at room temperature. After polymerisation of the gel, the butanol was washed out with 
plentiful amounts of distilled water. The comb was placed, the stacking gel (4 % acrylamide, 
Appendix 1) loaded and allowed to polymerise for 45 mins. After this period the gel plates 
were placed into the electrophoresis chamber (Hoefer Pharmacia Biotech Inc. SE250) and 
reservoir buffer was added (Appendix 1).   
Betanodavirus was prepared as described in Chapter 2. Several concentrations of 
purified virus were utilised (Table 3.2.) in order to verify the optimal concentration of 
betanodavirus for running the SDS-Gel. The virus sample diluted in TNE buffer was mixed 
with SDS sample buffer (Appendix 1), boiled for 4 mins and centrifuged for 5 mins at 15 800 
x g (Thermo IEC microlite). The ability of antibodies to bind to unboiled samples was also 
determined, as in Table 3.3. 
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Table 3.3 – Concentration of Betanodavirus samples analysed by SDS-
PAGE, with or without boiling.  
 
 Betanodavirus (μg l-1) 
 1 2.5 5 15 25 30 50 100 
Boiled + + + + + + + + 
Not boiled - - - - - + - - 
 
 
Two different molecular weight markers were used, Protein Marker Broad Range 
(BioLabs Inc., New England) for SDS-PAGE gel, and Full Range Rainbow (Amersham) for 
Western-blot. 
The samples and molecular weights were loaded with loading tips and gel was 
electrophoresed for 90 mins at 120 V (Amersham Pharmacia Biotech EPS 1001). 
The gel was stained with Coomassie Brilliant Blue (Appendix 1) in order to observe 
the molecular weight of the betanodavirus proteins and to confirm the success of the gel. 
 
3.2.4.4.2 -  Western blot 
 
Optimisation of Western blot to use the MABs against betanodavirus was performed 
using the protocol established by Weins et al. (1990). 
Unstained SDS-PAGE gel, filter paper (Whatman n.1), nitrocellulose membrane 
(Hybond™-ECL™, Amersham) and sponge pads were equilibrated in transblot buffer 
(Appendix 1) for 20 mins. 
The blot holder was mounted from the cathode to the anode in the following order – 
sponge pad, three sheets of filter paper, nitrocellulose membrane, SDS gel, three sheets of 
filter paper and sponge pad. The procedure was carefully carried out to prevent the formation 
of bubbles. 
The blot holder was placed into the blotting chamber (Fisher FEB10) and filled with 
transblot buffer. The nitrocellulose membrane was then blotted at 60 V for 70 mins 
(Amersham Pharmacia Biotech EPS 1001).  
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The lanes with molecular markers were cut, rinsed in distilled water, dried and stored 
in the dark. The non-specific binding sites on the membrane containing sample lanes were 
blocked over-night at 4°C with 1 % (w/v) BSA in TBS (Appendix 1).  
The following morning the membrane was washed 3 times with TTBS (Appendix 1) 
for 5 mins each and incubated with hybridoma supernatant. Two incubation periods, 1 h at 
room temperature and over-night at 4°C, and several concentrations of hybridoma cells 
(1:100; 1:50, 1:25, 1:10 (v/v in TNE buffer), neat and 2 × concentrated) and polyclonal 
antibodies (1:100; 1:50; 1:30) were tested. 
After this incubation the washing procedure with TTBS was repeated and the 
membrane was incubated for 1 h at room temperature with anti-mouse IgG HRP conjugated 
(1:100 in PBS) (Diagnostics Scotland, Edinburgh, Scotland). The membrane was washed 3 
times with TTBS for 5 mins each and finally washed 1 min in TBS. The membrane was 
developed with chromogen/ substrate solution (4CN Membrane Peroxidase Substrate System 
(2-C), KPL, Wembley U.K.). The reaction was allowed to proceed for a period no longer then 
30 mins and stopped with distilled water. 
 
3.2.4.5  -  Immunohistochemistry 
 
The immunohistochemistry protocol used was developed according to Adams and 
Marin de Mateo (1994). 
Tissue blocks were trimmed to facilitate access to the embedded tissues, and soaked 
in distilled water for 60 mins. Sections of 5 μm thickness were cut using a microtome (Jung 
Biocut 2035). Ribbons of sections were floated on 40°C distilled water and then slipped onto 
labelled glass slides. These were allowed to dry at 40°C, then transferred to a drying oven and 
further dried at 60°C overnight. 
The sections were de-waxed in xylene (2 × xylene, 5 mins each), re-hydrated through 
ethanol 100 % (5 mins), ethanol 70 % (3 mins) and distilled water (5 mins). 
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The tissues were encircled with a PAP pen (Liquid blocker Super pap pen, Agar 
Scientific, Essex U.K.) and the endogenous peroxidase was blocked by incubation with 3 % 
(v/v) hydrogen peroxide (Sigma, Dorset U.K.). 
After this period the slides were washed 3 times with buffer (TBS or PBS, see Table 
3.4) and the non-specific binding sites were blocked with 10 % (v/v) goat serum (Diagnostics 
Scotland, Edinburgh, Scotland). Excess liquid was tapped off and anti-betanodavirus MAb 
was added and slides incubated for a variety of times (Table 3.4). 
 
Table 3.4 – Variables tested for optimisation of the immunohistochemistry protocol for 
the detection of Betanodavirus. 
 
Variable Protocol step 
Reagent Diluted in 
Incubation time 
(mins) 
 Washing buffer TBS PBS   
 
 
Antigen 
 
Retrieval 
 
 
TBS 
Formic Acid 
 
 
 
 
Citric Acid 
 
850 W - 1’45 s; 80 W - 6’ 
850 W - 1’45 s; 80 W - 2’ 30s 
850 W - 2’ 30 s; 80 W - 2’ 30s 
850 W - 2’ 30 s; 80 W - 3’ 
850 W - 3’; 80 W - 3’ 
850 W - 3’30 s; 80 W - 3’ 
850 W - 6’; 80 W - 6’ 
Endogenous 
peroxidase H2O2 
Methanol 
PBS 
20; 30 
30 
Non-specific 
binding Goat serum 
1:10 in TBS 
1:10 in PBS 
10; 20 
20 
 
 
MAbs 
 
 
Supernatant ♦ 
Supernatant Ä 
Supernatant 3x 
concentrated Õ 
Supernatant 10x 
concentrated Õ 
Freeze drye Õ 
 
 
 
 
 
 
1:10 in PBS 
60; 120 
60 
180 
 
60; 180 
 
120 
Secondary antibody 
 
Anti-mouse HRP 
Anti-mouse Biotin 
 
 
Anti-mouse biotin 
(Vector ABC) 
1:75 in TBS 
1:50 in TBS 
1:100 in PBS 
1:1000 in PBS 
PBS and serum 
 
60; 75 
60 
60; 30 
30 
30 
 
Streptavidin-biotin 
amplification 
 
Extravidin HRP 
 
Streptavidin HRP 
 
Streptavidin  
(Vector ABC) 
1:50 in TBS 
1:100 in PBS 
1:200 in PBS 
1:2000 in PBS 
PBS 
 
60 
60 
20 
20 
30 
 
Chromogen 
DAB 
True Blue 
Vector VIP peroxidase 
substrate 
TBS 
20; 24 
10 
10 
 
Counterstain 
Mayer’s Haematoxilin
Contrast red 
Methyl Green 
 
3 
10; 2 
3 mins at 60°C 
♦ - MAbs 4C3, 3B10 and 4A12; Ä cocktail of 1:1:1 of MAbs 4C3, 3B10 and 4A12; 
Õ - MAb 4A12.   All incubations performed at room temperature. 
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 The slides were then washed 3 times with buffer (TBS or PBS), and incubated with 
secondary antibody. This antibody was anti-mouse or anti-rabbit antibody conjugated with 
HorseRadish Peroxidase (HRP) or biotin. These antibodies were diluted from a range between 
1:50 to 1:100 (v/v) in TBS or PBS, as described in Table 3.4.  
After washing 3 times with buffer (TBS or PBS) the slides were incubated with the 
chromogen or with the streptavidin-biotin complex. Following incubation with the chromogen 
and conterstaining the slides were de-hydrated (3 mins in ethanol 70 %; 5 mins in ethanol 100 
%; 2 × xylene, 5 mins each) and coverslipped with Pertex (Cellpath Ltd., Hemel Hempstead 
U.K.). 
The Vectorstain® ABC kit (Vector, Peterborough U. K.) was also tested for 
optimisation of the streptavidin-biotin amplification step. The chromogen used with this kit 
was Vector® VIP Peroxidase Substrate Kit (Vector, Peterborough U. K.) and the counterstain 
was performed with Methyl Green (Vector, Peterborough U. K.).  
The Atlantic cod tissue was kindly provided by Dr. David Gromam (University of 
Prince Edward Island, Canada). Doctor Bovo (Istituto Zooprofilattico Sperimentale, Venice 
Italy) and Professor Hugh Ferguson (IoA, Stirling Scotland) kindly provided the tissue 
samples from European sea bass and grouper. 
 
3.2.4.5.1 -  Antigen Retrieval 
 
After de-waxing and re-hydrating the slides were placed in a Copeland jar with buffer 
(Appendix 1) covered with microwaveable cling film and placed into a microwave oven 
(Sanyo). The slides were microwaved at 850 W, then at 80 W (Table 3.3). After these boiling 
periods the slides were allowed to cool down in the buffer for 5 mins. The slides were 
incubated another 5 mins in TBS (pH 7.6, Appendix 1) at room temperature and 
immunohistochemistry was performed as described in section 3.2.4.5.   
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3.3 -  Results 
3.3.1 - Monoclonal antibody production 
 
In order to obtain monoclonal antibodies two fusions needed to be performed. On the first 
fusion the clones obtained were not considered to be useful for further applications because 
the antibody titre was too low.  
 
 
Figure 3.4 – c Cloned cells surrounded by feeder cells (magnification 200x); d single clone 
adjacent to feeder cells (magnification 40x); hybridoma cells producing 
monoclonal antibodies (e magnification 400x and f magnification 100x). 
 
 
Some examples of clone cells surrounded by the feeder cells or hybridoma cells 
obtained are shown in Figure 3.4. 
With the second fusion 21.3 % of the clones showed a high positive response by 
ELISA against betanodavirus supernatant. These clones were amplified and screened once 
c d
e f
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more. After this amplification 10 % showed a positive response against the virus. These 
positive clones were classified as parental cells, cloned by limited dilution and screened three 
times. After this selection 3 clones (21 %) still give a positive result by ELISA and were 
considered to be hybridoma cells producing monoclonal antibodies (3B10, 4A12 and 4C3). 
The parental cells stored in liquid nitrogen were thawed and the cloning procedure 
was repeated once more. This process allowed a further two hybridoma cell lines – 1E3 and 
5G10, to be obtained. 
 
 
3.3.2 - Immunotyping 
 
All five MAbs were shown to belong to the same immunoglobin class IgG but have 
different subclasses. MAbs 4C3, 4A12 and 1E3 were IgG2a, and MAbs 3B10 and 5G10 were 
IgG2b, as demonstrated in Figure 3.5. 
 
 
Figure 3.5 – Immonotyping strips used for determining the type of immunoglobin of 
the MAbs. c 4C3, 4A12 and 1E3; d 3B10 and 5G10. 
 
 
1 
2 
3.3.3 - Cross-reactivity 
 
The reaction of the anti-betanodavirus MAbs against other betanodavirus strains and a 
variety of fish pathogens was determined by ELISA (Table 3.5).).  
 81 
Chapter 3 – MAbs and polyclonal antibody production 
As well as reacting against betanodavirus from European sea bass MAbs 4A12, 1E3 
and 5G10 also reacted with betanodavirus isolated from Atlantic cod and halibut strains. The 
MAbs 3B10 and 4C3 only showed reactivity against the strain of betanodavirus that was used 
to immunised the mice, i.e. the European sea bass strain. None of the MAbs reacted against 
the striped jack betanodavirus strain. 
None of the MAbs showed cross-reactivity against other viruses (IPNV, WISAV, 
SPPD, sleeping disease), or against the cell lines CHSE-214 and SKH-1 used to grow these 
viruses or to the cell line used to grow betanodavirus, SSN-1.  
 
 
Table 3.5 – Cross-reactivity of the anti-betanodavirus MAbs with several strains of betanodavirus 
and other fish viruses and bacterioses. 
 
MAbs  Antigen 3B10 4A12 4C3 1E3 5G10 
      
 Virus      
     IPNV (serotype) - - - - - 
     SPPD - - - - - 
     WISAV - - - - - 
     SDV - - - - - 
     Betanodavirus strains      
       European sea bass 
        (Dicentrarchus labrax) + + + + + 
       Atlantic cod 
        (Gadus morhua) - + - + + 
       Halibut 
        (Hippoglossus hippoglossus) - + - + + 
       Striped jack 
        (Pseudocaranx dentex) - - - - - 
      
   
 Cell lines      
     CHSE - 214 - - - - - 
     SSN-1 - - - - - 
     SHK-1 - - - - - 
      
   
 Bacteria      
     Vibrio vulnificus (biotype 2) - - - - - 
     Vibrio harveyii (CECT 5978) - - - - - 
     Vibrio anguillarum (type II) - - - - - 
     Vibrio parahaemolyticus - - - - - 
     Vibrio splendidus - - - - - 
     Vibrio alginolyticus - - - - - 
     Vibrio mimicus - - - - - 
     Photobacterium damselae subspecies piscicida - - - - - 
     Mycobacterium fortuitum (1294) - - - - - 
     Mycobacterium chelonae - - - - - 
     Piscirickettsia salmonis LF-89 - - - - - 
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Bacterial pathogens including Piscirickettsia salmonis, Photobacterium damselae 
subspecies piscicida and several strains of Vibrio and Mycobacterium were also tested with 
negative results. 
 
 
3.3.4 - Neutralisation 
 
The supernatant of five clone hybridoma cells and one polyclonal antibody were 
tested using an in vivo neutralisation test (Table 3.6). The Mabs 3B10 and 4C3 neutralised the 
European sea bass nodavirus strain. 
  
Table 3.6 – Neutralisation index of polyclonal antibodies 
and MAbs 3B10, 4A12, 4C3, 1E3 and 5G10. 
 
Neutralisation Index (NI)  
 European sea bass Atlantic cod 
Mabs   
3B10 3.16 - 
4A12 0.36 1.26 
4C3 3.44 - 
1E3 1.68 0.20 
5G10 2.74 1.80 
Polyclonal antibody 4.56 3.74 
 
 
 
 
 
 
 
MAb 4A12 had no neutralisation capacity against the European sea bass strain but 
gave a questionable NI with cod nodavirus strain (NI = 1.26). MAb 1E3 showed the opposite 
behaviour. This MAb had no neutralisation capacity against the betanodavirus cod strain (NI 
< 1), but with the European sea bass strain the NI value (1.68) can be considerered significant 
(NI ≥ 1.7). Both nodavirus strains were neutralised by MAb 5G10. 
The polyclonal antibodies produced against the European sea bass strain revealed 
neutralisation ability against betanodavirus strain from European sea bass (NI = 4.56) and 
against the Atlantic cod strain (NI = 3.74).  
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3.3.5 - Western-Blot 
 
Western Blot analysis showed that all the MAbs obtained have the ability to bind to a 
virus protein of approximately 42 kDa. 
 
 
 
Figure 3.6 – Western Blot of all the MAbs and 
polyclonal antibodies. The virus 
sample was boiled. 
 
4C3 4A12 3B10 5G10 1E3  Poly 
250 kDa 
160 kDa 
75 kDa 
50 kDa 
35 kDa 
30 kDa 
25 kDa 
105 kDa 
                4A12 
 
   Boiled           Non-boiled
                4C3 
 
Boiled             Non-boiled
35 kDa 
105 kDa 
75 kDa 
160 kDa 
50 kDa 
30 kDa 
15 kDa 
25 kDa 
10 kDa 
 
Figure 3.7 – Western Blot with boiled and 
non-boiled virus samples.  
 
 
The polyclonal antibody recognised virus proteins of several different molecular 
weights at 160 kDa; 75 kDa; 55 kDa and the 42 kDa recognised by the MAbs. 
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MAbs 4A12 and 4C3 bound to boiled and non-boiled betanodavirus samples. These 
MAbs appear to recognise virus protein with different intensities, showing heavier staining to 
non-boiled virus samples (see Figure 3.6 and 3.7). 
 
 
3.3.6 - Immunohistochemistry 
 
The application of the MAbs in immunohistochemistry was possible only when 
streptavidin-biotin amplification or when antigen retrieval was performed. Monoclonal 
antibody 4A12 was the only one capable of recognising the virus by immunohistochemistry.  
For both methods the optimised protocol is described in Table 3.7. Both methods 
show similar results but biotin-streptavidin amplification protocol is less labour and time 
demanding.  
Using immunohistochemistry it was possible to verify that the virus is widely spread 
in the infected tissue, and it is not possible to detect localised areas of virus at the stage where 
these tissue samples were collected (Figure 3.8 f, h and Figure 3.9 d to h).  
When non-infected tissue sample was analysed MAb 4A12 revealed no cross-
reactivity with non-infected tissue (Figure 3.8 d). The use of PBS instead of MAb revealed 
that none of the reagents used react with fish tissue (Figure 3.8 c, e and g; Figure 3.9 c). 
Immunohistochemistry using MAb 4A12 appeared to be very sensitive for detecting 
virus in European sea bass diagnosed with VNN. These samples were diagnosed with VNN 
but did not show clear histological symptoms (Figure 3.8 f and h). However, with 
immunohistochemistry they revealed the presence of the virus and allowed the confirmation 
of the diagnosis. Fish tissue samples with the characteristic vacuoles in the retina layers and 
brain could be observed in Atlantic cod (Figure 3.9 e to h). 
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Table 3.7 – Immunohistochemistry optimised protocols. 
 
Variable Protocol Protocol step 
Reagent Diluted in 
Incubation time 
(mins) 
 Washing buffer TBS   
Antigen Retrieval Formic Acid  850 W - 3’30 s 80 W - 3’ 
Endogenous peroxidase H2O2 Methanol 30 
Non-specific binding Goat serum 1:10 in PBS 20 
MAb Supernatant 10x concentrated  180 
Secondary antibody Anti-mouse HRP 1:100 in PBS 60 
Chromogen 
 
 
Antigen 
 
Retrieval 
DAB TBS 24 
Counterstain Mayer’s Haematoxilin  3 
Endogenous peroxidase H2O2 Methanol 30 
Non-specific binding Goat serum 1:10 in TBS 20 
MAb ADL 1:10 in PBS 120 
Secondary antibody Anti-mouse biotin  (Vector ABC) PBS and serum 30 
Streptavidin-biotin 
amplification 
Streptavidin  
(Vector ABC) PBS 30 
Chromogen Vector VIP peroxidase substrate PBS 10 
 
 
Biotin-
streptavidin 
 amplification 
Counterstain Methyl Green  3 mins at 60°C 
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Figure 3.8 – Immunohistochemistry of paraffin section of normal and infected fish tissue. Streptavidin-
biotin amplification was performed with Vectorstain ABC kit. The presence of virus is 
revealed by the colour purple. Eye of non-infected Atlantic cod incubated with PBS c 
and MAb d shows no immunostaining. Immunostaining can be observed in the photo-
receptors (PR) and in the ganglionic layer (GL) of European sea bass infected with VNN 
incubated with MAb f. The same sample incubated with PBS e shows no 
immunostained. Brain of European sea bass infected with VNN was incubated with PBS 
g and MAb h and shows the widely spread disposition of the virus in the brain tissue. 
Bar = 100 μm. 
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Figure 3.9 – Immunohistochemistry of paraffin section of infected Atlantic cod using antigen retrieval 
step. The presence of virus is revealed by a brown colour. Spinal cord was incubated with 
c PBS and d MAb. Immunostaining and vacuoles can be observed in the major parts of 
the spinal cord d, eye e, f, g (bipolar nuclear layer (BN) and ganglionic layer (GL)) 
and brain h. Bar = 100 μm. 
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3.4 -  Discussion 
 
The production of MAbs for use as diagnostic tools is widespread and has been 
carried outfor 30 years. Monoclonal antibodies are attractive reagents since, once generated, 
they provide a perpetual source of a well-defined antibody (Yelton and Scharff, 1981). The 
discriminatory power of monoclonal antibodies makes them ideal reagents for investigation of 
antigenic relationships between viral proteins (Yewdell and Gerhard, 1981).  
The ultimate aim in the production of Mabs that recognise European sea bass 
nodavirus strain was to apply them in antigenic analysis. It is known that the relevance of this 
type of analysis with MAbs may depend largely on the availability of a diverse panel of 
antibodies (Yewdell and Gerhard, 1981). In order to try to obtain the most diverse and best 
panel possible two fusions were performed. The clones obtained with the first fusion revealed 
very low titre values. Usually this type of result is a consequence of the chromosomal 
instability associated with the fusion process of the spleen cells and the myeloma cells. The 
MAbs obtained with the first fusion were therefore discarded and a second fusion was 
performed. With this second fusion it was possible to obtain and characterise five hybridoma 
cell lines. The produced MAbs all belonged to the IgG class. As the affinity to the antigen of 
IgG is higher than that of the IgM antibodies (Nakajima and Sorimachi, 1995), this suggests 
that the MAbs obtained can be used in serological and diagnostic assays.  
Monoclonal antibody may not be specific, as it is possible that they will react not only 
with the antigen of interest but also with other antigens with similar structural features (Yelton 
and Scharff, 1981). This cross-reaction demonstrates shared determinants that are indicative 
of structural or chemical similarities between the antigen and the other “substance” (Yelton 
and Scharff, 1981, Nelson et al. 2000). Thus, an ELISA was used to determine the cross-
reactivity of the five MAbs against other betanodavirus strains, viruses and bacterial 
organisms that can be found in fish and the aquatic environment. The MAbs 4A12, 1E3 and 
5G10 recognised Atlantic cod and halibut strains as well as European sea bass betanodavirus 
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strain. However MAbs 4C3 and 3B10 just recognised the strain used for immunising the mice 
– European sea bass strain. European sea bass is grouped into the RGNNV clade (Red-Spotted 
Grouper Nervous Necrosis Virus) (Skliris et al. 2001), Atlantic cod and halibut into the 
BFNNV clade (Barfin Flounder Nervous Necrosis Virus) (Starkey et al. 2000, Starkey et al. 
2001) and the striped jack into the SJNNV clade (Striped Jack Nervous Necrosis Virus) 
(Nishizawa et al. 1997).  Benjamin et al. (1984), suggested that by applying the multi-
determinant-regulatory model nearly all evolutionary substitutions would directly affect 
immunologic cross-reactivity because most amino acid substitutions are immunologically 
detected. The lack of response of some of the MAbs against the different nodavirus strains 
may reveal that the MAbs recognise a less conserved region of the coat protein, and this 
region is not shared by RGNNV, BFNNV and SJNNV clades.  Nishizawa et al. (1995b) 
suggested that there is a difference in the epitopes between SJNNV and other nodavirus 
strains based on the lack of binding of MAbs to these strains. Monoclonal antibodies 4A12, 
1E3 and 5G10 appear to recognise a region on the coat protein shared by RGNNV and the 
BFNNV clusters, but 3B10 and 4C3 recognised a region that is not shared between these two 
clades and is specific to the RGNNV cluster. The results suggests the presence of five MAbs 
binding to at least two different epitopes, one where MAbs only recognise the European sea 
bass strain (MAbs 4C3 and 3B10) and another where MAbs also recognise Atlantic cod and 
halibut strains (MAbs 4A12, 5G10 and 1E3).  
Photobacterium damselae subspecies piscicida, Piscirickettsia salmonis and several 
species of Vibrio and Mycobacterium were tested for MAbs specificity. There was no cross-
reaction between these organisms and the MAbs. The same result was observed when four 
different fish viruses (IPNV, SPDV, WISAV and sleeping disease) were screened.  
An enormous advantage of hybridoma technology is the ability to generate specific 
antibodies even with impure antigens, due to the selection performed during the screening 
assays (Secher and Burke, 1980). The immunisation of the mice was performed with purified 
betanodavirus, but the selection of MAbs was performed with virus supernatant from tissue 
culture. There is always the possibility that the MAbs may recognise SSN-1 cell components 
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present in the supernatant. This could occur due to the presence of cell particles in the purified 
virus suspension used for the immunisation of the mice. In fact, the MAbs did not cross-react 
with SSN-1 supernatant. The lack of cross-reactivity between the MAbs and the cell lines 
(CHSE-214 and SHK-1) used to grow the other viruses tested was also confirmed.  
Antibodies specific for viral antigens are often crucial in containing the spread of a 
virus during acute infection and in protecting against re-infection (Kuby, 1994). Antibodies 
can reduce virus growth by preventing virus adsorption or penetration into host cells 
(Dimmock, 1984, Abbas et al. 2000). Work with polio virus suggested that different MAbs 
can neutralise virus by different mechanisms or a single MAb can neutralise by a number of 
alternative mechanisms (McCullough, 1986). The neutralisation index (NI) suggests the 
presence of MAbs that bind to different epitopes. The group comprising the MAbs that cross-
reacted with other betanodavirus strains can be sub-divided. The lack of neutralisation ability 
of MAb 4A12 to the European sea bass strain indicated that this MAb recognised a different 
epitope region to MAbs 5G10 and 1E3. Even these two MAbs do not appear to share the same 
epitope as the lack of neutralisation against Atlantic cod presented by MAb 1E3 indicates.  
Western blot analysis revealed that all the MAbs recognised a protein with an 
approximate molecular weight of 42 kDa, the size of the betanodavirus coat protein (Mori et 
al.  1992). The MAbs developed by Nishizawa et al. (1995b) against striped jack nodavirus 
and by Lai et al. (2001a) for Yellow Grouper Nervous Necrosis Nodavirus (YGNNV) also 
recognised this protein. The generation of MAbs that recognise this protein is not surprising as 
the coat protein is the outer structural component of the virion particle.  
Monoclonal antibodies recognised the proteins in their three-dimensional 
configuration on the viral surface and often recognise epitopes that depend upon the folded 
three-dimensional shape of the polypeptide chain (Dulbecco, 1988a). The detection of the coat 
protein is very important for future antigenic studies because it indicates the type of epitope 
that the MAbs recognise. Two of them (MAbs 4C3 and 4A12) revealed the ability to 
recognise the coat protein in both boiled and non-boiled samples suggesting that the epitope 
of these MAbs bind may not be dependent on protein folding.  
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Immunohistochemistry with the anti-nodavirus MAbs was only successful with MAb 
4A12 and the process required either an amplification or antigen retrieval step. Both antigen 
retrieval and signal amplification with streptavidin-biotin revealed similar results and a 
general binding of the MAb to the cytoplasm of infected tissue cells was observed. Such a 
result is not surprising as the betanodavirus particles are present in the cytoplasm of infected 
cells (Nishizawa et al. 1995b), where virus assembly occurs (Chi et al. 1997).  Such results, a 
generalised staining of the brain and eye were also observed by Lai et al. (2001a) and Shieh 
and Chi (2005) using anti-grouper nodavirus MAbs. When tested MAb 4A12 revealed no 
cross-reativity with normal nerve cell, eye or even with other organs tissue. These results 
indicate that MAb 4A12 can be useful for diagnosis and confirmational diagnosis of VER.  
Polyclonal antisera contain many different antibodies that will perform optimally in 
different assays (Yelton and Scharff, 1981). Therefore polyclonal antibodies can be use in a 
vast number of immunoassays. The exquisite specificity and homogenous structure of MAbs 
is the main reason why MAbs are so often considered to be superior to polyclonal antibodies. 
In the context of immunoassays this is not always an advantage (Peppard, 2000) because they 
may not performe well in as many immunoassays as polyclonal antibodies. These differences 
between MAbs and polyclonal antibodies were confirmed by the polyclonal antisera showing 
the highest neutralisation index to the betanodavirus strains and the binding to several proteins 
by Western Blot.  
A crucial aspect of the characterisation of MAbs is the study of how the MAbs react 
in different assay systems. This is especially pertinent for the use of MAbs as diagnostic 
reagents because some antibodies perform well is some assays but not in others. This 
phenomenon relates to how an antibody recognises its target epitope in the context of the 
assay system used with the target epitope being masked, denatured or rendered inaccessible by 
the immobilisation procedure adopted within a given technique (Nelson et al. 2000). The most 
crucial advantage of MAb is that once a useful hybridoma cell line has been generated it can 
be used by different laboratories eliminating a source of variation and providing a standard 
reagent (Pollock et al.  1984).  
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3.4.1 - Final reflection 
 
The production of hybridoma cell lines is a well-established technique. However, it is 
not a straightforward technique and often more than one fusion needs to be performed and this 
can be costly and time consuming. In order to obtain hybridoma cell lines producing 
antibodies against European sea bass betanodavirus two fusions were performed and five 
MAbs were generated.  
The results obtained suggest that the five hybridoma cell lines recognised different 
regions of the coat protein. This fact is extremely useful for achieving the major aim of the 
thesis i.e. producing MAbs against betanodavirus for application in antigenic mapping studies. 
Due to the characteristics shown by the MAbs several epitope mapping techniques could be 
used, e.g. escape mutants and pepscan. 
Cross-reactivity tests revealed that three of the MAbs (4A12, 5G10 and 1E3) 
recognised Atlantic cod and halibut betanodavirus strains. None of the MAbs produced cross-
reacted with other fish viruses, cell line culture supernatant or bacteria species common to fish 
and aquatic environment. This indicates the specificity of the MAbs to betanodavirus and the 
possibility that they may be utilised as diagnostic tools. 
The monoclonal antibodies produced can be applied to several techniques that require 
the use of antibodies against betanodavirus. For example the isolation of betanodavirus in cell 
culture can be confirmed by performing a neutralisation assay with the MAbs produced. The 
high signal obtained when infected tissue was staining using immunohistochemistry shows 
that the MAb 4A12 can be used for diagnosis and confirmation of VER in fish tissue samples. 
Further studies should be performed in order to confirm the ability of the MAbs to 
bind to other betanodavirus strains e.g. barramundi, turbot, Dover sole, groupers, guppy and 
sturgeon and to establish a wider range of possible application of these MAbs. 
 
 93 
Chapter 4 – Epitope mapping with escape mutants 
Chapter 4 - Epitope mapping with escape mutants 
 
4.1 -  Introduction  
 
During infection with bacteria or viruses, the host immune system produces an 
antibody response directed against the pathogen. These antibodies protect the organism by 
interaction between the paratope (antibody binding site) and the epitope (antigen binding site) 
(Klasse and Sattentau, 2002).  
The development of techniques for the production of monoclonal antibodies allowed 
the perpetual supply of antibodies directed against a single epitope (Yelton and Scharff, 
1981). Consequently, monoclonal antibodies stimulated the study of the antigen-antibody 
interaction and the characterisation of epitopes within viruses and other antigenic structures.  
Several techniques have been employed for epitope mapping, including random 
peptide phage display (Scott and Smith, 1990) and pepscan using overlapping panels of 
synthetic peptides (Geysen et al. 1984). However, these techniques are largely limited by their 
inability to represent conformational epitopes.  
Monoclonal antibodies directed against viral antigens have been available for over 20 
years. Some of these antibodies exhibit viral neutralising activity (Strauss et al. 1991). The 
biological processes involved in virus neutralisation by antibodies are not completely 
understood. However, it has been suggested that antibodies may neutralise viruses by 
preventing the binding of viral particles to cellular receptors or by blocking viral penetration 
into the cytoplasm (Kuby, 1994).  
When viruses are incubated with neutralising antibodies, rare mutants can be 
recovered that possess the ability to replicate despite the presence of the antibody neutralising 
activity (Gerhard  and Webster, 1978, Laver et al. 1979). These virus mutants are referred to 
as neutralisation escape mutants. Nucleotide sequencing of these viruses can then be used to 
identify which changes in the virus protein structure confers neutralisation resistance (Mateu 
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et al. 1990, Strauss et al. 1991, Balasuriya et al. 1995). This procedure is particularly suitable 
for the analysis of RNA viruses since these exhibit relatively high genetic variability due to 
error-prone replication machinery (Gitlin et al. 2002, Boden et al. 2003).  
The principle underlying this technique is that virus escape mutants are able to 
replicate in the presence of a neutralising antibody because they possess a mutation that 
confers a change in an amino acid residue situated at the antibody binding site. Thus the 
antibody is unable to bind and neutralise the escape mutant (Morris, 1996b). It has been 
demonstrated that a single amino acid substitution is sufficient to shift the antigenicity of a 
virus as occurs for example in the influenza virus HA1 polypeptide (Berton et al. 1984). The 
interaction between an antibody and an antigen can be abolished by the loss of a single 
hydrogen bond, provoking a reduction in the binding constant of nearly three orders of 
magnitude (Colman et al. 1987). 
The generation of mutants is a routine procedure exploited widely in structure-
function analyses and for the development of engineered viruses as vaccines or drugs 
(Yoshiyama et al. 1994, Shotton et al. 1995, Zhao et al. 2004, Schubert et al. 2005)  
The most widely used method for isolating and selecting escape mutants is based on 
the viral plaque reduction assay. However, for some viruses such as influenza virus the 
production of escape mutants has been achieved in eggs (Berton et al. 1984, Saito et al. 1994). 
In the plaque reduction assay the growth of the virus occurs in the presence of a 
neutralising antibody, so any plaques that occur are formed by the replication of a viral escape 
mutant. Plaques are formed by cytopathic viruses (Rovozzo and Burke, 1973) and these can in 
many cases be produced by the addition of an overlay such as agarose to an infected 
monolayer of cells  (Dulbecco and Vogt, 1954).  
In the majority of studies the plaque process is preceded by several passages of the 
virus in cell culture in the presence of the neutralising antibody (Weiland et al. 1999). 
However, selection of escape mutants may take place in the absence of an overlay (Borrego et 
al. 2002). This methodology is of use for the analysis of viruses that are refractory to plaque 
formation. 
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Escape mutants have been used for epitope mapping studies of the intracytoplasmic 
tail of Human Immunodeficiency Virus (HIV) type 1 gp41 (Kalia et al. 2005), xenotropic 
murine leukaemia virus (Li et al. 1999); equine arteritis virus (Balasuriya et al. 1995); 
hepatitis A virus (Ping and Lemon, 1992); influenza virus (Gerhard et al. 1981); measles 
virus, mumps virus, rubella virus (Tischer and Gerike, 2000) and poliovirus (Minor et al.  
1983). 
 
 
4.1.1 - Plaque Formation    
 
Zones of cell lysis or CPE occurring in virus infected cell monolayers are referred to 
as plaques (Hierholzer and Killington, 1996). Each plaque originates from a single virus 
particle (Rovozzo and Burke, 1973). 
 
 
Figure 4.1 - Plaques produced by measles virus. Overlay 
agarose stained with neutral red (bar = 0.5 
cm) (Borges et al.  1996). It is possible to 
observed the different plaque sizes produce 
by different measles strains. 
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In order to obtain plaques the virus is added to the cell culture monolayer and allowed 
to adsorb (Burleson et al. 1992) (see Figure 4.1). An overlay, typically agarose or carboxyl 
methylcellulose is then added and the infected monolayers are incubated. The overlay 
prevents diffusion of viral particles and permits better resolution of plaques by preventing the 
spread of virus to other areas of the cell monolayer (Bachmann et al. 1999, Hierholzer and 
Killington, 1996). 
After incubation a stain is (e.g. neutral red or tetrazolium) is used to visualise plaques 
(Burleson et al.  1992). Virus isolated from individual plaques can be isolated by “picking”.   
 
 
4.1.2 - Objectives 
 
The aim of this chapter was to isolate and characterise betanodavirus escape mutants. 
This would permit identification of the site(s) recognised by neutralising antibodies that play a 
major role in protection and recovery from infection. Neutralising monoclonal antibodies were 
used for escape mutant isolation. The production and characterisation of the MAbs are 
described in Chapter 3. Determination of the nucleotide sequence of the coat protein gene of 
isolated escape mutants would enable identification of amino acid changes in the coat protein 
associated with resistance to neutralisation. Two approaches were used to produce 
betanodavirus escape mutants: a) plaque isolation and b) isolation by limiting dilution. For 
producing betanodavirus plaques, several different overlays were tested. A limiting dilution 
procedure developed by Borrego et al. (2002) was also used.  
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4.2 -  Material and Methods 
4.2.1 - Plaque isolation  
 
The procedure for obtaining betanodavirus plaques was performed with a nodavirus 
isolated from European sea bass designated Mt/01/Sba. Virus growth was performed in 6 well 
plates (Nunc, Fisher Scientific Leicestershire U.K.).  
Agar number 1 (Oxoid, Hampshire U.K.); agarose type VII, low melting point 
(Sigma, Dorset U.K.); agar gum (Sigma, Dorset U.K.); carboxyl-methylcellulose medium 
viscosity (Sigma, Dorset U.K.) and carboxyl-methylcellulose high viscosity (Sigma, Dorset 
U.K.) were used as overlay. 
All the overlays were tested at different concentrations, 0.5 %, 1 % and 1.5% (w/v) in 
a solution 1:1 of distilled water and L-15/FBS. The gelling compounds were dissolved in 
distilled water, autoclaved and held above gelling temperature until Lebovitz L-15 medium 
containing 10 % FBS (L-15/FBS) was added. The L-15/FBS was added immediately before 
the overlay was used.  
Betanodavirus plaques were produced in pre-formed SSN-1 monolayers and also by 
simultaneous inoculation of SSN-1 monolayers. 
Culture of SSN-1 stock cells is described in Chapter 2. Seven day old cultures of 
SSN-1 cells (25 cm3 flask) were harvested and used to inoculate 6 well plates which were then 
incubated at 25°C. Cell monolayers were allowed to develop until 80 % confluent. Growth 
medium was then removed and monolayers washed three times with HBSS (supplemented 
with 2 % FBS). Betanodavirus strain Mt/01/Sba (500 μl) was added to each well and the 
plates were sealed with Nesco film. Virus was allowed to adsorb to the SSN-1 cells for one 
hour at 25°C, with gentle agitation (Mini Rocking platform, Biometra™). Monolayers were 
infected with between 102 to 106 TCID50 of virus. Negative controls were inoculated with L-15 
supplemented with 5 % of FBS.  
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After removal of non-adsorbed virus, cells were washed with HBSS (supplemented 
with 2 % FBS). The overlay (2 ml) was added and allowed to solidify. Plates were sealed with 
Nesco film and incubated at 25 °C. 
Plates were incubated for 2, 3, 4 and 5 days. After this period 500 μl of neutral red 
(0.1 % in HBSS/FBS 2 %) was added and monolayers were examined microscopically for the 
formation of plaques. 
For the simultaneous inoculation 2 ml of SSN-1 cells were mixed with 500 μl of the 
virus and allowed to seed for 24 hrs. Monolayers were then processed as described above for 
pre-formed monolayer. 
 
 
4.2.2 - Isolation by limiting dilution 
 
Two strains of betanodavirus were used for escape mutant isolation by limiting 
dilution, MT/01/Sba isolated from European sea bass and GB/32/cod, isolated from cod. 
Three MAbs were used 4C3, 4A12 and 3B10 (see Chapter 3 for details). The neutralisation 
ability of each of the MAb against each virus strain was determined as described in Chapter 3. 
MAbs 4C3 and 3B10 were used for MT/01/sba, and 4A12 was used for GB/32/cod. 
Virus neutralisation assay was performed as described by Borrego et al. (2002).  
HBSS (45 μl well-1) was added to each well of a 96 well plate. Betanodavirus (5 μl) 
was added to the wells in the first column wells and a 10-fold series of dilutions was then 
made. Equal volumes of MAbs (1:20 and 1:100 v/v in HBSS) were added to virus-containing 
wells. The virus and MAbs were allowed to interact for 90 mins at 25°C or 20°C with gentle 
agitation (Mini Rocking platform, Biometra™). After this period 90 μl of SSN-1 cells were 
added to wells, then plates were sealed with Nesco film and incubated for 4 to 6 days at 25°C 
(European sea bass strain) or 20°C (Atlantic cod strain). After this period monolayers were 
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examined for CPE. Virus was harvested from cells showing CPE that had received the 
greatest input dilution of virus.  
The harvested virus (100 μl well-1) was added to 5 wells of a 24 well plate and 
incubated with 100 μl of MAb (1:20 v/v in HBSS) for 90 mins at 25°C or 20°C with gentle 
agitation. After this period 1 ml of SSN-1 cells was added to each well, and plates sealed with 
Nesco film and incubated for 4-6 days. After this period the supernatant was collected and the 
procedure repeated two further times. After the 3rd passage in the presence of MAb the virus 
was grown twice in the absence of MAb in order to exclude the MAb from the sample. 
Positive and negative controls were incorporated into the limiting dilution procedure. 
These controls were processed in the same way as for samples. HBSS was added instead of 
MAb for a positive control, and HBSS (supplemented with 5 % FBS) was added instead of 
virus for a negative control. 
Borrego et al. (2002) screened the escape mutants obtained by ELISA. This step was 
performed in order to gain reassurance that the escape mutants were not recognised by the 
MAbs. This screening was performed prior to sequencing the escape mutant’s cDNA. An 
ELISA was performed as described in Chapter 2. An ELISA plate was coated with mutant 
virus supernatant from tissue culture of the virus. The MAbs used for the selection of the 
escape mutants were used as first antibody in the ELISA.   
Once escape mutants have been identified the coat protein should be sequenced and 
the results compared with the coat protein of the non-escape mutants virus. 
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4.3 -  Results 
 
The aim of this study was to isolate betanodavirus neutralisation escape mutants. Two 
approaches were used; plaque isolation and isolation by limiting dilution. 
 
 
4.3.1 - Plaque isolation 
 
Plaque assays were performed using five different types of overlay: agar no 1; agar 
gum, agarose type VII, of high viscosity carboxyl-methylcellulose and medium viscosity 
carboxy-methylcellulose. None of these techniques permitted the isolation of betanodavirus 
escape mutants, when either infection of pre-formed monolayers or simultaneous inoculation 
was used as the route of infection. 
Results varied considerably between experiments. On occasions, virus appeared to 
grow efficiently, whereas at other times, little growth was evident in infected monolayers. 
Agar type VII yielded plaques most consistently, but these were very small and tended to be 
surrounded by many other plaques. Cytopathic effects tended to be diffuse and present 
throughout infected monolayers rather than confined to discrete plaques, as shown in Figure 
4.2. 
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Figure 4.2  - SSN-1 monolayer showing cytopathic effects induced by betanodavirus MT/01/Sba. 
Monolayers were overlayed with Agar type VI and stained with 0.1% neutral red (c 
and d magnification 100x, e magnification 40x) 
 
 
4.3.2 - Isolation by limiting dilution 
 
Limiting dilution was also assessed as a method for betanodavirus escape mutant 
isolation. In Figure 4.3. and 4.4 can be observed the SSN-1 monolayer in the presence or 
absence of the virus. 
 Escape mutants obtained were screened by ELISA prior to the nucleotide sequence 
analysis. The ELISA results revealed that the neutralising escape mutants were recognised by 
the MAbs. The nucleotide sequence would be performed in the mutants revealing a negative 
result by ELISA. The lack of such negative results led to none of the escape mutants obtained 
being sequenced.   
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c d
Figure 4.3 – SSN-1 monolayer (c magnification 40 x and d magnification 100 x). 
 
 
 
e f
dc 
 
Figure 4.4 – Production of escape mutants by limiting dilution. European sea bass NNV infecting 
SNN-1 cells in the presence of 4C3 MAb (c magnification 40 x; d magnification 100 x; 
e magnification 200 x). Atlantic cod NNV infecting SNN-1 cells in the presence of MAb 
4A12 (f magnification 200x). 
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4.4 -  Discussion 
 
Sequence analysis of viral neutralisation escape mutants is a powerful tool for 
analysing the molecular interaction between the humoral immune response and viral 
pathogens. This methodology has been applied successfully to several viruses including 
Hantaan virus (Wang et al. 1993), influenza A virus (Laver et al. 1979), rabies virus (Raux et 
al. 1995) and HIV type 1 (Shotton et al. 1995). The results of epitope mapping studies can be 
used to aid the rational design of vaccines and immunodiagnostic reagents. The method is 
particularly suited to the study of RNA viruses, which exhibit high mutation rates (Morris, 
1996b, Das et al. 2004). 
Attempts to isolate betanodavirus neutralisation escape mutants were performed using 
the two classical virological procedures of plaque purification and limiting dilution. Escape 
mutants were selected with a panel of neutralising MAbs produced in an earlier stage of the 
project (Chapter 3).  
The plaque assay is ideally suited to escape mutant isolation because it allows for the 
easy isolation and propagation of viral clones resistant to the effects of neutralisation. This 
method had been used with success for the isolation of escape mutants to the rainbow trout 
virus VHSV (Béarzotti et al. 1995). The use of plaque assay required optimisation for 
betanodaviruses since plaque assays have not previously been described for this virus family. 
There is not a single method that can be used to plaque all known virus groups (Rovozzo and 
Burke, 1973). 
Virus plaques are formed after infection of a cell monolayer. Virus is allowed to 
adsorb prior to the addition of a solid or semi-solid overlay to restrict diffusion of replicating 
virus (Dulbecco, 1988b, Cann, 2001). In the present study 5 different types of overlay were 
used: agar no1, agar gum, agar type VII and carboxyl methylcellulose (high and medium 
viscosity). None of these methods permitted the formation and isolation of betanodavirus 
plaques. This result is in contrast to numerous other studies in which virus plaques have been 
successfully produced using the same experimental procedures. For example, plaque 
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formation has been described for coxsackievirus, influenza virus, measles virus, mumps virus, 
and rubella virus using carboxy-methylcellulose as an overlay (Bachmann et al. 1999, Pipkin 
et al. 1999, Triantafilou et al. 1999, Tischer and Gerike, 2000). Furthermore, Wolf and 
Quimby (1973) have produced plaques of a number of fish viruses (bluegill myxovirus, 
channel catfish virus, eel virus, Egtved virus, IPNV, lymphocystis virus and spring viraemia 
of carp). Agar has been widely used as an overlay since the 1950s (Dulbecco and Vogt, 1954, 
Moss and Gravell, 1969, Borges et al. 1996, Scotti and Dearing, 1996, Li et al. 1999, LaBarre 
and Lowy, 2001).  
In the present study, the betanodavirus strains studied formed microscopic plaques, 
however it was not technically feasible to collect the virus from plaques of this size. When 
longer incubation periods were used in attempts to produce larger plaques, the CPE spread 
throughout infected monolayers. 
Several factors can influence the growth and plaquing characteristics of viruses. These 
include the sensitivity of the cells used for virus growth, health status of the cells, adsorption 
time, type of overlay, incubation period (Burleson et al. 1992, Hierholzer and Killington, 
1996). All of these points were taken in to consideration in attempts to obtain betanodavirus 
plaques. 
The SSN-1 cells (Frerichs et al. 1996) are the most commonly used cell line for 
isolation and propagation of Betanodaviruses. Other cell lines have been developed (Lai et al.  
2001b) but it was not possible to obtain these. Whilst the use of other cell lines may ultimately 
permit the successful production of betanodavirus plaques, many of these are not available 
due to patent restrictions surrounding betanodavirus vaccine manufacture.  
The adsorption period could also be of critical importance in the formation of virus 
plaques. During the present study, a 90 mins adsorption step was used. This length of time 
should be sufficient for virus attachment and penetration to occur. Previous studies have 
shown that 60 mins is sufficient for adsorption of viruses to cells, and no gain is obtained by 
increasing the adsorption time (Fendrick and Hallick, 1983, Bushar and Sagripanti, 1990). 
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Some studies have reported better results when infected cells were fixed with formalin 
and then stained with crystal violet (Bushar and Sagripanti, 1990, Gaertner et al. 1993). 
However, these methods could not be utilised in the present study because they are destructive 
procedures that do not permit the recovery of viable virus for nucleotide sequencing analysis.  
Successful selection of escape mutants to IHNV, a fish rhabdovirus, was performed 
by Huang et al. (1996), when the escape mutants were selected by limiting dilution previous 
to plaque-purification. The use of limiting dilution is especially suitable for obtaining escape 
mutants of viruses that do not form plaques, but are capable of inducing cytopathic effects 
(Barclay and Almond, 2000). Since plaque based procedures did not yield betanodavirus 
escape mutants, attempts were made to isolate escape mutants using a limiting dilution 
procedure developed by Borrego et al. (2002). With this procedure selection was achieved 
with two dilutions of MAb (1:100 and 1:20 v/v). These were followed by further incubations 
in the presence of MAb at a dilution of 1:20. The dilutions of neutralising MAb were found to 
be suitable for obtaining escape mutants by limiting dilution (Minor et al. 1983, Ping and 
Lemon, 1992). 
The isolation of mutant virus by limiting dilution is possible because rare variants in a 
virus sample (typically 1:106) are not neutralised and these represent antigenic variants of the 
parental virus  (Yewdell et al. 1979). Betanodavirus is an RNA virus and the strains used 
replicated to a titre greater than 107 which is appropriate for use in limiting dilution based 
procedures for escape mutant isolation. RNA viruses are particularly suited for escape mutant 
selection because there are no error correction mechanisms operating in RNA replication, and 
thus RNA viruses tend to exhibit high mutation frequencies that favours the creation of escape 
mutants (Dimmock and Primrose, 1987).  
Neutralisation escape mutants are predicted to contain a single nucleotide sequence 
change corresponding to a single amino acid change compared to the parental virus (Parry et 
al. 1990). Several methods can be used to confirm resistance to the neutralising MAb used for 
selection such as ELISA and neutralisation test (Zhou et al. 1994, Béarzotti et al. 1995, 
Hörling and Lundkvist, 1997). In the present study the protocol developed by Borrego et al. 
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(2002) was followed so the escape mutants were screened by ELISA and found to be still 
recognised by the selecting antibody. Nucleotide sequencing of escape mutants was not 
performed because Borrego et al. (2002) considered the lack of recognition by ELISA as a 
pre-requisite for nucleotide sequencing. This may have lead to a failure to recognise the 
presence of mutations that had occurred in phage clones but did not prevent the binding of the 
MAbs. Nucleotide sequencing could be utilised to determine whether escape mutants were 
produced.  
A possibility for the inability to produce escape mutants may be due to an insufficient 
number of passages in the presence of neutralising MAbs. It is possible that three passages of 
betanodavirus were insufficient and a longer selection is necessary. 
 
 
4.4.1 - Final considerations 
 
The aim of this thesis section was not achieved. It was not possible to develop a 
method for the production of betanodavirus neutralisation escape mutants by plaque-selection. 
The use of different cell lines may have enabled this objective to be achieved. Virus 
isolated by limiting dilution was recognised by the selecting MAb in ELISA tests. According 
to Borrego et al. (2002) this recognition indicates that the production of escape mutants was 
unsuccessful. It is possible that several mutations are needed to alter the antigenicity of the 
betanodavirus or a higher number of passages may be required to obtain escape mutants.  
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Chapter 5 - Epitope mapping by phage display 
 
5.1 -  Introduction 
 
Antibodies represent a major component of the array of immune defence mechanisms 
directed against pathogens such as bacteria and viruses. Humoral immune responses are of 
great importance in the protective effects induced by vaccines (Irving et al. 2001). Antibody 
molecules interact with their target antigen through specific receptor regions generated 
through somatic recombination of V, D, and J gene segments during B-lymphocyte 
maturation. Hypervariable regions of VL and VH domains are brought together in three 
dimensional space to form an antigen binding surface (Abbas and Lichtman, 2001). The 
specific region of an antibody molecule that interacts with the antigen is referred to as the 
paratope, and the corresponding region of the target antigen recognised by this region of an 
antibody molecule is referred to as an epitope (Wang and Yu, 2004).  
Epitopes can be classified into two types. Those comprising a short sequential stretch 
of amino acids are referred to as linear epitopes. In contrast, epitopes that are formed by the 
juxtaposition of two or more distinct regions of a protein molecule are referred to as 
discontinuous or conformational epitopes (van Regenmortel, 1989a). Within this 
classification scheme, epitopes whose affinity is affected by unfolding of the protein are said 
to be constrained; almost all discontinuous and many linear epitopes are constrained (Geysen 
et al. 1987b). 
Characterisation of the primary amino acid sequence or structural conformation of 
epitopes has many applications in biological sciences including the deciphering of protein-
protein interactions, immunoassay development, elucidation of pathogen neutralising sites, 
vaccine development, investigation into the pathogenesis of autoimmune diseases and 
analysis of protein topology in intact cells or organelles (Morris, 1996a). 
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Several techniques have been developed for epitope mapping. One of the most 
commonly used techniques during the last 20 years has been phage display. This technique 
was first described in 1985 when George Smith demonstrated that it was possible to create a 
fusion between one of the phage fl minor coat protein genes with short stretches of DNA 
encoding foreign proteins. Smith showed that the sequence insert was translated and 
expressed as a fusion protein on the surface of the bacteriophage. Consequently, it was 
possible to create an epitope library by inserting tens of millions of short random DNA 
sequences into a phage population (Scott and Smith, 1990).  
The phage display methodology provides a direct physical link between phenotype 
and genotype (Hoogenboom and Chames, 2000). This is achieved because the fusion peptide 
is part of the capsid enclosing the phage genomic DNA (Cull et al. 1992). Thus phages 
expressing a single insert can be purified from the phage library by affinity binding to an 
antibody or other protein (Scott and Smith, 1990). The use of the simple and cost efficient 
process of bacteriophage replication is applied to the propagation of individual clones (Rodi 
and Makowsi, 1999). The DNA insert of the phage is identified by DNA sequence analysis 
(Burton, 1995). One of the key advantages of this technique is that it can be performed 
without the previous knowledge of the protein structure (Williams et al. 2001). 
A number of different phage display methods have been described (Kay and Hoess, 
1996): 1 phage display of natural peptides, used for mapping epitopes of monoclonal and 
polyclonal antibodies and generating immunogens; 2 phage display of random peptides, 
used for mapping epitopes of antibodies, identifying peptide ligands and mapping substrate 
sites for proteases and kinases; 3 phage display of proteins and protein domains, utilised in 
the study of directed evolution of proteins, isolation of high-affinity antibodies and cDNA 
expression screening.  
For the study of antigen-antibody interactions two types of phage display libraries 
have been used, random peptide libraries (RPL) and gene fragment libraries. Random peptide 
libraries are ideal for identifying peptide ligands of an antibody without prior knowledge of 
the recognition site (Irving et al.  2001). Both linear and discontinuous epitopes can be 
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mapped by phage display, but mapping of discontinuous epitopes represents a much more 
difficult task than the mapping of linear epitopes (Yip and Ward, 1999). Numerous attempts 
at epitope mapping discontinuous epitopes with phage display have been unsuccessful 
(Williams et al. 2001).  
Random peptide phage display has been used in several epitope mapping studies and 
analyses of protein-protein interaction, including: the VP2 protein of the coronavirus 
infectious bursal disease virus (IBDV) (Cui et al. 2003); feline immunodeficiency virus (FIV) 
coat protein (D'Mello et al. 1999); hepatitis B virus (Germaschewski and Murray, 1996, Pál 
et al.  2003), hepatitis C viruses (Barban et al. 2000, Hadlock et al. 2000, Bugli et al. 2001); 
apical membrane antigen-1 (AMA1) of Plasmodium falciparum (malaria) (Coley et al. 2001); 
multi-drug resistance associated protein MRP1 (one of the most important members of the 
ATO-binding cassette (ABC) protein family) (Poloni et al. 1995, Flego et al. 2003); crotoxin, 
a lethal venom of rattlesnake Crotalus durissus terrificus (Demangel et al. 2000); hormones 
(Li et al. 1995); interaction of the phosphorylation site of kinase CK2 with other peptides and 
proteins (Cardellini et al. 2004) and screening MAbs using antigen-displaying phage (Lijnen 
et al. 1997). 
 
 
5.1.1 - Bacteriophage  
 
Filamentous phages (Figure 5.1) constitute a large family of bacterial viruses that 
infect a variety of Gram-negative bacteria, and use pilin as a receptor (Russel et al. 1997). 
The best characterised phages are M13, fd and fl. The genomes of these phages are 
highly conserved, exhibiting 98 % sequence identity (Hill and Petersen, 1982). Because of 
this conservation and the dependence on the F plasmid for infection M13, fd and fl are 
collectively referred to as the Ff phage (Webster, 1996). This group of bacteriophages uses 
the tip of the F conjugative pilus as a receptor and thus are specific for Escherichia coli 
containing the F plasmid (F+) (Wang and Yu, 2004). In contrast to other groups of 
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bacteriophages that complete their life cycle by lysing the bacterial cell, filamentous phages 
do not kill their host. New phage particles are secreted without breaking the integrity of the 
cell envelope (Pereboev and Morris, 1996). 
 
 
 
 
Figure 5.1 – Filamentous phage by electron 
microscope (Petrenko and Vodyanoy, 
2003). 
 
 
The filamentous phages have a single stranded, covalently closed DNA genome, 
which is encased in a long cylinder (approximately 7 nm wide and 900-2000 nm in length) 
(Wilson and Finlay, 1998). The phage genome encodes 10 proteins, five of which are virion 
structural proteins, three are required for phage DNA synthesis, and two serve assembly 
functions (Webster, 1996).   
 Five copies of each of the minor coat proteins pIII and pVI are located at one end of 
the phage particle. The minor coat proteins pVII e pIX are located at the other end, and 2700 
copies of the major coat protein pVII are spread along the filamentous tube (Russel et al.  
1997, Smith and Petrenko, 1997).  
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Infection of E.coli by the Ff phage is initiated by the specific interaction of the phage 
with the tip of the F pilus (Webster, 2001). The N-terminus of the pIII protein is responsible 
for this interaction (Pereboev and Morris, 1996).  
After infection, the phage positive (+) strand DNA (ssDNA) enters the cytoplasm and 
the complementary strand (-) is synthesised by bacterial enzymes, creating a double-stranded 
replicative form (RF) (Wilson and Finlay, 1998). When the phage specific single-stranded 
DNA binding protein, pV, reaches a critical concentration, it binds to the newly synthesised 
DNA strands to form a pV-DNA complex (Webster, 2001). This complex prevents the (+) 
DNA strand from being used by host replication enzymes, facilitating virus encapsidation 
(Russel, 1995). Eventually, further increases in pV concentration halt RF synthesis, and the 
viral assembly process starts at the bacterial membrane (Webster, 1996). During assembly, 
pV molecules are displaced from the pV-DNA complex, and the capsid proteins assemble 
around the DNA as it is extruded through the envelope (Webster, 2001). The extrusion 
process is very well tolerated by the host bacteria, and they continue to multiply for several 
generations while extruding phage into the culture medium (Pereboev and Morris, 1996). The 
concentration of RF DNA and of progeny phage produced are very high (1011 to 1012 phage 
particles ml-1). Because of these high levels of replication it is relatively easy to isolate large 
quantities of both double and single-stranded phage DNA (Bainbridge, 2000).   
 
 
5.1.2 - Phage display system 
 
The life cycle of filamentous bacteriophages can be exploited using molecular 
biological techniques to generate large and diverse libraries of phage-displayed peptides, 
which can be used to isolate and characterise bioactive ligands such as antibodies (Smith and 
Petrenko, 1997, Zwick et al. 1998, Sidhu, 2001). 
Although it is theoretically possible to create phage libraries in any bacterial virus, 
the filamentous bacteriophages are particularly suited for this purpose in that they replicate to 
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high levels and have a small, easily manipulated genome (Hoess, 1993). Many of the vectors 
used in genetic manipulation studies are phages that infect Escherichia coli (Smith and 
Petrenko, 1997). Bacteriophage M13 has been the most frequently used biological vehicle for 
phage display, not just because it was the first and the best characterised library display, but 
also because it has proven to be amenable to successful screening (Rodi and Makowsi, 1999). 
In phage display, peptides or proteins are fused to one of the capsid proteins and are 
accessible to molecular interactions (Smith, 1985). Peptides have been expressed as fusions 
to a number of M13 capsid proteins, including pIII (Scott and Smith, 1990; Cwirla et al. 
1990; Devlin et al. 1990) and the major capsid protein pVIII (Felici et al. 1991) (Figure 5.2).  
 
 
Figure 5.2 –  c Localisation of phage encoded proteins in the filamentous phage 
Ff;   d localisation of the fusion proteins on the filamentous phage 
surface (Irving et al. 2001). 
 
 
The major coat protein, pVIII, may represent the best candidate for protein fusion 
because it is present at a high copy number (2700 copies) compared to the minor coat protein 
pIII of which only five copies are expressed on the phage surface (Kay et al. 1998). However, 
most studies have employed pIII, since this protein can accommodate longer inserts than 
pVIII, which can only accept a maximum of six amino acids (Greenwood et al. 1991). 
c 
d 
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Longer inserts in pVIII interfere with the phage assembly process (Smith and Petrenko, 
1997). Consequently, phagemid vectors are required to implement long inserts in this phage 
protein (Williams et al. 2001). 
The key concept of phage display is that the binding activity of a ligand displayed by 
the phage (the phenotype) is physically linked to the genetic information encoding that 
ligand, (the genotype) (Wang and Yu, 2004). It is this linkage between phenotype and 
genotype that enables the selection and characterisation of a specific peptide ligand (Sparks et 
al. 1996).  
Vast numbers of unique peptide sequences (≥ 108) can be generated and screened 
simultaneously through a process called biopanning (Dottavio, 1996). During this process, 
the target, e.g. a MAb, is immobilised onto a surface and interact with a phage display library 
(Gershoni et al. 1997) (Figure 5.3). Phages expressing inserts identical or similar to the 
epitope recognised by the target MAb will be recognised and bound (Pereboev and Morris, 
1996, Gershoni et al. 1997). Enrichment of bound phages is achieved by amplification in 
Escherichia coli between each round of the panning procedure (Pereboev and Morris, 1996). 
Clones derived from a single bound phage can thus be propagated, facilitating DNA isolation. 
Conventional nucleotide sequence analysis can then be used to determine the amino acid 
sequence of the peptide insert displayed on the phage surface (Dottavio, 1996, Sidhu, 2001). 
The propagation of individual clones also enables the application of further immunological 
techniques such as phage ELISA (Williams et al. 2001).   
 
     c      d          e   f 
 
Figure 5.3 -  Biopanning of phage libraries: c Screening of phage library with the target; d 
Washing to remove non-specific phage; e Elution of specific phage binders; f 
DNA sequencing of individual phage clones. 
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The success of this technique is dependent on the phage-display library quality.  A 
given phage component of a library can only be selected if the insert DNA sequence is 
efficiently expressed and displayed on the phage surface (Sidhu, 2001). 
 
5.1.2.1  -  Random peptide phage libraries  
 
The first generation of phage display random peptide libraries was described in 1990 
(Scott and Smith, 1990, Cwirla et al. 1990, Devlin et al. 1990). The fusion of random DNA 
sequences to the coat protein gene III permitted the construction of a large library that 
contained a vast number of different peptide sequences. Although each phage clone displayed 
a single peptide, the library as a whole may represent billions of various peptides altogether 
(Gershoni et al. 1997). 
When constructing a random peptide library the peptides are encoded by synthetic 
degenerate oligonucleotides and cloned into the pIII coat protein gene (Adey et al. 1996). If a 
stop codon (TAG, TAG and TGA) is present in the synthetic insert in a recombinant protein-
insert DNA molecule, translation of the capsid protein is terminated, precluding assembly of 
progeny phage (Burrit et al. 1996). This possibility is reduced by the use of the degenerate 
codon NNK or NNS, where N can be any of the four nucleotides (G, T, C and A), K is for G 
or T, and S is for G or C (Beck-Sickinger and Jung, 1993). Each degenerate codon can 
represent all of the 32 codons that encode all 20 amino acids plus one amber stop codon 
(TAG) (Scott, 2001). 
One of the principal objectives of a random peptide library is the maximisation of 
library complexity. The total number of variants, referred to as complexity of the library, is 
simply calculated as 20n, where n is the number of peptide residues (Burrit et al. 1996, 
Gershoni et al. 1997). The complexity of the library is dependent on the number of inserted 
peptides. Not even a relatively large size library can contain all possible amino acid 
sequences longer than six residues, thus not all peptides can be represented in any random 
peptide library (Fack et al. 1997). 
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5.1.2.2  -  Ph.D.™ libraries  
 
Phage display is a selection technique in which a library of variants are expressed on 
the outside of phage particles, coupled to the genetic material encoding each variant (Wilson 
and Finlay, 1998, Rodi and Makowsi, 1999). 
The Ph.D™ system is a commercially available random peptide library developed at 
the New England BioLabs. This phage library uses the phage vector M13KE for displaying 
random peptides as N-terminal fusions to the minor coat protein pIII (Noren and Noren, 
2001). M13KE is a conventional M13mp19 derivative that can be simply and rapidly 
propagated using standard techniques, without the requirement for antibiotic selection or 
helper phage super-infection (Devlin et al. 1990). The vector is based on wild-type M13, but 
contains a lacZ gene cloned into the plus-strand origin and the restriction sites KpnI and EagI 
in the gene III coding sequence to allow the construction of the libraries (Scott and Barbas 
III, 2001). 
The Ph.D.™ system comprises three different libraries, two not constrained (insert 
length 7 and 12 mer) and one constrained (insert length 7 mer flanked by a pair of cysteine 
residues). On this library a complexity of ~109 clones is sufficient to encode most of the 1.28 
x109 possible 7-mers, but only 1 millionth of the 4 x1015 possible 12-mers (Noren and Noren, 
2001). 
With just five copies of pIII per virion this type of library is more suited for the 
identification of high-affinity ligands (Noren and Noren, 2001). The use of a library with 
shorter peptide inserts is appropriate for targets that bind to short, contiguous stretches of 
amino acids e.g. an antibody with a linear epitope. The longer peptide library (12-mer) is 
useful for targets where ligand binding is spread out over a longer randomised “window” than 
that contained in a library of shorter (≤ 7-mer) peptides (Noren and Noren, 2001). 
The Ph.D™ system has been widely applied in biomedical research. Examples are 
included in Table 5.1. 
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Table 5.1 – Examples of studies performed with Ph.D™ system 
 
Ph.D™ system application studies Author 
Epitope mapping with:  
Mabs 
Human IgG1  
Syndecan-1 (human plasma cell) 
Receptor binding domain of human  α2-macroglobulin (α2-Mn) 
Human p53 protein 
Neisseria meningitidis outer membrane lipooligosaccharide (NmLOS) 
Rabies virus (RABV) 
Scorpion toxins Cn2 and noxiustoxin (NTX) 
Ehrlich and Bailon (1998) 
Dore et al. (1998) 
Birkenmeier et al. (1997) 
Blaydes et al. (2001) 
Charalambous and Feavers (2000) 
Mansfield et al. ( 2004) 
Gazarian et al. (2003 
Hernández et al. (2002 
Gazarian et al. (2000a) 
Rabbit 
polyclonal 
antibodies 
Anti-gliadin 
Mycoplasma hyopneumoniae IgG 
N-terminal of Taenia solium  paramyosin 
Yang and Shiuan (2003) 
Gazarian et al. (2000b) 
Osman et al. (1998) 
Human 
polyclonal 
antibodies 
Diabetes type 1; 
Primary biliary cirrhosis (PBC) 
Autoimmune thrombocytopenic purpura (AITP) 
Gliadin  
Davies et al. (1999) 
Gevorkian et al. (1998) 
Osman et al. (2000) 
Characterisation of immune factors 
 
C1q (subunit of C1 the initiator of the classical complement pathway) 
Tumor Necrosis Factor α (TNFα) 
Zinc sites 
Zhang et al. (2003) 
Messmer and Thaler (2000) 
Matsubara et al. (2003) 
Development of drugs 
 
gp120 of Human Immunodeficiency Virus type 1 (HIV) 
Biotinylated derivate of paclitaxel (high effective anti-neoplastic 
agent) 
Prolyl-tRNA synthetase (ProRS)] and protein kinase C alpha (PKCα) 
Ferrer and Harrison (1999) 
Ashraf et al. (2003) 
Tao et al. (2000) 
Rodi and Makowsi (1999) 
Enzyme inhibitors 
 
Class ligase (tyrosyl tRNA synthetase (haemophilus influenza) and 
proline RS (E. Coli)) 
Class oxidoreductase (alcohol dehydrogenase (Saccharomyces 
cerevisiae)) 
Class hydrolase (carboxypeptidase B (Sus scrofa – pig) and β-
glucosidase (Agrobacterium faecaelis)) 
Class transferase (hexokinase (Saccharomyces cerevisiae) 
Glycogen phosphorylase a (Oryctolagus cuniculus – rabbit) 
Hyde-DeRuyscher et al. (2000) 
Peptides directly to the antigen 
 
Spores of: 
Bacillus  anthracis, B. cereus, B. subtilis and B. globigii 
Eimeria acervulina and E. tenella 
 
Turnbough Jr. (2003) 
Silva et al. (2002) 
 
 
5.1.3 - Objectives  
 
The objective of the work described in this chapter was to identify the epitope/s on 
the betanodavirus coat protein recognised by a panel of MAbs using phage display 
technology. 
Two non-constrained phage libraries presenting inserts of either 7 or 12 random 
peptides fused to the coat protein pIII of M13 phage were used in this study.  
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5.2 -  Materials and Methods 
 
Phage display libraries Ph.D.-7™ and Ph.D.-12™ were obtained from New England 
Biolabs (Herts U.K.). The manufacturer's instructions were followed for all the phage 
manipulation procedures. Media and buffers are described in Appendix 1. 
The Ph.D.-7™ and Ph.D.-12™ phage display libraries are non-constrained 
combinatorial libraries of random peptides with inserts encoding 7 or 12 amino acid residues 
respectively. These are fused to the minor coat protein (pIII) of phage M13. The insert 
sequence is positioned such that expressed peptides are located at the N-terminus of the pIII 
protein. A short spacer (Gly-Gly-Gly-Ser) is present between the insert and the pIII coding 
sequence. The 7-mer phage display library (Ph.D.-7™) has a complexity of ≈ 2.8 x 109 
transformants. Approximately 70 copies of each insert sequence is contained in the 10 μl of 
phage supplied. The 12-mer phage display library (Ph.D.-12™) has a complexity of ≈ 2.7 x 
1010 transformants, and the 10 μl of phage supplied contains ≈ 55 copies of each sequence.  
Escherichia coli (ER2738) was used for phage-amplification. This E. coli strain is F´ 
lacIq ∆(lacZ)M15 proA+B+ zzf::Tn10(TetR)/fhuA2 supE thi ∆(lac-proAB) ∆(hsdMS-mcrB)5 
(rk– mk– McrBC–). The E. coli host strain was supplied in TBS supplemented with 50 % 
glycerol and was stored at -70°C. 
Streptavidin and biotin were used for a positive control.  
All the procedures were executed with sterile filter tips. 
The MAbs used for the assay were produced as described in Chapter 3. Purification 
and protein concentration of MAb preparations was also performed (Chapter 2).  
For phage display studies, MAbs were diluted to a concentration of 100 μg ml-1 in 
coating solution (Appendix 1). The Ph.D.-7™ library was used to characterise MAbs 3B10, 
4A12 and 4C3. The Ph.D.-12™ library was used to study MAbs 3B10, 4A12, 4C3, 1E3, and 
5G10. 
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5.2.1 - Escherichia coli host 
 
Although Escherichia coli strain ER2738 is defined as recA+, spontaneous in vivo 
recombination events were never observed. 
Escherichia coli used for M13 propagation was grown on LB-Tet media to select for 
the F-factor, since M13 is a male-specific coliphage.  
When E. coli of F+ Δ-tet background is used to create an M13-based library, only 
phage-infected cells exhibit tetracycline resistance, so the ability of the cells to grow in the 
presence of tetracycline is a selective marker (Pereboev and Morris, 1996). The mini-
transposon, which confers tetracycline resistance, was inserted in the F-factor of E. coli 
ER2738 strain. This resistance allows the selection of cells harboring the F-factor by plating 
and propagating on tetracycline-containing media. 
 The E. coli (ER2738) were grown on LB-Tet plates (Appendix 1), incubated at 37°C 
overnight. Plates were sealed with Nescofilm (Bando Chemical Ind. Ltd Japan, Fisher 
Scientific Leicestershire U.K.). Plates were stored at 4°C wrapped with aluminium foil for a 
maximum of 1 month. 
The E. coli (ER2738) used in phage display studies was cultured overnight prior to 
use.  
 
 
5.2.2 - Biopanning 
 
The biopanning procedure comprises several steps, which are described below in the 
order of execution.  
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5.2.2.1  -  Biopanning - 1st day 
 
Purified MAbs were diluted in antibody buffer (100 μg ml-1, Appendix 1) and 150 μl 
added to each well of a 96 well plate (Nunc, Fisher Scientific, Leicestershire U.K.). The plate 
was incubated overnight at 4°C, with gentle agitation (Mini Rocking platform, Biometra™) in 
a humidified container. The MAbs were tested in duplicate. Streptavidin (1.5 mg ml-1) 
(prepared as described in Appendix 1) was added to plates as a positive control.  
Escherichia coli was plated and incubated overnight at 37°C. 
 
5.2.2.2  -  Biopanning - 2nd day 
 
The coating solution was removed and wells drained by firmly slapping plates face 
down onto a clean paper towel. Each well was filled with blocking buffer (Appendix 1) and 
incubated for 60 mins at 4°C with gentle agitation. Wells containing streptavidin (+ control) 
were blocked with blocking solution supplemented with 0.1 μg ml-1 streptavidin, to complex 
to any biotin in BSA. 
Blocking solution was discarded and wells thoroughly drained. The wells were then 
washed 6 x with TBST (0.1 %) (Appendix 1). Washing was performed quickly to prevent 
plates drying. For Ph.D.-7™ the TBST was added with a pipette, while for Ph.D.-12™, TBST 
was added with a beaker. The latter method was adopted with Ph.D.-12™ due to the 
unsatisfactory results obtained with Ph.D.-7™, which potentially could have arisen due to the 
type of washing procedure used.  
The library, as supplied, was diluted 1:100 in TBST (0.1 %) and 100 μl added per 
well. Plates were incubated 60 mins at room temperature with gentle agitation.  
Non-binding phage was discarded and plates washed 10 x with TBST (0.1 %) as 
described above. 
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Bound phages were eluted with 100 μl of elution buffer (Appendix 1) by incubation 
for 8 mins at room temperature with gentle agitation. Elutes were pipetted into a microfuge 
tube and neutralised with 15 μl neutralising elution buffer (Appendix 1).  
Streptavidin containing wells (+ control) were eluted with 100 μl of biotin (0.1 mM 
in TBS, Appendix 1). Incubation was performed for 30 mins at room temperature with gentle 
agitation.  
An aliquot of 1 μl was used to quantitate eluted phage (see below). The remainder of 
the eluted phage was amplified in E. coli.  
LB medium was inoculated with E. coli in a 250 ml Erlenmeyer flask. E. coli were 
incubated at 37°C with vigorous shaking until mid-log phase was attained. After sample 
elution E. coli was aliquoted (20 ml per sample) into culture flasks and eluted phage samples 
were added. Phages were amplified for 4.5 hrs at 37°C with vigorous shaking.  
Cultures were transferred to 50 ml centrifuge tubes and centrifuge for 20 mins at 13 
500 x g at 4°C (Sanyo Mistral 3000i). The upper 80 % of the supernatant transferred to a 
fresh centrifuge tube to which 1:6 volumes of PEG/NaCl (Sigma, Dorset U.K.) (Appendix 1) 
was added. Phages were allowed to precipitate at 4°C overnight.  
 
 
Phage titration 
 
Five ml of LB broth (Appendix 1) was inoculated with a single colony E. coli and 
incubated at 37°C with shaking until mid-log phase was attained. The mid-log was based on a 
O.D. value of 0.5, on spectrophotometric analysis using a wave length of 600 nm. 
Agarose Top (Appendix 1) was melted in a microwave oven (Philips) and dispensed 
(3 ml) into sterile bijoux, one for each dilution of phage tested. Bijoux were kept at 45°C 
until used. 
For logistical and financial reasons one plate per dilution was used for phage titration.  
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LB/IPTG/Xgal plates (Appendix 1) (one per dilution), were pre-warmed at 37°C. 
A 10-fold serial dilution of phage was prepared in LB (Appendix 1). For amplified 
phage a dilution of 108-1010 was used. For un-amplified phage the dilution series ranged from 
101 and 103. 
When the E. coli culture had reached mid-log phase, 200 μl of culture was dispensed 
into 1.5 ml microfuge tubes. Ten μl of the appropriate phage dilution was added to tubes, 
which were vortexed briefly, then incubated at room temperature for 4 mins.  
Microfuge tubes containing phage-infected E. coli were transferred to bijoux 
containing Agarose Top, vortexed briefly, and then poured onto a pre-warmed LB/IPTG/Xgal 
plate. The Agarose Top was spread evenly by tilting the plate. 
The plates were sealed with Nescofilm and incubated overnight at 37°C. 
The plates with ~100 plaques were counted and the phage titre expressed as plaque 
forming units (pfu) was calculated using the formula: 
 
Phage titre (pfu) per 10 μl = 
s
dn ×   
 
Where: n is the number of clones.  
              d is the dilution factor. 
             s is the volume of phage added. 
 
 
5.2.2.3  -  Biopanning - 3rd day 
 
Phage samples precipitated in PEG were centrifuged for 30 mins 3500 x g at 4°C. 
The supernatant was decanted, re-centrifuged briefly and the residual supernatant removed 
with a pipette. The pellets were resuspended in 1 ml TBS and transferred into 1.5 ml 
microfuge tubes. After centrifugation for 5 mins at 12 000 x g at room temperature (Sanyo 
Micro centaur) to pellet residual cells, supernatants were transferred to fresh microfuge tubes 
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and 1:6 volumes of PEG/NaCl  was added. Phages were re-precipitated on ice for 60 mins. 
Tubes were centrifuge at 9500 g for 10 mins at room temperature, the supernatant was then 
discarded, prior to re-centrifugation and removal of residual supernatant. The pellet was 
resuspended in 200 μl storage buffer (Appendix 1), centrifuged at 9500 g for 1 min, and the 
supernatant transferred to a fresh tube prior to storage at 4°C. This is the first amplified 
eluate. 
The quantity of phage in the amplified product was titrated as described above. 
A 96 well plate was coated with MAbs and Streptavidin in order to performed the 
second round of panning. 
 
5.2.2.4  -  Biopanning - 4th day 
 
Coating buffer removal, blocking of non-specific sites, incubation, elution, titration 
and amplification were performed as described above for day 2. Washing steps were 
performed using TBST (0.5 %). 
An input volume corresponding to 2 x 1011 phage-pfu from the first round amplified 
elute was added to the wells of a 96 well plate for the incubation step. The sample chosen 
was that exhibiting the highest titre. Phage samples were diluted with TBST (0.1 %).  
 
5.2.2.5  -  Biopanning - 5th day 
 
The procedure on the fifth day was identical to that described above for day 3. The 
final product is the second amplified elute. 
A third 96 well plate was coated with MAbs and Streptavidin for the third round of 
panning. 
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5.2.2.6  -  Biopanning - 6th day 
 
On the 6th day the procedure was identical to that described above for day 4. Plate 
wells were incubated with 2 x 1011 pfu of phage from the second round amplified elute.  
Amplification of phages eluted in the third panning step is not require. These phages 
can be used for nucleotide sequencing of inserts in the pIII minor coat protein gene. 
Eluted phage samples were titred and the resulting plates were used in subsequent 
nucleotide sequencing analysis. Consequently, the plates were incubated longer (16 –18 hrs at 
36°C). 
 
5.2.2.7  -  Blocking experiment 
 
Taking into consideration the results obtained after three rounds of biopanning using 
both Ph.D.-7™ and Ph.D.-12™, it was possible that the blocking procedure was not 
functioning efficiently. Consequently, an experiment was performed to test this hypothesis. 
Blocking solution was added to one 96 well plate and incubated at 4°C for 60 mins 
with gentle agitation. Plates were drained and washed 6 x with TBST (0.5 % Tween 20) as 
described above.  
The original library (PhD 12™) was diluted 1:100 v/v in TBST (0.1% Tween 20) and 
incubated for 60 mins at room temperature with gentle agitation.  
The non-binding phage was discarded and the plate was washed 10 x with TBST (0.5 
%). 
Elution buffer (100 μl) was added to each well and incubated for 8 mins at room 
temperature with gentle agitation. The elute was transferred into a microfuge tube and 
neutralised with 15 μl neutralising elution buffer.  
The resulting elute was titred as described above. 
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5.2.2.8  -  4th Biopanning 
 
A 4th panning step was performed for assays using Ph.D.-12™. All of the steps in this 
procedure were identical to those described above, with the exception of the elution step. The 
elution step was performed with TBS supplemented with 20 μg ml-1 and 100 μg ml-1 of the 
target molecule (MAb used to coat the well) and the usual elution buffer (Zhang et al. 2003).  
The elution procedure was performed in 3 steps. The first elution step was performed 
by incubating the wells with 100 μl of TBS (20 μg ml-1 target) for 15 mins. The eluate was 
collected and transferred to a microfuge tube. For the second elution step, 100 μl TBS (100 
μg l-1 target) was added and incubated for 1 h. The eluate product was then collected and the 
3rd elution step performed with elution buffer incubated for 8 mins followed by addition of 
the neutralising elution buffer.  
The eluted products were titred and the clones harvested for nucleotide sequence 
analysis of inserts. 
 
 
5.2.3 - Nucleotide sequence analysis of phage 
5.2.3.1  -  Plaque amplification 
 
For characterisation of the clones only plates showing less then 100 colonies were 
used. Where this was not possible, eluted phage samples were further diluted to yield plates 
with suitable numbers of 100 plaques. 
LB medium was inoculated with E. coli and incubated until a value of mid-log phase 
was attained. Bacteria were aliquoted (1 ml) into culture flasks. 
Using a sterile pipette tip, blue plaques were stabbed and inoculated into a culture 
flask containing E. coli. Flasks were incubated at 37°C with vigorous shaking for 4.5–5 hrs. 
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With Ph.D.-7™ 10 plaques were selected and amplified for characterisation of the insert. For 
Ph.D.-12™ 20 plaques were used. An example of the plaques is depicted in Figure 5.4. 
 
 
 
Figure 5.4 - Selection of the phage with Xgal-IPTG. Phage clones grow blue. 
These clones were selected for amplification and DNA extraction. 
Contamination with wild M13 would result in the growth of white 
plaque phage  
 
 
After incubation, the cultures were transferred to 1.5 ml microfuge tubes, and 
centrifuged at 9500 x g for 30 seconds. The supernatant was transferred to a fresh tube and 
re-centrifuged. The upper 80 % of the supernatant was then transferred to a fresh tube. This 
product represents the amplified phage stock and was stored at 4°C for maximum of 8 weeks. 
For long-term storage, the phage samples were diluted 1:1 with sterile glycerol and stored at -
20°C. 
Phage clones selected and amplified as described above were found to contain 
insufficient DNA for nucleotide sequencing.   
Consequently, an extra amplification step was introduced to produce greater amounts 
of DNA. This was performed by adding 100 μl of phage to 10 ml of LB containing mid-log 
phase E. coli. After 4.5 hrs of incubation the product was transferred to a 15 ml centrifuge 
tubes and centrifuged for 10 mins at 3500 x g, 4°C. 
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The amplification products were always plated on LB/IPTG/Xgal plates to confirm 
the presence of phage clones. 
 
5.2.3.2  -  Rapid purification of amplified phage clones  
 
Purification of amplified phage clones was performed by transferring 500 μl of phage 
to a 1.5 ml microfuge tube. PEG/NaCl (200 μl) was added and mixed by inverting the tubes, 
which were allowed to stand at room temperature for 10 mins. The tubes were centrifuged for 
10 mins at 12 000 x g. The supernatant was discarded and the tubes re-centrifuged briefly. 
Any remaining supernatant was carefully pipetted away. 
In initial sequencing work, the quantity of DNA obtained from phage preparations 
was found to be insufficient. Consequently, greater amounts of purified phage were used. For 
each clone two extraction reactions were performed. In each reaction 1000 μl of amplified 
phage sample was mixed with 400 μl of PEG/NaCl. The procedure was performed as 
described above.  
The buffer used to re-suspend pellets depended on the DNA extraction method used. 
For the iodine DNA extraction method, the pellet was re-suspended with iodine buffer 
(Appendix 1) and with TE (appendix 1) for the phenol-chloroform DNA extraction method. 
 
5.2.3.3  -  Phage DNA extraction  
5.2.3.3.1 -  Iodine DNA extraction method 
 
The amplified phage pellet was re-suspended in 100 μl iodide buffer. Ethanol (250 
μl, Fisher Scientific, Leicestershire U.K.) was added and the mix incubated for 10 mins at 
room temperature. Samples were centrifuged for 10 mins at 12 000 x g and the supernatant 
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discarded. The pellet was washed in 500 μl of 70 % ethanol, and then allowed to air dry prior 
to re-suspension in 30 μl of TE buffer. 
Extracted DNA was found to be of low quality using this method, so the phenol-
chloroform extraction method was used as an alternative.  
 
5.2.3.3.2 -  Phenol-Chloroform DNA extraction method 
 
This method was kindly provided by Dr. David Landry of New England Biolabs, 
who suggested the use of Phenol buffered with TrisHCl (pH 8) as an alternative method to 
iodine DNA extraction.  
Phage pellets were re-suspended in 70 μl TE buffer. The same volume of Phenol 
(Sigma, Dorset U.K.) or Aquafenol (Qbiogene, Cambridge U.K.) was added and samples 
were then vortexed. The samples were centrifuged for 2 minutes at 15 800 x g (Thermo IEC 
microlite). The upper layer was collected, transferred to a clean tube and 70 μl of chloroform 
(Sigma, Dorset U.K.) was added. The tubes were vortexed and centrifuged for 2 minutes at 
15 800 x g. The upper layer was collected and transferred to a clean tube and 3 volumes of 
ethanol (92 %) was added. After incubation on ice for 3 mins the mix was centrifuged at 15 
800 x g for 15 minutes. The supernatants were discarded and pellets washed with 500 μl of 
ethanol (70 %) by centrifugation as described above. The supernatants were discarded and the 
pellets were dried, and then re-suspended in 30 μl nuclease-free water (Promega, 
Southampton U.K.). 
 
5.2.3.4  -  Nucleotide sequencing 
 
For nucleotide sequencing of the inserts fused to a minor coat protein gene (pIII) of 
M13 phage, the DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Biosciences, 
Bucks U.K.) was used.  
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All the procedures for nucleotide sequence have been described in Chapter 2. 
 The sequencing primer (5’ CGT TAC GCT AAC TAT GAG GGC 3’) was supplied 
with the phage display kit. The amount supplied was found to be insufficient, so this primer 
was subsequently obtained from MWG (Milton Keynes, U.K.).  
Amino acid sequences were deduced from the nucleotide sequence of inserts (Figure 
5.5). This was processed using BioEdit software  (Chapter 2).  
 
 
Figure 5.5 – Reduced genetic code (Phage display peptide 
library kit, NE BioLabs). 
 
 
The following steps were performed to ensure the fidelity of nucleotide sequence 
analysis of phage inserts:  
c The reverse complement sequence of the insert was determined;  
d The sequence read accuracy of the Kpn I (upstream of the insert) and the Eag I 
(downstream of the insert) containing regions was confirmed;  
e The third position of each codon in the randomised region was confirmed to be  G 
or T;  
f TAG codons were considered to represent glutamine (Q). 
g The phage clones obtained with streptavidin should exhibit amino acid sequence 
S/T/N_L_L/I/V_A/N_HPQ as the insert sequence. Being the major consensus amino acids 
the HPQ sequence. 
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5.2.3.5  -  Detection of phage clones by ELISA 
 
Phages corresponding to each amino acid sequence variant obtained were analysed 
by ELISA for verifying recognition by the selecting MAbs.  
The ELISA protocol was performed as described in Chapter 2, using the amplified 
phage samples (200 μl) to coat the 96 well ELISA plates. Phage samples were incubated 
overnight at 4°C. Monoclonal antibodies (neat supernatant) was added as the primary 
antibody. 
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5.3 -  Results 
 
After three - four biopanning rounds, the nucleotide sequence of the inserts in the 
M13 pIII gene was determined. This was used to deduce the amino acid sequence of the 
peptide displayed on the phage surface. The results obtained with the phage systems Ph.D.-
7™ and Ph.D.-12™ are presented below. 
 
5.3.1 - Ph.D.-7™ 
 
The Ph.D.-7™ system was used to characterise epitopes recognised by MAbs 4C3, 
4A12 and 3B10. Streptavidin was used as a positive control. Phage clones were sequenced 
after the third biopanning round.  
 
5.3.1.1  -  MAb 4C3 
 
The deduced amino acid sequence data obtained with Ph.D.-7™ when panning was 
performed with MAb 4C3 are presented in Table 5.2. 
No consensus sequence was evident based on the analysis of nine sequenced inserts. 
Attempts were made to sequence phage clone 4 but based on the criteria of validity described 
in 5.2.3.4, the sequence data was rejected. Clone 2 was found to contain a double insert (2a 
and 2b). 
Some of the clones contained the same amino acids in a given position, as can be 
observed with clone 2b and 5 (xxWSxxx). Clone 5 and 6 shared 3 amino acids, but their 
position within the insert was different, (x)HWSxx. 
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Table 5.2 – Amino acid sequence of the Ph.D.-7™  
inserts obtained after panning with 
MAbs 4C3. 
 
4C3 
Clone Insert sequence Clone Insert  sequence
1 HLRWHHT   
2a HSPSVLS 2b AKWSSRH 
3 QFSHYFN   
4 -   
5 NHWSLNG   
6 HWSHARH   
7 ALNYTNS   
8 HMRFIHY   
9 GHIMINR   
10 WPHKHFY   
 
 
5.3.1.2  -  MAb 4A12 
 
Table 5.3 present the deduced amino acid sequence data obtained with Ph.D.7™ 
when panning was performed with MAb 4A12.  
No consensus sequence was obtained from the clones analysed. Clones 3 and 8, 
revealed the same amino acid in the same position (xxxHHHx). 
 
Table 5.3 – Amino acid sequence of the Ph.D.-7™ 
inserts obtained after panning with 
MAbs 4A12. 
 
4A12 
Clone Insert sequence Clone Insert sequence
1a HRLHSYM 1b LPTNLHW 
2 HTSSKLV   
3 WTPHHHF   
4 MHRPHWH   
5 SPLHAWW   
6 LLPSYIY   
7a HYQSSVT 7b GPKIWHI 
8 HLRHHHY   
9a WQFHLPH 9b PRQYPRA 
10 -   
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Clones 1, 7 and 9 contained double inserts. Clones 1a and 7a contained the same two 
amino acids in the same position: HxxxSxx. Clones 1b and 7b also shared two amino acids: 
xPxxxHx. 
It was not possible to analyse sequence data for clone 10. 
 
5.3.1.3  -  MAb 3B10 
 
The deduced amino acid sequence data obtained with Ph.D.7™ when panning was 
performed with MAb 3B10 are presented in Table 5.4 
No consensus was obtained. Clones 9b and 10 showed the greatest similarity with the 
sequence RxxLRxL.  
 
Table 5.4 – Amino acid sequence of the Ph.D.-
7™ inserts obtained after panning 
with MAbs 3B10. 
 
3B10 
Clone Insert sequence Clone Insert sequence
1a GPKIWHT 1b HYQSSVT 
2 RPKRSPI   
3 NAMLQLR   
4a TVKYHHH 4b VSNMNTV 
5a ITPENST 5b HPRIHFW 
6 MSSAEAR   
7 MNLGALP   
8 APPSNLP   
9a HSNHLHN 9b RNVLRCL 
10 RLTLRSL  
 
 
Almost half of the clones (1, 4, 5 and 9) contained a double insert. Some of these 
clones contained common amino acids, e.g. xSNxxxx (clone 4b and 9a). 
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5.3.1.4  -  Streptavidin 
 
Streptavidin was used as a positive control. A consensus sequence was obtained in 
the clones that contained a double insert, which was present in 40 % of clones (Table 5.5). 
 
Table 5.5 – Amino acid sequence of the Ph.D.-
7™ inserts obtained after panning 
with Streptavidin. 
 
Streptavidin 
Clone Insert sequence Clone Insert sequence
1a DPAPRPR 1b NHAHSTP 
2 HLHIRFP   
3 HKRPRNN   
4a DPAPRPR 4b NHAHSTP 
5 RPKRSPI   
6a DPAPRPR 6b NHAHSTP 
7 -   
8a DPAPRPR 8b NHAHSTP 
9 AQRQPEH   
10 INHVHRL   
 
 
 
5.3.2 - Ph.D.-12™. 
 
The Ph.D.-12™ system was used to characterise epitopes recognised by MAbs 4C3, 
4A12 and 3B10, 1E3 and 5G10. Streptavidin was used as a positive control. Phage clones 
were sequenced after the third and fourth biopanning round.  
 
5.3.2.1  -  MAb 4C3 
 
No consensus sequence was obtained with MAb 4C3 after three rounds of panning 
(Table 5.6). Several clones contained the same amino acids in the same position, e.g. clones 
15 and 16 shared WHxxxLxPxxxx amino acids; clones 1 and 10 shared residues 
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xxxHHxxxxSxx and clones 5 and 6 shared residues xxxHxxxxxSRx. Clone 6 had some 
residues in common with clone 18, HLxxxYxxxxxx. 
The 4th panning revealed inter and intra-elution consensus sequences. Insert sequence 
HHRHNYAVEAPF occurred in 4 of 52 clones sequenced (two clones from the 1st elution, 
one clone of the 2nd and one clone of the 3rd elution) (Table 5.7). The sequence 
WHKHSYNSMPVY was present in two 1st elution clones and one 3rd elution clone. Clone 17 
from the 1st elution and clone 7 of the 2nd elution contained the same amino acid sequence, 
GWKSHHNHERVF. Clone 4 of 1st panning and clone 13 of the 2nd panning contained the 
insert sequence HHKHGINQISP. This sequence, HHHKHGINQISP, was almost identical to 
clone 11 of the 1st panning sequence, differing by just a single residue (I or D) at the 10th 
position. Clones 5 and 7 of the 1st elution shared the same amino acid sequence with the 
exception of the final amino acid (L or P).  
 
Table 5.6 – Amino acid sequence of Ph.D.-12™ clones obtained after panning with MAb 4C3. 
 
Amino acid sequence 
4th panning 
MAbs 
4C3 3rd panning 
1st elution 2nd elution 3rd elution 
1 HRSHHMHLPSPW KPYHSWHQWQTS HPRPHSHLEMPR - 
2 Double insert HHRHNYAVEAPF GHKHWQHNHSTH WHKHSYNSMPVY 
3 ALYKHSHHVWRL HHRHNYAVEAPF HTKVPWWGAFIT IPHHYQFLKHRH 
4 Double insert HHHKHGINQISP FHKHSYNYAHMH WHKNTNWPWRTL 
5 WPYHKHAFPSRP WHKPWYSQPWPL HSQWNTMQAIAT WHRTYQPPLEPR 
6 HLNHAYWQHSRA VHWKNPTVFSYY LPWHWHTSQRSL HSRHHYNVHLNA 
7 LHKPRPWHEFNR WHKPWYSQPWPP GWKSHHNHERVF HHRHNYAVEAPF 
8 HWKHFNGTRLLD WHKHSYNSMPVY HPLSKMHYRIHM RFVIFILVIGLL 
9 Double insert - - IIVIIRIFLGGI 
10 WPHHHHTRLSTV APWWYHQWKAEQ HSYHHTQRLLTR FHKPSWHAWSGR 
11 HHRYFNSNYLAW HHHKHGINQDSP YPWHKSHLREVT HHWHQNNRQALV 
12 FHKHPHSGRWYP - HHRHNYAVEAPF FPRNHHQWLPHR 
13 GQISNLPPLFRT HFKHQHSYARPP HHHKHGINQISP YPHHHNSRYFPM 
14 HLSKINRHFDHY GLRHHHTIPNVS HYKHHHTPILLN Double insert 
15 WHANKLPPRYFY - - SHKHYNNYAHMH 
16 WHKYPLFPPMTA WHKHSYNSMPVY HPSTHHRGASHI FHKHSPRSPIFI 
17 IIVIRLCRLLLM GWKSHHNHERVF HHWHSRSQLSWF WHKPRLHTFDFA 
18 HLRMNYPLHTYH FHKHSPISPIFI DHGLWRYYLYYQ FHKHSPRSPIFI 
19 HHRHTFVPLTPN WNPHNHYRWFPH - HHRHIHTALWQN 
20 MHRDYYPRYVPW WNPHNHYRWFPH HPFHQRHWLQLP HHRAVPTFTWYS 
Note – consensus clones are marked in colour. 
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Table 5.7 – Occurrence of insert selected with MAb 4C3. 
 
Panning MAb 4C3 Occurrence 
3rd 4th 
HHRHNYAVEAPF 4/52  
1st elution (2/17) 
2nd elution (1/17) 
3rd elution (1/18) 
WHKHSYNSMPVY 3/52  1
st elution (2/17) 
3rd elution (1/18) 
HHHKHGINQISP 2/52  1
st elution (1/17) 
3rd elution (1/18) 
GWKSHHNHERVF 3/52  1
st elution (2/17) 
2nd elution (1/17) 
WHKPWYSQPWPL 
WHKPWYSQPWPP 
1/52 
1/52  1
st elution (2/17) 
WNPHNHYRWFPH 2/52  1st elution (2/17) 
FHKHSPRSPIFI 2/52  3rd elution (2/18) 
Note – the remaining insert sequences just occurred once. 
 
No insert consensus sequences were obtained from phages derived from the second 
elution.  
For the 3rd elution just two clones (16 and 18) exhibited a consensus sequence 
(FHKHSPRSPIFI). Clone 18 from the 3rd panning had a similar sequence that differed by a 
single amino acid, with an I instead of an R residue at position 7. Clone 14 from the 3rd 
panning contained a double insert. 
Both pannings yielded samples that were impossible to sequence. 
 
5.3.2.2  -  MAb 4A12 
 
No consensus sequence was observed in clones from the 3rd panning after selection 
with MAb 4A12 (Table 5.8). Some clones contained amino acid residues in the same 
position. For example clones 13 and 14 contained the sequence xxxxxHHRSxxx and clones 
17 and 20 contained xxxxxHxxPWRS. Clones 7, 9 and 15 were impossible to sequence. 
A consensus sequence was observed for seven clones from the 1st elution of the 4th 
panning (HHHKHGINQISP/R) (Table 5.8). This sequence occurred at a frequency of 34/60 
clones from the 2nd and 3rd elutions (Table 5.9). With this sequence it was impossible to 
distinguish between a P or an R at the last amino acid position of the insert. 
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Table 5.8 – Amino acid sequence of Ph.D.-12™ clones obtained after panning with MAb 4A12. 
 
Amino acid sequence 
4th panning 
MAbs 
4A12 3rd panning 
1st elution 2nd elution 3rd elution 
1 WNMPHISHRHWR HVKSHYHSLPHS HHHKHGINQISP/R HHHKHGINQISP/R 
2 HIRHNHYTTSPF HSKHRHLLWQAI HHHKHGINQISR HHHKHGINQISP/R 
3 HHVHTPRWKLPL SPPLYHKHHRHY HHHKHGINQISP HHHKHGINQISR 
4 GKYHHHTPAHPQ HHHKHGINQISP/R HHHKHGINQISP HHHKHGINQISP/R 
5 VPFTKGYPPFDT HHWHSGTHMSHV HHHKHGINQISR HHHKHGINQISP/R 
6 FHRHHISPTWSP SIWHSHHRYSWL HHHKHGINQISP HHHKHGINQISP/R 
7 - HHNHIRTYVWSA HHHKHGINQISP/R HHHKHGINQISP 
8 PFHHKSTVAKNR HNKHQHPPFMFG HHHKHGINQISP/R HHHKHGINQISP/R 
9 - VHRHHYWAPWSQ HHHKHGINQISP/R HHHKHGINQISR 
10 LPHHHRYWDYPY HSKVFHGLHSLK HHHKHGINQISP/R HHHKHGINQISP 
11 TWSWHNSHIHMR HHHKHGINQISP/R HHHKHGINQISP/R HHHKHGINQISP/R 
12 YKSHHTRVAPST HHHKHGINQISP HHHKHGINQISP/R HHHKHGINQISP 
13 PKSTVHHRSAAA HHHKHGINQISR HHHKHGINQISP/R HHHKHGINQISR 
14 ISLMHHHRSTVP HHHKHGINQISP/R HHHKHGINQISP/R HHHKHGINQISP/R 
15 - HHHKHGINQISP/R HHHKHGINQISP/R HHHKHGINQISP/R 
16 MQMILSPVKHHL HHHKHGINQISP HHHKHGINQISP/R HHHKHGINQISP/R 
17 HKSCTHVPPWRS HHHKHGINQISP/R HHHKHGINQISP/R HHHKHGINQISP/R 
18 LLQIVSATRHHH HHHKHGINQISP/R HHHKHGINQISP/R HHHKHGINQISP/R 
19 Double insert HHHKHGINQISP/R HHHKHGINQISR HHHKHGINQISP 
20 GIVLLHHRPWRS HHHKHGINQISP/R HHHKHGINQISP/R HHHKHGINQISP 
Note – consensus clones are marked in colour. 
 
 
Table 5.9 - Occurrence of insert selected with MAb 4A12. 
 
Panning MAb 4A12 Occurrence 
3rd 4th 
HHHKHGINQISP/R 34/60  
1st elution (8/20) 
2nd elution (14/20) 
3rd elution (12/20) 
HHHKHGINQISP 10/60  
1st elution (2/20) 
2nd elution (3/20) 
3rd elution (5/20) 
HHHKHGINQISR 7/60  
1st elution (1/20) 
2nd elution (3/20) 
3rd elution (3/20) 
                              Note – the remaining insert sequences just occurred once 
 
 
 
 
 
. 
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5.3.2.3  -  MAb 3B10 
 
The insert sequences obtained after the 3rd and 4th pannings with MAb 3B10 are 
presented in Table 5.10. After the 3rd panning, clones 14 and 18 contained an insert consensus 
sequence (NHWSWYWSAQLN). Some of the clones had the same amino acids in the same 
sequence position. As an example clone 10 and 17 shared the first four amino acids of the 
insert sequence (FHKHxxxxxxxx). 
 
Table 5.10 – Amino acid sequence of Ph.D.-12™ clones obtained after panning with MAb 3B10. 
 
Amino acid sequence 
4th panning 
MAbs 
3B10 3rd panning 
1st elution 2nd elution 3rd elution 
1 HHNHIRTYVWSA HHHKHDINQISP HHHKHGINQISP SARIHTHFPSHT 
2 STFKFHKHHLPL HHHKHGINQISP/R HHHKHGINQISP Double insert 
3 HHWHIRLPSSES HHHKHGINQISP/R HHHKHGINQISP - 
4 FPHHPKIHVPWR HHHKHDINQISP HHHKHGINQISP WHKAPRPTYLSY 
5 HWWDYNMRYHKS HHHKHGINQISP HHHKHGINQQSP - 
6 AKSPHWYHSHQR HHHKHGINQISP HHHKHGINQQSP IHRTPHHHYYLY 
7 LSTNHHTHPNPR HHHKHGINQISP/R HASRHPHPPWHP Double insert 
8 HMKHPRPLWPYW HHHKHGINQISP/R HHHKHGINQISP HHHKHGINQISP 
9 WSWHIHRPPILP HHHKHDINQISP - WHKAPRPTYLSY 
10 FHKHSPRSPIFI HHHKHGINQISP/R HHHKHGINQISP HSIRLYQEPQIH 
11 WHGSLKQNLWWY HHHKHGINQISP WHRIPEKIFVWQ HTRTVHYHSLVP 
12 HMPHKFHTHTRL HHHKHGINQISP IHRTPHHHYYLY WHKAPRPTYLSY 
13 SHWYQRTYWLST HHHKHGINQISP IHRTPHHHYYLY IHRTPHHHYYLY 
14 NHWSWYWSAQLN HHHKHGINQISP/R SHWHWRMLPPFS WHKAPRPTYLSY 
15 WHRHSPPTLKFQ HHHKHGINQISP IHRTHPSVWWHL HHHKHGINQISP 
16 - HHHKHGINQISP WPSYFTRHNQNM HHTSAHGINPSV 
17 FHKHHKAPALVR HHHKHGINQISP SARIHTHFPSHT LHKAPRPTYLSY 
18 NHWSWYWSAQLN HHHKHGINQISP HHRLHAHHWAIN - 
19 HGTAHGWKAYWY HHHKHGINQISP - SARIHTHFPSHT 
20 - HHHKHGINQISP/R - IHRTHPSVWWHL 
Note – consensus clones are marked in colour. 
 
A consensus sequence (HHHKHGINQISP) was obtained from the 1st elution of the 
4th panning in half of the clones analysed. This sequence was also obtained with six clones of 
2nd elution and two clones of 3rd elution. In total this insert sequence occurred in 17 of the 53 
clones analysed (Table 5.11). 
 
138
Chapter 5 – Epitope mapping by phage display 
The remaining insert clones sequences of 1st elution were very similar, exhibiting a 
single amino acid difference. Clones 1, 4 and 9 contained a D instead of a G at the 6th 
position of the insert. With the remaining clones derived from the 1st elution, it was not 
possible to distinguish between a P or a R at the last amino acid position of the insert.  
With the 2nd elution two clones (5 and 6) contained a similar insert sequence 
(HHHKHGINQISP), which varied by a single amino acid – Q instead of an I in the 10th 
position.  
The insert IHRTPHHHYYLY occurred in four clones, representing 4 of the 53 
clones analysed. 
 
Table 5.11 - Occurrence of insert selected with MAb 3B10. 
 
Panning MAb 3B10 Occurrence 
3rd 4th 
HHHKHDINQISP 3/53  1st elution (3/20) 
HHHKHGINQISP 17/53  
1st elution (10/20) 
2nd elution (5/17) 
3rd elution (2/16) 
HHHKHGINQISP/R 8/53  1
st elution (7/20) 
2nd elution (1/17) 
HHHKHGINQQSP 2/53  2nd elution (2/17) 
IHRTPHHHYYLY 2/53  2nd elution (2/17) 
SARIHTHFPSHT 3/53  2
nd elution (1/17) 
3rd elution (2/16) 
WHKAPRPTYLSY 4/53  3rd elution (4/16) 
IHRTPHHHYYLY 2/53  3rd elution (2/16) 
 
 
The amino acid sequence WHKAPRPTYLSY occurred in four clones of the 3rd 
elution. SARIHTHFPSHT and HHHKHGINQISP were each present in two clones. Clones 2 
and 7 contained a double insert.  
 
5.3.2.4  -  MAb 5G10 
 
The insert sequences derived from phage panning with MAb 5G10 are presented in 
Table 5.12. A consensus sequence (VPHWHTEYLRWL) occurred in six clones from the 3rd 
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panning round (6:16 clones - Table 5.13). Clone 5 of the 3rd elution contained the same amino 
acid sequence. Clones 9, 15 and 18 from the 3rd panning were impossible to sequence and 
clone 14 contained a double insert.  
In the 4th panning, clones 16 and 18 from the 1st elution contained a consensus 
sequence (SHRTTKTQSLTQ). The sequence HGSHQHRWQHSV occurred in 2/58 samples, 
(clone 7 of 1st elution and clone 7 of 2nd elution) (Table 5.13). 
 
Table 5.12 – Amino acid sequence of Ph.D.-12™ clones obtained after panning with MAb 
5G10. 
 
Amino acid sequence 
4th panning 
MAbs 
5G10 3rd panning 
1st elution 2nd elution 3rd elution 
1 GHWKLFPYWARS SIWHSHHRYSWL WHKIPQKAPLNP LPHHHRWPIPRV 
2 VPHWHTEYLRWL YHKNYRSLPYFM APRWHHHIILIG LPHHHRWPIPRV 
3 VPHWHTEYLRWL LCAGQRHETSLL GPHTYHSKHRLF HHKLPTRITHYW 
4 HMNKHSAHLVHL HPKWHSFPPQLL SFRHHHPTYQHL LPHHHRWPIPRV 
5 APWHLHNPIYRL HTTYKSHHFFRT HTWHLKYPTHRT VPHWHTEYLRWL 
6 VPHWHTEYLRWL SWPSRHYHHLLP HHNHIRTYVWSA HHKHQIQPMLNL 
7 VPHWHTEYLRWL HGSHQHRWQHSV HGSHQHRWQHSV HFRKFHAERHLR 
8 YHTEYMLWLGST HVKHTHSYGIHY Double insert TPHAHPLKTGLS 
9 - HTNHSHWPLVRN SHWHSKLRYFPP HFRIHDNTHSLR 
10 VPHWHTEYLRWL FHKHSPRSPIFI HHKHRALEPFLL YPHHHHSWRLHT 
11 HSRIHNHTDRNI SPYHFHHRYTPT SWPALSRHNDHT TLFKHHPHSPRT 
12 HTSLNYRPWLTI HDRHKVHTPYYS WHKHSYNSMPVY LPHHHRWPIPRV 
13 HSTHHLSKHILA GNKNTNWPWRTL HSFHNHLSRARL HHRHFYSPWMSN 
14 Double insert FHKPYFKAPHMF WHKIPQKAPLNP FPKHSFHNHHAP 
15 - HHRHFSSPWMSN YERMCHLDNYSD FPSKWHGHWTAF 
16 VPHWHTEYLRWL SHRTTKTQSLTQ VHKTHSHVNWRF - 
17 W/GHRHTPPPYPVI WHKTSWQSWPGS FPSKWHGHWTAF APGHRHHYHQSF 
18 - SHRTTKTQSLTQ HSLHSLYRLHSH LPQWHHWHAPSR 
19 HHRHFVQPPPTF HHRHIPGWQLHT HHTHQRPFYLAS HIRFPYSHFFHA 
20 KGIHWHHWNYGV HVRHFYNTPPSY LPSPKHHSREPH GVNHWWHHGHLK 
Note – consensus clones are marked in colour. 
 
An insert consensus sequence was also present in clone 15 of the 1st panning and 
clone 13 of the 3rd panning (HHRHFSSPWMSN). 
The 2nd elution contained a consensus sequence (WHKIPQKAPLNP) in 2 clones (1 
and 14). A consensus sequence (FPSKWHGHWTAF) was present in clone 17 of this elution 
and clone 15 of the 3rd elution. Clone 8 contained a double insert. 
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In the 3rd elution a consensus insert sequence was obtained between clone 1, 2 and 4 
(LPHHHRWPIPRV).  
 
Table 5.13 – Occurrence of insert selected with MAb 5G10. 
 
Panning MAb 5G10 Occurrence 
3rd 4th 
VPHWHTEYLRWL 6/16 1/58 6/16 3
rd elution (1/19) 
HGSHQHRWQHSV 2/58  1
st elution (1/20) 
2nd elution (1/20) 
HHRHFSSPWMSN 
HHRHFYSPWMSN 
1/58 
1/58  
1st elution (1/20) 
3rd elution (1/20) 
SHRTTKTQSLTQ 2/58  1st elution (2/20) 
WHKIPQKAPLNP 2/58  2nd elution (2/19) 
FPSKWHGHWTAF 2/58  2
nd elution (1/19) 
3rd elution (1/19) 
LPHHHRWPIPRV 3/58  3rd elution (3/19) 
 
 
5.3.2.5  -  MAb 1E3 
 
An insert consensus sequence (FHKHSPRSPIFI) was identified in phage clones 
derived from the 3rd and 4th panning with MAb 1E3 (Table 5.14). This sequence was present 
in 4/18 clones from the 3rd panning and 27/56 clones from the 4th panning (eleven clones of 
the 1st elution and eight clones of 2nd elution and 3rd elution) (Table 5.15). The sequence 
LHKHPHSHYNLE was also present in clones from each elution from the 3rd and 4th panning 
rounds. This insert sequence was present in four clones from the 3rd panning. The same 
sequence occurred in several clones from the fourth panning: clone 12 from the 1st elution, 
clones 1 and 19 of the 2nd elution and clones 4, 6, 7 and 19 of the 3rd elution. 
Clones 13 and 15 from the 3rd panning contained the sequence FHRPHVHAHPPY. 
As described above, the insert sequence FHKHSPRSPIFI occurred in phage clones 
(27/56) derived from all of the 4th panning elutions. 
A similar sequence was present in two other 1st elution clones (2 and 4), which 
differed by a single amino acid residue (D instead of a P at the 6th position). The insert 
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sequence HHHKHGINQISP was also present in clones derived from each of the elutions 
from the 4th panning round. Clone 3 of the 1st elution, clones 7, 8 and 15 of the 2nd elution and 
clone 17 of the 3rd elution contained this insert amino acid sequence. 
 
Table 5.14 – Amino acid sequence of Ph.D.-12™ clones obtained after panning with MAb 1E3. 
 
Amino acid sequence 
4th panning 
Mabs 
1E3 3rd panning 
1st elution 2nd elution 3rd elution 
1 LHKHPHSHYNLE FHKHSPRSPIFI LHKHPHSHYNLE FHKHSPRSPIFI 
2 FHKHSPRSPIFI FHKHSDRSPIFI - - 
3 - HHHKHGINQISP FHKHSPRSPIFI FHKHSPRSPIFI 
4 FHKHSPRSPIFI FHKHSDRSPIFI FHKHSPRSPIFI LHKHPHSHYNLE 
5 FHKHSPRSPIFI FHKHSPRSPIFI FHKHSPRSPIFI - 
6 FHKHSPRSPIFI FHKHSPRSPIFI HSAHSHRWSGHP LHKHPHSHYNLE 
7 HRTHNHTNWPPH FHKHSPRSPIFI HHHKHGINQISP LHKHPHSHYNLE 
8 IHRTPHHHYYLY FHKHSPRSPIFI HHHKHGINQISP FHKHSPRSPIFI 
9 ASQHHNHKWTLR RRPHQRLHSTSH FHKHSPRSPIFI GKPHREPVLTLR 
10 LHKHPHSHYNLE FHKHSPRSPIFI FHKHSPRSPIFI FHKHSPRSPIFI 
11 AHKHLSFWLRDG FHKHSPRSPIFI FHKHSPRSPIFI FHKHSPRSPIFI 
12 LHKHPHSHYNLE LHKHPHSHYNLE FHKHSPRSPIFI HSAHSHRWSGHP 
13 FHRPHVHAHPPY FHKHSPRSPIFI FHKHNYKSPPII FHKHSPRSPIFI 
14 SHRHIHNHLLSR FHKHSPRSPIFI AHKAHMHTHSRP FHKHSPRSPIFI 
15 FHRPHVHAHPPY FHKHSPRSPIFI HHHKHGINQISP GKPHREPVLTLR 
16 - FHKHSPRSPIFI VLKPTYQSFKLH HHKHTSPRTVLT 
17 SPPLYHKHHRHY HMNKHSAHLVHL FHKHSPRSPIFI HHHKHGINQISP 
18 YYPLHLHRHGLH HRLHVPHQVTHM AHKAHMHTHSRP HSAHSHRWSGHP 
19 HHKYSSTLYSSP WHKHIPSPRASS LHKHPHSHYNLE LHKHPHSHYNLE 
20 LHKHPHSHYNLE double insert GKPHREPVLTLR FHKHSPRSPIFI 
Note – consensus clones are marked in colour. 
 
The 2nd elution showed a consensus sequence (AHKAHMHTHSRP) occurring in 
phage clones 14 and 18 from the 2nd elution. Two other clones from this elution shared insert 
sequences with clones derived from the 3rd elution (GKPHREPVLTLR and 
HSAHSHRWSGHP, respectively). 
The insert sequence GKPHREPVLTLR amino acid sequence was present in clone 20 
of the 2nd elution and clones 9 and 15 of the 3rd elution. Clone 6 of 2nd elution and clones 12 
and 18 of the 3rd elution shared the amino acid insert sequence HSAHSHRWSGHP. 
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Table 5.15 - Occurrence of insert selected with MAb 5G10. 
 
Panning MAb 1E3 Occurrence 
3rd 4th 
LHKHPHSHYNLE 4/18 7/56 4/18 
1st elution (1/19) 
2nd elution (2/19) 
3rd elution (4/18) 
FHKHSPRSPIFI 4/18 27/56 4/18 
1st elution (11/19) 
2nd elution (8/19) 
3rd elution (8/18) 
FHRPHVHAHPPY 2/18 2/18  
FHKHSDRSPIFI 2/56  1st elution (2/19) 
HHHKHGINQISP 5/56  
1st elution (1/19) 
2nd elution (3/19) 
3rd elution (1/18) 
HSAHSHRWSGHP 2/56  2
nd elution (1/19) 
3rd elution (1/18) 
AHKAHMHTHSRP 2/56  2nd elution (2/19) 
GKPHREPVLTLR 3/56  2
nd elution (1/19) 
3rd elution (2/18) 
 
 
5.3.2.6  -  Streptavidin 
 
Steptavidin was used as a positive control. After biopanning a consensus sequence 
containing as a minimum the amino acid residues HPQ should be obtained. 
Three different consensus sequences were present in phage clones derived from the 
3rd panning using streptavidin (Table 5.16). The amino acid sequence IGHHTLYINHPQ 
occurred in 3 out of 18 clones sequenced (clones 7, 16 and 17) (Table 5.17).  
The two other consensus sequences were obtained from clones 3 and 8 
(WHKPHARPALDL), and clones 1 and 12 (AHKAHMHTHSRP). Clones 10, 15 and 20 
shared four amino acid residues (WHKxxRxxxxxx). Clones 10 and 15 also shared a P residue 
at the 5th position and an L residue at the 10th position. 
All of the phage clones analysed (n = 19), obtained from the 4th panning contained the 
same amino acid insert sequence – HHHKHGINQISP. 
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Table 5.16 – Amino acid sequence of the Ph.D.-12™ inserts 
obtained after panning with Streptavidin. 
 
Amino acid sequence  Streptavidin 
3rd panning 4th panning 
1 HIRLGHLVSPHP - 
2 FHRHSDLSWFTI HHHKHGINQISP 
3 WHKPHARPALDL HHHKHGINQISP 
4 - HHHKHGINQISP 
5 WHNSWRSYSSSF HHHKHGINQISP 
6 HHKHFERVPRPP HHHKHGINQISP 
7 IGHHTLYINHPQ HHHKHGINQISP 
8 WHKPHARPALDL HHNKHGINQISP 
9 AHKAHMHTHSRP HHHKHGINQISP 
10 WHKHPRYYPLPP HHHKHGINQISP 
11 LPSYWHFSHYMR HHHKHGINQISP 
12 AHKAHMHTHSRP HHHKHGINQISP 
13 YPHQHTHPPKKT HHHKHGINQISP 
14 - HHHKHGINQISP 
15 WHKAPRPTYLSY HHHKHGINQISP 
16 IGHHTLYINHPQ HHHKHGINQISP 
17 IGHHTLYINHPQ HHHKHGINQISP 
18 LQTQYRPHQNHL HHHKHGINQISP 
19 AHKAHMHTHSRP HHHKHGINQISP 
20 WHKPVRRWSTLI HHHKHGINQISP 
                             Note – consensus clones are marked in colour. 
 
 
Table 5.17 - Insert consensus sequences in phage clones 
selected with streptavidin. 
 
Panning Streptavidin Occurrence 
3rd 4th 
WHKPHARPALDL 2/18 2/18  
IGHHTLYINHPQ 3/18 3/18  
AHKAHMHTHSRP 3/18 3/18  
HHHKHGINQISP 19/19  19/19 
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5.3.3 - Blocking experiment 
 
The inability to obtain consensus sequences after the third panning suggested that it 
may be due to the blocking step not working correctly. In order to confirm or reject this 
possibility a blocking experiment was performed. 
The titre of the phage recovered after incubation and elution exhibited the same range 
of values for both kits used. The amount of phage Ph.D-7™ and Ph.D-12™ added to the wells 
was 2 × 109 pfu μl-1 and 4 × 108, respectively. With Ph.D-7™ was possible to recover 2 × 102 
pfu μl-1, and with Ph.D-12™ 2.65 × 102 pfu μl-1 was recovered.  
 
 
5.3.4 - ELISA 
 
Elisa was performed in order to confirm the reactivity of the clone phage with the 
MAb used in the biopanning selection assays. The reactivity of the MAbs was only tested 
against phages recovered from the 4th panning round. Samples exhibiting an absorbance value 
< 3 × negative control absorbance value were considered negative and rejected. The rejected 
samples are not presented in table 5.18. The ELISA results indicate that all of the phage 
clones selected after panning with MAbs 4A12, 3B10 and 1E3 were not recognised by these 
monoclonal antibodies.  
The majority of the phage clones isolated, 37 out of 52, were identified by MAb 4C3 
in ELISA. Only one of the clones selected by panning with MAb 5G10 was recognised by 
ELISA. 
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Table 5.18 – Insert sequences of phage clones identified by MAbs 4C3 and 5G10 in 
ELISA. 
 
MAb Insert - amino acid sequence Occurrence  
Insert - amino acid 
sequence Occurrence 
4C3 HHRHNYAVEAPF 4/52  HPLSKMHYRIHM 1/52 
 WHKHSYNSMPVY 3/52  HYKHHHTPILLN 1/52 
 GWKSHHNHERVF 2/52  HHWHSRSQLSWF 1/52 
 WHKPWYSQPWPL 1/52  IPHHYQFLKHRH 1/52 
 WHKPWYSQPWPP 1/52  HHRAVPTFTWYS 1/52 
 WNPHNHYRWFPH 2/52  WHKNTNWPWRTL 1/52 
 FHKHSPRSPIFI 2/52  WHRTYQPPLEPR 1/52 
 VHWKNPTVFSYY 1/52  HSRHHYNVHLNA 1/52 
 APWWYHQWKAEQ 1/52  RFVIFILVIGLL 1/52 
 HFKHQHSYARPP 1/52  HHWHQNNRQALV 1/52 
 GLRHHHTIPNVS 1/52  FPRNHHQWLPHR 1/52 
 WHKHSYNSMPVY 1/52  YPHHHNSRYFPM 1/52 
 FHKHSPISPIFI 1/52  SHKHYNNYAHMH 1/52 
 GHKHWQHNHSTH 1/52  WHKPRLHTFDFA 1/52 
 FHKHSYNYAHMH 1/52  HHRHIHTALWQN 1/52 
 LPWHWHTSQRSL 1/52  HSQWNTMQAIAT 1/52 
5G10 YHTEYMLWLGST 1/16    
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5.4 -  Discussion 
 
The discussion of the epitope mapping by phage display results comprises two 
sections. In the first section, the validity of the experimental protocol is analysed. The second 
section is concerned with the significance of the phage display data with respect to 
betanodavirus epitopes.  
 
 
 Section 1 - Validity of the phage display assays 
 
The development of filamentous bacteriophage vectors has facilitated the construction 
of phage-displayed random peptide libraries that can mimic hundreds of millions of unique 
peptide sequences (Burrit et al. 1996). The small size and stability of the phage particle allows 
phage libraries of high titre (1014 particles ml-1) to be produced and stored at 4°C for long 
periods (Smith and Scott, 1993). 
The basic strategy of this technique is affinity selection of individual clones from a 
random peptide phage library. This is achieved through biopanning with a selected analyte 
(e.g. a MAb) immobilised on the surface of 96 well plates or on beads. After several 
biopanning steps the DNA of individual clones can be sequenced, permitting the deduced 
amino acid sequence to be determined. This can then be compared to the amino acid sequence 
of the protein under investigation. A consensus between the sequences of individual phage 
clones selected by a given analyte points to the interacting site(s) of the target protein.   
According to Jefferies (1998) the main advantages of phage display are: c 
biopanning efficacy, that permits the selection of high affinity phage present at extremely low 
levels in a phage library; d amplification of the selected phage in bacteria allowing the 
enrichment of rare binding phage; e the physical link between genotype and phenotype that 
enables a fast and simple method for elucidation the binding sequence.  
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There are some studies that point to a small bias in random peptide libraries. Some of 
them are not explicable, but one is described as "a bias in the oligonucleotide sequence" 
(Bonnycastle et al. 1996). Generally phage display libraries show higher levels of glycine (G) 
and lysine (K) and lower levels of proline (P) and cysteine (C) than expected (Wilson and 
Finlay, 1998). However, provided that the affinity between displayed peptides and MAbs is 
high (as is the case for antibody-antigen interactions), the results obtained in the present study 
are unlikely to be influenced by this possible source of bias. 
When a phage display experiment is designed, it is important to bear in mind that a 
given phage library is composed of different populations: non-binding phage (the dominant 
population); non-specific-binding phage, that binds for example to plastic or BSA (known as 
plate-binders); phage that specifically binds the screened molecule weakly and phage that 
specifically binds the screened molecule tightly (Menendez et al. 2001).  
Several steps may be taken to enhance the elimination of undesired components of the 
phage population. High stringency washing can greatly reduce the background absorption of 
non-specifically binding phage (Lowman, 1997). However, a very high stringency in the first 
panning may lead to an unwanted decrease in the library complexity. A strategy using a 
combination of conditions favouring multivalent and monovalent interactions may thus be 
advantageous. The first rounds of panning are performed with conditions that promote 
multivalent interactions by using a lower stringency washing buffer. Subsequent panning 
rounds are performed on the basis of monovalent interactions that enrich for the higher 
affinity peptides using high stringency washing buffer (Cwirla et al. 1990, Dyson and Murray, 
1995). In the present study, this strategy was used by performing the first panning washing 
steps with a buffer containing a relatively low amount of the detergent Tween 20 (0.1 %) and 
increasing the Tween 20 content to 0.5 % in the washing steps of the remaining panning 
rounds.  
The plate-binder phages are usually removed by pre-adsorption of the libraries in 
microwells containing all the components of the screening assay, except the screening (target) 
molecule (Menendez et al. 2001). Alternatively, the phage library can be diluted in the 
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blocking agent. In this study, BSA was used as a blocking agent. Pre-incubation or dilution of 
the phage library in the presence of BSA was not performed during this experiment. Such an 
additional step was not considered to influence results, because the majority of previously 
published studies (14 of 19) performed with the Ph.D.™ system successfully yielded results 
without pre-incubation with BSA.  
It has been observed that with libraries of different peptide length the yield of phage 
clones on panning with a given antibody may vary significantly and some instances the yield 
may be very low (Wilson and Finlay, 1998). In order to exclude this potential problem two 
different peptide length libraries were used in the present study, Ph.D-7™ and Ph.D-12™, 
which contain inserts of 7 and 12 residues respectively. The use of two different phage 
libraries was based on the major advantages and disadvantages of each phage display system. 
Longer inserts are more likely to assume a folded structure that may be required for binding to 
a selecting antibody. However, phage libraries constructed with peptides longer than six or 
seven residues will not fully represent all the possible peptide combinations (Miceli et al. 
1994). Thus, the use of these two libraries (Ph.D-7™ and Ph.D-12™) will increase the overall 
chances of identifying the ligand of interest. 
 
 
Section 2 - Analysis of the phage display assays data 
 
Detailed analyse of the data obtained with the Ph.D-7™ and Ph.D-12™ phage libraries 
are discussed separately. The first part of this section will focus on the data obtained with 
Ph.D-7™. The second part will focus on discussion of the results obtained with Ph.D-12™.  
 
Ph.D.-7™. 
 
The phage library Ph.D-7™ has been successfully applied to the screening of 
antibodies to many different targets including: syndecan-1 core protein (Dore et al. 1998), 
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protein kinase C alfa (PKCα, (Ashraf et al. 2003), and protozoan sporozoite (Eimeria 
acervulina and E. tenella) (Silva et al. 2002). When screening MAbs to human α2-
macroglobulin, Birkenmeier et al. (1997) obtained a consensus sequence SxxAxxL in each of 
twenty-five clones sequenced. However, in some studies performed using the Ph.D-7™ 
system the consensus sequence present amongst selected clones was less clear. For instance in 
the study performed by Yang and Shiuan (2003) only 21 of 70 clones sequenced formed a 
consensus sequence. All clones sequenced by Messmer and Thaler (2000) shared the motif 
PF, which was present in different positions of the insert sequence. 
No consensus sequence was unequivocally present in phage clones selected by 
panning with the three MAbs analysed during this study. For this reason the insert sequences 
present in selected phage clones were analysed for the occurrence of smaller amino-acid 
motifs. In phage clones selected by MAb 4C3, several pairs of clones shared the same motifs, 
HxR, RH, HxxxN and HWS. Another clone also exhibited a WS motif (Table 5.19). When the 
phage clones insert sequences selected by MAb 4C3 were aligned, W, S, H residues were 
found to occur in five clones. This suggests, but does not definitively prove that WSH may 
represent a motif contained in the binding region of MAb 4C3.  
In the phage clones selected by MAb 4A12, three inserts contained a PH motif and 
several clones exhibited WH, SY, SS, HHH and LP motifs (Table 5.19). An alignment of the 
deduced amino acid sequence of inserts from these clones suggests that a WH motif may be 
present in the recognition site of MAb 4A12.   
When the same analysis was applied to MAb 3B10 two clones shared the RxxLRxL 
motif (Table 5.19). Another two clones exhibited some similarity with this motif with LxxL 
and LR. The sequence SN was present in three clones and two-residue motifs (SS, LP, MN) 
were present in several clones. It is possible that the motif LRxL is a component of the 
betanodavirus coat protein epitope recognised by MAb 3B10. W and P residues may also be 
involved. 
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Table 5.19 - Common motifs in phage clones selected by MAbs 4C3, 4A12 and 
3B10 with Ph.D-7™. 
 
4C3 
insert sequence 
4A12 
insert sequence 
3B10 
insert sequence 
1 HLRWHHT 1a HRLHSYM 1a GPKIWHT 
2a HSPSVLS 1b LPTNLHW 1b HYQSSVT 
2b AKWSSRH 2  HT-SSKLV 2 RPKRSPI 
3 QFSHYFN 3 WTPHHHF 3 NAMLQLR 
5 NHWSLNG 4 MHRPHWH 4a TVKYHHH 
6 HWSHARH 5 SPLHAWW 4b VSNMNTV 
7 ALNYTNS 6 LLPSYIY 5a ITPENST 
8 HMRFIHY 7a HYQSSVT 5b HPRIHFW 
9 GHIMINR 7b GPKIWHI 6 MSSAEAR 
10 WPHKHFY 8 HLRHHHY 7 MNLGALP 
  9a WQFHLPH 8 APPSNLP 
  9b PRQYPRA 9a HSNHLHN 
    9b RNVLRCL 
    10 RLTLRSL 
 
Note – the residues highlighted occurred more than once at that particular position. Italic residues are 
shared by 2 clone inserts; underlined residues are shared by ≥ 3 clone inserts; blue bold 
underlines the same motif shared by ≥ 2 clone inserts; red bold underlines residues of the 
proposed motif. 
 
 
One of the drawbacks of epitope mapping by phage display arises from the analysis of 
an insufficient number of phage clones. This may lead to a failure to detect important insert 
sequences (Scott, 2001). During the present study, the number of clones sequenced was that 
recommended by the manufacturer. Other studies suggest that greater numbers of phage 
clones should be sequenced. Screening of thirty-two clones selected with MAbs to Neisseria 
meningitidis outer membrane lipooligosaccharide (NmLOS) revealed only three clones 
containing a consensus sequence. A second consensus sequence was contained in two further 
clones (Charalambous and Feavers, 2000). Thus, it is possible that the absence of consensus 
sequences in the present study is a reflection of the relatively small number of clones 
sequenced. However, greater numbers of clones were not studied because of the high 
percentage of double inserts discovered in the clones analysed.  
The presence of double inserts in Ph.D.-7™ phage clones selected by MAbs has not 
been described previously. A small percentage (< 1 %) of clones in each library can pick up 
more than one insert during ligation to the coat protein gene  (Ph.D.™ Manual, New England 
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BioLabs). The high occurrence of phage clones containing double inserts may be a 
consequence of using a phage display system expressing a relatively short insert. An epitope 
has 15-22 contact residues with an antibody molecule (Laver et al. 1990). The region of the 
antigen in contact with an antibody is estimated to be between 650-900 Å2 in area (Laver et al. 
1990). Important contact residues may be further apart than can be mimicked by a short 
peptide. Phages with tandem inserts are potentially capable of binding to larger ligands.  
Screening performed with the streptavidin positive control failed to yield either a 
consensus sequence or any phage clones with inserts containing the streptavidin consensus 
motif (HPQ) described by Devlin et al. (1990). The most plausible explanation for these 
observations is failure to remove non-specifically bound phages during the washing steps. 
 
 
Ph.D.-12™ 
 
The phage library Ph.D.-12™ has been used to characterise ligand interactions in 
diverse areas of biological science, including: Human and rabbit sera recognition of gliadin 
(Osman et al. 1998, Osman et al. 2000); MAbs to Human Immunodeficiency Virus type 1 
gp120 (HIV-1) (Ferrer and Harrison, 1999); rabies virus glycoprotein (Mansfield et al. 2004).  
Nucleotide sequence analysis of twenty phage clones from the third panning with 
MAbs 4C3 and 4A12 indicated that no consensus sequence was present in any of these clones.  
Two clones selected with MAb 3B10 contained the same insert sequence. Five clones selected 
by MAb 5G10 also contained the same insert sequence. Clones selected with MAb 1E3, 
contained three consensus sequence groups, two of these were present in four clones, and the 
third in two clones.  
The absence of a clear consensus sequence in any Ph.D.12™ clone could indicate the 
requirement for further rounds of biopanning, or else point to inefficient blocking or the use of 
non-specific elution buffer.  
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A similar failure to detect a consensus sequence in clones derived from three panning 
rounds was described by Gevorkian et al. (1998) who were only able to generate clones 
exhibiting insert consensus  sequences after a total of five pannings. An extra panning round 
(four in total) with Ph.D.-12™ was performed with success by several researchers (Ehrlich and 
Bailon, 1998, Gazarian et al. 2000b, Turnbough Jr., 2003, Mansfield et al. 2004).  
A "blocking" experiment designed to estimate phage recovery rates indicated that 
only 0.00001 % and 0.0000663 % were recovered to Ph.D-7™ and Ph.D-12™, respectively. 
This suggests that non-specific binding of phage particles has not biased the results of the 
present study. However, these recovery values represent ≈ 2 × 102 pfu μl-1 that may be 
sufficient to introducing error by amplification and sequencing of non-consensus insert 
sequence. The non-specific binding to plastic has been reported by Adey et al. (1995) and 
Gebhardt et al. (1996) and could potentially explain the lack of consensus motifs detected 
during this study. 
The majority of studies employing Ph.D.™ phage libraries have utilised a non-specific 
elution buffer (Glycine-HCl). However the results obtained with the streptavidin positive 
control, eluted with biotin, indicated that the use of a specific elution buffer might be 
advantageous. Whilst specific elution is not technically possible, methods for competitive 
elution have been described. Zhang et al. (2003) used a competitive elution followed by non-
specific elution in their work with successful results.   
These observations (greater selection efficiency of increased panning rounds, phage 
recovery, and efficacy of multi-step elution) considered with the presence of consensus 
sequences within the MAb-selected phage inserts, and an HPQ motif in three positive control 
clones, indicate that the biopanning selection procedure was successful, and that better results 
may have been obtained with a fourth panning round. Consequently, a series of experiments 
was performed using a fourth panning combined with two competitive elutions and one non-
specific elution.  
The fourth panning revealed an increase in the number of insert consensus sequences 
in phage clones selected by all of the MAbs studied. A visible enrichment of the library was 
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obtained with the insert sequence FHKHSPRSPIFI in clones selected with MAb 1E3. This 
sequence revealed an occurrence frequency of 12.5 % in the third panning, and 52 % in the 
fourth panning. A consensus sequence (HHHKHGINQISP/R) occurred in 85 % of clones 
selected with MAb 4A12. This sequence also occurred in 57 % of clones selected with MAb 
3B10, 6 % of clones selected with MAb 4C3 and 9 % of 1E3-selected clones. The high 
occurrence of one insert sequence in four of the five MAbs analysed suggests the presence of 
a bias towards this sequence (HHHKHGINQISP/R). Gazarian et al. (2003) considered clones 
with inserts occurring at a frequency of 70 % to result from bias and as such should be 
rejected.  
In the present study, bias may result from overpanning of the phage library, such that 
only a limited number of clones predominate in the population to the exclusion of others 
which have similar or better affinities (Scott, 2001), even though the characteristics of the 
predominant clone bears no relevance to the selecting antibody (Burrit et al. 1996). The 
positive streptavidin control experiment strongly suggests that panning bias had influenced 
results. The HPQ control motif was not detected in any of the clones and all of the clones 
studied matched a single sequence (HHHKHGINQISP/R). 
There is an inherent bias of growth competition within a biological system, which 
may explain the observed results. Each round of affinity selection is followed by competitive 
growth of the MAb-selected phages. During the phage growth of the screening cycles there is 
the chance that specifically-binding phages will be over-grown by poor or none-specific 
binders which have better growth properties (Rodi and Makowsi, 1999). This overgrowth can 
be favoured by the use of liquid medium for amplification of the adherent clones (Burrit et al. 
1996).  
An ELISA experiment was performed to confirm that panning bias in the Ph.D-12™ 
4th panning had influenced the results of the present study, and to verify that the phage-clones 
were recognised by the MAbs used for selection. This is a recognised final screening 
procedure to identify reactive clones (Yip and Ward, 1999). The majority (37 of 52) of clones 
selected with MAb 4C3 and one clone selected by MAb 5G10 were identified in ELISA tests. 
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The sequence, HHHKHGINQISP/R, suggested to result from bias in the 4th panning was not 
recognised by any of the MAbs by ELISA. These data strongly suggest that 
HHHKHGINQISP/R sequence may be a consequence of a phage overgrowth. No binding was 
observed between any of the phage clones selected with MAbs 4A12 and 3B10. Similar 
findings were reported by Lane and Stephen (1993) in epitope mapping studies of the p53 
protein.  
The analysis of the clones identified by ELISA revealed that no consensus sequence is 
unequivocally present. Following the same approach as for Ph.D-7™, ELISA selected phage 
clones were analysed for the occurrence of smaller amino acid motifs.  
As can be observed in Table 5.20 it is impossible to suggest just one or few smaller 
amino acid motifs. However, the amino acid residues known for their involvement in active 
sites, serine (S), aspartic acid (D), histidine (H), tryptophan (W), tyrosine (Y) and arginine (R) 
(Villar and Kauvar, 1994, Ma et al. 2003, Mansfield et al. 2004), are present in the majority of 
the reactive clones.  
In the present study, the alignment of the deduced amino acid sequences of phage 
inserts with the betanodavirus coat protein did not produce meaningful results. Unlike earlier 
studies where alignments were restricted to a target of 20 amino acid residues in length 
(Gazarian et al. 2000b), the betanodavirus coat protein is comprised of 338 amino acid 
residues, significantly reducing the probability of identifying the sites mimicked by short 
consensus motifs. 
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Table 5.20 – Common motifs in clones selected by MAb 4C3 identified with Ph.D-12™. 
 
Amino acid sequence 
4th panning MAbs 3rd panning 
1st elution 2nd elution 3rd elution 
4C3     
HL 
H-S 
H--------S 
HLSKINRHFDHY 
HLRMNYPLHTYH 
HLNHAYWQHSRA 
HRSHHMHLPSPW 
   
HK----Q--P 
HK-----(-)P 
HK--(-)FP 
HKHSYN 
HKH—N 
HKH 
HK-S 
WPYHKHAFPSRP 
WHKYPLFPPMTA 
FHKHPHSGRWYP 
HHHKHGINQISP 
WHKPWYSQPWPP 
WHKHSYNSMPVY 
 
FHKHSYNYAHMH 
GHKHWQHNHSTH 
WHKHSYNSMPVY 
SHKHYNNYAHMH 
FHKPSWHAWSGR 
HHRH 
HHR 
HHR---T--W 
HHRHTFVPLTPN HHRHNYAVEAPF HHRHNYAVEAPF HPSTHHRGASHI 
HHRHNYAVEAPF 
HHRHIHTALWQN 
HHRAVPTFTWYS 
HHH WPHHHHTRLSTV HHHKHGINQISP HHHKHGINQISP HYKHHHTPILLN YPHHHNSRYFPM 
WHK—Y 
WHKP 
WHK 
WHK-----P 
WHK--------A 
WH---L-P 
WH---(-)R 
WH------P 
HHWH 
WH 
HW 
WQ 
W---QP 
HQW 
WHP 
WP-H-H---S 
W-H---TRL 
WHKYPLFPPMTA 
WHANKLPPRYFY 
LHKPRPWHEFNR 
HLNHAYWQHSRA 
WPYHKHAFPSRP 
WPHHHHTRLSTV 
HWKHFNGTRLLD 
WHKPWYSQPWPL 
WHKPWYSQPWPP 
WHKHSYNSMPVY 
KPYHSWHQWQTS 
VHWKNPTVFSYY 
APWWYHQWKAEQ
YPWHKSHLREVT 
LPWHWHTSQRSL 
HHWHSRSQLSWF 
GHKHWQHNHSTH 
HSQWNTMQAIAT 
WHKHSYNSMPVY 
WHKPRLHTFDFA 
FHKPSWHAWSGR 
HHWHQNNRQALV
WHKNTNWPWRTL 
WHRTYQPPLEPR 
HHRHIHTALWQN 
FPRNHHQWLPHR 
 
PRY WHANKLPPRYFY MHRDYYPRYVPW    
PLF GQISNLPPLFRT WHKYPLFPPMTA    
FHKHS 
FHK-S 
F-KH 
  FHKHSYNYAHMH 
FHKHSPRSPIFI 
FHKPSWHAWSGR 
IPHHYQFLKHRH 
VI------L IIVIRLCRLLLM   RFVIFILVIGLL 
E--F  HHRHNYAVEAPF WKSHHNHERVF 
GWKSHHNHERVF 
HHRHNYAVEAPF HHRHNYAVEAPF 
SHH HRSHHMHLPSPW ALYKHSHHVWRL    
RH 
H-RH-Y-V HLSKINRHFDHY 
HHRHNYAVEAPF 
GLRHHHTIPNVS HHRHNYAVEAPF 
HSRHHYNVHLNA 
HHRHNYAVEAPF 
5G10     
YH—Y 
Y--WL 
HS--H 
WH--N 
PY 
 
VPHWHTEYLRWL 
GHWKLFPYWARS 
YHTEYMLWLGST 
HSRIHNHTDRNI 
HSTHHLSKHILA 
HTSLNYRPWLTI 
KGIHWHHWNYGV 
APWHLHNPIYRL 
YHKNYRSLPYFM   
         Note – the residues depicted in bold type underline same motif are shared by ≥ 2 clone inserts. 
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The failure to identify unequivocally a consensus sequence has been associated with 
plate-binder clones represent a probable explanation for the results. Insert sequences 
containing tryptophan (e.g. WxxWxxxW) and tyrosine are usually associated with this 
phenomenon (Adey et al. 1995, Gebhardt et al. 1996). Six clones of seventy-one sequenced 
contained two or more W or Y residues.  
Christian et al. (1992) were unable to map epitopes recognised by MAbs to HIV-1 
gp120. The authors associated the failure with an inability of their phage display protocol to 
discriminate between rare high-affinity insert sequences and more common low affinity 
sequences.  
 
 
5.4.1 - Final reflection 
 
Although the phage display methodology has been applied to epitope mapping studies 
for over 15 years, to our knowledge this is the first time that the technique has been used to 
identify epitopes on a fish virus.  
Two phage libraries that expressed different sizes of random peptides fused to the pIII 
coat protein were used. After several affinity selection steps, biopanning, and sequence 
analysis of MAb selected clones, a consensus insert amino acid sequence should be obtained. 
However, the recognition of a consensus sequence is dependent upon the interpretation of 
short amino acid sequences and their relationship to the target antigen. The relationship 
between phage insert and the target antigen can “range from obvious to surprisingly obscure” 
(Burrit et al. 1996). 
In the present study, no consensus sequence was identified in inserts from phages 
selected with MAbs raised against the betanodavirus coat protein. Phage clones selected with 
the Ph.D.-7™ system contained double inserts. An epitope comprises 14-22 residues (Kuby, 
1994) and sometimes a peptide comprised of seven amino acid residues in length is not large 
enough to bind sufficient critical residues on an antibody molecule.  
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The use of the Ph.D.-12™ system, which expresses longer peptides (12 amino acids) 
also failed to yield a consensus sequence in MAb-selected phage clones after three rounds of 
panning. For this reason, a fourth round of panning was performed. However, this additional 
step created a bias in the MAb-selected procedure that was confirmed by the non-reactivity of 
peptides with the selecting MAbs in ELISA tests. The lack of consensus can also be 
associated with the presence of plate-binder phages that contaminate the elution step.  
In future work, these problems should be taken into consideration and may potentially 
be solved with a pre-incubation of the phage library with possible sources of non-specific 
binding, such as for example, the plastic plate, BSA and buffers. 
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Chapter 6 - Epitope mapping with synthetic peptides 
 
6.1 -  Introduction 
6.1.1 - Synthetic peptides 
 
An important component of immune responses to many diseases is the ability of the 
host’s antibodies to recognise foreign antigens, such as surface proteins or toxins (Carter, 
1994). 
The region of an antigen that is recognised by an antibody is designated as an 
antigenic site or B-cell epitope. In the case of viruses, the antigenic sites frequently 
correspond to parts of the capsid or envelope protein. The region of the antibody molecule that 
recognises an epitope is known as the combining site or paratope (van Regenmortel, 1992).  
Antibodies to protein epitopes are usually highly specific and able to distinguish between 
proteins differing by only a single amino acid in the target epitope (Alexander et al. 1983). 
There are two main approaches to identifying the regions of a protein that are 
recognised by antibodies. These are based on either a) generation of successively smaller 
fragments of the native protein, or b) use of chemically synthesised synthetic peptides. 
Knowledge of the amino sequence of a given protein is a requirement of the latter approach. 
Over the last two decades, the simultaneous synthesis of large numbers of peptides, 
either as discrete members of sets or as mixtures, has become an important tool in both 
molecular immunology and the drug discovery process (Ede, 2002). A revolutionary advance 
in this technology was described by the development of parallel synthesis of large sets of 
peptides by Geysen et al. in 1984. This methodology represented a major advance in epitope 
mapping of protein antigens because of its ability to characterise the interaction between 
antibodies and large numbers of overlapping synthetic peptides required to identify epitopes 
of protein molecules (Geysen et al. 1987a). 
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The use of synthetic peptides to identify epitopes recognised by monoclonal 
antibodies as described by Geysen et al. (1984) has been widely used in epitope mapping 
studies, e.g  influenza A virus (Hatta et al. 2000), foot and mouth virus (Geysen et al. 1984), 
beet necrosis yellow vein virus (BNYVV) (Commandeur et al. 1994). For fish viruses the 
synthetic peptides have been applied to epitope mapping of Viral Haemorrhagic Septicaemia 
Virus (VHSV) (Estepa and Coll, 1996, Fernandéz-Alonso et al. 1998).  
The principle of the pepscan technique is based on the fact that antibodies produced 
against a native protein are, by definition, directed to the immunogenic epitopes. Thus by 
representing an entire protein in the form of short overlapping synthetic peptides, antibody 
recognition sites can be mapped to regions defined by the length of the peptides used and 
sometimes even less, when the overlap of adjacent peptides is taken into consideration 
(Gershoni et al. 1997). Peptides are frequently coupled to a solid surface or a carrier molecule 
in order to allow detection of binding interactions between the peptide and the monoclonal 
antibody. This coupling procedure can significantly affect the presentation of the peptide, 
even to the extent of masking potentially reactive amino acid side chains (Geysen et al. 
1987a).  
The physical state of the peptides used in epitope mapping studies depends on the 
immune recognition molecule studied. For mapping B-cell epitopes either bound or cleaved 
peptides can be used. For T-cell epitope mapping cleaved peptides must be used (Sumar, 
2001).  
The synthesis of peptides has been a challenge to organic chemists since the turn of 
the 20th century. Classical methods of peptide synthesis are poorly suited for high throughput, 
simultaneous synthesis of peptides (Atherton and Sheppard, 1989). In 1964 Merrifield 
developed a completely new approach for peptide synthesis utilising solid phase synthesis 
(Merrifield, 1964). In this procedure the nascent peptide molecule is constructed  whilst bound 
to a stable, solid particle throughout all of the synthesis steps, and is separated from soluble 
reagents and solvents by simple filtration and washing (Atherton and Sheppard, 1989).  
 
160
Chapter 6 – Epitope mapping with synthetic peptides 
The PEPSCAN procedure is a variation of the solid-phase peptide synthesis method 
developed by Geysen et al. (1984) and uses synthesis of peptides on the tip of polyacrylated 
grafted polyethylene rods arranged in an 8x12 microtitre plate array. The modular format that 
complements a 96 well plate permits the simultaneous handling of hundreds to thousands of 
individual peptides (Maeji et al. 1995). The original application of this technique enabled the 
identification and characterisation of epitopes within protein antigens to a resolution of one 
amino acid (Geysen et al. 1984). Although the PEPSCAN procedure has been shown to be 
particularly effective for mapping linear/continuous epitopes, it is also possible to detect 
discontinuous epitopes (Gao and Esnouf, 1996).  
A further variation of the solid phase peptide synthesis was developed by Frank and 
Döring (1988), who used cellulose paper discs for the solid phase. With this technique 
individual amino acid coupling reactions in a multiple parallel synthesis are performed 
simultaneously on distinct areas of a continuous pure cellulose chromatography paper sheet 
(Frank, 1992, Frank, 2002). This technique has been named SPOT-synthesis.  
The overlapping peptide scan utilising SPOT synthesis is a popular tool for 
characterisation of molecular interactions (Reineke et al. 2001). The best-known applications 
of this technology are the analysis of epitope mapping and receptor-ligand interaction sites 
(Laune et al. 2002). Continuous and discontinuous epitopes can be detected. The 
identification of discontinuous epitopes is based on the detection of low affinity interactions 
(Reineke et al. 1998, Reineke et al. 1999). These low affinity interactions can be detected by 
measuring the dissociation constant (Kramer et al. 1997, Reineke et al. 2002).  
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6.1.2 -  Flow cytometry  
 
Flow cytometry enables discrete measurements of optical signals from a single 
particle such as cells or beads (Edwards et al. 2004). These signals can be read by electrical 
impedance, light scattering and fluorescence (Shapiro, 2003). 
Flow cytometers are divided in to two main types, analysers and sorters. The sorters 
have the ability to collect data on cells (analyse cells) and sort cells with particular properties 
(Chapman, 2000). The Becton Dickinson FACScan is an example of the sorters currently 
available. xMAP-based products from Luminex are of  the analyser type. 
For flow cytometric analysis, mono-dispersed cell suspensions must be produced 
(Mandy et al. 2001). These are achieved by the use of a laminar sheath-flow technique to 
confine cells to the center of a flow stream, reducing clogging due to clumps (Horan and 
Wheeless Jr., 1977). Single particles or cells are scanned as they flow in a liquid medium past 
an excitation light source (Radcliff and Jaroszeski, 1998).  
With the flow cytometry technique, each cell is exposed to excitation light only for 
the brief period during which it passes through the illuminating beam, usually a few 
microseconds, and the flow velocity is typically constant for all the cells examined (Shapiro, 
2003). The use of these uniform conditions of measurement make it possible to attain high 
precision, by obtaining nearly equal measurement values for cells containing equal amounts of 
fluorescent material (Shapiro, 2003).  
Typically fluorochromes are fluorescent probes conjugated to monoclonal antibodies. 
These fluorescent probes react with the cells or particles of interest before analysis. Therefore 
the amount of fluorescence emitted as a particle passes the light source is proportional to the 
amount of fluorescent probe bound to the cell (Radcliff and Jaroszeski, 1998). 
Cytometers can be used for sensitive chemical analyses involving the binding of 
suitable labelled ligands to solid substrates or to particles such as polystyrene beads (Shapiro, 
2003). During development, the terminology describing microsphere-based assays saw many 
variations including: multiplex bead assay (MBA), particle-based micro-array technology 
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(PBMT), microparticle-based flow cytometric technology (MFCT), multiplexed particle-
based flow cytometry assay (MPBFC), micro-array immunoassay (MAI), cytometric bead 
array (CBA) and suspension array technology (SAT) (Mandy et al. 2001, Nolan and Mandy, 
2001). 
For many years, the concept of performing immunological assays on microspheres 
has been both theorized and applied. Recently the technology been developed to the extent 
that both reagents and software are now commercially available (McHugh, 1994, McDade and 
Spain, 1997).  
In 1977, Horan and Wheeless Jr. described for the first time the use of flow cytometry 
combined with microspheres for the determination of analytes in serum and other fluids. 
Initially two different sizes of beads were used. Rapid advances in instrumentation permitted 
the use of four different bead sizes (McHugh et al. 1988, Scillian et al. 1989). The ability to 
discriminate between different sized microspheres facilitated the simultaneous detection of 
several analytes. However the inability to distinguish aggregates of smaller microspheres from 
larger microspheres severely limited the extent of multiplexing that could be achieved (Fulton 
et al. 1997). This limitation jeopardised the opportunities that multiplexed binding assays 
offered for exploration of complex binding interactions in a single reaction volume (Iannone 
et al. 2001). Eventually, codifying the microspheres provided an elegant solution to this 
methodological problem. 
The most commonly used encoding method in bead-based assays is optical encoding 
with fluorescent dyes (Yingyongnarongkul et al. 2003). To prepare microsphere sets, two 
hydrophobic fluorophores are used, one emitting in the red region of the light spectrum, and 
one emitting in the orange region (McDade and Spain, 1997). These two fluorophores are 
combined within microspheres to a unique ratio (Smith et al. 1998). By adjusting these 
intrinsic optical properties, it became possible to prepare arrays of microspheres in which 
individual microsphere subsets possess a unique spectral address, and thus can be used to 
perform multiplexed analyses (Nolan and Sklar, 2002).  
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These techniques require microspheres coated with a unique capture reagent 
(McHugh, 1994). There are several types of microspheres coated with different linkers for 
non-covalent coupling (Kellar and Iannone, 2002). However, when the orientation of the 
protein on the bead surface is critical, as is the case of antibodies, covalent coupling should be 
used (McHugh and Stites, 1991). Carboxyl (COOH), amine/hydrazide and maleimide groups 
are used for covalent coupling (Kellar and Iannone, 2002). 
Microspheres of several sizes and composed of different polymers are currently 
available commercially. 
Assays that combine flow cytometry and microspheres consist of four basic steps: c 
coating of the beads with the antibody/antigen or capture reagent; d addition of the analyte to 
the microspheres; e addition of a fluorescent reporter molecule that binds to the analyte and 
f fluorescent quantitation. These four steps are depicted in Figure 6.1. 
 
 
Figure 6.1 – Flow cytometry using SAT. c beads coated with antibody/antigen; d sample 
containing analyte added; e molecular reporter added; f fluorescent quantitation. 
 
c d 
e f 
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The combination of microspheres, flow cytometry technology and digital signal 
processing has facilitated the development of a fast and precise assay platform (McDade and 
Spain, 1997). This new generation of fluorescent microsphere-based immunological assays 
reduces the time and cost of traditional microtitre plate-based assays, by relying on the rapid 
association kinetics of antibodies and antigens in solution, as well as the use of a smaller 
surface area. Consequently, smaller quantities of reactants are required than in conventional 
immunoassays (Kellar et al. 2001). 
Since the 1960s, flow cytometry has been applied to several fields of research. Until 
recently, the combination of this technique with labelled microspheres has predominantly 
been employed in immunological research (Table 6.1). 
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Table 6.1– Application of the microspheres and flow cytometry technology. 
 
 Reference 
Immunology studies 
Quantification of cytokines 
Tumour necrosis factor-alpha (TNF-α) 
 
Intereukin: IL-1β, IL-1α, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-
15, IL-17, IL-18 
Gamma interferon (IFN-γ) 
Granulocyte-macrophage colony-stimulating factor (GM-CFS)
Prabhakar et al. (2002 
de Jager et al. (2003) 
 
Kellar and Douglass (2003) 
Hulse et al. (2004) 
Quantification of antibodies 
 
Human papilloma virus 
Toxins of anthrax, tetanus and diphtheria 
Haemophilus influenzae type b 
Opalka et al. (2003) 
Biagini et al. (2004b) 
Pickering et al. (2002a) 
Detection of antibodies in autoimmune diseases 
 Systemic rheumatic disorders Systemic lupus erythematosus 
Rouquette et al. (2003 
Mahler et al. (2004) 
Characterisation of antibodies 
 HIV-1 infected individuals Opalka et al. (2004) 
Detection of antibodies 
 
Flavivirus 
Pneumococcal polysaccharides (PnPs) 
Genotype-specific to respiratory syncytial virus 
Wong et al. (2004) 
Pickering et al. (2002b) 
Jones et al. (2002) 
Expression 
 CD40 in diabetic people Vosters et al. (2004) 
Other studies 
Detection and/or quantification 
 
Phosphorylation levels in cell signalling proteins: 
phospho-JNK 
phospho-p38 MAPK 
phospho-IκB-α 
phospho-ERK2 
phospho-Akt 
phospho-ATF-2 
phospho-MEK2phospho-STAT3 
Herbicides in human urine  (glyphosate, atrazine and metolachlor) 
Common foodborne illnesses (E. coli, Listeria monocytogenes, Salmonella and 
Campylobacter jejuni) 
Staphylococcal protein toxins (ETA and ETB) 
 
Gao et al. (2003) 
 
 
 
 
 
 
Biagini et al. (2004b) 
Dunbar et al. (2003) 
 
Joubert et al. (2003) 
Molecular techniques 
 
Single nucleotide polymorphism (SNP) 
Forensic analyses with human identity testing (SNP of African American vs 
Caucasian) 
Bacterial identification using 16S rDNA 
Identification and quantification of DNA in environmental samples 
Detection and quantification of viral nucleic acids 
Chen et al. (2000) 
Vallone and Butler (2004) 
 
Ye et al. (2001) 
Spiro et al. (2000) 
Smith et al. (1998) 
Hybridoma technology 
 Characterisation of monoclonal antibodies Jia et al. (2004) 
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6.1.2.1  -  Suspension array technology with xMAP  
 
For suspension array technology (SAT) the interaction between analyte and target is 
detected on the surface of solid fluorospheres (Mandy et al. 2001).  
The Luminex-100 instrument has been designed by the Luminex Corporation (Austin, 
Texas) for fluorosphere-based flow cytometry (Nolan and Mandy, 2001). This technique is 
referred to as xMAP technology.  
The Luminex-100 uses traditional flow cytometry hardware and spectrally discrete 
polystyrene beads, or microspheres, to measure multiple analytes simultaneously (Seideman 
and Peritt, 2002).  
By varying the ratio of the two fluorophores (red and orange), up to 100 different 
bead sets can be distinguished and each bead set can be coupled to a different biological probe 
(Figure 6.2 c) (Dasso et al. 2002). 
5.5 μm, cross linked polystyrene microspheres with surface carboxylate groups were 
found to provide the best combination of thermal stability, uniformity (coefficient of variation 
1% for diameter) and reagent density required for a wide range of possible assays (McDade 
and Spain, 1997). 
The Luminex-100 has a dual laser system. The 532-nm, 13-mW yttrium aluminium 
garnet (YAG) laser (green laser) is used because it improves the excitation efficiency of R-
phycoerythrin (PE, 578-nm emission) as compared to a 488-nm laser (Kellar and Iannone, 
2002), and is dedicated to the quantitative analysis (Mandy et al. 2001). The 635-nm 10-mW 
red diode laser excites the two classification fluorochromes embedded within the 
microspheres (Kellar and Iannone, 2002) that are used to define a spectral address (Mandy et 
al. 2001) (Figure 6.2 d).  
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c d 
 
Figure 6.2 - c Matrix of beads available by Bio-Rad; d Dual lasers identifying the beads. 
 
 
 
Data is acquired on the Luminex-100 by a PC equipped with a special digital signal 
processing board and control software that runs in the Windows environment. The software 
uses the orange and red data to separate the pool of microspheres into individual bead sets, 
and presents the average amount of green to each bead set (Vignali, 2000). The concentration 
of the analytes can be determined by extrapolation to a standard curve. The data can be 
exported to a spreadsheet program such as Microsoft-Excel for further analysis.  
The most commonly used reporter molecules are antibodies either conjugated with a 
fluorochrome or biotin, which can be used to bind a streptavidin-fluorochrome conjugate 
(Sklar et al. 2002). R-phycoerythrin (R-PE) is considered the most suitable fluorochrome for 
quantitative fluorescence measurement in clinical flow cytometry (Haugland, 1994, Gratama 
et al. 1998), because its extinction coefficient and quantum yield are high (Mandy et al. 
2001). Low background fluorescence is achieved through the use of homogenous multi-
parameter measurements coupled with quantitative fluorescence detection capacity at low 
emission levels (Nolan and Mandy, 2001). The sensitivity of the instrument is high, and it can 
detect less than 500 PE molecules bound to beads (Shapiro, 2003). 
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6.1.3 - Objectives 
 
The objective of this chapter was to identify B-cell epitopes on the betanodavirus coat 
protein using a new approach. This was achieved through the use of xMAP technology and 
the synthesis of a panel of overlapping synthetic peptides that mimicked the betanodavirus 
coat protein. This procedure was used by Opalka et al. (2004) for epitope mapping in Human 
Immunodeficiency Virus (HIV). Sets of overlapping peptides that mimic the betanodavirus 
coat protein were synthesised and coupled to polystyrene beads. The peptide-bead sets were 
incubated with antibodies and the reaction read in a Bio-Plex™ system array, to determine 
which region(s) of the betanodavirus coat protein are recognised. This technique was used to 
characterise the binding sites of murine monoclonal antibodies, rabbit polyclonal antibodies, 
and sera from fish (European sea bass Dicentrarchus labrax) naturally-infected with 
nodavirus. The production of monoclonal and polyclonal antibodies use in this study is 
described in Chapter 3.   
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6.2 -  Materials and Methods 
6.2.1 - Synthetic peptides 
 
The Dragon Fish Nervous Necrosis Virus (DFNNV) coat protein (Genbank protein 
access number AAG22496) was used as template for the production of the synthetic peptides. 
Synthetic peptides were 12 amino acid residues in length (12 mers) and overlapped by two 
residues.  
The cross-reactivity of peptides may be influenced by the immunoassay format, 
simply due to the fact that different conformations can be adopted by peptides in the various 
experimental conditions of different immunoassays (van Regenmortel, 1989b). An N-terminal 
AHX linker (amino hexanoic acid) was introduced in the peptide sequence in order to prevent 
conformation problems related with direct binding of the peptide sequence to the beads.  
Two additional peptides were synthesised for use as negative controls. These peptides 
corresponded to the amino acid 30-41 and 305-316 but were synthesised in reverse sequence 
order. The sequences of peptides used in this study are presented in Table 6.2. The negative 
control peptides are marked in bold.  
COOH beads were chosen for coupling to synthetic peptides. These beads are most 
useful for binding antibodies or small molecules, which can lose function when passively 
adsorbed to the microsphere surface (McHugh, 1994). The amine group of the peptides was 
coupled to the carboxyl group of the COOH beads (Bio-Rad, Hertfordshire U.K.). The 
coupling reaction was performed using the Bio-Plex Amine Coupling kit (Bio-Rad, 
Hertfordshire U.K.) according to the manufacturer's instructions. 
The overlapping peptides were produced by Pepscan Systems (Lelystad, The 
Netherlands) and were supplied coupled to beads. After coupling beads were stored in the 
dark at 4°C. 
Bead concentration was determined with a hemocytometer. 
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Table 6.2 – Sequences of synthetic peptides used for epitope mapping. Sequences were derived from 
the DFNNV coat protein.  
 
Peptide 
(residue) Amino acid sequence 
Bead 
reference  
Peptide 
(residue) 
Amino acid 
sequence 
Bead 
reference 
1 (1-12) MVRKGEKKLAKP 171-506046  19 (181-192) GRLILLCVGNNT 171-506042 
2 (11-22) KPPTTKAANPQP 171-506046  20 (191-202) NTDVVNVSVLCR 171-506042 
3 (21-32) QPRRRANNRRRS 171-506046  21 (201-212) CRWSVRLSVPSL 171-506042 
4 (31-42) RSNRTDAPVSKA 171-506046  22 (211-222) SLETPEETTAPI 171-506042 
5 (41-52) KASTVTGFGRGT 171-506046  23 (212-232) PIMTQGSLYNDS 171-506042 
6 (51-62) GTNDVHLSGMSR 171-506046  24 (231-242) DSLSTNDFKSIL 171-506042 
7 (61-72) SRISQAVLPAGT 171-506046  25 (241-252) ILLGSTPLDIAP 171-506042 
8 (71-82) GTGTDGYVVVDA 171-506046  26 (251-262) APDGAVFQLDRP 171-506042 
9 (81-92) DATIVPDLLPRL 171-506046  27 (261-272) RPLSIDYSLGTG 171-506042 
10 (91-102) RLGHAARIFQRY 171-506028  28 (271-282) TGDVDRAVYWHL 171-506024 
11 (101-112) RYAVETLEFEIQ 171-506028  29 (281-292) HLKKFAGNAGTP 171-506024 
12 (111-122) IQPMCPANTGGG 171-506028  30 (291-302) TPAGWFRWGIWD 171-506024 
13 (121-132) GGYVAGFLPDPT 171-506028  31 (301-312) WDNFNKTFTDGV 171-506024 
14 (131-142) PTDNDHTFDALQ 171-506028  32 (311-322) GVAYYSDEQPRQ 171-506024 
15 (141-152) LQATRGAVVAKW 171-506028  33 (321-332) RQILLPVGTVCT 171-506024 
16 (151-162) KWWESRTVRPQY 171-506028  34 (327-338) VGTVCTRVDSEN 171-506024 
17 (161-172) QYTRTLLWTSSG 171-506028  35 (41-30) KSVPADTRNSRR 171-506024 
18 (171-182) SGKEQRLTSPGR 171-506028  36 (316-305) SYYAVGDTFTKN 171-506024 
 
 
The assay was multiplexed to 4 different peptides per well, because peptides were 
coupled with beads of four different spectral addresses. Peptides were grouped into 9 groups 
for analysis as indicated in Table 6.3. 
 
 
Table 6.3 – Synthetic peptide groupings used for multiplex analysis in the Bio-Plex™ system. 
 
Group Peptide Bead  Group Peptide Bead 
PepS 1 
1 
10 
19 
28 
171-506046 
171-506028 
171-506042 
171-506024 
 PepS 6 
6 
15 
24 
33 
171-506046 
171-506028 
171-506042 
171-506024 
PepS 2 
2 
11 
20 
29 
171-506046 
171-506028 
171-506042 
171-506024 
 PepS 7 
7 
16 
25 
34 
171-506046 
171-506028 
171-506042 
171-506024 
PepS 3 
3 
12 
21 
30 
171-506046 
171-506028 
171-506042 
171-506024 
 PepS 8 
8 
17 
26 
35 
171-506046 
171-506028 
171-506042 
171-506024 
PepS 4 
4 
13 
22 
31 
171-506046 
171-506028 
171-506042 
171-506024 
 PepS 9 
9 
18 
27 
36 
171-506046 
171-506028 
171-506042 
171-506024 
PepS 5 
5 
14 
23 
32 
171-506046 
171-506028 
171-506042 
171-506024 
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6.2.1.1  -  Peptide synthesis 
 
The overlapping peptides were produced by Pepscan Systems (Lelystad, Netherlands) 
using solid phase synthesis and Fmoc chemistry.  
To ensure the correct synthesis of a peptide it is necessary for inappropriate binding of 
the amino group of one amino acid and the carboxyl group of the other amino acid be 
prevented (Atherton and Sheppard, 1989). This is achievable by linking a protective group to 
the amino acids. The protective group used depends on the type of synthesis chosen. 
However, it must be easily removed during or after the polypeptide synthesis (Atherton and 
Sheppard, 1989). Fmoc (flurenylmethyloxycarbonyl) was used as for the α-N amino 
protecting groups during the synthesis of the peptides produced by Pepscan Systems. Usually 
this protective group is chosen because it requires mild conditions for removal and for the 
cleavage from the solid support (Sumar, 2001) (Figure 6.3). 
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Figure 6.3 – Diagram of solid phase peptide synthesis using the Fmoc technique (Adapted from Sumar 
(2001). 
 
 
Attachment of the 1st aa 
 to linker 
N-α-protecting group 
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Side chain protecting
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support ⎯ 
        ⏐   
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NH2-CH-C-OH⎯ 
Side chain protecting
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                               ⏐   
         R2   O       R1   O 
          ⏐   ⏐⏐       ⏐   ⏐⏐ 
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         R2   O       R1   O 
          ⏐   ⏐⏐       ⏐   ⏐⏐ 
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6.2.2 -   xMAP  technology    
 
The xMAP technology (Luminex™) used in this study was the Luminex-100 
marketed by Bio-Rad (Hertfordshire U.K.). Bio-Rad have named this equipment Bio-Plex™. 
The Bio-Plex™ suspension array system integrates the xMAP technology with 
instrument controls and data analysis software, system validation and calibration tools 
together with all supplementary materials required to perform xMAP-based assays in a 96-
well plate format (Willis et al. 2003). 
The Bio-Plex™ system is comprised of an array reader, an XY platform, an HTF 
system (Figure 6.4) and a computer (PC). The Bio-Plex™ array reader is a compact flow 
analysis unit integrating a dual laser detection system, optics, fluidics and advanced digital 
signal processing.  
 
 
 
Figure 6.4 - Bio-Plex™ system: HTF system, array reader and XY platform. 
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The XY platform allows the automated processing of samples from a 96 well plate. 
The HTF (High Throughput Fluidics) system is designed to automate the introduction of 
sheath fluid into the Bio-Plex™ array reader.  
The HTF system automatically draws sheath fluid from a non-pressurized bulk 
container to constantly maintain a reservoir of pressurized sheath fluid.  
Minimum computer hardware and software requirements are IBM PB, Pentium III 
processor. Microsoft Windows 2000 operating system, Excel and Access software are 
essential. A high-speed digital signal processor and Bio-Plex Manager™ 3.0 software record 
the fluorescent signals simultaneously for each bead, and translate the signals into data for 
each bead-based assay. The data can then be exported to Microsoft Excel for further analysis. 
The Bio-Plex™ has a MCV plate specially designed for needle adjustments and for 
performing the validation, calibration and washing 
(Figure 6.5). 
 
 
 
 
 
Figure 6.5 - MCV plate. 
 
 
6.2.3 - Antibody samples 
 
In this study, mouse MAbs, rabbit polyclonal antibodies and fish polyclonal sera were 
used. 
The production of mouse MAbs was described in Chapter 3. Five monoclonal 
antibodies were used. These were designated 1E3, 3B10, 4A12, 4C3 and 5G10. The 
purification and estimation of MAb concentration using the BCA protein kit (Pierce, 
Northumberland U.K.) were performed as described in Chapter 2.  
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Polyclonal antibodies were produced in Rabbit immunised with European sea bass 
betanodavirus as described in Chapter 3. 
The fish serum samples were kindly supplied by Professor Alexandra Adams (Aquatic 
Vaccine Unit, Stirling University, U.K.). The samples were collected from European sea bass 
(Dicentrarchus labrax L.) naturally infected with betanodavirus. The samples were tested for 
betanodavirus antibodies by ELISA. Nine fish serum samples were used. Seven of these were 
positive and two negative. The positive samples chosen represented those samples with the 
highest nodavirus antibody titres as presented in Table 6.4. 
 
 
Table 6.4 – Betanodavirus antibody titres in samples of European sea bass serum as 
determined by ELISA.  
 
Sample 1 3 4 7 10 15 17 2 9 
Titre 1/16 1/32 1/32 1/32 1/32 1/64 1/32 - - 
 
 
As a negative control one betanodavirus-negative European sea bass serum sample 
was kindly supplied by Dr. W. Roy of the Machrihanish fish farm. European sea bass were 
sourced from a hatchery in Wales. No outbreaks of betanodavirus infection have been 
recorded at this site. 
 
 
6.2.4 - Protocol for epitope mapping with SAT  
 
The experimental xMAP protocol used in this thesis was based on previously 
published work (Kellar et al. 2001, Dasso et al. 2002, Prabhakar et al. 2002, Seideman and 
Peritt, 2002, Joubert et al. 2003). Some of the experimental steps were optimised as described 
in Table 6.5. 
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Table 6.5 – Overview of the protocol used for epitope mapping with SAT.  
 
    Amount Volume per well Incubation 
Blocking analyte Block interactions between synthetic peptides and buffer 
Analyte (bead/peptide) in 
DPBS+ 
2000 beads per 
well of each 
peptide 
 30 minutes RT Preliminary Steps 
Pre-wetting plate Block filter plate Wetting the filter membrane DPBS+  200 μl 
2 x 30 minutes 
RT 
Analyte Analyte added to the well plate Analyte in DPBS+ 
2000 beads per 
well of each 
peptide 
50 μl  
Sample incubation Binding bead-peptide to antibodies 
Antibodies (polyclonal, MAbs 
and fish antibodies) in DPBS+
Required 
optimisation 50 μl 
Required 
optimisation 
Wash  DPBS+  3 x 100 μl  
Primary antibody* Binding the primary antibody to fish serum Anti-sea bass IgM 
Required 
optimisation DPBS+ 
3.5 hours 
RT 
Wash  DPBS+  3 x 100 μl  
Reporter molecule 
Binding the antibody 
conjugated with fluorochrome 
to the bead-peptide-abs 
Anti-mouse IgG PE 
Anti-rabbit IgG PE 
Required 
optimisation 50 μl 
30 minutes 
RT 
Wash  DPBS+  3 x 100 μl  
Pre-reading Re-suspend the beads for reading DPBS+  100 μl  
 
 
 
Protocol Steps 
Reading 50 μl of the sample were read by Bio-Plex™ and minimum of 100 beads per analyte are analysed 
RT – room temperature;  * required only for fish serum samples 
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All antibody dilution, blocking and washing steps were performed using Dulbecco’s 
PBS (Gibco, Paisley U.K.) containing 1 % BSA (w/v) (Sigma, Dorset U.K.) and 0.02 % (w/v) 
sodium azide (Sigma, Dorset U.K) (DPBS+).  
Assays were performed in sterile MultiScreen HTS™ (Millipore, Watford U.K.) 96 
well filter plates. These plates have a 1.2 μm hydrophil, low protein binding Durapore® 
membrane. 
The fluorochrome phycoerythrin (PE) conjugated directly to antibodies was used as a 
reporter molecule. Goat anti-mouse IgG conjugated with PE (mouse IgG-PE) and goat anti-
rabbit IgG conjugated with PE (rabbit IgG-PE) were obtained from Molecular Probes (Paisley 
Scotland). 
All washing steps were performed with a vacuum manifold (Bio-Rad, Hertfordshire, 
U.K.) connected to a vacuum pump. The vacuum pressure was kept at –10 mm Hg. 
The protocol used for screening the polyclonal and MAbs was identical. For fish sera 
an additional step was incorporated due to a requirement for the inclusion of a primary 
antibody (anti-fish IgM monoclonal antibody). The antibody used was mouse anti-European 
sea bass IgM monoclonal antibody (sea bass IgM) (Aquatic Diagnostics Ld, Stirling 
University, Stirlinghire Scotland). The IgG MAb was reconstituted in 1 ml of DPBS+. 
The beads and phycoerythrin (PE) are photosensitive, and exposure to light for a 
period of two hours has been demonstrated to adversely influence assays due to photo-
bleaching (Carson and Vignali, 1999). Special precautions were taken to avoid 
photobleaching. Beads and reporter molecules were protected from light at all steps of the 
experimental protocol. Laboratory illumination was minimised and directed away from 
benches used for experimental work. Light exposure was reduced to minimum levels. The 
beads, reporter molecules and the assay plates were wrapped in aluminium foil at all times.  
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6.2.5 - Antibody Screening Assay  
 
Before screening the full set of synthetic peptides with antibody samples three steps of 
the protocol were optimised.  
 
6.2.5.1  -  Sample Incubation Time 
 
The incubation time for allowing an optimal rate of antibody-peptide was the first step 
to be optimised, by incubating MAbs with PepS1 group (Table 6.6).  
 
Table 6.6 – Optimisation of sample incubation time for epitope mapping with SAT. 
 
Sample Incubation Step Antibody Reporter 
Time Temperature 
60 minutes Room temperature 
Sample 
Incubation 
MAbs 
1E3, 3B10, 4A12, 
4C3, 5G10 
 
20 μg ml-1 
Mouse IgG PE 
7.5 μg ml-1 
Overnight 4°C 
 
 
The concentration of MAbs and reporter molecule used are shown in Table 6.6. All 
protocol steps were performed as described in Table 6.5.  
 
6.2.5.2  -  Antibody concentration 
 
Different concentrations of the anti-betanodavirus antibodies were tested (Table 6.7). 
For mouse MAbs four concentrations were tested and for European sea bass three different 
dilutions of sera were used. The rabbit polyclonal serum assay was optimised with seven 
different serum dilutions. Antibodies were diluted in DPBS+. A previous run with a randomly 
chosen peptides revealed MAb 4A12 as the one with more heterogeneous behaviour, showing 
both very low and very high MFI values. These MFI values revealed MAb 4A12 as the best 
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antibody for optimisation of the assay, in order to achieve high MFI values without increasing 
non-specific background due to an excess of mouse-PE. Samples 10 and 15 (SB10 and SB15) 
were used for the optimisation of the fish serum concentration. These samples were chosen 
because of the high titre values that they present and the higher amount of sample (as shown 
in Table 6.3).  
The protocol steps were performed as described in Table 6.5. 
 
Table 6.7 – Optimisation of antibody concentration for epitope mapping with SAT. 
 
Sample Incubation Step Antibody Primary Ab Reporter 
Time Temperature 
Sample 
 
Incubation 
MAb - 4A12 
 
20 μg ml-1 
50 μg ml-1 
80 μg ml-1 
100 μg ml-1 
- 
Mouse IgG PE 
 
7.5 μg ml-1 
Overnight 4°C 
 
 
 
Polyclonal 
 
1/10 
1/100 
1/500 
1/1000 
1/2500 
1/5000 
1/10000 
 
- 
Rabbit IgG PE 
 
25 μg ml-1 
Overnight 4°C 
 
 
 
Fish sera 
 
Sample 10 
1/10 
1/50 
Sample 15 
1/50 
1/100 
 
Sea Bass IgM 
 
6 μg ml-1 
Mouse IgG PE 
 
25 μg ml-1 
Overnight 4°C 
 
 
6.2.5.3  -   Reporter antibody concentration 
 
The optimum reporter antibody concentration was determined as indicated in Table 
6.8. Mouse IgG PE was optimised with MAb 4A12 (20 μg ml-1) and rabbit IgG PE was 
optimised with polyclonal antibodies (1/250 v/v). The protocol steps were performed as 
described in Table 6.5.  
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Table 6.8 – Optimisation of the reporter antibody concentration used in SAT. 
 
Sample Incubation Step Antibody Reporter 
Time Temperature 
MAb 
 
4A12 
 
20 μg ml-1 
Mouse IgG PE 
7.5 μg ml-1 
15 μg ml-1 
25 μg ml-1 
35 μg ml-1 
Overnight 4°C  
 
Reporter 
 
antibodies 
 
 
Polyclonal 
 
1/250 (v/v) 
Rabbit IgG PE 
7.5 μg ml-1 
10 μg ml-1 
15 μg ml-1 
25 μg ml-1 
Overnight 4°C 
 
 
6.2.5.4  -  Concentration of anti-European sea bass monoclonal antibodies 
 
Primary antibody was used at a concentration (6 μg ml-1) as recommended by the 
supplier (Aquatic Diagnostics Ltd) for use in ELISA (section 6.2.5.2). Several different 
concentrations of anti-European sea bass IgM were tested with fish sample 10 (Table 6.9). 
The protocol was carried out as described in Table 6.5. 
 
Table 6.9 – Optimisation of primary antibody concentration used for SAT. 
 
Sample Incubation Step Antibody Primary Ab Reporter 
Time Temperature 
Primary 
 
Antibody 
 
 
 
Fish sera 
 
Sample 10 
 
1/10 (v/v) 
Anti-sea bass MAb 
 
4 μg ml-1 
6 μg ml-1 
10 μg ml-1 
20 μg ml-1 
Mouse IgG PE 
 
25 μg ml-1 
Overnight 4°C 
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6.2.6 - Data Analysis 
 
Data analysis is comprised of the following steps; 
c Subtraction of the blank from the raw sample data. The blank was obtained by 
running a simultaneous assay using the same procedure where antibody samples were 
replaced with DPBS+. 
d Background elimination. According to Carter (1994) the background should be the 
mean of 10-25 % of the lowest values read. Opalka et al. (2004) considered all values 
obtained below 50 MFI as background. During this study both of these concepts of 
background were employed. The mean of the 25 % lowest values read was determined and 
subtracted from the data obtained. Then all readings below 50 MFI were rejected.  
e Sensitivity may be a problem when analysing serum samples where background is 
a problem (Johansson and Andersson, 2003). To reduce the influence of the background 
readings in the analysis of fish serum samples an additional step was incorporated. The values 
obtained for each peptide with the negative serum sample (Machrihanish fish farm sample) 
were subtracted from the corresponding peptide MFI value for the naturally infected fish 
serum samples. After this subtraction the average of the 25 % lower readings was determined 
and subtracted from the data. A further step was performed - all the points below 150 MFI 
were rejected and not analysed.  
 
The betanodavirus coat protein amino acid sequence was submitted into 
www.compbio.dundee.ac.uk/~www-jpred/jnet/ for prediction of the secondary structure of the 
protein using the Jnet secondary structure prediction method (Cuff and Barton, 1999). Jnet is a 
neural network prediction algorithm which applies multiple sequence alignments against 
PSIBLAST and HMM profiles. This secondary structure prediction program achieves an 
average accuracy of 76.4 %. 
The 3D structure of the Betanodavirus coat protein has not been determined using X-
ray crystallography. Consequently, in this study, CPHmodels 2.0 homology-modelling server 
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(Lund et al. 2002) was used to predict the 3D-structure. This algorithm is available on: 
www.cbs.dtu.dk/services/CPHmodels/. The program searches for homologies between a 
target protein sequence and the sequences of proteins contained in three databases (NCBI, 
SWISS-PROT and RCSB). The betanodavirus sequence was aligned with the template and 
modelled according to Lund et al. (2002) recommendations. Regions of protein molecules that 
are modelled at less than 95 % accuracy are excluded from the predicted structural model. 
 
Amino acids may be classified as either hydrophobic or hydrophilic. The 
hydrophobicity of amino acids contributes to the folding of protein molecules. Hydrophobic 
radical groups tend to be located on the inside of a protein whereas hydrophilic groups tend to 
occur on the exterior interacting with water molecules (Kyte and Doolittle, 1982).   
The hydropathicity profile of the betanodavirus coat protein was analysed using a 
method developed by Kyte and Doolittle in 1982. In this procedure, each amino acid is given 
a hydrophobicity score between -4.5 and 4.5, where 4.5 represents the most hydrophobic, and 
-4.5 represents the most hydrophilic (Table 6.10).  
   
Table 6.10 – Hydropathicity of each amino acid according to Kyte and Doolittle (1982). 
 
Amino Acid  Amino Acid 
(Hydrophobic) 
Hydropathy 
Score  (Hydrophilic) 
Hydropathy 
Score 
Isoleucine I 4.5  Glycine G -0.4 
Valine V 4.2  Threonine T -0.7 
Leucine L 3.8  Tryptophan W -0.9 
Phenylalanine F 2.8  Serine S -0.8 
Cysteine C 2.5  Tyrosine Y -1.3 
Methionine M 1.9  Proline P -1.6 
Alanine A 1.8  Histidine H -3.2 
    Glutamic acid E -3.5 
    Glutamine Q -3.5 
    Aspartic acid D -3.5 
    Asparagine N -3.5 
    Lysine K -3.9 
    Arginine R -4.5 
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In the present study, hydropathicity profiles were analysed in a window of seven 
amino acids. Hydrophobicity scores were averaged and assigned to the amino acid located in 
the centre of each window. The computer program starts with the first window of amino acids 
and calculates the average of all the hydrophobicity scores in that window. Then the computer 
program moves down one amino acid and calculates the average of all the hydrophobicity 
scores in the second window. This pattern continues to the end of the protein, computing the 
average score for each window and assigning it to the middle amino acid in the window.  
Hydropathicity analyses were performed with the programme Pepwindow, contained 
within the EMBOSS (European Molecular Biology Open Software Suite, 
http://bioinfo.hku.hk/EMBOSS).  
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6.3 -  Results 
 
The goal of this chapter was identification of B-cell epitopes on the betanodavirus 
capsid protein.  This was approached in two stages: i) optimisation of xMAP technology and 
ii) epitope mapping with overlapping synthetic peptides. 
  
 
6.3.1 - Optimisation of the assays 
 
Optimisation assays was performed in three different experiments. These were 
designed to optimise: sample incubation time, amount of primary antibody, amount of 
reporter and amount of sample antibody. 
 
6.3.1.1  -  Reporter 
 
Sample incubation time was optimised using mouse MAbs. Overnight incubation at 
4°C was found to be optimal. This incubation period was used in all subsequent experiments, 
and also applied to assays using rabbit and fish antibodies.  
The concentration of the conjugate (mouse IgG PE) was optimised with MAb 4A12. 
A concentration of 25 μg ml-1 was found to be optimal. This concentration of mouse IgG PE 
was used in mapping experiments with fish sera.  
Experimental analysis of the optimal concentration of reporter molecule was also 
performed for rabbit IgG PE. A concentration of 25 μg ml-1 was also found to be optimal.  
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6.3.1.2  -  Target antibody 
 
For monoclonal antibodies, a concentration of 100 μg ml-1 of purified MAb was 
optimal. For rabbit and fish polyclonal antibodies, optimal results were achieved with serum 
dilutions of 1:250 and 1:25 respectively. 
Optimised incubation times and reactant concentrations used in epitope mapping 
studies are summarised in Table 6.11.  
 
Table 6.11 – Optimised conditions for mouse MAbs, rabbit polyclonal antibodies and fish 
sera in epitope mapping with SAT. 
 
Procedure step 
Sample Incubation Antibody 
Amount Ab Time Temperature 
Primary Ab Reporter 
MAb 100 μg ml-1 Overnight 4°C - Mouse IgG PE 25 μg ml-1 
Polyclonal 1/250 (v/v) Overnight 4°C - Rabbit IgG PE 25 μg ml-1 
Sea bass sera 1/25 (v/v) Overnight 4°C Sea bass IgM 20 μg ml-1 
Mouse IgG PE 
25 μg ml-1 
 
 
 
6.3.2 - Epitope Mapping 
 
B-cell epitope mapping of the betanodavirus coat protein was performed using 
antibodies or serum samples from three different species; mouse monoclonal antibodies, and 
polyclonal sera from rabbit and European sea bass. 
All the data shown are above the cut off established for the assay.   
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6.3.2.1  -  Monoclonal antibodies 
6.3.2.1.1 -  Negative control 
 
Epitope mapping with mouse MAbs using the xMAP technology yielded a wide range 
of Mean Fluorescence Intensity (MFI) values. The antibodies bound to synthetic peptides are 
themselves bound by the PE-labelled conjugated. The MFI is proportional to the fluorescence 
of the PE, and thus a measure of the amount of antibody bound to a bead.   
 During this study an anti-Tetracapsuloides bryosalmonae MAb was used as a 
negative control. This MAb did not show any affinity with the any of the synthetic peptides 
used in this study.  
 
 
Table 6.12 – Mean Fluorescence Intensity values for T. bryosalmonae and MAbs 1E3. 
 
Monoclonal Antibodies (MFI)  Monoclonal Antibodies (MFI) Peptide 
1E3 T. bryosalmonae  
Peptide 
1E3 T. bryosalmonae 
1 0.00 0.0  19 3.6 0.0 
2 2.0 0.0  20 19.3 0.0 
3 9.0 0.0  21 3.6 0.0 
4 0.0 0.0  22 0.0 0.0 
5 2.3 0.0  23 0.3 0.0 
6 0.0 0.0  24 0.0 0.0 
7 0.0 0.0  25 0.0 0.0 
8 0.0 0.0  26 0.0 0.0 
9 0.0 0.0  27 0.0 0.0 
10 0.0 0.0  28 0.0 0.0 
11 0.0 0.0  29 0.0 0.0 
12 0.0 0.0  30 6.3 0.0 
13 0.0 0.0  31 0.0 0.0 
14 0.0 0.0  32 0.0 0.0 
15 0.0 0.0  33 3.3 0.0 
16 8.7 0.0  34 3.3 0.0 
17 0.0 0.0  35 9.7 0.0 
18 0.0 0.0  36 1.7 0.0 
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6.3.2.1.2 -  MAb 1E3 
 
Fluorescence values obtained with MAb 1E3 were slightly higher than T. 
bryosalmonae, however, these were excluded since they were lower than the cut-off value of 
50 MFI. Results obtained with the Mabs raised against T. bryosalmonae and 1E3 are shown in 
Table 6.12. 
 
6.3.2.1.3 -  MAb 5G10 
 
MAb 5G10 showed lower MFI values than 4A12, 4C3 and 3B10, however 
approximately 1/3 of these were greater than the threshold of 50 MFI, and thus considered to 
be valid. MAb 5G10 recognised peptides 16 (190 MFI), and 20 (110 MFI) most strongly 
Figure 6.6).  
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Figure 6.6 –MAb 5G10 binding to synthetic peptides. 
 
The majority of the synthetic peptides recognised by 5G10 are located on the same 
region of the coat protein, between peptides 16-21 (amino acids 151-212 of the capsid 
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protein). Peptide 35 was also recognised (88 MFI). This peptide was synthesised to act as 
negative control.  
 
6.3.2.1.4 -  Mab 3B10 
 
MAb 3B10 recognised peptides 19 and 20 most strongly (MFIs 1399 and 2138 
respectively) (Figure 6.7).  
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Figure 6.7 – MAb 3B10 binding to synthetic peptides. 
 
 
The peptides recognised by MAb 3B10 were located in four different regions of the 
betanodavirus coat protein. Peptide 5 (MFI 1162) and peptide 1 (MFI 1153) were also 
recognised. These are located in the N-terminus of the coat protein. A further region was 
recognised by MAb 3B10 comprising peptides 28 - 32, situated near the C terminus of the 
capsid protein. 
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6.3.2.1.5 -  MAb 4A12 
 
MAb 4A12 exhibited the highest MFI values of the MAbs analysed (peptide 3, MFI 
3704). This MAb strongly recognised the three consecutive peptides, 19, 20 and 21 with very 
high MFI (Figure 6.8). 
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Figure 6.8– MAb 4A12 binding to synthetic peptides. 
 
 
MAb 4A12 recognised three regions of the coat protein. Two of these are located in 
the N and the C termini of the coat protein, and the third region is situated in the central 
region of the protein. This antibody recognised both control peptides (35 and 36).  
 
6.3.2.1.6 -  MAb 4C3 
 
MAb 4C3 exhibited lower binding to the synthetic peptides than either MAb 4A12 or 
3B10 (Figure 6.9). This MAb recognised peptides situated in the centre of the coat protein 
most strongly, together with peptide 35 (control peptide). These results were obtained for two 
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groups of consecutive peptides, peptide 15-16 and peptide 19-20. Peptide 20 revealed the 
highest binding values (842 MFI) follow by peptide 35 (669 MFI).  
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Figure 6.9 – MAb 4C3 binding to synthetic peptides. 
 
 
6.3.2.1.7 -  MAbs - analysis of the peptides recognised most strongly 
 
None of the MAbs analysed bound to all the peptides. However all peptides were 
recognised by at least one MAb, although in some cases, the MFI values were low. For each 
MAb studied, the three peptides recognised with the highest MFI value were located in three 
regions of the coat protein: peptide 1 to 5; peptide 15 to 16 and peptide 19 to 21 (Table 6.13).  
Within the peptides that were recognised most strongly, i.e. greatest MFI values, 
peptide 20 was most frequently recognised, showing high MFI with all five MAbs studied. 
Peptides 16 and 35 were recognised by MAbs 5G10 and 4C3. These two MAbs showed 
similar binding affinities, and recognised the same peptides. The other peptides recognised 
with high MFI values were recognised by a single MAb.  
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Table 6.13 – The three peptides with highest 
MFI for each of the MAbs 
analysed. 
 
 Peptide MFI 
5G10 16 KWWESRTVRPQY 190 
 20 NTDVVNVSVLCR 110 
 35 KSVPADTRNSRR 88 
3B10 20 NTDVVNVSVLCR 2138 
 19 GRLILLCVGNNT 1399 
 5 KASTVTGFGRGT 1162 
4A12 3 QPRRRANNRRRS 3704 
 21 CRWSVRLSVPSL 1658 
 20 NTDVVNVSVLCR 1440 
4C3 20 NTDVVNVSVLCR 842 
 35 KSVPADTRNSRR 669 
 16 KWWESRTVRPQY 648 
 
 
 
The six peptides showing the highest MFI values were aligned with the predicted 
secondary structure of the betanodavirus coat protein (Figure 6.10). All peptides showing high 
MFI values could be mapped to regions of the coat protein that form areas of β-sheet 
conformation. 
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Peptide 3 Peptide 35
Peptide 5
Peptide 19
Peptide 16
Peptide 20
Peptide 21
 
Figure 6.10 – Synthetic peptides recognised by MAbs, aligned with the secondary structure of DFNNV 
coat protein (Jnet secondary structure prediction method).  is α-helix regions and 
 is β-sheet regions. 
 
 
 
6.3.2.2  -  Polyclonal Antibodies 
 
The xMAP procedure was also used to map regions of the betanodavirus coat protein 
recognised by polyclonal antibodies from rabbit immunised with European sea bass 
betanodavirus. The results of this study are presented in Figure 6.11. Peptide 20 (1290 MFI) 
followed by peptide 13 (679 MFI) were recognised most strongly. 
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Four different regions of the coat protein were recognised by rabbit polyclonal 
antibodies: peptides 1 to 4; peptides 10 to 13; peptides 19 to 21 and peptides 28 to 30.  
 
 
0
200
400
600
800
1000
1200
1400
pe
p.
 1
pe
p.
 3
pe
p.
 5
pe
p.
 7
pe
p.
 9
pe
p.
 1
1
pe
p.
 1
3
pe
p.
 1
5
pe
p.
 1
7
pe
p.
 1
9
pe
p.
 2
1
pe
p.
 2
3
pe
p.
 2
5
pe
p.
 2
7
pe
p.
 2
9
pe
p.
 3
1
pe
p.
 3
3
pe
p.
 3
5
M
FI
Polyclonal antibody
Figure 6.11 – Rabbit polyclonal antibodies binding to synthetic peptides. 
 
 
The three peptides showing the highest MFI values (peptides 10, 13 and 20) were 
located in three different regions of the coat protein (Table 6.14).  
 
 
Table 6.14 - The three peptides with 
highest MFI to rabbit 
polyclonal antibodies. 
 
Polyclonal antibodies 
Peptide MFI 
20 NTDVVNVSVLCR 1290 
13 GGYVAGFLPDPT 679 
3 QPRRRANNRRRS 511 
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After aligning these peptides with the predicted secondary structure of the 
betanodavirus coat protein, peptide 20 was found to correspond to region with B-sheet 
structure. Peptide 13 has a mixture of α-helix and β-sheet regions (Figure 6.12). 
 
 
Peptide 3
Peptide 13
Peptide 20
  
Figure 6.12 – Synthetic peptides recognised by polyclonal antibodies aligned with the 
secondary structure of DFVVN coat protein (Jnet secondary structure prediction 
method).  is α-helix regions and  is β-sheet regions. 
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6.3.2.3  -  European sea bass sera 
 
The xMAP procedure was also used to study the interaction between fish (European 
sea bass) antibodies and the coat protein of betanodavirus. Nine serum samples, obtained from 
a natural VNN outbreak in Greece, were used in this study. 
 
6.3.2.3.1 -  Negative control serum samples 
 
For negative controls, fish sera were obtained from European sea bass held at 
Machrihanish fish farm. This fish have never been exposed to a betanodavirus infection. All 
the peptides showed a degree of non-specific binding to the fish serum (Table 6.15).  
 
Table 6.15 – Negative control, European sea bass 
sera, binding to synthetic peptides.  
 
Machrihanish fish serum 
Peptide MFI  Peptide MFI 
1 44  19 53 
2 50  20 168.5 
3 256  21 175.5 
4 65  22 72.5 
5 60  23 85 
6 76  24 31.5 
7 30  25 42.5 
8 40.5  26 69 
9 50  27 70.5 
10 83.5  28 66.5 
11 89  29 211.5 
12 125.5  30 214.5 
13 107  31 93 
14 44.5  32 77.5 
15 41  33 78.5 
16 198.5  34 60 
17 72.5  35 144.5 
18 67  36 86 
 
This was considered a result of natural binding capacity of fish serum to the synthetic 
peptides being used as background. This background value obtained per peptide was 
subtracted from the corresponding peptide for infected European sea bass (Sb).   
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6.3.2.3.2 -  Serum samples betanodavirus infected European sea bass 
 
European sea bass serum sample 1 (SB1) showed high MFI towards peptides 15 and 
16 (1113 MFI and 1030 MFI, respectively), however the highest value was obtained with 
peptide 21 (2108 MFI) (Figure 6.13). These peptides mapped to the two main regions of the 
coat protein (peptide 15-16 and 19-21). Other regions are comprised by singular peptides as 
number 3 and 12. 
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Figure 6.13 – European sea bass antibodies binding to synthetic peptides (c sample 1 
and d sample 3). 
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 Sample 3 (SB3) strongly identified peptide 20 (1394 MFI) and peptide 1 (612 MFI) 
(Figure 6.14). 
 Serum sample 4 (SB4) revealed similar affinities for peptide 1 and peptide 16, (1224 
MFI and 1207 MFI respectively) (Figure 6.14). Peptide 16 belongs to a region, defined by 
amino acid residues 141-212 (peptides 15-21) that reveal high binding (MFI) values.  
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Figure 6.14 - European sea bass antibodies binding to synthetic peptides (c sample 4 and 
d sample 7). 
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SB7 bound most strongly to peptide 10 (1297 MFI), followed by peptide 19 (1107 
MFI). Peptides 21 and 22 have similar affinities to SB7 with an MFI of 883 and 888, 
respectively. These two peptides with peptide 19 comprise a regions of the coat protein 
recognised by SB7 antibodies. Other regions are not so easy to define because the peptides are 
located throughout the coat protein (Figure 6.14). 
 
Serum sample 10 (SB10) showed similar binding affinities to peptides 1, 22 and 10 
(891, 879 and 802 MFI, respectively) (Figure 6.15).  
 
0
200
400
600
800
1000
pe
p.
 1
pe
p.
 3
pe
p.
 5
pe
p.
 7
pe
p.
 9
pe
p.
 1
1
pe
p.
 1
3
pe
p.
 1
5
pe
p.
 1
7
pe
p.
 1
9
pe
p.
 2
1
pe
p.
 2
3
pe
p.
 2
5
pe
p.
 2
7
pe
p.
 2
9
pe
p.
 3
1
pe
p.
 3
3
pe
p.
 3
5
M
FI
SB10 
0
100
200
300
400
500
600
700
pe
p.
 1
pe
p.
 3
pe
p.
 5
pe
p.
 7
pe
p.
 9
pe
p.
 1
1
pe
p.
 1
3
pe
p.
 1
5
pe
p.
 1
7
pe
p.
 1
9
pe
p.
 2
1
pe
p.
 2
3
pe
p.
 2
5
pe
p.
 2
7
pe
p.
 2
9
pe
p.
 3
1
pe
p.
 3
3
pe
p.
 3
5
M
FI
SB15
Figure 6.15 – European sea bass antibodies binding to synthetic peptides (c sample 10 
and d sample 15). 
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Fish serum sample 15 (SB15) showed relatively higher specificity for the synthetic 
peptides (Figure 6.16). This sample yielded MFI values that were lower than those recorded 
for other serum samples. Peptides 20-21 were recognised with the highest MFI (621 MFI and 
381 MFI, respectively). A further region was recognised by sample 15. This comprised 
peptide 1, which is located near the N terminus of the coat protein.  
 
Serum sample 17 (SB17) recognised one region comprising peptides 20 and 21 (MFI 
values with 745 and 1161 respectively). Peptide 1 and peptide 12 were also recognised with 
high MFI values (Figure 6.16). 
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Figure 6.16 – European sea bass antibodies binding to synthetic peptides (sample 17). 
 
 
 
6.3.2.3.2.1 SB2 and SB9 
 
Serum samples SB2 and SB9 did not recognised betanodavirus when assessed by 
ELISA. These samples were used as negative controls, both SB2 and SB9 showed similar 
levels of MFI to the peptides as the samples from infected fish (Figure 6.17). 
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European sea bass serum sample SB2 exhibited the greatest level of binding to any 
peptide (peptide 10, 2239 MFI). This fish serum sample recognised two consecutive peptides, 
15 and 16, with the second and the third highest binding value with 2168 MFI and 1435, 
respectively. With this sample it is possible to distinguish several peptides or group of 
peptides of the coat protein with high MFI values. The peptides/regions are peptide 3, 10 and 
peptides 15-16 and 20-23. 
 
 
Figure 6.17 – European sea bass antibodies binding to the synthetic peptides (c sample 2 
and d sample 9). 
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Serum sample 9 (SB9) showed the greatest level of binding to peptide 21 (2164 MFI). 
As was observed for sample SB2, sample SB9 bound to two consecutive peptides, 15 and 16, 
(1620 MFI and 1595 MFI respectively). Sample SB9 also strongly recognised peptide 3 (1210 
MFI) and peptide 10 (1273 MFI).  
 
 
6.3.2.3.3 -   European sea bass sera – analysis of the peptides recognised most 
strongly 
 
The three peptides recognised by the serum samples with the greatest MFI values 
were submitted to further analysis. The three peptides recognised most strongly (i.e. three 
highest MFI values) by each fish serum sample are shown in Table 6.16. These peptides map 
to two major regions of the coat protein defined by peptides 15-16 and peptides 18-22. The 
region comprising peptides 15-16 (aa 141-162) was recognised by five sera, and the region 
comprising peptides 18-22 (aa 171-222) was recognised by eight sera. Additionally, peptide 1 
(aa 1-12) was recognised by four serum samples. 
Using this approach the most commonly recognised peptides were peptides 1, 16 and 
21. These peptides were recognised by four of the nine fish serum samples analysed. One 
third of the fish serum antibodies recognised peptides 10, 15 and 21. Peptides 19 and 22 were 
recognised by two of the fish samples, and a single serum sample recognised peptide 18 and 
peptide 12.  
The same three peptides were recognised by SB1 and SB9 (15, 16 and 21). These 
peptides were identified by serum sample SB2, however, this sample recognised peptide 10 as 
opposed to peptide 21. Both samples SB7 and SB10 bound strongly to peptides 10 and 22. 
SB15 and SB17 both showed high binding levels to two peptides, 20 and 21. 
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Table 6.16 - The three peptides showing the highest MFI values to each of the European sea 
bass samples analysed.  
 
 Peptide MFI   Peptide MFI 
SB 1 21 CRWSVRLSVPSL 2108  SB 9 21 CRWSVRLSVPSL 2164 
 15 LQATRGAVVAKW 1113   15 LQATRGAVVAKW 1620 
 16 KWWESRTVRPQY 1030   16 KWWESRTVRPQY 1595 
SB 2 10 RLGHAARIFQRY 2239  SB 10 1 MVRKGEKKLAKP 891 
 15 LQATRGAVVAKW 2168   22 SLETPEETTAPI 879 
 16 KWWESRTVRPQY 1435   10 RLGHAARIFQRY 802 
SB 3 20 NTDVVNVSVLCR 1394  SB 15 21 CRWSVRLSVPSL 621 
 1 MVRKGEKKLAKP 612   20 NTDVVNVSVLCR 381 
 18 SGKEQRLTSPGR 349   1 MVRKGEKKLAKP 361 
SB 4 1 MVRKGEKKLAKP 1243  SB 17 21 CRWSVRLSVPSL 1161 
 16 KWWESRTVRPQY 1071   20 NTDVVNVSVLCR 745 
 19 GRLILLCVGNNT 754   12 IQPMCPANTGGG 474 
SB 7 10 RLGHAARIFQRY 1377      
 19 GRLILLCVGNNT 1117      
 22 SLETPEETTAPI 879      
 
 
The peptides showing the three highest binding levels for each fish serum sample 
were mapped onto a computer predicted model of the secondary structure of the beta-
nodavirus coat protein. (Figure 6.18). One peptide (#10) mapped to a region predicted to form 
an α-helix. The other peptides mapped to regions of the coat protein that form β-sheets.  
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Peptide 1
Peptide 10
Peptide 5
Peptide 19
Peptide 16
Peptide 20
Peptide 21
Peptide 12
Peptide 15
Peptide 18
Peptide 22
 
Figure 6.18 – Synthetic peptides recognised by fish antibodies aligned with secondary 
structure of DFNNV coat protein (Jnet secondary structure prediction method). 
 is α-helix regions and  is β-sheet regions. 
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6.3.3 - Comparison of peptides recognised by mouse, rabbit and fish 
antibodies 
  
The three peptides recognised most strongly by each monoclonal antibody or serum 
sample are presented in Figure 6.19 and Table 6.17.  
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Figure 6.19– The three peptides recognised most strongly (i.e. highest MFI) by c mouse MAbs, d 
rabbit polyclonal antibodies, e European sea bass antibodies). 
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Antibodies from mouse, rabbit, and European sea bass recognised peptide 20. All of 
the mouse MAbs, the rabbit polyclonal sera, and one third of the fish serum samples identified 
this peptide, which mapped to amino-acid residues 191-202 of the coat protein. Peptide 16 
was recognised by four fish sera and two MAbs. Peptide 21 was recognised by one MAb 
(4A12) and four fish serum samples. Peptide 19 was also strongly recognised by one MAb, 
but only two fish serum samples. The region defined by peptides 18-22 contained almost half 
of the peptides that were recognised most strongly. 
 
Table 6.17 – The three peptides recognised most strongly by Mabs and serum samples. 
 
Peptide Coat protein residue Antibody 
1 MVRKGEKKLAKP 1-12 SB3, SB4, SB10, SB15 
3 QPRRRANNRRRS 21-32 4A12, Poly 
5 KASTVTGFGRGT 41-52 3B10 
10 RLGHAARIFQRY 91-102 SB2, SB7, SB10 
12 IQPMCPANTGGG 111-122 SB17 
13 GGYVAGFLPDPT 121-132 Poly 
15 LQATRGAVVAKW 141-152 SB1, SB2; SB9 
16 KWWESRTVRPQY  
151-162 
 
4C3, 5G10, SB1, SB2, 
SB4, SB9 
18 SGKEQRLTSPGR 171-182 SB3 
19 GRLILLCVGNNT 181-192 3B10, SB4, SB7 
20 
 
NTDVVNVSVLCR 
 
191-202 
 
3B10, 4A12, 4C3, 5G10, Poly, 
SB3, SB15, SB17 
21 CRWSVRLSVPSL 201-212 4A12, SB1, SB9, SB15, SB17 
22 SLETPEETTAPI 211-222 SB7, SB10 
35 KSVPADTRNSRR 41-30 4C3, 5G10 
Note - MAbs: 3B10, 4A12, 4C3 and 5G10 
        - Polyclonal antibodies: Poly 
        - European sea bass: SB1, SB2, SB3, SB4, SB7, SB9, SB10, SB15 and SB17  
 
 
Some peptides were recognised by antibodies from only one of the species studied. 
Peptides 5 and 35 were only identified by mouse antibodies. Peptide 13 was only recognised 
by rabbit polyclonal antibodies, and peptides 1, 10, 12, 15, 18 and 22 by fish antibodies. 
The warm blooded species, mouse and rabbit, were the only ones that strongly 
recognised peptide 3. 
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The three peptides recognised most strongly by each antibody or serum sample were 
mapped onto a hydropathicity profile of the betanodavirus coat protein produced using the 
method described by Kyte and Doolittle (1982).  
As can be observed in Figure 6.20, peptide 3 mapped to the most hydrophilic region 
of the coat protein and was only identified by MAb 4A12 and rabbit polyclonal sera. Peptide 
19 which is strongly recognised by one mouse MAb and two European sea bass sera maps to 
the most hydrophobic region. Peptide 1 is hydrophilic and peptide 15 can be considered 
neutral. These peptides were recognised only by European sea bass sera. The first residues of 
peptides 5, 13, 10, 16 and 35 are hydrophobic but most of the peptide sequence is hydrophilic. 
Peptides 12, 20, 21 and 22 have different behaviour in the plot but they are all hydrophobic.   
The most hydrophobic region (peptide 19-22) is recognised by all the mouse MAbs, 
the rabbit polyclonal and eight of nine fish sera samples.   
 
1 10
 
Figure 6.20 – Positions of the most strongly recognised peptides mapped onto a hydropathicity plot of 
the betanodavirus coat protein. 
 
 
Mapping of peptides that were most strongly recognised by antibodies onto the 
predicted secondary structure of the coat protein indicates that the majority of these peptides 
belong to regions comprised of β-sheet (Figure 6.21). Only peptide 10 mapped to a region of 
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the coat protein that possessed an α-helical structure. A mixture of β-sheet and α-helix region 
can be observed in peptide 13 mapped to a region containing both β-sheet and α-helix 
structure. 
 
 
 
Peptide 1
Peptide 10
Peptide 5
Peptide 3
 
Figure 6.21 – The most strongly recognised peptides aligned with the secondary structure of 
DFNNV coat protein. The red boxes show the peptides that were recognised by 
more than 1 species.  is α-helix regions and  is β-sheet regions. 
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6.4 -   Discussion  
 
This discussion is divided into four sections. Section one focuses on the use of SAT 
technology and synthetic peptides for epitope mapping studies.  Section two deals with the 
validity of the experimental results. In section three, the peptides predicted to be of greatest 
significance in epitope mapping studies are highlighted and mapped onto the native structure 
of the betanodavirus coat protein. Finally in section four, the results of the present study are 
compared and contrasted with those obtained from other epitope mapping studies of 
betanodaviruses. 
 
 
Section 1 - SAT technology and synthetic peptides       
 
In the first part of this section, assay optimisation and accuracy are discussed. This is 
followed by a discussion of the use of synthetic peptides in epitope mapping studies. 
 
Optimisation 
 
The epitope mapping procedure used in this thesis was based on two principles: c - 
the ability of flow cytometry to distinguish separate sets of labelled beads based on their 
unique optical properties. Results are expressed as fluorescence intensities for each 
microsphere subset. This value is proportional to the concentration of analyte contained in 
individual samples (Yingyongnarongkul et al. 2003); d - the identification of peptide 
fragments derived from a protein molecule that are able to react with antibodies raised against 
the intact protein (Arnon and van Regenmortel, 1992). 
A Bio-Plex™ system utilising xMAP technology was used for flow cytometric 
measurements, and a panel of synthetic peptides 12 amino-acid residues in length that 
mimicked the betanodavirus coat protein were used to identify antibody binding sites. 
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Antibodies to betanodavirus from three different species were studied: mouse (monoclonal 
antibodies), rabbit (polyclonal antibodies) and European sea bass (polyclonal antibodies).  
 
As with any equipment the accuracy and reproducibility of the results obtained using 
the Bioplex™ may be influenced by a number of parameters. Validation assays were 
employed to optimise the equipment, which was also calibrated on a daily basis using 
materials supplied by the manufacturer.  
SAT assays are dependent on the consistent and predictable performance of the 
microspheres and the properties of the antibody molecules used in conjugates (Mandy et al.  
2001). High quality microspheres supplied by the manufacturer were used throughout the 
present study, ensuring full compatibility between the detection system and software. 
Antibody conjugates produced by Molecular Probes and recommended for SAT assays were 
also used to ensure efficient analyses.  
Optimisation of the experimental protocol was performed prior to epitope mapping 
studies. The parameters studied were sample incubation period, and concentrations of sample, 
primary antibody and reporter molecule (Table 6.11). The optimal incubation times for use in 
Bio-Plex™ based assays is currently undefined. Whilst some data suggest that short incubation 
periods are advantageous (Pickering et al. 2002b, Seideman and Peritt, 2002, Kellar and 
Douglass, 2003) other studies suggest that the opposite is true (Vignali, 2000) and that short 
sample incubation periods can reduce assay sensitivity up to 100 fold. Two incubation periods 
were used in the present study: 1 hour at room temperature and overnight at 4°C. Overnight 
incubation yielded superior results. For logistical reasons (costs; time) extensive analyses of 
the effects of incubation temperature and duration were not performed. However, it is possible 
that shorter incubation times could be employed in combination with different incubation 
temperatures as described by Dasso et al. (2002) and Prabhakar et al. (2002). 
The optimal concentration of antibodies used in SAT assays was found to vary 
according to the host species. Polyclonal rabbit and fish antibodies were used at a dilution of 
1:250 and 1:25 (v/v), respectively. Purified MAbs were used at a concentration of 100 μg ml-1. 
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This is a relatively high value in comparison to the detection levels that can be obtained for 
cytokines (1.6 to 32000 pg ml-1) and pesticides (0.1 to 300 ng ml-1) (Jenmalm et al. 2003, 
Biagini et al. 2004b). This may be due to the fact that antibodies raised against a native 
protein antigen usually show lower affinities for binding to fragments of the antigen (Sachs et 
al. 1972). This lower affinity has been related to the absence in the peptide of a portion of a 
determinant residue; conformational differences between peptides and the native molecule; 
and the absence in the peptide of long-range effects (e.g. electrostatic) that may exist in the 
native protein (Al Moudallal et al. 1982).  
The sensitivity of SAT assays may be influenced by ratio of reporter molecules per 
microsphere and the number of microspheres with the same classification address. As long as 
both of these values exceed one hundred, statistical limitations imposed by the Poisson 
distribution have a nominal effect (Mandy et al. 2001). These limitations were avoided by 
careful assay optimisation, and the use of a concentration of 25 μg ml-1 of PE-conjugated 
antibody in all assays. Furthermore, a minimum of 100 beads per analyte were used as 
recommended.  The requirement for just 100 readings is due to the fact that reaction on the 
microsphere surface is uniform between microspheres (McHugh, 1994).  
 
Synthetic peptides 
 
The length and overlap of synthetic peptides are significant factors that can influence 
epitope mapping analyses. In the present study, synthetic peptides twelve amino acid residues 
in length were chosen. Adjacent peptides overlapped by two amino acid residues. The ideal 
length of synthetic peptides used in epitope mapping studies is not known with certainty. 
Sumar (2001) suggested that the ideal overlapping can be calculated using the formula: 
 
X= [n-(n-1)]  
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where: X is the number of overlapping residues and n is the number of residues of the 
protein. 
As a first approach synthetic peptides should not be shorter then eight residues and 
with an overlap of five residues (Tribbick and Rodda, 2002), instead of the seven residues 
recommended when using the formula mentioned above. However, several works have been 
performed using different peptide sizes with good results. Peptides 15 residues in length were 
used for epitope mapping of the fish virus Viral Haemorrhagic Septicaemia Virus (VHSV) 
(Estepa and Coll, 1996) and peptides 13 residues in length were used for epitope mapping of 
the G glycoprotein of Herpes Simplex Virus type 2 (Liljeqvist et al. 2002). Decapeptides have 
also been widely used for epitope mapping many different proteins, for instance anti-troponin 
(Filatov et al. 1998), Beet Necrosis Yellow Vein Virus (BNYVV) (Commandeur et al. 1994) 
and interleukin-10 (Reineke et al. 1998). The epitope mapping of interleukin-10 by these 
authors was also successful when peptides 6 residues in length were used. Thus previous 
studies suggested that synthetic peptides 12-residues in length could be used successfully and 
represented a balance between maximising the efficacy of epitope mapping and the funding 
available for the project.  
However, the use of such peptides should be borne in mind during interpretation of 
results. For example, use of longer peptides could explain why several peptides were 
recognised by many of the antibodies analysed. An increase in the peptide length has been 
associated with an increase in the number of peptides identified (Geysen et al. 1987a). 
Furthermore, the detection of some epitopes may be compromised by the use of synthetic 
peptides that overlap by only two residues. (Sumar, 2001). The use of greater numbers of 
synthetic peptides of shorter length was not possible in the present study due to financial and 
logistical constraints. However, in future studies, the use of a set of synthetic peptides of 
reduced length and with greater overlap could facilitate the identification of epitopes on the 
betanodavirus capsid protein with greater resolution, especially within the regions that are 
predicted to be of significance based upon the present study. 
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Section 2 - Validity of the assay 
 
In this section, the precautions taken to ensure assay validity are discussed.  
 
Several precautions were taken to ensure validity of the assay. Negative controls were 
incorporated to confirm the specificity of results. These comprised a Betanodavirus-negative 
sea bass serum sample, and a mouse MAb; and two control peptides (with the same amino 
acid composition as two test-peptides, but synthesised in the reverse sequence (i.e. C terminus 
- N terminus). The latter were designated peptides 35 and 36. 
The specificity of the interaction between antibodies or serum samples with synthetic 
peptides was supported by the lack of affinity of MAbs raised against the fish parasite 
Tetracapsuloides bryosalmonae towards the panel of peptides. The lack of reaction between 
an unrelated antibody (anti-Tetracapsuloides bryosalmonae MAb) and the panel of peptides 
reinforced confidence in the specificity of the nodavirus epitope mapping data. 
In order to assess the specificity of European sea bass sera to synthetic peptides two 
different types of serum samples were used. The first type comprised two European sea bass 
serum samples that exhibited no activity to betanodavirus as determined by ELISA. However, 
in SAT assays, these serum samples demonstrated strong binding to the panel of synthetic 
peptides. This could be due to the relatively greater sensitivity of SAT assays as compared to 
ELISA (Carson and Vignali, 1999, Biagini et al. 2004a, Biagini et al. 2004b). Furthermore, at 
lower concentrations of analyte, SAT microspheres have been demonstrated to be four times 
more sensitive than assays performed using the microtitre plate format (McDade and Spain, 
1997).  
The second type of negative control serum was obtained from European sea bass that 
had never been exposed to betanodavirus. This European sea bass serum showed non-specific 
binding to synthetic peptides. This fluorescence was considered to represent non-specific 
background, and on this basis was subtracted from all the fluorescence values of all test 
samples. 
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The use of peptides synthesised in the reverse sequence as controls yielded 
contradictory results. None of the serum samples analysed recognised control peptide 36 but 
MAbs 4C3 and 5G10 recognised control peptide 35, showing high MFI values. The ability of 
these MAbs to recognise control peptide 35 could be due to the presence of common residues 
between this peptide and the recognition target of the MAbs studied (Saul and Alzari, 1996). 
The recognition of this peptide indicates that epitope mapping with synthetic peptides requires 
careful interpretation. Pepscan results are presented such that all of the peptides recognised by 
a given MAb or serum sample are evident.  
 
 
Section 3 – Discussion of pepscan results 
 
Discussion of the pepscan results is divided into three sub-sections. The first sub-
section compares and contrasts the results obtained with antibodies from different host 
species. The second sub-section comprises an analysis of the synthetic peptides that were 
most strongly recognised by antibodies/serum samples. In the final sub-section, the peptides 
recognised by antibodies/serum samples are discussed with reference to the structure of the 
betanodavirus coat protein. 
 
Comparation of pepscan data obtain with antibodies from different species 
 
The immune systems of different species may react to different sets of epitopes in a 
given antigen (Geysen et al. 1984). In this thesis, the recognition sites of mouse MAbs, rabbit 
antibodies and European sea bass sera were characterised using synthetic peptides that 
mimicked the betanodavirus coat protein. Antibodies and serum samples from all species 
studied exhibited similar levels of binding to synthetic peptides. Maximum MFI values were 
3704, 2138, 842 and 190 for the four mouse MAbs; 1290 for rabbit polyclonal antibodies; and 
 
214
Chapter 6 – Epitope mapping with synthetic peptides 
2239, 2164, 2108, 1394, 1377, 1243, 1161, 891 and 621 for the nine European sea bass serum 
samples. 
 
Mice and rabbit were immunised with a standardised betanodavirus preparation 
facilitating a comparison of the immune responses in these species. Both mouse and rabbit B-
cell immune responses were directed against two principal regions of the betanodavirus coat 
protein defined by peptides 1-5 and 19-21. Additionally, mouse MAbs recognised another 
region represented by peptide 15-16. Rabbit polyclonal antibodies also recognised two further 
regions (peptides 10-13 and 28-30).   
Binding of rabbit polyclonal antibodies to several peptides is in agreement with 
previous studies. Valle et al. (1999) mapped the bacteriophage φ29 connector protein 
recognised by rabbit polyclonal antibodies and identified 11 regions. Although polyclonal 
antibody responses are frequently directed against several epitopes, in many cases, one 
epitope is recognised more strongly than the others (Carter, 1994).  
The results of the present study suggest that peptide 20 may contain a major epitope. 
This peptide was the most strongly recognised by half of the mouse MAbs analysed (3B10 
and 4C3) and by the rabbit antibodies. Peptide 20 was also amongst those most strongly 
recognised by the other two MAbs.  
When the three peptides that were recognised most strongly by each antibody/serum 
sample are compared, peptide 3 was recognised by mouse MAb 4A12 and rabbit antibodies, 
but not by the natural host (European sea bass). Similar findings have been reported in studies 
of immune responses to African Horse Sickness Virus (AHSV) (Martínez-Torrecuadrada et 
al. 2001). Further similarities in the patterns of epitopes recognised by MAbs and polyclonal 
antibodies were reported by Quesniaux et al. (1990). These studies conflict with the 
hypothesis that MAbs tend to be directed towards minor epitopes that are not 
immunodominant and are not detected by polyclonal antisera (van Regenmortel, 2000). 
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The mouse MAbs studied recognised several epitopes. At first sight, this is a 
surprising result since a MAb should only recognise a single target sequence (Carter, 1994). 
Short peptides are believed only to be capable of mimicking linear or continuous epitopes. 
Thus antibodies recognising short synthetic peptides are believed to be directed against linear 
epitopes (van Regenmortel, 1990a). However, a linear epitope defined by a single peptide may 
represent a part of a larger discontinuous epitope present on the native antigen (van 
Regenmortel, 1989b). Carter (1994) has hypothesised that an antibody recognition site may be 
comprised of two or three discontinuous regions of a protein sequence that fold into a discrete 
conformation. In this thesis, mice were immunised with a live betanodavirus for production of 
MAbs. Thus, B-cell clones selected during the production of MAbs may be directed against 
portions of discontinuous epitopes that are created by the molecular folding which forms the 
three dimensional structure of a protein antigen. Consequently, individual synthetic peptides 
may represent fractions of a discontinuous epitope present on the native virus coat protein. 
Accordingly, it is possible for MAbs derived from an immunisation with intact virus to 
recognise more than one synthetic peptide in epitope mapping studies as occurred in the 
present study. Similar findings have been described in epitope mapping studies of β-factor 
XIIa (a component of human blood coagulation factor XII), where multiple peptides located 
throughout the protein were recognised by mouse (Gao and Esnouf, 1996). 
 
The spectrum of epitopes recognised in antiviral immune responses varies between 
individuals of the same host species, the route of infection, and the strain of virus  (de Vegvar 
and Robinson, 2004). Idiosyncrasies are evident in immune responses by individual European 
sea bass. The peptides that were recognised most strongly (20 % highest MFI) by each 
European sea bass serum are located in two large regions that span almost all of the coat 
protein. This type of immune response may be a reflection of unique characteristics of fish 
immune systems. It is known that the major immunoglobulin class (IgM) of fish that exhibits 
neutralising activity towards bacteria and viruses is similar in structure to IgM of higher 
vertebrates (Shelton and Smith, 1970). In fish of the class Actinopterygii, IgM forms a 
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tetramer instead of the pentamer structure displayed by IgM in higher vertebrates ([Pilstrøm 
1998]). These structurally diverse and flexible IgM tetramers may easily provide binding 
capabilities through cross linking not available to higher vertebrates (Kaattari et al. 1999). 
These authors suggest that the flexibility in accommodating differentially spaced epitopes 
could serve to increase the avidity of binding over a more rigid, fully-polymerised form. A 
more flexible array of Fabs would be able to accommodate more epitopes by physically 
adjusting in orientation, enabling an antibody to bind a wider range of epitopes (Kaattari et al. 
1999). The versatility of fish IgM might compensate for the lack of a diverse antibody 
response such as that found in higher vertebrates. 
When the three peptides recognised most strongly by European sea bass sera are taken 
into consideration, the majority of samples were found to be directed against four regions of 
the coat protein defined by: a) peptide 1; b) peptide 10-12; c) peptide 15-16; and d) peptide 
18-22. Mouse MAbs and rabbit polyclonal antibodies also identified two of these four regions, 
suggesting that there are similarities in antibody responses between these species. Similar 
findings have been reported for immune responses to varicella-zoster virus by Fowler et al. 
(1995), who suggested that some of the differences in immune responses by mice and humans 
may have been due to differences in the form of antigen presented to the immune systems of 
these species. In the present study, European sea bass were naturally infected with 
betanodavirus, whereas mice and rabbits received a virus/adjuvant preparation.  
All the antibody samples analysed showed reactivity to several peptides with different 
amino acid sequences. This may be due to the fact that these peptides contain a sufficient 
proportion of the amino acids that comprise the recognition site of a given antibody (van 
Regenmortel, 1999). Some of the residues in a linear epitope can be replaced by any of the 
other 19 amino acids without impairing antigenicity, and the linear fragment may in fact be 
antigenically discontinuous (Geysen et al. 1988). Thus, peptides of differing primary amino 
acid sequence may be antigenically similar. In the absence of crystallographic data on the 
peptide-antibody complex, it is not clear whether such replaceable residues actually interact 
with the antibody only through their main chain or whether they play merely an indirect role 
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by acting as a scaffold to bring the neighbouring essential residues at the required location for 
contacting the antibody (van Regenmortel, 2001).  
 
Comparation of pepscan data with respect to betanodavirus coat protein 
structure  
 
The recognition of a synthetic peptide by an antibody does not necessarily establish 
the presence of a continuous epitope in the corresponding region of the protein (van 
Regenmortel, 1992). Consequently the interpretation of epitope mapping studies such as those 
reported in this thesis is not straightforward.  
 
Rabbit antibodies, mouse MAbs and 5/9 of the fish serum analysed identified the 
region comprised by peptides 20 and 21 (coat protein amino acids 191-212, see Table 6.17). 
The identification of this region by many diverse antibodies/sera suggests that it may 
represent a significant immunogenic domain. When peptides 20 and 21 are aligned together, it 
is evident that they posses similarities in amino acid sequence. This comprises two residues 
(CR) flanked by SV residues on the N and C termini, suggesting that the amino acid sequence 
SVxCRxSV is potentially an important epitope that is recognised by the majority of the 
antibody/serum samples analysed. This hypothesis is experimentally testable, and has 
important implications for the design of immunodiagnostic reagents and vaccines to counter 
betanodavirus infections.  
The region represented by peptides 15 and 16 (amino acids 141-162) was recognised 
by three European sea bass serum samples (SB1, SB2 and SB9). When peptides 15 and 16 are 
aligned, it is possible to observe a common motif, in which, lysine-tryptophan residues, 
overlapped residues between the peptides (Figure 6.22, residues labelled in red), are flanked 
by glutamine residues at a spacing of 8 residues. Arginine residues also flank the tryptophan 
at a spacing of 6 residues  (QxxRxxxxxKWxxxxxxRxQ).  
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A similar motif is also present in peptide 21 (amino acids 201-212) recognised by 
serum samples SB1 and SB9. Arginine (R) proline (P) residues occur at the same spacing 
from a tryptophan (W) residue (Figure 6.22, residues labelled in blue). Valine  (V) and serine 
(S) residues also occur at the same positions in peptide 16 and peptide 21 (Figure 6.22, 
residues labelled in green).  
 
Peptide 15/16      LQATRGAVVAKWWESRTVRPQY 
Peptide 21                   CRWSVRLSVPSL 
 
 
Figure 6.22 – Alignment of peptides 15, 16 and 21 recognised by SB1 and SB9. In 
red can be visualised the overlapping residues of peptide 15 and 
16. In bold are the amino acids with the same spacing to KW. In 
blue are the consensus amino acids of peptide 16 and 21 and in 
green the similar residues between the two sequences.   
 
 
 
 
 
Figure 6.23 – The 3D view of the nodavirus coat 
protein showing the amino acid 
residues identified by SB1 and SB9. 
V 158  
A 147  
A 150 
Q  161  
P 160  
V 149  
R 156  
S 151  
W 152 
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When all of these peptide sequences are taken into consideration, it is possible that 
residues W, V, S, R, P and Q are involved in the recognition site of serum samples SB1 and 
SB9. This conclusion is supported by the predicted three-dimensional structure of the 
betanodavirus coat protein (Figure 6.23). Protein folding brings peptides 20 and 21 into 
proximity, and shows that peptide 16 shares residues in common with this region.  
 
Comparison of peptide 10 (amino acids 91-102) with peptides 15 and 16 suggests that 
serum sample SB2 recognises a different epitope (Figure 6.24). The overlapping residues, 
lysine and tryptophan (KW) are flanked by an  alanine residue (A) and an aromatic amino acid 
(W). An arginine (R) occurs in the fifth positions before the alanine (Figure 6.24, residues 
labelled in blue). The same motif occurs, RxxxxAxxF is also present in peptide 10.  
 
 
Peptide 15/16      LQATRGAVVAKWWES TVR
Peptide 10             RLGHAARIFQRY 
RPQY 
 
Figure 6.24 – Alignment of peptides 15, 16 and 10 recognised by SB2. In red 
can be visualised the overlapping residues of peptide 15 and 16. 
In bold the amino acids that with the same distance to KW. In 
blue the consensus amino acids of peptide 10 and peptides 15-16 
and in green the similar residues between the two sequences.   
 
 
Both peptides 16 and 10 contain glutamine (Q) and tyrosine (Y) residues near their C 
termini.  
Based on analysis of the amino acid sequences of the peptides recognised by serum 
sample SB2, it is possible that the target epitope of this serum comprises K, A, W/F, Q and Y. 
The 3D structure of this sample does not confirm the epitope content, because the folding of 
the protein does not bring together peptide 10 and peptide 15-16 region  (Figure 6.25). 
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Only serum samples SB1, SB2, and SB9 contained aromatic amino acid residues (W, 
F and Y). Relative scarcity of aromatic amino acids in B cell epitopes has also been identified 
in lysozyme (Davies and Cohen, 1996).  
 
 
Q 100 R 101 
A 147 
A 
143 
   P 160   A 97 
Peptide 
15-16 
Peptide 
10 
Figure 6.25 – The 3D view of the nodavirus coat protein 
showing the amino acid residues identified by 
SB2. 
 
 
 
The same three peptides (16, 20 and 35) were recognised most strongly (i.e. highest 
MFI values) by mouse MAbs 4C3 and 5G10. Peptide 35 was used as a negative control. If the 
MFI obtained with the control peptide 35 is considered to represent background fluorescence 
and used as a cut-off value, MAb 4C3 only binds to peptide 20 and MAb 5G10 binds to 
peptides 16 and 20. Analysis of the amino acid sequence of these peptides and 3D structure of 
the coat protein suggest that Serine (S), Valine (V), and Arginine (R) are present within the 
epitope recognised by these Mabs (Figures 6.26 and 6.27).  
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Figure 6.26 – Alignment of peptides 16 and 20 recognised by 
MAb 5G10. In blue the consensus amino acids 
of peptide 16 and 20. In bold the common 
residues between the two peptides 
 
 
 
 
Peptide 16         KWWESRTVRPQY 
Peptide 20     NTDVVNVSVLCR 
S 204 
R 202 
V 158 
S 155 
 
Figure 6.27 - The 3D view of the nodavirus coat 
protein showing the amino acid 
residues identified by MAbs 4C3 
and 5G10. 
 
 
However, the amino acid residues (S, V and R) that are predicted to be present in the 
epitopes recognised by MAbs 4C3 and 5G10 may not be the crucial residues for the binding 
of these MAbs. This is because in neutralisation and cross-reactivity assays, 4C3 and 5G10 do 
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not exhibit equivalent binding patterns which suggests that the epitopes recognised by these 
two MAbs may not be composed of the same residues. The MAbs were produced by 
immunisation of mouse with a European sea bass nodavirus strain, but 5G10 is also cross-
reacts by ELISA (Chapter 3) with Atlantic cod and halibut strains, and is capable of 
neutrali
protein 
akes the functional epitope 
much smaller than the structural epitope (van Regenmortel, 2000). 
sing the European sea bass and Atlantic cod strains.  
Epitope mapping studies of the glycoprotein of Viral Haemorrhagic Septicemia Virus 
(VHSV) glycoprotein also identified conformation constraints. In this case, peptide 
recognition only occurred with non-neutralising MAbs (Fernandéz-Alonso et al. 1998). These 
authors concluded that a glycoprotein neutralising epitope was only available when the 
was in the native form and situated on the surface of the infected cells. 
The results of the present study which suggest B-cell epitopes can be comprised of 
several regions of a polypeptide molecule are supported by X-ray crystallographic analysis of 
protein structure. The surface area of the interaction between an antibody and an antigen 
varies from 600-900 Å2, involves 14-20 amino acid residues, is discontinuous, and is formed 
from two to five separate stretches of the antigen polypeptide chain (Laver et al. 1990, Saul 
and Alzari, 1996, van Regenmortel, 2000). Calculations suggest that a smaller sub-set of 3 to 
6 of these residues contributes most of the binding energy, with the surrounding residues 
merely "indulging in complementarity" (Laver et al. 1990). The disproportionate contribution 
of such a small number of residues to the overall binding energy m
 
The fact that different peptides are recognised by MAbs is not surprising, and 
supports the idea that almost any part of the surface of a protein may be antigenic (Benjamin 
et al. 1984). The capacity for immune recognition of several sites of a pathogen is 
advantageous to the host, and facilitates effective immune responses against pathogens. This 
is particularly true for RNA viruses, which exhibit high rates of evolution and variability. 
Similar findings have been described in mouse humoral immune responses to influenza A 
virus (Hatta et al. 2000). Involvement of different amino acid residues within an epitope in 
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antibody binding has been reported in immune responses to human epithelial mucins (MCU1) 
protein core, molecules associated with secretory epithelia and with carcinoma of breast, 
ovary and other tissues (Petrakou et al. 1998).   
omparasion of pepscan data with respect to betanodavirus coat protein regions 
 
 
C  
fferent amino acid residues can be involved in the binding of antibodies to the coat 
protein.
 
In the present study mouse MAbs, rabbit polyclonal antibodies and European sea bass 
antibodies recognised different regions of the betanodavirus coat protein. Within a given 
region, di
  
 
The abundance of charged amino acids residues in the N terminal region of the 
betanodavirus coat protein, which possesses nine arginine residues and six lysine residues 
within the first 50 amino acids, could explain the recognition of this region by the majority of 
the antibodies studied. Basic/charged amino acids have been identified in antibody 
recognition sites in many proteins (Shi et al. 1984).  A similar abundance of arginine and 
lysine residues is present in the coat protein of insect nodaviruses and is believed to be 
involved in the interaction between the coat protein and viral RNA genome required for 
encapsidation (Sideris, 1997). This region of the coat protein plays an essential role in 
replication and thus represents a "logical" target for protective immune responses. In fact all 
of the MAbs studied that showed neutralising activity (Chapter 3) recognised a region 
comprising coat protein amino acid residues 29-52, that contains five arginine residues and 
one lysine residue. Studies performed with the betanodavirus dragon grouper NNV show the 
triple arginine motif at 29-31 to be critical for virus particles formation (Lu and Chan-Shing, 
2003). Similar studies in the alphanodavirus Flock House Virus (FHV) indicate that the region 
of the coat protein between amino acids 31 and 50 is critical for the assembly of the coat 
proteins into virus particles, and the deletion of this region completely blocks particle 
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formation (Schneemann et al. 1998). The amino acid residues 23-31 have been identified as a 
nucleolus localisation signal for greasy grouper NNV (Guo et al. 2003). Deletion of this 
region p
 of the N terminal region of the coat 
protein tentially represent an immunogenic domain. 
revents the accumulation of viral particles in the nucleolus of the cells.  
These results suggest that amino acid residues
po
 
The region of the coat protein containing amino acids 181-212 contains only two 
arginine residues and no lysine residues. However, this region was recognised by all of the 
antibodies analysed with the exception of SB2 and SB10. This region is rich in leucine (n = 6) 
and valine residues (n = 7). These amino acids are very hydrophobic. The region of the 
betanodavirus coat protein within residues 181-212 is the most hydrophobic portion of the 
coat protein (Figure 6.20). The high hydrophobicity suggests that this region is situated in the 
interior of the coat protein molecule, and not available on the surface for antibody binding. 
However, the involvement of hydrophobic residues in antibody binding has been 
demonstrated in, for example, VP1 of Foot and Mouth Diseases Virus (FMDV), in which one 
epitope not predicted to be surface-presented is largely dependent on two leucine residues for 
antibody binding (Geysen et al. 1984). The interaction of antibody and antigen involves 
conformational changes in both, that can range from insignificant to considerable (Davies and 
Cohen, 1996). The amino acid residues flanking an epitope may influence the three 
dimensional structure of the latter, or alter physicochemical properties such as 
hydrophillicity/hydrophobicity or van der Waals forces, bulkiness or charge, (van 
Regenmortel, 1992). An epitope of Herpes Simplex Virus type 2 (HSV-2) has been found to 
contain predominantly positively charged arginines and residues that are hydrophobic 
(Liljeqvist et al. 2002). This finding is in agreement with X-ray crystallographic analysis of 
antibody-antigen interactions that show that discontinuous epitopes are usually composed of 
highly charged amino acids flanking a central core of hydrophobic residues (Smith et al. 
1996, Kwong et al. 1998). This pattern occurs in the region comprising residues 181-212 of 
the betanodavirus coat protein, where the first leucine residue (L) is flanked by an arginine 
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residue (R). Two further arginines and an aspartic acid (D) are contained in this region, and 
the final leucine residue is flanked by another charged amino acid – glutamic acid (E). The 
prominence of hydrophobic residues in the most frequently recognised region suggests that 
the surface structure of the betanodavirus coat protein when combined with antibody differs 
from the native structure. This phenomenon has been identified in FMDV by Geysen et al. 
(1988). These results suggest that region (aa 181-212) is highly antigenic, and contains 
epitopes recognised by many serum samples studied in this thesis.  
e 
nodavir
 important areas of this protein may be an important strategy for 
surviva
 
The C terminus of the betanodavirus coat protein is predicted to be located at the outer 
surface of the virus capsid, and the region comprised by amino acids 83-216 forms the inner 
shell of the capsid (Lin et al. 2001, Tang et al. 2002). This is in marked contrast to the 
localisation of the C terminus of insect nodavirus coat proteins, which is on the inside of the 
folded molecule (Wery et al. 1994, Lin et al. 2001). A surface location of the C terminus 
would be predicted to make this region a primary target for antibody binding, yet this 
prediction is in conflict with the results of the present study. None of the antibodies studied 
recognised the C-terminal region. A lack of recognition of the C-terminal region of th
us coat protein by European sea bass sera was reported by Coeurdacier et al. (2003). 
The short C-terminal segment of the insect nodavirus coat protein is cleaved to yield 
mature infectious virus particles, and is believed to play a role in the delivery of viral RNA 
into host cells (Fisher and Johnson, 1993). Encapsidation of insect nodavirus (BBV) is 
mediated through the C terminus of the coat protein (Schneemann and Marshal, 1998). 
European sea bass nodavirus coat protein is shorter and is believed to lack a critical 
proteolytic cleavage site situated at C terminal residues Asn363-Ala364 (Delsert et al. 1997a). 
The lack of this functional site would confer less importance with respect to immune control. 
However, the essential role of the C-terminal region for virus particle formation has been 
demonstrated for dragon grouper NNV (Lu and Chan-Shing, 2003). The deflection of humoral 
immune responses to less
l and propagation. 
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Section 4 - Comparison with previous studies of betanodavirus epitopes 
) 
suggested that the first 14 amino acids of the coat protein contain neutralising determinants.  
B17 was the only antibody 
sample 
protein 
 
In this section results are discussed in relation to the two previous studies aimed at the 
identification of neutralising epitopes in the betanodavirus coat protein. The first of these 
studies was performed by Nishizawa et al. (1999), who identified an amino acid motif, PAN , 
in the coat protein as immunogenic. The second study performed by Coeurdacier et al. (2003
  
A putative major neutralising epitope, with the amino acid sequence PAN, has been 
predicted to occur at amino acid residues 254-256 of the coat protein of the betanodavirus 
SJNNV (Nishizawa et al. 1999). PAN is encoded by a fragment of the coat protein gene 
referred to as T4. The MAbs utilised by Nishizawa et al. (1999) also recognised a target 
situated in the T2 region of the coat protein gene of three other nodavirus genotypes. The 
cross-reactivity was mapped to a region of the coat protein located between amino acids 83-
216. This region is highly conserved (> 93 % sequence identity), whereas the T4 region is 
located in a variable region (sequence identity 62 %) that encodes amino acids 235-315 
(Nishizawa et al. 1995a). In the T2 region, a PAN sequence is situated between amino acid 
116-118. In the present study, European sea bass serum sample S
that recognised this region (contained within peptide 12).  
In the nodavirus coat protein peptides 12, 20 and 21 recognised by SB17 are brought 
together by the tertiary protein folding. It is known that antigenic sites are often complex 
conformations dependent on the tertiary folding of the protein chain (Geysen et al. 1987b). 
The software used, in the present study, to predict the betanodavirus 3D coat protein structure 
was unable to incorporate the amino acid residues 1 to 87 and 213 to 336 of the nodavirus 
coat protein. The lack of these residues was revealed by the incomplete appearance of the 
and the presence of a gap between residues N 191 and N 118 as shown in Figure 6.28.  
The three peptides sequences recognised by SB17 were compared and amino acids 
were located in the 3D structure. This analysis suggests that the amino acid residues involved 
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in SB 17 epitope are C, P, V and S. The analysis of the peptide sequences and 3D structure of 
the protein suggests that the amino acids involved in the SB17 epitope are not the linear 
“PAN” sequence as described by Nishizawa et al. (1999). However, both the PAN sequence 
and the putative epitope containing residues identified in the present study may represent 
components of a single immunogenic domain that is the target of neutralising immune 
response. This is of considerable relevance to the design of betanodavirus vaccines.  
 
Figure 6.28 – The 3D view of the nodavirus coat protein showing the amino acid residues identified by 
SB17. 
their location on cell surfaces (Thornton and Sibanda, 1983). Surface orientation of the coat 
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The region of the coat protein between amino acid 1 and 12 (peptide 1) has been 
postulated to represent a potential vaccine target in European sea bass by Coeurdacier et al. 
(2003). These authors evaluated the degree of protection conferred by immunisation with 
synthetic peptides mimicking the N-terminus (amino acids 1-14) and C terminus (amino acids 
325-338). The strong antigenicity of terminal segments of proteins is believed to arise from 
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protein N-terminus is not observed in insect nodaviruses, in which the N and C termini of the 
coat protein are situated within the interior of the molecule (Schneemann et al. 1998).  
In the present study, this region of the N-termini was strongly recognised by four of 
the European sea bass serum samples analysed suggesting that region comprising peptide 30-
50 is potentially immunogenic. The region comprised by peptide 1 (coat protein residues 1-
12) has been suggested to represent a putative immunogenic region in European sea bass 
(Coeurdacier et al. 2003) . The region represented by peptide 1 is rich in charged amino acids, 
containing four lysines and one arginine. It is known that the addition of a single lysine 
residue to a peptide can result in a ten-fold increase in antibody binding (Shi et al. 1984). This 
high content may have led to over production of antibody. However the recognition of this 
region by four European sea bass serum samples confirms that it is probably important in fish 
humoral immune response to betanodavirus. Future work on the development of vaccines 
against betanodavirus should consider the N-terminal as a potentially important immunogenic 
site. 
 
 
6.4.1 - Final reflection 
 
It is believed that this is the first time that SAT technology has been used for epitope 
mapping of a fish viral pathogen. At the time of writing, a single publication exists describing 
the use of synthetic peptides coupled to microspheres for epitope mapping of the gp41 protein 
of HIV-1 (Opalka et al. 2004) by SAT. 
The combination of SAT technology and synthetic peptides has proved to be a useful 
technique for epitope mapping of the betanodavirus coat protein but was compromised by 
background fluorescence as evident in the results obtained with peptide 35 and European sea 
bass serum. 
Further optimisation of the SAT protocol is possible. The use of different incubation 
periods and temperatures for each incubation step might yield better results. Optimisation of 
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the incubation steps may also permit smaller volumes of antibodies to be used in assays. The 
requirement for all washing steps could be confirmed, since their omission would simplify the 
protocol. 
It was possible to verify that all the antibodies analysed, mouse MAbs, rabbit 
polyclonal antibodies and European sea bass sera identified multiple peptides, which may 
have been linear fragments of discontinuous epitopes.  
Analysis of the three peptides with highest MFI values identified by each antibody or 
serum sample resulted in the identification of two regions of the coat protein which may 
represent important immunogenic domains. These are located at amino acid residues 1-50 and 
181-212, in agreement with previous studies performed by Nishizawa et al. (1999) and 
Coeurdacier et al. (2003). A further potentially immunogenic region was identified between 
amino acids 141-162 based on analysis of European sea bass sera. Further work is required to 
confirm the role of these regions as sites that are of importance in protective immune 
responses to betanodaviruses. The precise location of residues within these regions and their 
involvement in antibody binding should also be determined. Furthermore, the ability of 
synthetic peptides mimicking these regions to serve as vaccines could be investigated. The 
development of such a synthetic vaccine that could be synthesised inexpensively and 
reproducibly would be of great benefit to the aquaculture industry. 
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Chapter 7 - General discussion and future prospects  
 
 
The B-cell epitopes of a virus represent the regions of virus encoded proteins that are 
specifically recognised by the antigen binding sites of B-cell immunoglobulin receptors and 
antibody molecules (van Regenmortel, 1990a). 
Betanodavirus epitopes are poorly characterised. Nishizawa et al. (1999) suggested 
that a region defined by the amino acid sequence PAN within the coat protein was a putative 
epitope. This conclusion was based on a comparison of MAbs to recognise different 
betanodavirus genotypes with defined coat protein amino acid sequence. In 2003 Couerdacier 
et al. suggested that the first fourteen N-terminal amino acids of the coat protein constitute an 
immunogenic region. Fish were immunised with synthetic peptides mimicking both N and C 
terminal regions, but only the fish immunised with the N-terminal region produced an 
immune response. However, this study did not examine the full-length of the coat protein and 
other regions may be involved in the immune response.  
The aim of this thesis was to map B-cell epitopes in betanodavirus. The first step in 
the identification of these regions involved the production of betanodavirus monoclonal 
antibodies. Two fusions were required in order to obtain monoclonal antibodies directed 
against European sea bass NNV. Successful production of MAbs was crucial to the thesis as 
these were to be utilised to produce neutralisation escape mutants, in phage display and 
pepscan methodology in epitope mapping experiments. 
Selection and characterisation of neutralisation escape mutants was facilitated by the 
capacity of the MAbs produced in the project to neutralise betanodaviruses. This technique is 
applicable to the identification of discontinuous epitopes and is based on the isolation of 
neutralisation resistant viral clones through plaque purification. However, the betanodaviruses 
studied were refractory to plaque production, and consequently, a limiting dilution procedure 
established by Borrego et al. (2002) for swine vesicular disease virus was used. In this 
procedure, cDNA sequence analysis of putative neutralisation-resistant clones is performed 
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after an ELISA that is used to confirm that isolated virus variants are not recognised by the 
selecting monoclonal antibody. In the present study, all betanodaviruses obtained by limiting 
dilution were recognised by MAbs in the confirmatory ELISA, and so no sequencing analyses 
were performed, based on the assumption that escape mutant selection was not successful. It 
is possible that strict adherence to the protocol of Borrego et al. (2002) may have resulted in 
an inability to detect escape mutants. This is because virus recognised by a MAb in the 
screening ELISA may not necessarily be neutralised by the same antibody. Thus, the 
characterisation of potential escape mutants by neutralisation tests with the selecting antibody 
may increase the effectiveness of the procedure. This could be incorporated into future 
studies. Nucleotide sequencing of viruses recognised by MAbs in the confirmatory ELISA 
could also be performed. Financial and time constraints ruled out this approach in the present 
study. 
Monoclonal antibodies that bind to proteins in Western blot assays are almost always 
directed against linear epitopes (Morris, 1996a). The MAbs used in phage display and pepscan 
studies were shown to bind to the betanodavirus coat protein in Western Blots, indicating their 
suitability for use in these epitope mapping procedures as these techniques are more suitable 
for the identification of linear epitopes. However, a number of proteins that are completely 
denatured in Western blots have been found to renature during or after electroblotting (Wang 
and Yu, 2004). Thus it is potentially possible for epitopes recognised by MAbs in Western 
blots to possess conformational structure (Morris, 1996a, Wang and Yu, 2004). The majority 
of epitopes recognised by host antiviral responses are usually conformational (Hadlock et al. 
2000). This is of relevance to the present study as the results obtained by epitope mapping 
with synthetic peptides, suggests that the MAbs recognised a discontinuous epitope on the 
betanodavirus coat protein. 
This hypothesis may explain the results obtained using phage display. This technique 
depends on the affinity between randomly expressed peptides on the phage surface and the 
antigen recognition site of a MAb. Usually antibodies against discontinuous epitopes do bind 
linear and constrained phage libraries efficiently (Bonnycastle et al. 1996). When the spatial 
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presentation of random peptides does not match the original three-dimensional structure of the 
natural protein, binding affinity is lost (Rodi and Makowsi, 1999). This could explain why a 
clear consensus sequence was not obtained in phage display experiments. It is difficult to 
obtain epitope mapping data for discontinuous epitopes with phage display (Williams et al. 
2001). However in some cases antibodies that are directed against discontinuous sequences 
recognise phage displayed peptides (Balass et al. 1993, Luzzago et al. 1993, Birkenmeier et 
al. 1997). 
When analysing the data obtained from the phage display system Ph.D.-7™ and from 
pepscan analyses, it is possible to align the sequence of the phage clones with the synthetic 
peptides recognised in pepscan (Figure 7.1). This alignment strengthens confidence in the 
results obtained with the pepscan procedure, that identified three major epitope containing 
regions in the betanodavirus coat protein: amino acid residues 1-50 (peptide 1-5), 141-162 
(peptide 15-16) and 181-212 (peptide 19-21).  
As discussed in Chapter 5 in studies employing the Ph.D.™-7 library the high 
occurrence of phage clones containing double inserts may be due to the relatively short insert 
size (i.e. 7 residues). Confidence in this explanation is increased when the phage display 
results are considered together with the data from pepscan analysis (e.g. phage clones 1a and 
1b selected with MAb 4A12). Unfortunately the use of a phage library with a longer insert (12 
amino acid residues, Ph.D.-12™) did not produce conclusive results.  
Analysis of phage clones with double inserts also enables identification of some of the 
amino acid residues that may potentially be involved in the interaction between MAbs and 
betanodavirus. For MAb 3B10 the critical binding residues (CBRs) are represented by the 
sequence VxxxNTxV(T)xxRSVLxR. For MAbs 4A12 and 4C3 the identification of CBRs 
and their localisation in the betanodavirus coat protein amino acid sequence is less clear. 
However, for MAb 4A12, possible CBRs are SVLxRWxRLxSxPS and PrxxRAxxRxxS; and 
for MAb 4C3 NxSVLxR and KW(S)xSR. The identification of the negative control peptide 
35 by MAb 4C3 may be explained by the presence of the CBRs TxNxSR. This number of 
amino acid residues can be sufficient to allowing antibody binding, once it is been 
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demonstrated that a sub-set of 3 to 6 of these residues contributes to most of the binding 
energy (Laver et al. 1990).  
 
c MAb 3B10 
  
Peptide 19 GRLILLCVGN-NT 
Peptide 20             ...    .   NTDVVN--VSVLCR 
Ph 6             ...    .   .. .   MSSAEAR 
Ph 3             ...    .   .. .  NAMLQL-R 
Ph 9b               ...    .   .. .    RNVL-RCL 
Ph 10               ...    .   .. .    RLTL-RSL 
Ph 4b        ...    VSNMNT-V    . 
Peptide 5          ...      KAST-VTGFGRGT 
Ph 1b    ...     HYQSS-VT 
Ph 5a ...   ITPENST 
Peptide 5          KASTVTGFGRGT 
Ph 7               MNLGALP 
  
  
  
d MAb 4A12 
  
Peptide 20 NTDVVNVSVLCR 
                  ...CRWSVRL-SVPSL Peptide 21 
Ph 1a                LPTHLH-W  .. . .. 
Ph 1b                 ...  ..HRLHSYM  
                 ... HTSSKLV  .. Ph 2 
Ph 5                  SPLHAWW  .   .. 
Ph 6                     ...  .   L--LPSYIY 
Ph 7a         HYQSSVT  .   . 
Ph 7b             .GPKIWHI . 
Ph 8              HL-RHHHY.      
Ph 9a                    WQFHLPH 
  
Peptide 3 QPR--RRANNRRRS 
Ph 1b                   ..   .. HRLHSYM       
Ph 9b                   PRQYPRA 
  
  
  
e MAb 4C3 
  
Peptide 20 NTDVVNVSVLCR 
Ph 1          . .HL-RWHHT 
Ph 2b    HSPSVLS 
Ph 7                  ALNYT-N-S 
Peptide 35                KSVPADTRN-SRR 
Ph 9                   GHIMIN--R 
  
Peptide 16 KWWESRTVRPQY 
Ph 1                 HLRWHHT 
Ph 2b                  AKWS-SRH 
Ph 5                  NHWSLNG 
Ph 6                   HWSHARH 
Ph 10                    WPHKHFY 
  
  
  
 
Figure 7.1 - Alignment of the peptides and phage clones selected 
with c MAb 3B10, d MAb 4A12 and e MAb 4C3. 
Ph stands for phage display clone selected with Ph.D.-
7™. 
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Recommendations for future research 
 
The identification of potential epitopes within the betanodavirus coat protein is of 
significance to the development of diagnostic reagents and vaccines. 
 
 
Betanodavirus vaccines 
 
In the last four years, a number of studies on the development of betanodavirus 
vaccines have been published, including recombinant protein and DNA vaccines. Thus far the 
most encouraging results have been achieved with recombinant protein vaccines using the 
betanodavirus coat protein as the immunogen (Húsgarð et al. 2001, Tanaka et al. 2001, Yuasa 
et al. 2002). However, even the most efficient vaccine constructs were unable to achieve 
complete protection. Mortalities reached forty percent in vaccinated fish populations. This is 
inadequate for a commercial fish vaccine. Furthermore vaccines based on DNA constructs or 
recombinant proteins are problematic in relation to licensing. Public perception of these 
vaccines also may affect the marketability of vaccinated stocks.  
Against this background, there are advantages associated with the use of peptide 
based vaccines. These are chemically defined and not produced using genetic modified 
organisms, like recombinant protein or DNA vaccines. They also do not pose risks to wild fish 
associated with live-attenuated vaccines (Arnon and van Regenmortel, 1992). 
A knowledge of protective epitopes is required to develop peptide based vaccines. 
The work of Coeurdacier et al. (2003), indicates the potential use of synthetic peptides for fish 
vaccines. Recently developed techniques permit the presentation to the immune system of 
multiple peptides through the use of an engineered bacterial protein as a scaffolding construct 
(Laplagne et al. 2004). Use of this system would facilitate the development of vaccine 
constructs containing several copies of one or more betanodavirus epitopes, or copies of 
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betanodavirus epitopes combined with T-cell epitopes (if and when these are identified and 
their role in fish immune responses elucidated) which may improve immunogenicity.  
Peptide vaccines have been developed for a number of viruses including respiratory 
syncitial virus (Steward, 2001) and canine parvovirus (CPV) (Langeveld et al. 1994). A 
peptide vaccine developed against CPV demonstrated good protective efficacy. 
Whilst peptide vaccines represent one logical continuation of the work reported in this 
thesis, the putative epitopes identified through pepscan studies could also be used to inform 
the development of different types of vaccines, such as those based on the use of recombinant 
proteins, or DNA / RNA vaccines. In these instances, candidate vaccines could be trialled for 
induction of humoral immune responses. 
The results of the present study suggest three candidate regions (amino acids 1-50, 
141-162 and 181-212) for a vaccine, although the optimum region of the coat protein could be 
further defined using epitope mapping of greater resolution. A series of overlapping synthetic 
peptides could be synthesised using an overlap of a single amino acid. A peptide set of shorter 
length (i.e. n = 7) could also be used, permitting a more accurate mapping of the residues 
recognised by neutralising antibodies. Once these regions are identified then amino acid 
replacement could be used to identify the critical binding regions. Certain amino acids are 
more difficult and expensive to synthesise than others. Thus the use of peptides that do not 
contain such residues in vaccines would simplify the chemical manipulation involved in 
vaccine synthesis. Thus, these two steps would help to produce a more effective and 
inexpensive vaccine.  
An effective vaccine should be able to induce protection against several betanodavirus 
strains or ideally against the four betanodavirus genotypes (RJNNV, SJNNV, BFNNV and 
TPNNV). The importance of multi-genotype vaccines was highlighted by Thiéry et al. (2004) 
who showed that three betanodavirus genotypes could be isolated from a single country. 
European sea bass were found to be infected with betanodavirus viruses belonging to the 
RJNNV and BFNNV groups, and Solea senegalensis were infected with viruses from the 
SJNNV clade. Solea senegalensis is a novel species in aquaculture and in Portugal and Spain 
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this species is produced in polyculture systems together with European sea bass and gilthead 
sea bream.  
To produce a vaccine to protect against all or at least several strains of betanodavirus, 
it would be necessary to investigate whether antibodies from other fish species infected with 
different betanodavirus strains recognise the same regions identified in this study.  
In preliminary vaccine development studies, the regions of the coat protein identified 
as containing putative epitopes could be synthesised and used to immunise fish. The 
production of anti-peptide antibodies could be confirmed by ELISA or SAT and the protective 
efficacy of the peptides could be confirmed by challenge studies.  
Further studies are clearly needed to facilitate the development of betanodavirus 
vaccines. In this respect, a number of research themes require investigation, including the 
functions of the betanodavirus proteins, the mechanisms of virus replication and accurate 
definition of betanodavirus structure using X-ray crystallography. The mechanisms through 
which the virus infects host cells are not fully understood. It is not known whether 
betanodavirus inhibits post-transcriptional gene silencing or other methods of immune escape. 
The mechanism of virus recognition by the host immune system also requires research.  
 
 
Diagnostic tests 
 
Non-invasive sensitive diagnostic methods are essential for screening broodstock, 
ongrowing stock or fish stock prior to introduction into a fish-farm. Screening methods should 
ideally be fast and not technically complex. ELISA is a widely used method. However, 
ELISA tests for betanodavirus are compromised by antigenic variation between different 
betanodavirus strains. None of the MAbs produced during this study were able to recognise 
three genotypes groups of betanodavirus (BFNNV, RGNNV and SJNNV). Nevertheless two 
MAbs, 3B10 and 4C3, are specific to European sea bass betanodavirus, a RGNNV strain used 
to immunise the mice for their production. The remaining MAbs (4A12, 1E3 and 5G10) also 
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recognised BFNNV. This same specificity was observed by Chi et al. (2003), with MAbs 
produced against grouper betanodavirus (RGNNV). This lack of ability of the MAbs to 
recognised SJNNV strain may be associated with the phylogenetic distances observed 
between the clades. Such phylogenetic distances reflected differences in the coat protein 
amino acid sequence, and may lead to differences in the 3-dimentional structure of the 
betanodavirus coat protein that invalidate the binding of the MAbs to SJNNV. Iwamoto et al. 
(2004) identified viral RNA2 and/or encoded coat protein as being responsible for host 
specificity in SJNNV and SGNNV.  
Taking to account the restrictions on their ability to identify the multiple genotypes of 
betanodavirus mentioned above, the MAbs developed during this project could still be used 
for the detection of betanodavirus. As been demonstrated MAb 4A12 is suitable for 
confirmation of the virus in histological samples by immunohistochemistry and this MAb is 
now commercially available from Aquatic Diagnostic Ltd (University of Stirling, Stirling 
Scotland) as product number P09 (www.aquaticdiagnostics.com). However, other diagnostic 
techniques such as sandwich ELISA could be developed and optimised for the detection of 
betanodavirus. Different MAbs could be used as capture and detection antibodies. For 
validating ELISA as a betanodavirus diagnostic tool the sensitivity of the assay should be 
compared with nested-PCR or NASBA. These molecular techniques have been indicated to be 
more sensitive for the detection of betanodavirus and ideally suitable for diagnostics (Dalla 
Valle et al. 2000, Starkey et al. 2004). The use of anti-SJNNV polyclonal antibody revealed to 
be less sensitive than RT-PCR (Mushiake et al. 1994). However, in several studies it has been 
demonstrated that ELISA can be as sensitive as PCR (Mycoplasma bovis) or RT-PCR 
(hepatitis C virus) (Attallah et al. 2003, Ghadersohi et al. 2005), ans ELISA possesses the 
advantage of being a high-throughput screening technique. 
Alternatively the ELISA could be set up to detect fish antibodies against 
betanodavirus. This would have the advantage of being non-destructive, only requiring a 
serum sample. The use of multiple peptides mimicking several regions of the betanodavirus 
coat protein to coat the ELISA plate could permit generic assays to be developed, capable of 
 
238
Chapter 7 – Final discussion 
detecting fish antibodies against all the betanodaviruses. The results obtained from pepscan 
analyses in this project could be exploited to develop such an ELISA test to detect anti-
betanodavirus fish antibodies. The use of synthetic peptides has been applied in 
serodiagnostics for the detection of antibodies to parasites, such as Leishmania donovani 
(Fargeas et al. 1996) or viruses, for example SARS - coronavirus (Chan  et al. 2004). These 
ELISA tests demonstrated high sensitivity and specificity. Optimal results were achieved by 
use of a mixture of peptides to avoid epitope restrictions (Soto et al. 1998, Noya et al. 2003). 
Since synthetic peptides are used as the target antigen, assays are easy to standardise, less 
subject to the variation between batches of antigen that may occur with cell culture grown 
material, cheaper and ideal for large-scale screening. The use of synthetic peptides in 
serodiagnostic assays may also be less labour intensive, and confers several advantages since 
there is also no requirement for infectious virus. 
Synthetic peptides could also be linked to beads allowing for sensitive and rapid 
multiplex testing with high throughput. The SAT is also less labour intensive than ELISA. 
The use of beads would allowed the multiplexing of the assay and the possibility for screening 
for antibodies against other pathogens simultaneously. 
  
 
The main achievement of this work was the identification of putative epitope 
containing domains in the betanodavirus capsid. It is believed that this is the first time that 
SAT technology has been used for antigenic epitope mapping of a fish virus. The regions 
identified in this thesis may have important consequences for vaccine development programs 
aimed at the control of VNN.  
As a complement to the application in vaccine development the epitope regions 
identified may also be applied in the development of hight-throughput screening ELISA or 
SAT assays. 
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Appendix I 
DEPC treatment 
 
Concentration 
 
Add 1ml DEPC per litre of water. 
 
Glass or plastic 
 
o Fill the glass with water 
o Add DEPC, mix well and leave overnight in the fume hood 
o Following morning autoclave 
o Water in the glass can be thrown away in the normal drain 
o Glass is autoclaved 
 
 
 Water 
 
Same procedure mentioned for the glass. The flask where the water is kept needs to have been 
DEPC treated previously.  
 
 
 
 
TNE-buffer 
 
Prepare a stock solution of NaCl (1 M) and EDTA (0.1 M) in distilled water and filter sterilise 
(0.2 μm filter).  
All the procedures should be done in a sterile environment. 
 
 
o Add 50 ml of 1 M NaCl and 5 ml of 0.1 M EDTA to a 500 ml DEPC treated bottle that 
has been scored at 500 ml. 
o Add 400 ml of DEPC treated distilled water and mix well 
o Remove a small aliquot and check the pH with an indicator stick 
o Adjust the pH until ± pH 7 with NaOH or HCL. Mix well  
o Remove a small aliquot and measure in pH meter  
o Adjust pH to 7.4-7.6 using NaOH or HCl 
o Add 500 μl of DEPC and leave overnight 
o Autoclave to remove any last trace of DEPC 
o Allow the solution to cool down 
o Add 5 ml sterile, RNAse-free Tris (pH 7.5, 1M) 
o Adjust the volume until 500 ml with DEPC treated water 
o Remove a small aliquot and check the pH. 
DEPC treatment and TNE buffer  
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Hi Trap protein G HP 
 
All the solutions are made on the day of using. 
 
 
 
 
Binding buffer 
(20 mM sodium phosphate, pH 7.0) 
 
  150 ml 
Na2HPO4 (20 mM) 0.534 g 
NaH2PO4 (20 mM) 0.468 g 
 
       
 
Both solutions are mixed until pH 7.0 is reached. Filter through a sterile 0.45 μm filter. 
 
 
 
 
 
Elution buffer 
(0.1 M Glycine-HCl, pH 2.7) 
 
 
Glycine - 0.375 g in 50 ml of distilled water. 
 
Add HCl until pH 2.7 is reached. Filter through a sterile 0.45 μm filter. 
 
 
 
 
 
Tris-Hcl 
(1 M Tris, pH 9.0) 
 
 
Trizma base - 6.057 g in 50 ml of distilled water. 
 
Add HCl until pH 9.0 is obtained. Filter through a sterile 0.45 μm filter. 
Hi Trap protein G HP 
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ELISA 
 
Poly-L-lysine  
(Solution at 0.01 %) 
 
1.5 ml of solution dissolved in 13.5 ml of coating buffer. 
 
 
 
 
Coating Buffer 
(Carbonate-bicarbonate solution, pH 9.6) 
 
 1000 ml 
Na2CO3 1.59 g 
NaHCO3 2.93 g 
 
Dissolve in distilled water and adjust pH to 9.6 with HCl. 
 
OR  
 
Dissolved 1 tablet of carbonate-bicarbonate buffer (Sigma) in 100 ml of distilled water. Must 
be made fresh 
 
 
 
 
Glutaraldehyde  
(Solution at 0.05%) 
 
   Add 10 μl of glutaraldehyde to 10 ml of PBS. 
 
 
 
 
Low Salt Wash Buffer (LSWB) 
(0.02 M Tris; 0.38 M NaCl; 0.05 % Tween 20; pH 7.3) 
 
This solution is 10x concentrate.  
 
 1000 ml 500 ml 
Trisma base 24.2 g 12.1 g 
NaCl 222.2 g 111.1 g 
Tween 20 5 ml 2.5 ml 
 
 
Dissolve in distilled water and adjust pH to 7.3 with HCl.  
 
 
 
Phosphate Buffered Saline (PBS)  
(0.02 M phosphate; 0.15 M NaCl) 
 
 1000 ml 500 ml 
NaCl 8.77 g 4.385 g 
NaH2PO4. 2H2O 0.876 g 0.438 g 
Na2HPO4. 2H2O 2.56 g 1.28 
 
Dissolve in distilled water and adjust pH to 7.2 with HCl. 
 
ELISA 
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Blocking buffer 
(3 % casein) 
 
Add 3 g of skimmed milk to 100 ml of distilled water. 
 
 
 
 
Antibody Buffer 
(solution at 1 %) 
 
Add 1 g of BSA to 100 ml PBS. 
 
Must be made fresh 
 
 
 
 
Conjugate Buffer 
(solution at 1 %) 
 
Add 1g of BSA to 100 ml LSWB. 
 
Must be made fresh. 
 
 
 
 
High Salt Wash Buffer (HSWB) 
(0.02M Tris; 0.5 M NaCl; 0.1% Tween 20) 
 
This solution is 10x concentrated.  
 
 1000 ml 500 ml 
Trisma base 24.2 g 12.1 g 
NaCl 292.2 g 146.1 g 
Tween 20 10 ml 5 ml 
 
Dissolved in distilled water and adjust pH to 7.7 with HCl. 
 
 
 
 
Substrate 
 
To 15 ml of substrate buffer add 150 μl of substrate solution and 5 μl of hydrogen peroxidase. 
 
 
 
    Substrate buffer  
(0.1 M Citric acid; 0.1 M Sodium acetate) 
 
 1000 ml 500 ml 
Citric acid 21 g 10.5 g 
Sodium acetate 8.2 g 4.1 g 
 
 
Dissolved in distilled water and adjust pH to 5.4 with NaOH. 
 
 
ELISA 
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     Substrate Solution 
(42 mM TMB, 3’3’5’5’ – tetramethylbenzidine dihydrochloride) 
 
Prepare the TMB: 
 0.07896 g  to  6 ml 
0.0658   g  to  5 ml 
0.03948 g  to  3 ml 
 
 
 
Dissolved in distilled water. Add acetic acid in a proportion 1:2 (acid:water). Must be made 
fresh. 
 
 
 
 
 
Stop Reagent  
(H2SO4 2 M)  
 
For 500 ml of solution add 55.5 ml of sulphuric acid (98%) to 444.5 ml of distilled water. 
 
ELISA 
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Western Blot 
 
 
Separating Gel Buffer 
(1.5 M Tris; 0.4 % (w/v) Sodium Dodecyl Sulphate (SDS)) 
 
 1000 ml 500 ml 
Trisma base 182 g 91 g 
SDS 4 g 2 g 
 
Dissolve in distilled water and adjust pH to 8.7 with HCl. 
 
 
 
 
Stacking Gel Buffer 
(0.5M Tris; 0.4% (w/v) Sodium Dodecyl Sulphate (SDS)) 
 
 1000 ml 500 ml 
Trisma base 60.5 g 30.25 g 
SDS 4 g 2 g 
 
Dissolve in distilled water and adjust pH to 6.8 with HCl. 
 
 
 
 
Ammonium Persulphate Solution  
(10 % v/v ammonium persulphate) 
 
Dissolve 0.1 g ammonium persulphate solution in 1 ml distilled water. Must be done fresh 
every time 
 
 
 
 
Sample Buffer 
(100 mM Tris; 4% SDS; 2mM DTT; 0.02 % Bromophenol blue) 
 
This solution is 5x concentrated 
 
Tris HCl 0.5 M (pH 6.8) 2.5 ml 
Glycerol  2 ml 
SDS (10% (w/v)) 4 ml 
DTT  0.31 ml 
Bromophenol blue 2 mg 
Distilled water 0.9 ml 
 
 
 
Reservoir Buffer 
 
This solution is 5x concentrated  
 
 1000 ml 500 ml 
Tris  15 g 7.5 g 
Glycine 43.2 g 21.6 g 
SDS  5 g 2.5 g 
 
Dissolved in distilled water and adjust pH to 8.3 with HCl. 
Western blot 
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Separating Gel (12 % Acrylamide) 
 
Separating buffer 5 ml 
Acrylamide (30 %) 8 ml 
TEMED 15 μl 
Ammonium persulphate (10 %) 7 μl 
Distilled water 7 ml 
 
The TEMED should be the last reagent to be added. 
 
 
Stacking Gel  
 
Distilled water 2.7 ml 
SDS (10%) 40 μl 
Tris-HCl (1M, pH 6.8) 0.5 ml 
Acrylamide (30 %) 0.67 ml 
Ammonium persulphate  (10 %) 40 μl 
TEMED 4 μl 
 
The TEMED should be the last reagent to be added. 
 
 
Tris Buffered Buffer (TBS) 
(0.02 M Tris; 0.5% NaCl) 
 
 1000 ml 500 ml 
Trisma base 2.42 g 1.21 g 
NaCl 29.24 g 14.62 g 
 
Dissolved in distilled water and adjust pH to 7.5 with HCl. 
 
 
TBS with Tween (TTBS)  
(1.5M Tris; 0.4% (w/v) SDS) 
 
Tween 20 0.5 ml 
TBS 1000 ml 
 
Adjust pH to 7.5. 
 
 
 
Transblot Buffer 
 
 1000 ml 500 ml 
Glycine 14.4 g 7.2 g 
Trizma base 3.03 g 1.515 g 
 
Adjust pH to 8.3. 
 
 
Coomassie Brilliant Blue Staining  
 
Coomassie Brilliant Blue 2.5 g 
Methanol 400 ml 
Acetic acid 100 ml 
Distilled water 500 ml 
 
 
Western blot 
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Immunohistochemistry 
 
 
TBS 
(0.05 M Tris; 0.15 M NaCl) 
 
Tris 6.055 g 
NaCl 8.766 
 
Dissolved in 1000 ml of distilled water and adjust the pH to 7.6. 
 
 
 
 
Formic acid  
(0.1 M formic acid; 2 % gelatine; pH 6.0) 
 
Gelatine 8 g 
Formic acid 1.576 ml 
Distilled water Until 400 ml 
 
Dissolve the gelatine in the microwave and then add the formic acid. Adjust the pH to 6. 
 
 
 
 
Citrate buffer 
(0.1 M citric acid; 0.2 M Na2HPO4. 2H2O) 
 
Na2HPO4. 2H2O 3.6 g 
Citric acid 2.1 g 
Distilled water 100 ml 
 
 
 
 
DAB 
 
Dissolve 1 tablet in 6.67 ml of TBS. Aliquot into 0.5 ml and freeze. Keep in the dark until 
further use. 
 
For use: to the 0.5 ml DAB aliquot add 5 ml TBS and 0.1 ml of H2O2 (1 %) 
 
 
Immunohistochemistry 
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Molecular Biology  
 
 
Dilution buffer 
 
Mix 200 mM Tris-HCl to 5mM MgCl2 in nanopure water. Adjust the pH to 9. 
 
 
Precipitation buffer 
 
For each sample mix throughly 50 μl of ethanol 95 % (kept at – 20°C) with 2 μl of NaAc (3 
M). 
 
 
 
Acrylamide Sequencing gel 
 
Nanopure water 26 ml 
Mix beads  0.5 g 
Urea 18 g 
Long Ranger (acrylamide) 5 ml 
 
 
Mix well and allow to reach room temperature. Filter through 0.2 μm cellulose nitrate 
membrane filter and degas for 4 minutes. Just before loading the gel add: 
 
Ammonium persulphate  (10%) 250 μl 
TEMED 35 μl 
 
 
TBE 
 
This solution is 10x concentrate  
 
Nanopure water Bring up to 1000 ml 
Tris 108 g 
EDTA(Na2) 8.3 g 
Boric acid 55 g 
 
Filter through 0.45 μm filter. 
 
 
Ficoll loading buffer 
 
Ficoll (10 %) – 0.5 g ficoll in 5 ml deionised water 
Blue dextran stock solution – 0.01 g of blue dextran in 1 ml of deionised water  
     
Mix well 4.5 ml of ficoll 10 % with 0.5 ml of blue dextran stock solution. Aliquot and freeze at 
–20°C. 
 
 
 
Agarose gel  
 
Agarose 1 g 
TBE (1x) 100 ml 
 
Dissolve in the microwave. Add 50 μl ethidium bromide (1 mg l-1) when the gel temperature < 
60°C. 
Molecular biology 
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Phage display 
 
 
Microbiology  
 
LB Medium 
 
 Per liter Per 450 ml 
Bacto-Tryptone 10 g 4.5 g 
Yeast extract 5 g 2.25 g 
NaCl 5 g 2.25 g 
 
 Autoclave and store at room temperature. 
 
 
 
Agarose Top 
 Per liter Per 450 ml 
Bacto-Tryptone 10 g 4.5 g 
Yeast extract 5 g 2.25 g 
NaCl 5 g 2.25 g 
Agarose 7 g 3.15 g 
MgCl2•6H2O 1 g 0.45 g 
 
 
Autoclave, dispense into 50 ml aliquots. Store solid at room temperature, melt in microwave as 
needed. 
 
 
 
Tetracycline Stock  
 
Tetracycline  200 mg 
Ethanol 10 ml 
 
Store at –20°C in the dark. Vortex before using. 
 
 
 
LB-Tet Plates 
 
LB medium 1000 ml 450 ml 
Agar  15 g 6.75 g 
 
 
Autoclave, cool down to < 70°C and add Tetracycline stock solution (0.1 %). Pour 
and store plates at 4°C in the dark. Do not use plates if brown or black.  
 
 
 
LB/IPTG/Xgal Plates 
 
 
LB medium 1000 ml 450 ml 
Agar  15 g 6.75 g 
 
 
Autoclave, cool down to < 70°C and add IPTG/Xgal (0.1 %). Pour and store plates at 4°C in 
the dark. 
 
Phage display 
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IPTG/Xgal 
 
IPTG (isopropyl β-D-thiogalactoside) 1.25 g 0.5 g 
Xgal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) 1 g 0.4 g 
dimethyl formamide 25 ml 10 ml 
 
Solution can be stored in glass or polypropylene tube protected from light at -20°. 
 
 
 
 
Panning   
 
 
Antibody buffer 
(0.1 M NaHCO3, pH 8.6) 
 
    
NaHCO3 - 0.840 g in 100 ml of distilled water. Adjust the pH to 8.6. Autoclave and store at 
4°C. 
 
 
 
Blocking Buffer 
(0.1 M NaHCO3, pH 8.6; 0.5 % BSA; 0.02 % NaN3) 
 
NaHCO3  0.840 g 
BSA  0.5 g 
NaN3  0.02 g 
Distilled water 100 ml 
    
Filter sterilize, store at 4°C. 
 
 
 
Neutralising Elution Buffer 
(1 M Tris-HCl, pH 9.1) 
 
 
 Tris-HCl - 7.88 g in 50 ml of distilled water.  
 
 
Filter sterilize, store at 4°C. 
 
 
 
 
TBS 
(50 mM Tris-HCl, pH 7.5; 150 mM NaCl) 
 
Tris-HCl  0.394 g 0.788 g 
NaCl  0.4383 g 0.8766 g 
Distilled water 50 ml 100 ml 
   
 
 
Prepared Tri-HCl 10x concentrated and filter sterilize. Prepared the NaCl and autoclave. 
Mix both solutions, dispense into universals and store at 4°C. 
 
 
Phage display 
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Elution Buffer 
(0.2M Glycine-HCL, pH 2.2; 0.1 % BSA) 
 
 
Glycine-HCL  - 1.501 g in 100 ml of distilled water  
 
 
Adjust pH to 2.2 with HCl and then filter sterilize, store at 4°C.Previously to use add BSA (1 
mg/ml). Filter sterilize, store at 4°C until used. 
 
 
Storage Buffer 
(50 mM Tris-HCl, pH 7.5; 0.02 % Sodium azide; 150 mM NaCl) 
 
 
Tris-HCl (50 mM, pH 7.5) 0.394 g 0.788 g 
Sodium azide (0.02%) 0.01 g 0.02 g 
NaCl (150 mM) 0.4383 g 0.8766 g 
Distilled water 50 ml 100 ml 
 
 
Prepared Tris 10x concentrated, adjust pH to 7.5 with HCl. Prepared sodium azide 10x 
concentrated. Mix Tris and sodium azide solutions and filter sterilize. Prepare the NaCl and autoclave. 
Mix both solutions, dispense into universals and store at 4°C. 
 
 
PEG/NaCl 
(20 % (w/v) PEG; 2.5 M NaCl) 
 
 
PEG (polyethylene glycol 8000) 20 g 
NaCl  14.61 g 
Distilled water 100 ml 
 
Autoclave, dispense into bijoux and universals, store at room temperature. 
 
 
TBST 
(50 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.1 % or 0.5% Tween-20) 
 
Tris-HCl  3.94 g 
NaCl  4.383 g 
Tween-20 (0.1 %) 0.5 ml 
Tween-20 (0.5 %) 2.5 ml 
Distilled water 500 ml 
   
 
Prepared Tri-HCl 10x concentrated and filter sterilize. Prepared the NaCl and autoclave. 
Mix both solutions, dispense into universals and store at 4°C. 
 
 
TE buffer 
(10 mM Tris-HCl, pH 8.0; 1 mM EDTA)        
                
 
Tris-HCl 0.121 g 
EDTA 0.03722 g 
Distilled water 100 ml 
 
Filter sterilized and store at 4°C. 
Phage display 
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Iodide Buffer 
 (10 mM Tris-HCl, pH 8.0; 1 mM EDTA; 4 M NaI) 
 
 
Tris-HCl 0.0605 g 
EDTA 0.01861 g 
NaI 29.978 g 
Distilled water 50 ml 
 
 
Store at room temperature in the dark. 
 
 
 
 
Streptavidin Stock Solution 
 
 
Dissolved 1.5 mg of Streptavidin (supplied with the Phage display kit) in 1 ml of 
Na2PO4/NaCl/NaN3.  
 
Store at 4°C or –20°C (avoid repeated freezing/thawing). 
   
 
Na2PO4 (10 mM, pH 7.2)  /NaCl (100 mM)/NaN3 (0.02 %)  
                 
Na2HPO4 (10 mM)     0.0234 g 
NaH2PO4 (10 mM)    0.0267 g 
 
 
Dissolve each phosphate in 15 ml of distilled water. Mix until pH 7.2. 
Then to 10 ml of sodium phosphate add 0.5844 g of NaCI and 0.002 g of NaN3. 
Phage display 
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Reagents/ Chemicals/ Kits/ Consumables 
 
Reagents/ Chemicals 
 
o Acetic Acid, CH3COOH (100%) – BDH (1001CU) 
o Acrylamide/Bis acrylamide stock solution (30 % w/v acrylamide ratio 20:1 –Bis 
acrylamide) – Severn Biotech Lta (20-2600-05) 
o Agar bacteriologic (no. 1) – Oxoid (LP0011) 
o Agarose MP – Roche (1388938) 
o Albumin standard – Pierce (23209) 
o Ammonium persulphate, (NH4)2S2O8 – Sigma (A-3678), SDS Page  gel 
o Ammonium persulphate, (NH4)2S2O8 – amresco® USA (0486) ACS grade, sequence 
gel  
o Aquafenol – Qbiogene (AQUAPH01) 
o Blue dextran – Sigma (D-5751) 
o Boric acid electrophoresis purity reagent – Bio-Rad (161-0750)  
o BSA (Albumine Bovine, fraction V) – Sigma (A-9647) 
o Carbonate-bicarbonate buffer capsules (0.05 M carbonato-bicarbonato buffer pH 9.6) 
– Sigma (C-3041)  
o Citric Acid (monohydrate), C6H8O7.H2O – Sigma (C-1909) 
o Chlorophorm, CH4Cl3 – Sigma (C-2432) 
o Contrast Red – KPL (71-00-05) 
o DAB (3,3’ diaminobenzidine), 3, 3’ 4, 4’ tetra amino biphenyl tetrahydrochloride – 
Sigma (D-5905) 
o DEPC (diethyl pyrocarbonate), C6H10O5 – Sigma (D-5758) 
o DMSO (dimethyl sulphoxide) – HyBri-max® Sigma (D-2650) 
o DTT (DL-Dithiothreitol, Cleland’s reagent), C4H10O2S2 – Sigma (D-5545) 
o Dulbecco’s Modified Eagle’s Medium – Sigma (D-5671) 
o Dulbecco’s PBS (DPBS, CaCl2, MgCl2) – Gibco (14190-094) 
o EDTA (ethylenediaminetetraacetic acid), C10H14N2O8Na2.2H2O – Sigma (E-5134) 
o EDTA (ethylenediaminetetra acetic acid disodium salt, EDTA(Na2)), 
C10H14N2O8Na2.H2O – AnalaR® BDH (100933 T), sequence gel 
o Ethanol absolute – Fisher Scientific (E/0650DF/21) 
o FBS (fetal bovine serum) – Sigma (F-6178), hybridoma culture 
o FBS (fetal bovine serum) – Gibco (10106-169), virus culture 
o Ficoll, type 400 (approx. mol wt 400000) – Sigma (F-4375) 
o Formic acid – Sigma (F-4636) 
o Gluteraldehyde, C5H8O2 (50% solution photographic grade) – Sigma (G-6403) 
o Glycerol, C3H8O3 – Sigma (G-7757) 
o Glycine (amino acetic acid), C2H5NO2 – Sigma (G-7126)  
o HAT media supplement (50x) – HyBri-max® Sigma (H-0262)  
o HBSS (CaCl2, MgCl2) – Gibco (14170-088) 
o Heparin sodium salt grade I-A: from porcine intestinal mucosa – Sigma (H-3149) 
o HT media supplement (50x) – HyBri-max® Sigma (H-0137) 
o Hydrogen peroxide H2O2 (30% w/w) – Sigma (H-1009)  
o IPTG (isopropyl β-D-thiogalacto-pyranoside), C9H18SO5 – Sigma (I-6758)  
o L-15 (Leibovitz) with GlutaMAX™ - Gibco (31425-029) 
o L-Glutamine – HyBri-max® Sigma (G-2150)  
o Long Ranger® gel solution (acrylamide 50 % stock solution) – Cambrex Bio 
Science, USA (50611) 
o Magnesium chloride hexahydrate, MgCl2.6H2O – BDH (10149) 
o Methanol, CH3.OH – Fisher Scientific (M/3950/21) 
o Methyl green - Vector (H-3402) 
o Mixed bead resin for molecular biology – Sigma (M-8032) 
o Nuclease-free water – Promega (P 119C) 
o PEG (polyethylene glycol), Av Mol.Wt. 8000 C2H602 – Signa (p-5413) 
o Penicillin-Streptomycin solution -– HyBri-max® Sigma (P-7539)  
o Pertex - Cellpath Ltd (UN 1866) 
o Phenol (saturated Tris-HCl) – Sigma (P-4557) 
Reagents, consumables & equipment        
Appendix I 
o Poly-L-Lysine solution (0,1% w/v in water thimerosal 0,01% added as preservative) – 
Sigma (P-8920)  
o SDS (sodium dodecylsulphate), C12H25O2SNa – Sigma (3771) 
o Sodium acetate (pH 5.2 3M), NaAc – Sigma (S-7899) 
o Sodium azide, NaN3 – Sigma (S-2002) 
o Sodium bicarbonate, NaHCO3 – Sigma (S-6014) 
o Sodium acetate (anhydrous), C2H3O2Na – Sigma (S-7545) 
o Sodium choride, NaCl – Sigma (S-9625) 
o Sodium dihydrogen orthophosphate dehydrated, NaH2PO4.2H2O – BDH (301324 Q)   
o di-Sodium hydrogen orthophosphate , NaHPO4.2H2O – BDH (301517 J)   
o Sodium iodine, NaI – BDH (301724 F) 
o TBE (tris-borate-EDTA) – Sigma (T-4415) 
o TEMED (N,N,N’,N’-tetramethyl ethylenediamine), C6H16N2 – Sigma (T-9281), SDS 
Page gel 
o TEMED (N,N,N’,N’-tetramethyl ethylenediamine), C6H16N2 – Sigma (T-8133), 
sequence gel 
o TiterMax® Gold – TiterMAx USA, Inc (G-1), CytRx® Corporation  
o Tris, electrophoresis purity reagent (tris(hydroximethyl)-aminomethane) – Bio-Rad 
(161-0719), sequence gel 
o Trizma® (Tris base), C4H11NO3 – Sigma (T-1503)  
o True blue™ peroxidase substrate – KPL (71-00-64) 
o Trypsin-EDTA (1x) in HBSS w/o CA&MG w/EDTA.4NA – Gibco (25300-054) 
o Tryptone – Oxoid (LP0042) 
o TMB (3,3’,5,5’ – tetramethylbenzidine dehydrochloride) – Sigma (T-8768)  
o Tween 20 (Polyoethylene-sorbitan monolaurate) – Sigma (P-1379)  
o Urea electrophoresis purity reagent – Bio-Rad (161-0731) 
o Xgal (5-bromo-4chloro-3-indolyl-β-D-galactopyranoside), C14H15BrCINO6 – Sigma 
(B-4252) 
o Yeast extract – Oxoid (LP0021) 
 
 
Antibodies 
 
o Anti-European Sea Bass (Dicentrarchus labrax) IgM monoclonal antibody – Aquatic 
Diagnostic Ltd (F01) 
o Anti-Nodavirus IgG monoclonal antibody – Aquatic Diagnostic Ltd (P09) 
o Biotin anti-mouse IgG – Vector (BA-9200)  
o Goat Anti-mouse conjugated with HRP – Scotland Diagnostic 
o Goat Anti-rabbit conjugated with HRP – Sigma (A-6154)  
o Goat Anti-mouse IgG conjugated with PE – Molecular Probes (P-852) 
o Goat Anti-rabbit IgG conjugated with PE – Molecular Probes (P-2771)  
o Goat Sera - Scotland Diagnostic 
o Stretavidin-HRP - Vector (SA-5004) 
 
 
 
Kits 
o BCA™ protein assay reagent – Pierce (23225) 
o Bio-Plex™ Amine Coupling Kit – Bio-Rad (171-406001) 
o Bio-Plex™ Calibration Kit – Bio-Rad (171-203060) 
o Bio-Plex™ COOH Bead 24 – Bio-Rad (171-506024) 
o Bio-Plex™ COOH Bead 28 – Bio-Rad (171-506028) 
o Bio-Plex™ COOH Bead 42 – Bio-Rad (171-506042) 
o Bio-Plex™ COOH Bead 46 – Bio-Rad (171-506046) 
o Bio-Rad™ Validation kit – Bio-Rad (171-203000) 
o DYEnamic ET Terminator Cycle Sequencing Kit - Amersham Biosciences (US81050) 
o Hi Trap protein G HP – Amersham (17-0404-03) 
o Immunotype™ kit – Sigma (ISO-I) 
o Ph.D-7™ phage display peptide library kit – New England BioLabs® Inc. (E8100S) 
o Ph.D-12™ phage display peptide library kit – New England BioLabs® Inc. (E8110S) 
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o Vectorstain® ABC kit – Vector (PK-6102) 
o Vectors® VIP peroxidase substrate kit – Vector (SK-4600) 
o 4CN membrane peroxidase substrate system (2-C) – KPL (50-73-00) 
 
 
 
 
Consumables 
 
o 64 well paper shark tooth comb ABI Prism377 – PE Biosystems (A64-199904-0007) 
o Cell culture – flasks of 25 cm2, 75 cm2 and 175 cm2; 12 well plates; 24 well plates, 
Greiner and Nunc 
o Comb membrane unlaminated – The gel company (CAM64) 
o Cryotube™ - Nunc 
o Hybond™-ECL™ nitrocellulose membrane - Amersham (RPN303D) 
o Immulon® 4 HBS flat bottom microtitre 96 well plates, Thermo Labsystems (3855), 
ELISA plates 
o MultiScreen HTS™ - Millipore (MSBV1210) 
o Nescofilm – Bando Chemical Ind. Ltd, Japan 
o PAP pen - Liquid blocker Super pap pen, Agar Scientific 
o SDS plates - Hoefer™ glass plates 8x10 cm - Amersham (80-6136-81) 
o SDS loading tips – Gel loading tip round – Alpha Laboratoires Lda (LW1255R) 
o Syringe 1 ml and 5 ml - Terumo™ 
o Syringe 1 ml – Norm-Ject Turberkulin, Henke Sass Wolf GMBH, immunised animals 
o Ultra-Clear™ tubes, Beckman (344φ59, 44 x 89 mm; 344φ58, 25 x 89 mm) 
o Whatman number 1 (1001 917) 
o 0.20 μm cellulose nitrate membrane filter – Whatman (7182-004) 
o 0.20 μm syringe sterile filter - Sartorius (16532) 
o 0.45 μm filter – Whatman (7184-004) 
o 0.45 μm syringe sterile filter -  Sartorius (16555) 
o 15 ml sterile centrifuge tubes – Cellstar®, Greiner bio-one  
o 50 ml sterile centrifuge tubes – Bibby Sterilin Ltd 
 
 
 
Equipment 
 
Centrifuges  
o Beckman L80 
o Denville Scientific Inc. Micro 240A 
o Eppendorf centrifuge 5804R 
o Heraus biofuge pico 
o Sanyo Mistral 3000i 
o Sanyo MSE 2000R 
o Sanyo Micro centaur 
o Thermo IEC microlite 
o Wifug 500E 
 
Electrophoresis  
o Amersham Pharmacia Biotech, electrophoresis power supply EPS 1001, Western blot and 
SDS 
o Fisher blotting unit FEB10, Western blot 
o Hoefer Pharmacia Biotech Inc. SE250, SDS 
o Pharmacia, gel electrophoresis apparatus GNA-100, agarose gel 
o Pharmacia, electrophoresis power supply LKS CPS 200/400, agarose gel 
 
 
Molecular biology 
o ABI Prisma™ 377 DNA sequencer  
o Biometra™ Tgradient 
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Rocker platforms 
o Bibby Gyro-rocker  
o Mini Rocking platform, Biometra™ 
 
Spectrophotometer 
o Cecil CE 2041 
o Cecil CE 2021 
 
Others 
o Bioplex – Bio-Rad 
o Dynex Technologies MRXII, ELISA reader 
o Dual gel caster, Might™ Small SE245, Hoefer Pharmacia Biotech Inc., SDS 
o Econo System (Bio-Rad) – 2110 fraction collector, MAb purification 
o Fraction Recovery System 270-331580, Beckman, virus purification  
o Jung biocut 2035, microtome 
o Philips cooktronic 7910, microwave 
o Refractometer 60-70 ABBE, Bellingham + Stanley Limited, virus purification 
o Sanyo Super Showerwave, microwave 
o Techne UB-8, water bath 
o ThermoShadon citadel 2000, tissue processor 
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Chapter 6 – Epitope mapping with synthetic peptides 
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